FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Velle-Forbord, T
   Eidlaug, M
   Debik, J
   Saether, JC
   Follestad, T
   Nauman, J
   Gigante, B
   Rosjo, H
   Omland, T
   Langaas, M
   Bye, A
AF Velle-Forbord, Torbjorn
   Eidlaug, Maria
   Debik, Julia
   Saether, Julie Caroline
   Follestad, Turid
   Nauman, Javaid
   Gigante, Bruna
   Rosjo, Helge
   Omland, Torbjorn
   Langaas, Mette
   Bye, Anja
TI Circulating microRNAs as predictive biomarkers of myocardial infarction:
   Evidence from the HUNT study
SO ATHEROSCLEROSIS
LA English
DT Article
DE Cardiovascular disease; Serum; Prevention; Risk prediction
ID CARDIOVASCULAR RISK PREDICTION; C-REACTIVE PROTEIN; DISEASE; SCORE;
   FRAMINGHAM; SERUM; MARKERS; OBESITY; PROFILE; CANCER
AB Background and aims: Several risk prediction models for coronary heart disease (CHD) are available today, however, they only explain a modest proportion of the incidence. Circulating microRNAs (miRs) have recently been associated with processes in CHD development, and may therefore represent new potential risk markers. The aim of the study was to assess the incremental value of adding circulating miRs to the Framingham Risk Score (FRS).
   Methods: This is a case-control study with a 10-year observation period, with fatal and non-fatal myocardial infarction (MI) as endpoint. At baseline, ten candidate miRs were quantified by real-time polymerase chain reaction in serum samples from 195 healthy participants (60-79 years old). During the follow-up, 96 participants experienced either a fatal (n = 36) or a non-fatal MI (n = 60), whereas the controls (n = 99) remained healthy. By using best subset logistic regression, we identified the miRs that together with the FRS for hard CHD best predicted future MI. The model evaluation was performed by 10-fold cross-validation reporting area under curve (AUC) from the receiver operating characteristic curve (ROC).
   Results: The best miR-based logistic regression risk-prediction model for MI consisted of a combination of miR21-5p, miR-26a-5p, mir-29c-3p, miR-144-3p and miR-151a-5p. By adding these 5 miRs to the FRS, AUC increased from 0.66 to 0.80. In comparison, adding other important CHD risk factors (waist-hip ratio, triglycerides, glucose, creatinine) to the FRS only increased AUC from 0.66 to 0.68.
   Conclusions: Circulating levels of miRs can add value on top of traditional risk markers in predicting future MI in healthy individuals.
C1 [Velle-Forbord, Torbjorn; Eidlaug, Maria; Debik, Julia; Saether, Julie Caroline; Nauman, Javaid; Bye, Anja] Norwegian Univ Sci & Technol NTNU, Fac Med & Hlth Sci, Dept Circulat & Med Imaging, Trondheim, Norway.
   [Saether, Julie Caroline; Bye, Anja] St Olavs Hosp, Dept Cardiol, Trondheim, Norway.
   [Follestad, Turid] Norwegian Univ Sci & Technol NTNU, Fac Med & Hlth Sci, Dept Publ Hlth & Nursing, Trondheim, Norway.
   [Nauman, Javaid] United Arab Emirates Univ, Coll Med & Hlth Sci, Inst Publ Hlth, Al Ain, U Arab Emirates.
   [Gigante, Bruna] Karolinska Inst, Inst Environm Med, Unit Cardiovasc Epidemiol, Stockholm, Sweden.
   [Rosjo, Helge; Omland, Torbjorn] Akershus Univ Hosp, Div Med, Lorenskog, Norway.
   [Rosjo, Helge; Omland, Torbjorn] Univ Oslo, Div Med & Lab Sci, Oslo, Norway.
   [Langaas, Mette] Norwegian Univ Sci & Technol NTNU, Fac Informat Technol & Elect Engn, Dept Math Sci, Trondheim, Norway.
RP Bye, A (reprint author), NTNU, Dept Circulat & Med Imaging, Med Teknisk Forskningssenter, Postboks 8905, N-7491 Trondheim, Norway.
EM Anja.Bye@ntnu.no
OI Gigante, Bruna/0000-0003-4508-7990
FU K.G. Jebsen Foundation; Norwegian Health Association; Liaison Committee;
   St. Olavs hospital; Medical Faculty at NTNU; Foundation for
   Cardiovascular Research at St.Olav's Hospital; NTNU
FX The study was supported by grants from the K.G. Jebsen Foundation, the
   Norwegian Health Association, the Liaison Committee between the Central
   Norway Regional Health Authority (RHA) and the Norwegian University of
   Science and Technology. St. Olavs hospital and the Medical Faculty at
   NTNU and Foundation for Cardiovascular Research at St.Olav's Hospital
   and NTNU.
NR 68
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 1
EP 7
DI 10.1016/j.atherosclerosis.2019.07.024
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400001
PM 31437610
DA 2019-10-28
ER

PT J
AU Zhang, J
   Du, R
   Peng, K
   Wu, XY
   Hu, CY
   Li, M
   Xu, Y
   Xu, M
   Wang, SY
   Bi, YF
   Wang, WQ
   Lu, JL
   Chen, YH
AF Zhang, Jie
   Du, Rui
   Peng, Kui
   Wu, Xueyan
   Hu, Chunyan
   Li, Mian
   Xu, Yu
   Xu, Min
   Wang, Shuangyuan
   Bi, Yufang
   Wang, Weiqing
   Lu, Jieli
   Chen, Yuhong
TI Serum lipoprotein (a) is associated with increased risk of stroke in
   Chinese adults: A prospective study
SO ATHEROSCLEROSIS
LA English
DT Article
DE Prospective cohort study; Lipoprotein (a); Stroke
ID INCIDENT ISCHEMIC-STROKE; LOW-DENSITY-LIPOPROTEIN;
   CORONARY-HEART-DISEASE; HEMORRHAGIC STROKE; ATHEROSCLEROSIS RISK;
   CHOLESTEROL; APOLIPOPROTEIN(A); MORTALITY; SUBTYPES; GENETICS
AB Background and aims: Epidemiological evidence on the association between elevated lipoprotein (a) (Lp (a)) with risk of stroke remains inconsistent. We aimed to investigate the association between serum Lp (a) level and the risk of stroke among middle-aged and elderly Chinese.
   Methods: A community-based prospective cohort study of 8500 participants aged 40 years or older was conducted in Jiading district, Shanghai, China, in 2010. The incident strokes were documented at follow-up visit during 2014-2015.
   Results: During a mean follow-up of 5.1 years, 444 incident cases of stroke occurred. The incidences of stroke were 4.44%, 5.14% and 6.14% from the lowest to the highest serum Lp (a) tertile, respectively. A significant association between serum Lp (a) tertile and the risk of incident stroke was observed (p for trend < 0.05). Compared with individuals in the lowest tertile of serum Lp (a), the multivariable adjusted hazards ratio (HR) and 95% confidence interval (CI) for incident stroke in Lp (a) tertile 3 were 1.34 (1.06-1.70).
   Conclusions: Serum Lp (a) concentration was associated with increased risk of incident stroke in Chinese adults.
C1 [Zhang, Jie; Chen, Yuhong] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp North, Dept Endocrine & Metab Dis, 999 Xi Wang Rd, Shanghai 201801, Peoples R China.
   [Zhang, Jie; Du, Rui; Peng, Kui; Wu, Xueyan; Hu, Chunyan; Li, Mian; Xu, Yu; Xu, Min; Wang, Shuangyuan; Bi, Yufang; Wang, Weiqing; Lu, Jieli; Chen, Yuhong] Shanghai Jiao Tong Univ, Shanghai Inst Endocrine & Metab Dis, Natl Clin Res Ctr Metab Dis, Dept Endocrine & Metab Dis,Rui Jin Hosp,Sch Med, 197 Rui Jin 2nd Rd, Shanghai 200025, Peoples R China.
RP Chen, YH (reprint author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp North, Dept Endocrine & Metab Dis, 999 Xi Wang Rd, Shanghai 201801, Peoples R China.; Lu, JL (reprint author), Shanghai Jiao Tong Univ, Shanghai Inst Endocrine & Metab Dis, Natl Clin Res Ctr Metab Dis, Dept Endocrine & Metab Dis,Rui Jin Hosp,Sch Med, 197 Rui Jin 2nd Rd, Shanghai 200025, Peoples R China.
EM jielilu@hotmail.com; chenyh70@126.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81870604, 81700764, 81670795]; Ministry of Science
   and Technology of the People's Republic of ChinaMinistry of Science and
   Technology, China [2016YFC1305600, 2016YFC1305202, 2016YFC1304904];
   Shanghai Shen Kang Hospital Development Center [16CR4020A]
FX This study was supported by National Natural Science Foundation of
   China, Grant/Award Numbers: 81870604, 81700764 and 81670795; Ministry of
   Science and Technology of the People's Republic of China, Grand/Award
   Numbers: 2016YFC1305600, 2016YFC1305202 and 2016YFC1304904. Yuhong Chen
   was supported by the Shanghai Shen Kang Hospital Development Center for
   improving the control of type 2 diabetes in the suburbs of Shanghai
   (16CR4020A).
NR 50
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 8
EP 13
DI 10.1016/j.atherosclerosis.2019.07.025
PG 6
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400002
PM 31437611
DA 2019-10-28
ER

PT J
AU Suehiro, C
   Suzuki, J
   Hamaguchi, M
   Takahashi, K
   Nagao, T
   Sakaue, T
   Uetani, T
   Aono, J
   Ikeda, S
   Okura, T
   Okamura, H
   Yamaguchi, O
AF Suehiro, Chika
   Suzuki, Jun
   Hamaguchi, Mika
   Takahashi, Kayo
   Nagao, Tomoaki
   Sakaue, Tomoki
   Uetani, Teruyoshi
   Aono, Jun
   Ikeda, Shuntaro
   Okura, Takafumi
   Okamura, Haruki
   Yamaguchi, Osamu
TI Deletion of interleukin-18 attenuates abdominal aortic aneurysm
   formation
SO ATHEROSCLEROSIS
LA English
DT Article
DE Abdominal aortic aneurysm; Interleukin-18; Macrophage; Osteopontin;
   Matrix metalloproteinase
ID IFN-GAMMA; T-CELLS; ATHEROSCLEROSIS; OSTEOPONTIN; IL-18; INFLAMMATION;
   EXPRESSION; PATHOGENESIS; MACROPHAGES; MECHANISMS
AB Background and aims: Abdominal aortic aneurysm (AAA) is a common disease; however, its exact pathogenesis remains unknown, and no specific medical therapies are available. Interleukin (IL)-18 plays a crucial role in atherosclerotic plaque destabilization and is a strong predictor of cardiovascular death. Here, we investigated the role of IL-18 in AAA pathogenesis using an experimental mouse model.
   Methods and results: After infusion of angiotensin II (Ang II) for 4 weeks and beta-aminopropionitrile (BAPN) for 2 weeks, 58% of C57/6J wild-type (WT) mice developed AAA associated with enhanced expression of IL-18; however, disease incidence was significantly lower in IL-18(-/-) mice than in WT mice (p < 0.01), although no significant difference was found in systolic blood pressure between WT mice and IL-18(-/-) mice in this model. Additionally, IL-18 deletion significantly attenuated Ang II/BAPN-induced macrophage infiltration, macrophage polarization into inflammatory M1 phenotype, and matrix metalloproteinase (MMP) activation in abdominal aortas, which is associated with reduced expression of osteopontin (OPN).
   Conclusions: These findings indicate that IL-18 plays an important role in the development of AAA by enhancing OPN expression, macrophage recruitment, and MMP activation. Moreover, IL-18 represents a previously unrecognized therapeutic target for the prevention of AAA formation.
C1 [Suehiro, Chika; Suzuki, Jun; Hamaguchi, Mika; Takahashi, Kayo; Nagao, Tomoaki; Uetani, Teruyoshi; Aono, Jun; Ikeda, Shuntaro; Yamaguchi, Osamu] Ehime Univ, Grad Sch Med, Dept Cardiol Pulmonol Hypertens & Nephrol, Toon, Ehime 7910295, Japan.
   [Sakaue, Tomoki; Okura, Takafumi] Ehime Univ, Grad Sch Med, Dept Community & Emergency Med, Toon, Ehime 7910295, Japan.
   [Okamura, Haruki] Hyogo Coll Med, Lab Tumor Immunol & Cell Therapy, Nishinomiya, Hyogo 6638501, Japan.
RP Suzuki, J (reprint author), Ehime Univ, Grad Sch Med, Dept Cardiol Pulmonol Hypertens & Nephrol, Toon, Ehime 7910295, Japan.
EM junbell@m.ehime-u.ac.jp
OI Suehiro, Chika/0000-0003-2194-2964
NR 47
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 14
EP 20
DI 10.1016/j.atherosclerosis.2019.08.003
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400003
PM 31445353
DA 2019-10-28
ER

PT J
AU Hoyer, C
   Hogh, AL
   Sandermann, J
   Zacho, HD
   Petersen, LJ
AF Hoyer, Christian
   Hogh, Annette L.
   Sandermann, Jes
   Zacho, Helle D.
   Petersen, Lars J.
TI Risk factors and haemodynamic variables in patients with low
   toe-brachial index but normal ankle-brachial index
SO ATHEROSCLEROSIS
LA English
DT Article
DE Peripheral arterial disease; Toe brachial index; Clinical laboratory
   techniques; Diagnostic test
ID PERIPHERAL ARTERIAL-DISEASE; AMPUTATION-FREE SURVIVAL;
   DIAGNOSTIC-ACCURACY; BLOOD-PRESSURE; MORTALITY; CALCIFICATION;
   PREVALENCE; PREDICTOR; SOCIETY; PAD
AB Background and aims: Classically, peripheral arterial disease (PAD) is diagnosed by a low ankle-brachial index (ABI), but the diagnosis can also be made based on toe-brachial index (TBI) measurements. The objective of this study was to characterize patients with low TBI but normal ABI, and chart potential underestimation of PAD prevalence by solitary use of ABI.
   Methods: A total of 3739 consecutive patients with known or suspected PAD referred for ABI and TBI measurements in a four-year period were compared to an age- and gender matched control group (n = 17,340).
   Results: In the patient cohort, 65.0% had low ABI, 20.5% had low TBI but normal ABI, and 14.5% had normal indices. When comparing the frequencies of comorbidities related to atherosclerotic disease (myocardial infarction, congestive heart failure, cerebrovascular disease, diabetes mellitus, chronic kidney failure), there were no significant differences among patients with low ABI or low TBI with normal ABI in any of the variables (all p > 0.06). Of the patients with low TBI and normal ABI, 18.7% were diagnosed with diabetes mellitus type I or II, and 8.2% with chronic kidney disease.
   Conclusions: Patients with low TBI but normal ABI represented 20.5% of patients referred with the suspicion of PAD. Furthermore, patients with low TBI but normal ABI presented similar comorbid characteristics to patients with low ABI, who have a well-described increased risk of cardiovascular morbidity and mortality. The solitary use of ABI underestimated the prevalence of PAD in the population, and PAD screening could potentially be improved by routine application of TBI.
C1 [Hoyer, Christian] Viborg Reg Hosp, Dept Clin Physiol, Heibergs Alle 4, DK-8800 Viborg, Denmark.
   [Hogh, Annette L.; Sandermann, Jes] Viborg Reg Hosp, Dept Vasc Surg, DK-8800 Viborg, Denmark.
   [Zacho, Helle D.; Petersen, Lars J.] Aalborg Univ Hosp, Dept Nucl Med, DK-9100 Aalborg, Denmark.
RP Hoyer, C (reprint author), Viborg Reg Hosp, Dept Clin Physiol, Heibergs Alle 4, DK-8800 Viborg, Denmark.
EM christian.hoeyer@midt.rm.dk
FU Morten Scheibel Foundation; Aase and Ejner Danielsen Foundation
FX This study was financially supported by The Morten Scheibel Foundation,
   and The Aase and Ejner Danielsen Foundation.
NR 26
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 21
EP 26
DI 10.1016/j.atherosclerosis.2019.08.005
PG 6
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400004
PM 31446210
DA 2019-10-28
ER

PT J
AU Cortes, YI
   Catov, JM
   Brooks, M
   El Khoudary, SR
   Thurston, RC
   Matthews, KA
   Isasi, CR
   Jackson, EA
   Barinas-Mitchell, E
AF Cortes, Yamnia I.
   Catov, Janet M.
   Brooks, Maria
   El Khoudary, Samar R.
   Thurston, Rebecca C.
   Matthews, Karen A.
   Isasi, Carmen R.
   Jackson, Elizabeth A.
   Barinas-Mitchell, Emma
TI Pregnancy-related events associated with subclinical cardiovascular
   disease burden in late midlife: SWAN
SO ATHEROSCLEROSIS
LA English
DT Article
DE Cardiovascular disease; Midlife; Reproductive history; Subclinical
   atherosclerosis; Women's health
ID INTIMA-MEDIA THICKNESS; PULSE-WAVE VELOCITY; REPRODUCTIVE RISK-FACTORS;
   CORONARY-HEART-DISEASE; CAROTID-ARTERY; INSULIN CONCENTRATIONS; WALL
   THICKNESS; WOMENS HEALTH; ATHEROSCLEROSIS; COMPLICATIONS
AB Background and aims: Reproductive factors are associated with later life CVD in women (e.g., age at first birth, preeclampsia, gestational diabetes), but studies have focused largely on premenopausal women. We examined the relationship of reproductive factors with subclinical CVD burden in late midlife women.
   Methods: We included 964 parous women from the Study of Women's Health Across the Nation (SWAN), who completed a reproductive history questionnaire at the 13th SWAN visit (2011-2012), and a carotid ultrasound and brachial-ankle pulse wave velocity (baPWV) assessment. The primary outcomes were carotid intima-media thickness, plaque, and baPWV; our secondary outcome was a composite subclinical CVD index created using these measures. Linear and logistic regression was performed to examine associations with individual subclinical CVD measures, and multinomial logistic regression was used in analyses of the composite index. Models adjusted for socio-demographics and cardiovascular risk factors.
   Results: Mean age at subclinical CVD assessment was 60.2 years (SD +/- 2.7). History of gestational hypertension/preeclampsia was associated with greater carotid IMT (beta: 0.038, p = 0.004). Earlier age at first birth was associated with subclinical CVD, but not when accounting for CVD risk factors. History of gestational diabetes was associated with greater baPWV, but not related to our composite index.
   Conclusions: Pregnancy history is an important marker of subclinical CVD in late midlife and may impact the vasculature through distinct pathways. Future studies are necessary to evaluate racial/ethnic differences in the observed associations and to assess the benefit of a composite subclinical CVD index for earlier CVD risk modification in midlife women.
C1 [Cortes, Yamnia I.] Univ N Carolina, Sch Nursing, Campus Box 7460, Chapel Hill, NC 27599 USA.
   [Catov, Janet M.] Univ Pittsburgh, Sch Med, Dept Obstet, Pittsburgh, PA USA.
   [Catov, Janet M.] Univ Pittsburgh, Sch Med, Dept Gynecol, Pittsburgh, PA USA.
   [Catov, Janet M.] Univ Pittsburgh, Sch Med, Dept Reprod Sci & Epidemiol, Pittsburgh, PA USA.
   [Catov, Janet M.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA.
   [Catov, Janet M.] Dept Magee Womens Res Inst, Pittsburgh, PA USA.
   [Brooks, Maria; El Khoudary, Samar R.; Thurston, Rebecca C.; Matthews, Karen A.; Barinas-Mitchell, Emma] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA.
   [Thurston, Rebecca C.; Matthews, Karen A.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA.
   [Isasi, Carmen R.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA.
   [Jackson, Elizabeth A.] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA.
RP Cortes, YI (reprint author), Univ N Carolina, Sch Nursing, Campus Box 7460, Chapel Hill, NC 27599 USA.
EM yicortes@email.unc.edu
OI Barinas-Mitchell, Emma/0000-0002-7280-7781
FU National Institutes of Health (NIH), DHHS, through the National
   Institute on Aging (NIA)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   on Aging (NIA); National Institute of Nursing Research (NINR)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Nursing Research (NINR); NIH
   Office of Research on Women's Health (ORWH)United States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Office of Research on Women's Health (ORWH) [U01NR004061, U01AG012505,
   U01AG012535, U01AG012531, U01AG012539, U01AG012546, U01AG012553,
   U01AG012554, U01AG012495]; Cardiovascular Epidemiology Training Program
   at the University of Pittsburgh Graduate School of Public Health [T32
   HL083825]
FX The Study of Women's Health Across the Nation (SWAN) has grant support
   from the National Institutes of Health (NIH), DHHS, through the National
   Institute on Aging (NIA), the National Institute of Nursing Research
   (NINR) and the NIH Office of Research on Women's Health (ORWH) (Grants
   U01NR004061; U01AG012505, U01AG012535, U01AG012531, U01AG012539,
   U01AG012546, U01AG012553, U01AG012554, U01AG012495). The content of this
   manuscript is solely the responsibility of the authors and does not
   necessarily represent the official views of the NIA, NINR, ORWH or the
   NIH.; At the time of this analysis, Yamnia I. Cortes was supported as a
   Postdoctoral Fellow in the Cardiovascular Epidemiology Training Program
   (T32 HL083825, PI: Orchard) at the University of Pittsburgh Graduate
   School of Public Health.
NR 63
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 27
EP 35
DI 10.1016/j.atherosclerosis.2019.07.012
PG 9
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400005
PM 31446211
DA 2019-10-28
ER

PT J
AU He, XW
   Shi, YH
   Liu, YS
   Li, GF
   Zhao, R
   Hu, Y
   Lin, CC
   Zhuang, MT
   Su, JJ
   Liu, JR
AF He, Xin-Wei
   Shi, Yan-Hui
   Liu, Yi-Sheng
   Li, Ge-Fei
   Zhao, Rong
   Hu, Yue
   Lin, Chang-Chun
   Zhuang, Mei-Ting
   Su, Jing-Jing
   Liu, Jian-Ren
TI Increased plasma levels of miR-124-3p, miR-125b-5p and miR-192-5p are
   associated with outcomes in acute ischaemic stroke patients receiving
   thrombolysis
SO ATHEROSCLEROSIS
LA English
DT Article
DE Biomarkers; microRNAs; Ischaemic stroke; Thrombolysis
ID TISSUE-PLASMINOGEN ACTIVATOR; POTENTIAL BIOMARKERS; MICRORNA; BRAIN;
   CLASSIFICATION; INFLAMMATION; MANAGEMENT; ETIOLOGY; THERAPY; INJURY
AB Background and aims: Circulating microRNAs (miRNAs) have recently emerged as promising biomarkers for acute ischaemic stroke (AIS). However, the expression profiles of miRNAs in AIS patients receiving intravenous thrombolysis, and their associations with outcome have not been investigated.
   Methods: In a prospective cohort study, a total of 84 AIS patients, who received intravenous thrombolysis (21.4% received combined reperfusion therapy) and completed 3 month follow-up visits, were included. Favourable and unfavourable outcomes were defined as modified Rankin Scale (mRS) scores of 0-1 and 2-6, respectively. Plasma samples were collected at 24 h after thrombolysis. We used RNA sequencing to study miRNA profiles in 5 patients with unfavourable outcomes and 5 matched patients with favourable outcomes. Differentially expressed miRNAs were further validated in all cohorts using quantitative real-time polymerase chain reaction assays.
   Results: After identification and validation, we found that miR-124-3p, miR-125b-5p and miR-192-5p levels were higher in patients with unfavourable outcomes than in patients with favourable outcomes. Logistic regressions and receiver-operating characteristic curve analyses demonstrated that these altered miRNAs may function as predictive biomarkers for outcome in AIS patients receiving thrombolysis, whether combined with endovascular thrombectomy or not. In addition, miR-124-3p and miR-125b-5p were closely associated with stroke severity.
   Conclusions: A set of circulating microRNAs (miR-124-3p, miR-125b-5p and miR-192-5p) are associated with unfavourable 3 month outcomes and might have clinical utility in AIS patients receiving thrombolysis.
C1 [He, Xin-Wei; Shi, Yan-Hui; Liu, Yi-Sheng; Li, Ge-Fei; Zhao, Rong; Hu, Yue; Lin, Chang-Chun; Zhuang, Mei-Ting; Su, Jing-Jing; Liu, Jian-Ren] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Neurol, Shanghai 200011, Peoples R China.
   [He, Xin-Wei; Shi, Yan-Hui; Liu, Yi-Sheng; Li, Ge-Fei; Zhao, Rong; Hu, Yue; Lin, Chang-Chun; Zhuang, Mei-Ting; Su, Jing-Jing; Liu, Jian-Ren] Shanghai Jiao Tong Univ, Sch Med, Clin Res Ctr, Shanghai 200011, Peoples R China.
RP Zhao, R; Su, JJ; Liu, JR (reprint author), 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.
EM 118092@sh9hospital.org; 112035@sh9hospital.org; liujr021@sjtu.edu.cn
FU Biomedicine Key Programme of the Shanghai Municipal Science and
   Technology Commission [16411953100]; National Natural Science Foundation
   of ChinaNational Natural Science Foundation of China [81271302];
   Shanghai Municipal Science and Technology CommissionScience & Technology
   Commission of Shanghai Municipality (STCSM) [18dz2313603, 14JC1404300];
   "Prevention and Control of Chronic Diseases Project" of the Shanghai
   Hospital Development Center [SHDC12015310]; project of Shanghai
   Municipal Education Commission-Gaofeng Clinical Medicine Grant Support
   [20161422]; Clinical Research Project of Shanghai Jiao Tong University
   School of Medicine [DLY201614]
FX This work was supported by the Biomedicine Key Programme of the Shanghai
   Municipal Science and Technology Commission [16411953100], the National
   Natural Science Foundation of China [81271302], a science popularization
   project and research innovation project of the Shanghai Municipal
   Science and Technology Commission [18dz2313603 and 14JC1404300], the
   "Prevention and Control of Chronic Diseases Project" of the Shanghai
   Hospital Development Center [SHDC12015310], a project of Shanghai
   Municipal Education Commission-Gaofeng Clinical Medicine Grant Support
   [20161422], and the Clinical Research Project of Shanghai Jiao Tong
   University School of Medicine [DLY201614].
NR 43
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 36
EP 43
DI 10.1016/j.atherosclerosis.2019.08.002
PG 8
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400006
PM 31450012
OA Other Gold
DA 2019-10-28
ER

PT J
AU Playford, MP
   Dey, AK
   Zierold, C
   Joshi, AA
   Blocki, F
   Bonelli, F
   Rodante, JA
   Harrington, CL
   Rivers, JP
   Elnabawi, YA
   Chen, MY
   Ahlman, MA
   Teague, HL
   Mehta, NN
AF Playford, Martin P.
   Dey, Amit K.
   Zierold, Claudia
   Joshi, Aditya A.
   Blocki, Frank
   Bonelli, Fabrizio
   Rodante, Justin A.
   Harrington, Charlotte L.
   Rivers, Joshua P.
   Elnabawi, Youssef A.
   Chen, Marcus Y.
   Ahlman, Mark A.
   Teague, Heather L.
   Mehta, Nehal N.
TI Serum active 1,25(OH)(2)D, but not inactive 25(OH)D vitamin D levels are
   associated with cardiometabolic and cardiovascular disease risk in
   psoriasis
SO ATHEROSCLEROSIS
LA English
DT Article
DE Vitamin D; Psoriasis; Coronary artery disease; Inflammation; Imaging
ID AORTIC VASCULAR INFLAMMATION; 25-HYDROXYVITAMIN D; CHOLESTEROL EFFLUX;
   ACTIVATION; EXPRESSION; SEVERITY; ATHEROSCLEROSIS
AB Background and aims: Vitamin D exists as an inactive 25-hydroxyvitamin D (25(OH)D) in the bloodstream, which is converted to active 1,25-dihydroxyvitaminD (1,25(OH)(2)D) in target tissues. Cohort studies reporting cardiovascular disease among individuals with low vitamin D are inconsistent and solely measure 25(OH)D. Psoriasis, a chronic inflammatory disease, is a vitamin D deficient state and is associated with increased cardiovascular disease risk. While serum 25(OH)D is routinely measured, we hypothesized that measurement of 1,25(OH)2D in psoriasis may perform better than 25(OH)D in capturing cardiovascular risk.
   Methods: Consecutive psoriasis patients (N = 122) at baseline underwent FDG PET/CT and CCTA scans to measure visceral adipose volume, aortic vascular uptake of FDG, and coronary plaque burden respectively. Blood levels of both 1,25(OH)(2)D and 25(OH)D were measured by chemiluminescence (LIAISON XL DIaSorin, Stillwater, MN).
   Results: The psoriasis cohort was middle-aged (mean +/- SD: 49.6 +/- 13.0), predominantly male (n = 71, 58%), in majority Caucasians (n = 98, 80%), and had moderate-to-severe skin disease [psoriasis area severity index score, PASI score, med. (IQR): 5.5 (3.2-10.7)], with almost one-fourth of the cohort on biologic psoriasis therapy for skin disease management (n = 32, 27%) at baseline. Interestingly, serum levels of 1,25(OH)(2)D but not 25(OH)D were found to be inversely associated with visceral adipose, a marker of cardiometabolic risk in fully adjusted models (beta = -0.43, p = 0.026 and beta = -0.26 p = 0.13). Similarly, we found an inverse relationship between 1,25(OH)(2)D, but not 25(OH)D, and aortic vascular uptake of FDG independent of traditional risk factors (beta = -0.19, p = 0.01). Finally, we found that serum 1,25(OH)(2)D, but not 25(OH)D, was inversely associated with non-calcified coronary plaque burden, as measured by CCTA independent of traditional risk factors (beta = -0.18, p = 0.03).
   Conclusions: In conclusion, we demonstrate that low 1,25(OH)(2)D levels were associated with visceral adipose volume, vascular uptake of FDG and coronary plaque burden independent of traditional risk factors, suggesting that 1,25(OH)(2)D may better capture the cardiometabolic risk associated with vitamin D deficient states.
C1 [Playford, Martin P.; Dey, Amit K.; Joshi, Aditya A.; Rodante, Justin A.; Harrington, Charlotte L.; Rivers, Joshua P.; Elnabawi, Youssef A.; Chen, Marcus Y.; Ahlman, Mark A.; Teague, Heather L.; Mehta, Nehal N.] NHLBI, Sect Inflammat & Cardiometab Dis, NIH, Bldg 10, Bethesda, MD 20892 USA.
   [Zierold, Claudia; Blocki, Frank; Bonelli, Fabrizio] DIaSorin Inc, 1951 Northwestern Ave, Stillwater, MN USA.
RP Mehta, NN (reprint author), NHLBI, Sect Inflammat & Cardiometab Dis, Clin Res Ctr, 10 Ctr Dr,Room 5-5140, Bethesda, MD 20892 USA.
EM nehal.mehta@nih.gov
OI Joshi, Aditya/0000-0003-4842-8666
FU National Heart, Lung and Blood Institute (NHLBI) Intramural Research
   Program [HL006193- 05]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA; Doris Duke Charitable
   Foundation (DDCF)Doris Duke Charitable Foundation (DDCF) [2014194];
   American Association for Dental Research; Colgate-Palmolive Company;
   GenentechRoche HoldingGenentech; Elsevier
FX This study was supported by the National Heart, Lung and Blood Institute
   (NHLBI) Intramural Research Program (HL006193- 05). This research was
   also made possible through the NIH Medical Research Scholars Program, a
   public-private partnership supported jointly by the NIH and generous
   contributions to the Foundation for the NIH from the Doris Duke
   Charitable Foundation (DDCF Grant #2014194), the American Association
   for Dental Research, the Colgate-Palmolive Company, Genentech, Elsevier,
   and other private donors.
NR 43
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 44
EP 50
DI 10.1016/j.atherosclerosis.2019.08.006
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400007
PM 31450013
DA 2019-10-28
ER

PT J
AU Imran, TF
   Orkaby, A
   Chen, JY
   Selvaraj, S
   Driver, JA
   Gaziano, JM
   Djousse, L
AF Imran, Tasnim F.
   Orkaby, Ariela
   Chen, Jiaying
   Selvaraj, Senthil
   Driver, Jane A.
   Gaziano, J. Michael
   Djousse, Luc
TI Walking pace is inversely associated with risk of death and
   cardiovascular disease: The Physicians' Health Study
SO ATHEROSCLEROSIS
LA English
DT Article
DE Walking pace; Gait speed; Cardiovascular disease; Mortality;
   Epidemiology
ID CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; GAIT SPEED; OLDER-PEOPLE;
   FRAILTY; WOMEN; PERFORMANCE; PREVENTION; VALIDITY; EVENTS
AB Background: Walking pace is increasingly being used to assess functional status in ambulatory settings.
   Methods: We conducted a prospective analysis within the Physicians' Health Study to examine whether walking pace is associated with mortality and incident cardiovascular disease (fatal or nonfatal myocardial infarction, coronary artery bypass grafting and percutaneous transluminal coronary angioplasty). Participants included 21,919 male physicians with a mean age of 67.8 +/- 9.0 years.
   Results: After a median follow-up of 9.4 years (IQR: 7.9-10.3), 3906 deaths and 2487 incident CVD events occurred. In a multivariable Cox proportional hazards model adjusting for age, body mass index, smoking, exercise frequency, and prevalent hypertension, diabetes mellitus, heart failure, peripheral vascular disease, cancer, and total weekly walking time, hazard ratios for mortality were 0.72 (95% CI: 0.64-0.81) for walking pace of 2-2.9mph, 0.63 (95% CI: 0.55-0.73) for walking pace of 3-3.9mph and 0.63 (95% CI: 0.48-0.83) for walking pace of >= 4mph compared to the group that reported not walking regularly (p trend < 0.0001). Similar findings were observed for incident CVD: HRs were 0.88 (95% CI: 0.75-1.03) for a walking pace of 2-2.9mph, 0.75 (95% CI: 0.63-0.89) for a walking pace of 3-3.9mph and 0.70 (0.53-0.94) for a walking pace of >= 4mph compared to the group that reported not walking regularly (p trend 0.0001). These associations persisted after excluding those who exercised regularly.
   Conclusion: We found that walking pace is inversely associated with risk of mortality and CVD among US male physicians.
C1 [Imran, Tasnim F.] Boston Univ, Sch Med, Boston Med Ctr, 72 E Concord St, Boston, MA 02118 USA.
   [Imran, Tasnim F.; Orkaby, Ariela; Chen, Jiaying; Selvaraj, Senthil; Driver, Jane A.; Gaziano, J. Michael; Djousse, Luc] Boston Vet Affairs Healthcare Syst, 150 S Huntington Ave, Boston, MA 02130 USA.
   [Imran, Tasnim F.; Orkaby, Ariela; Chen, Jiaying; Selvaraj, Senthil; Driver, Jane A.; Gaziano, J. Michael; Djousse, Luc] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Aging, 1620 Tremont St, Boston, MA 02120 USA.
RP Imran, TF (reprint author), Boston Univ, Sch Med, Boston Med Ctr, 1 Boston Med Ctr Pl, Boston, MA 02118 USA.
EM tasnim.imran@bmc.org
FU National Cancer InstituteUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [CA-34944, CA-40360, CA-097193]; National Heart, Lung,
   and Blood InstituteUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung
   & Blood Institute (NHLBI) [HL-26490, HL-34595]
FX The Physicians' Health Study is supported by grants no. CA-34944 and
   CA-40360 and CA-097193 from the National Cancer Institute and grants no.
   HL-26490 and HL-34595 from the National Heart, Lung, and Blood
   Institute.
NR 25
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 51
EP 56
DI 10.1016/j.atherosclerosis.2019.08.001
PG 6
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400008
PM 31450014
DA 2019-10-28
ER

PT J
AU Piaserico, S
   Osto, E
   Famoso, G
   Montisci, R
   De Michieli, L
   Zanetti, I
   Iliceto, S
   Tona, F
AF Piaserico, Stefano
   Osto, Elena
   Famoso, Giulia
   Montisci, Roberta
   De Michieli, Laura
   Zanetti, Irene
   Iliceto, Sabino
   Tona, Francesco
TI Long-term prognostic value of coronary flow reserve in psoriasis
   patients
SO ATHEROSCLEROSIS
LA English
DT Article
DE Psoriasis; Coronary microcirculation; Prognosis; Coronary flow reserve;
   Cardiovascular risk
ID MICROVASCULAR DYSFUNCTION; MYOCARDIAL-INFARCTION; CHRONIC INFLAMMATION;
   RISK-FACTORS; CARDIOVASCULAR-DISEASE; YOUNG-PATIENTS; HEART-DISEASE;
   COHORT; MORTALITY
AB Background and aims: Psoriasis affects more than 3% of the general population and is associated with an increased risk of premature cardiovascular events and death. We assessed the prognostic role of coronary flow reserve (CFR) as a marker of coronary microvascular function in psoriasis patients asymptomatic for cardiovascular disease.
   Methods: We retrospectively analyzed 153 prospectively collected patients affected by psoriasis (123 male; age 36 +/- 8 years) without cardiovascular disease. CFR in the left anterior descending coronary artery was detected by transthoracic Doppler echocardiography, at rest, and during adenosine infusion. CFR was the ratio of hyperemic to resting diastolic flow velocity. CFR <= 2.5 was the cut off to define the presence of coronary microvascular dysfunction (CMD).
   Results: CMD was present in 23 patients (15%). Multivariable logistic regression analysis showed that CMD was associated with severe psoriasis (OR 3.1, p = 0.03), psoriatic arthritis (OR 2.9, p = 0.03), hypertension (OR 4.1, p = 0.009), and time elapsing since psoriasis diagnosis > 6 years (OR 1.9, p = 0.03). Patients with CFR <= 2.5 had a lower survival free from events (p < 0.0001).
   Conclusions: In psoriasis patients, CFR may be a reliable prognostic marker for cardiovascular event-free survival and may help identify patients at higher risk of developing cardiovascular complications. Whether novel biologic therapies able to reduce skin disease will improve CMD and prognosis in these patients needs to be further studied, prospectively.
C1 [Piaserico, Stefano] Univ Padua, Dept Med, Dermatol Unit, Padua, Italy.
   [Osto, Elena] Univ Padua, Univ Heart Ctr, Padua, Italy.
   [Osto, Elena] Univ Padua, Inst Clin Chem, Padua, Italy.
   [Famoso, Giulia; De Michieli, Laura; Zanetti, Irene; Iliceto, Sabino; Tona, Francesco] Univ Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Padua, Italy.
   [Montisci, Roberta] Univ Cagliari, Dept Med Sci & Publ Hlth, Clin Cardiol, Cagliari, Italy.
RP Tona, F (reprint author), Univ Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Padua, Italy.
EM francesco.tona@unipd.it
OI MONTISCI, ROBERTA/0000-0002-7218-6751
FU Swiss National Science Foundation PRIMA Grant [PR00P3_179861/1]; Swiss
   Card-Onco-Grant (Alfred and Annemarie von Sick Grant) at the Institute
   of Clinical Chemistry, University Hospital Zurich, Zurich, Switzerland
FX Dr. Osto is recipient of the Swiss National Science Foundation PRIMA
   Grant (PR00P3_179861/1) and of the Swiss Card-Onco-Grant (Alfred and
   Annemarie von Sick Grant) at the Institute of Clinical Chemistry,
   University Hospital Zurich, Zurich, Switzerland.
NR 41
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 57
EP 63
DI 10.1016/j.atherosclerosis.2019.08.009
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400009
PM 31476732
DA 2019-10-28
ER

PT J
AU Wang, YD
   Jia, LL
   Xie, Y
   Cai, ZJ
   Liu, ZJ
   Shen, J
   Lu, Y
   Wang, YP
   Su, SA
   Ma, YK
   Xiang, MX
AF Wang, Yidong
   Jia, Liangliang
   Xie, Yao
   Cai, Zhejun
   Liu, Zhenjie
   Shen, Jian
   Lu, Yi
   Wang, Yaping
   Su, Shengan
   Ma, Yuankun
   Xiang, Meixiang
TI Involvement of macrophage-derived exosomes in abdominal aortic aneurysms
   development
SO ATHEROSCLEROSIS
LA English
DT Article
DE Abdominal aortic aneurysms; Exosomes; Macrophages; Matrix
   metalloproteinase-2
ID SMOOTH-MUSCLE-CELLS; EXTRACELLULAR VESICLES; CROSS-TALK; INFLAMMATION;
   CYTOKINES
AB Background and aims: Abdominal aortic aneurysm (AAA) is characterized by infiltration of inflammatory cells, extracellular matrix (ECM) degradation, and dysfunction of vascular smooth muscle cells (VSMCs). Recent studies reported that exosomes mediate intercellular communication and are involved in different diseases. Whether exosomes play a role in AAA is poorly understood. Hence, this study evaluated the function of exosomes in AAA development.
   Methods: The presence of exosomes in human and calcium phosphate (CaPO4)-induced AAA tissues was determined by immunofluorescence staining of CD63 and Alix. GW4869, an inhibitor of exosome biogenesis, was intraperitoneally injected into CaPO4-induced AAA tissues to evaluate the effects of exosomal inhibition on AAA development. To explore the underlying mechanisms, the human monocytic cell line THP-1 was differentiated into macrophages, and exosomes were collected from macrophages. VSMCs were treated with macrophagederived exosomes, and the expression of matrix metalloproteinase-2 (MMP-2) was evaluated. The activation of mitogen-activated protein kinases (MAPKs) pathways was also investigated in vitro and in vivo.
   Results: Exosomes were detected in the adventitia of aneurysmal tissues obtained from humans and mice. They were mainly expressed in clusters of macrophages. Intraperitoneal injection of GW4869 for two weeks significantly attenuated the progression of CaPO4-induced AAA, preserved elastin integrity and decreased MMP-2 expression. Similarly, administration of GW4869 suppressed the systemic and aneurysmal exosome generation. In vitro, treatment with macrophage-derived exosomes elevated MMP-2 expression in human VSMCs, while pretreatment with GW4869 abolished these effects. It was also found that JNK and p38 pathways mediated the production of MMP-2 in VSMCs following treatment with macrophage-derived exosomes.
   Conclusions: This study suggests that exosomes derived from macrophages are involved in the pathogenesis of AAA. Macrophage-derived exosomes trigger MMP-2 expression in VSMC via JNK and p38 pathways. GW4869 supplementation attenuates CaPO4-induced AAA in mice.
C1 [Wang, Yidong; Jia, Liangliang; Xie, Yao; Cai, Zhejun; Shen, Jian; Lu, Yi; Wang, Yaping; Su, Shengan; Ma, Yuankun; Xiang, Meixiang] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Cardiol,Key Lab Cardiovasc Dis Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China.
   [Liu, Zhenjie] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Vasc Surg, Hangzhou, Zhejiang, Peoples R China.
RP Xiang, MX (reprint author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Cardiol,Key Lab Cardiovasc Dis Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China.
EM xiangmx@zju.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81670259, 81700412]
FX This study was supported by grants from the National Natural Science
   Foundation of China (NO.81670259 and 81700412).
NR 29
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 64
EP 72
DI 10.1016/j.atherosclerosis.2019.08.016
PG 9
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400010
PM 31479773
DA 2019-10-28
ER

PT J
AU Desjarlais, M
   Dussault, S
   Rivard, F
   Harel, S
   Sanchez, V
   Hussain, SNA
   Rivard, A
AF Desjarlais, Michel
   Dussault, Sylvie
   Rivard, Francois
   Harel, Sharon
   Sanchez, Veronica
   Hussain, Sabah N. A.
   Rivard, Alain
TI Forced expression of microRNA-146b reduces TRAF6-dependent inflammation
   and improves ischemia-induced neovascularization in hypercholesterolemic
   conditions
SO ATHEROSCLEROSIS
LA English
DT Article
DE Angiogenesis; Inflammation; Hypercholesterolemia; microRNA;
   Neovascularization
ID ENDOTHELIAL PROGENITOR CELLS; NECROSIS-FACTOR-ALPHA; THERAPEUTIC
   ANGIOGENESIS; INHIBITION; ATHEROSCLEROSIS; VASCULOGENESIS; MIR-146A/B;
   MECHANISMS; DISEASE; MICE
AB Background and aims: MicroRNA (miR)-146 is a key regulator of inflammation, endothelial activation and atherosclerosis. This study sought to define its potential role for the modulation of ischemia-induced neovascularization in atherosclerotic conditions.
   Methods: Next generation sequencing and qRT-PCR analyses were used to compare microRNA expression in the ischemic muscles of hypercholesterolemic ApoE-deficient (ApoE(-/-)) mice vs. wild type mice, and in HUVECs exposed or not to oxLDL. Neovascularization was investigated in a mouse model of hindlimb ischemia and the functional activities of HUVECs and pro-angiogenic cells (PACs) were assessed in vitro.
   Results: We found that miR-146b (but not miR-146a) is significantly reduced in the ischemic muscles of ApoE(-/-) mice, and in HUVECs exposed to oxLDL. Inhibition of miR-146b reduces angiogenesis in vitro, whereas forced expression of miR-146b rescues oxLDL-mediated impairment of endothelial cell proliferation and tube formation. Mechanistically, miR146b directly targets tumor necrosis factor-alpha (TNFa) Receptor Associated Factor 6 (TRAF6) to inhibit inflammation. We found that hypercholesterolemia and oxLDL exposure are associated with higher levels of TRAF6, and increased expression of TNFa. However, forced expression of miR-146b in high cholesterol conditions reduces the expression of these inflammatory factors. In vivo, intramuscular injection of miR-146b mimic reduces ischemic damages and restores blood flow recuperation and capillary density in the ischemic muscles of ApoE(-/-) mice. Treatment with miR-146b also increases the number and functional activities of pro-angiogenic cells (PACs).
   Conclusions: Hypercholesterolemia is associated with reduced expression of miR-146b, which increases TRAF6-dependent inflammation and is associated with poor neovascularization in response to ischemia. Forced expression of miR-146b using a miR mimic could constitute a novel therapeutic strategy to improve ischemiainduced neovascularization in atherosclerotic conditions.
C1 [Desjarlais, Michel; Dussault, Sylvie; Rivard, Francois; Rivard, Alain] Ctr Hosp Univ Montreal CHUM Res Ctr, Dept Med, Montreal, PQ, Canada.
   [Harel, Sharon; Sanchez, Veronica; Hussain, Sabah N. A.] McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ, Canada.
RP Rivard, A (reprint author), Ctr Rech CHUM, R08-464900 Rue St Denis, Montreal, PQ H2X 0A9, Canada.
EM alain.rivard@umontreal.ca
FU Canadian Institute of Health ResearchCanadian Institutes of Health
   Research (CIHR) [CIHR MOP-123490]; Heart and Stroke Foundation of
   CanadaHeart & Stroke Foundation of Canada [HSFC G-17-0019106]
FX This study was supported by grants from the Canadian Institute of Health
   Research (CIHR MOP-123490) and the Heart and Stroke Foundation of Canada
   (HSFC G-17-0019106) to AR.
NR 40
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 73
EP 84
DI 10.1016/j.atherosclerosis.2019.08.010
PG 12
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400011
PM 31479774
DA 2019-10-28
ER

PT J
AU Duell, PB
   Gidding, SS
   Andersen, RL
   Knickelbine, T
   Anderson, L
   Gianos, E
   Shrader, P
   Kindt, I
   O'Brien, EC
   McCann, D
   Hemphill, LC
   Ahmed, CD
   Martin, SS
   Larry, JA
   Ahmad, ZS
   Kullo, IJ
   Underberg, JA
   Guyton, J
   Thompson, P
   Wilemon, K
   Roe, MT
   Rader, DJ
   Cuchel, M
   Linton, MF
   Shapiro, MD
   Moriarty, PM
   Knowles, JW
AF Duell, P. Barton
   Gidding, Samuel S.
   Andersen, Rolf L.
   Knickelbine, Thomas
   Anderson, Lars
   Gianos, Eugenia
   Shrader, Peter
   Kindt, Iris
   O'Brien, Emily C.
   McCann, Dervilla
   Hemphill, Linda C.
   Ahmed, Catherine D.
   Martin, Seth S.
   Larry, John A.
   Ahmad, Zahid S.
   Kullo, Iftikhar J.
   Underberg, James A.
   Guyton, John
   Thompson, Paul
   Wilemon, Katherine
   Roe, Matthew T.
   Rader, Daniel J.
   Cuchel, Marina
   Linton, MacRae F.
   Shapiro, Michael D.
   Moriarty, Patrick M.
   Knowles, Joshua W.
TI Longitudinal low density lipoprotein cholesterol goal achievement and
   cardiovascular outcomes among adult patients with familial
   hypercholesterolemia: The CASCADE FH registry
SO ATHEROSCLEROSIS
LA English
DT Article
DE Familial hypercholesterolemia; Low density lipoprotein (LDL)
   cholesterol; Cardiovascular disease; LDL cholesterol goal achievement;
   PCSK9 inhibitor
ID PCSK9 INHIBITORS; STATEMENT; DISEASE; RISK
AB Background and aims: There are limited data from the US on outcomes of patients in specialty care for familial hypercholesterolemia (FH).
   Methods: CASCADE FH Registry data were analyzed to assess longitudinal changes in medication usage, in low density lipoprotein cholesterol (LDL-C) levels, and the rate of major adverse cardiovascular events (MACE (myocardial infarction, coronary revascularization, stroke or transient ischemic attack) in adults with FH followed in US specialty clinics.
   Results: The cohort consisted of 1900 individuals (61% women, 87% Caucasian), with mean age of 56 +/- 15 years, 37% prevalence of ASCVD at enrollment, mean pretreatment LDL-C 249 +/- 68 mg/dl, mean enrollment LDL-C 145 mg/dl and 93% taking lipid lowering therapy. Over follow up of 20 +/- 11 months, lipid lowering therapy use increased (mean decrease in LDL-C of 32 mg/dl (p< 0.001)). Only 48% of participants achieved LDL-C< 100 mg/dl and 22% achieved LDL-C< 70 mg/dl; ASCVD at enrollment was associated with greater likelihood of goal achievement. MACE event rates were almost 6 times higher among patients with prior ASCVD compared to those without (4.6 vs 0.8/100 patient years). Also associated with incident MACE were markers of FH severity and conventional ASCVD risk factors.
   Conclusions: With care in FH specialized clinics, LDL-C decreased, but LDL-C persisted> 100 mg/dl in 52% of patients. High ASCVD event rates suggest that adults with FH warrant designation as having an ASCVD risk equivalent. Earlier and more aggressive therapy of FH is needed to prevent ASCVD events.
C1 [Duell, P. Barton; Shapiro, Michael D.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA.
   [Gidding, Samuel S.; Kindt, Iris; Ahmed, Catherine D.; Wilemon, Katherine] FH Fdn, 959 E Walnut St,Suite 220, Pasadena, CA 91106 USA.
   [Andersen, Rolf L.; Anderson, Lars] Lancaster Gen Hlth Penn Med, Lancaster, PA USA.
   [Knickelbine, Thomas] Minneapolis Heart Inst Fdn, Minneapolis, MN USA.
   [Gianos, Eugenia] Northwell Hlth, Lenox Hill Hosp, New York, NY USA.
   [Shrader, Peter; O'Brien, Emily C.; Roe, Matthew T.] Duke Clin Res Inst, Durham, NC USA.
   [McCann, Dervilla] CMMC, Cent Maine Heart & Vasc Inst, Lewiston, ME USA.
   [Hemphill, Linda C.] Massachusetts Gen Hosp, Boston, MA 02114 USA.
   [Martin, Seth S.] Johns Hopkins Univ, Baltimore, MD USA.
   [Larry, John A.] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA.
   [Ahmad, Zahid S.] UT Southwestern Med Ctr, Dallas, TX USA.
   [Kullo, Iftikhar J.] Mayo Clin, Rochester, MN USA.
   [Underberg, James A.] NYU, Langone Med Ctr, New York, NY USA.
   [Guyton, John] Duke Univ, Med Ctr, Durham, NC USA.
   [Thompson, Paul] Hartford Hosp, Hartford, CT 06115 USA.
   [Rader, Daniel J.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Cuchel, Marina] Univ Penn, Philadelphia, PA 19104 USA.
   [Linton, MacRae F.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.
   [Moriarty, Patrick M.] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA.
   [Knowles, Joshua W.] Stanford Univ, Stanford, CA 94305 USA.
RP Gidding, SS (reprint author), FH Fdn, 959 E Walnut St,Suite 220, Pasadena, CA 91106 USA.
EM sg@thefhfoundation.org; irishommeskindt@hotmail.nl
OI Underberg, James/0000-0002-6615-8535; Gianos,
   Eugenia/0000-0001-7720-7470
FU FH Foundation; AmgenAmgen; the Medicines Company; Sanofi; Regeneron
   Pharmaceuticals
FX The CASCADE FH Registry has received financial support from FH
   Foundation including the following donors: Amgen, the Medicines Company,
   and Sanofi and Regeneron Pharmaceuticals.
NR 26
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 85
EP 93
DI 10.1016/j.atherosclerosis.2019.08.007
PG 9
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400012
PM 31487564
OA Other Gold
DA 2019-10-28
ER

PT J
AU Fang, C
   Dai, JN
   Zhang, ST
   Wang, YD
   Wang, JF
   Li, LL
   Wang, YN
   Yu, H
   Wei, G
   Zhang, XL
   Feng, N
   Liu, HM
   Xu, ME
   Ren, XF
   Ma, LJ
   Tu, YF
   Xing, L
   Hou, JB
   Yu, B
AF Fang, Chao
   Dai, Jiannan
   Zhang, Shaotao
   Wang, Yidan
   Wang, Jifei
   Li, Lulu
   Wang, Yini
   Yu, Huai
   Wei, Guo
   Zhang, Xiling
   Feng, Na
   Liu, Huimin
   Xu, Maoen
   Ren, Xuefeng
   Ma, Lijia
   Tu, Yingfeng
   Xing, Lei
   Hou, Jingbo
   Yu, Bo
TI Culprit lesion morphology in young patients with ST-segment elevated
   myocardial infarction: A clinical, angiographic and optical coherence
   tomography study
SO ATHEROSCLEROSIS
LA English
DT Article
DE Age; Culprit lesion; Myocardial infarction; Optical coherence
   tomography; Young patient
ID ACUTE CORONARY SYNDROME; PLAQUE RUPTURE; RISK-FACTORS; CHOLESTEROL
   CRYSTALS; CALCIFIED NODULE; HYALURONAN; THROMBOSIS; OUTCOMES; DEATH; AGE
AB Background and aims: About 20% of patients with ST-segment elevated myocardial infarction (STEMI) are young adults. Morphological characteristics of culprit lesion in young STEMI patients have not been systematically evaluated in vivo. The present study aimed to investigate culprit lesion characteristics in young patients versus older patients using optical coherence tomography (OCT).
   Methods: 1442 STEMI patients who underwent OCT examination of culprit lesion were included and divided into young group (age =50 years, n= 400) and older group (age> 50 years, n= 1042). Clinical characteristics, angiography and OCT findings were compared between the two groups.
   Results: Culprit lesions in STEMI patients aged <= 50 years had more plaque erosion (32.0% vs. 21.1%, p < 0.001) and larger minimal lumen area (2.3 +/- 1.7mm(2) vs. 1.9 +/- 1.1mm(2), p < 0.001) than in those aged> 50 years. As compared with older patients, lipid rich plaque (80.5% vs. 87.2%, p= 0.001), thin cap fibroatheroma (TCFA, 59.5% vs. 69.5%, p < 0.001), calcification (31.3% vs. 48.7%, p < 0.001), spotty calcification (25.3% vs. 36.1%, p < 0.001) and cholesterol crystals (26.3% vs. 38.4%, p < 0.001) were less frequently observed in young patients. A gradient increase in typical plaque vulnerability was observed from age <= 50 years to 50-70 years to > 70 years. In multivariate regression analysis, age =50 years was independently associated with less frequency of plaque rupture, TCFA, spotty calcification, cholesterol crystals and smaller lumen area stenosis.
   Conclusions: Morphological characteristics of culprit lesion in young STEMI patients were different from those in older patients. Patients aged <= 50 years had more plaque erosion and less vulnerable plaque features.
C1 [Dai, Jiannan; Yu, Bo] Harbin Med Univ, Affiliated Hosp 2, Dept Cardiol, 246 Xuefu Rd, Harbin 150086, Heilongjiang, Peoples R China.
   [Dai, Jiannan; Yu, Bo] Chinese Minist Educ, Key Lab Myocardial Ischemia, 246 Xuefu Rd, Harbin 150086, Heilongjiang, Peoples R China.
RP Dai, JN; Yu, B (reprint author), Harbin Med Univ, Affiliated Hosp 2, Dept Cardiol, 246 Xuefu Rd, Harbin 150086, Heilongjiang, Peoples R China.; Dai, JN; Yu, B (reprint author), Chinese Minist Educ, Key Lab Myocardial Ischemia, 246 Xuefu Rd, Harbin 150086, Heilongjiang, Peoples R China.
EM daijiannandr@163.com; dryu_hmu@163.com
OI Wang, Jifei/0000-0002-4724-3080
FU National Key R&D Program of China [2016YFC1301100]; National Natural
   Science Foundation of ChinaNational Natural Science Foundation of China
   [81827806, 81801861]; China Postdoctoral Science FoundationChina
   Postdoctoral Science Foundation [2018M630373, 2019T120283]; Hei Long
   Jiang Postdoctoral Foundation [LBH-TZ15]
FX This work was supported by National Key R&D Program of China (grant No.
   2016YFC1301100 to B.Y.), National Natural Science Foundation of China
   (grant No. 81827806 to B.Y. and No. 81801861 to J.D.), China
   Postdoctoral Science Foundation (grant No. 2018M630373 and No.
   2019T120283 to J.D.), and Hei Long Jiang Postdoctoral Foundation (grant
   No. LBH-TZ15 to J.D.).
NR 27
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 94
EP 100
DI 10.1016/j.atherosclerosis.2019.08.011
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400013
PM 31487565
DA 2019-10-28
ER

PT J
AU Hori, M
   Ohta, N
   Takahashi, A
   Masuda, H
   Isoda, R
   Yamamoto, S
   Son, C
   Ogura, M
   Hosoda, K
   Miyamoto, Y
   Harada-Shiba, M
AF Hori, Mika
   Ohta, Naotaka
   Takahashi, Atsushi
   Masuda, Hiroaki
   Isoda, Rieko
   Yamamoto, Suguru
   Son, Cheol
   Ogura, Masatsune
   Hosoda, Kiminori
   Miyamoto, Yoshihiro
   Harada-Shiba, Mariko
TI Impact of LDLR and PCSK9 pathogenic variants in Japanese heterozygous
   familial hypercholesterolemia patients
SO ATHEROSCLEROSIS
LA English
DT Article
DE Familial hypercholesterolemia; Pathogenic variant; LDLR; PCSK9;
   Annotation
ID DENSITY-LIPOPROTEIN RECEPTOR; GENETIC-VARIATION; MUTATIONS; DATABASE;
   ASSOCIATION; SCORE; FH
AB Background and aims: More than 4970 variants in the low-density lipoprotein receptor (LDLR) gene and 350 variants in the proprotein convertase subtilisin/kexin 9 (PCSK9) gene have been reported in familial hyperch-olesterolemia (FH) patients. However, the effects of these variants on FH pathophysiology have not been fully clarified. We aimed to update the LDLR and PCSK9 variants in Japanese heterozygous FH (HeFH) patients and annotate their clinical significance for the genetic diagnosis of HeFH.
   Methods: A genetic analysis of the LDLR and PCSK9 genes was performed in 801 clinically diagnosed HeFH patients. The association of the pathogenic variants with the clinical FH phenotype was examined.
   Results: Pathogenic variants in the LDLR and PCSK9 genes were found in 46% (n= 296) and 7.8% (n= 51) of unrelated FH patients (n= 650), respectively. The prevalence of Achilles tendon thickness was low (44%) in patients harbouring PCSK9 pathogenic variants. Furthermore, 17% of unrelated FH patients harboured one of five frequent LDLR pathogenic variants: c.1845+2T > C, c.1012T > A: p.(Cys338Ser), c.1297G > C: p. (Asp433His), c.1702C > G: p.(Leu568Val), and c.2431A > T: p.(Lys811*). Patients harbouring the c.1845+2T > C and c.1702C > G: p.(Leu568Val) variants had significantly lower serum LDL-cholesterol levels and higher serum HDL-cholesterol levels, respectively, compared with those harbouring the other LDLR pathogenic variants. The proportion of LDLR pathogenic variants was higher in patients with a younger age of coronary artery disease (CAD) onset and significantly decreased as the age of CAD onset increased.
   Conclusions: This study annotated the clinical significance and characteristics of LDLR and PCSK9 pathogenic variants in Japanese HeFH patients.
C1 [Hori, Mika; Ogura, Masatsune; Harada-Shiba, Mariko] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Mol Innovat Lipidol, 6-1 Kishibe Shinmachi, Suita, Osaka 5648565, Japan.
   [Ohta, Naotaka; Masuda, Hiroaki; Isoda, Rieko; Yamamoto, Suguru; Son, Cheol; Hosoda, Kiminori; Miyamoto, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Lab Clin Genet, 6-1 Kishibe Shinmachi, Suita, Osaka 5648565, Japan.
   [Takahashi, Atsushi] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Genom Med, 6-1 Kishibe Shinmachi, Suita, Osaka 5648565, Japan.
RP Hori, M; Harada-Shiba, M (reprint author), Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Mol Innovat Lipidol, 6-1 Kishibe Shinmachi, Suita, Osaka 5648565, Japan.
EM mihori@ncvc.go.jp; mshiba@ncvc.go.jp
FU Ministry of Health, Labour and Welfare of JapanMinistry of Health,
   Labour and Welfare, Japan [H26-nanji-ippan-056, H30-nanji-ippan-003];
   JSPS KAKENHIMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT)Japan Society for the Promotion of
   ScienceGrants-in-Aid for Scientific Research (KAKENHI) [JP17K08681];
   Japan Agency for Medical Research and DevelopmentJapan Agency for
   Medical Research and Development (AMED) [16ek0210075h0001]; Intramural
   Research Fund for Cardiovascular Diseases of the National Cerebral and
   Cardiovascular Center [28-2-2, 29-6-11]; Japan Heart Foundation;
   Astellas Grant for Research on Atherosclerosis Update; Takeda Science
   FoundationTakeda Science Foundation (TSF); Kanae Foundation for the
   Promotion of Medical Science; Novartis Research Grants; Japanese
   Circulation SocietyJapanese Circulation Society
FX This work was partly supported by grants from the Ministry of Health,
   Labour and Welfare of Japan for Clinical Research on Intractable
   Diseases (H26-nanji-ippan-056 and H30-nanji-ippan-003), JSPS KAKENHI
   (JP17K08681), the Japan Agency for Medical Research and Development
   (16ek0210075h0001), and the Intramural Research Fund for Cardiovascular
   Diseases of the National Cerebral and Cardiovascular Center (28-2-2;
   29-6-11), by a Japan Heart Foundation & Astellas Grant for Research on
   Atherosclerosis Update, and by funds from the Takeda Science Foundation,
   the Kanae Foundation for the Promotion of Medical Science, the Novartis
   Research Grants, and the Japanese Circulation Society.
NR 34
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 101
EP 108
DI 10.1016/j.atherosclerosis.2019.08.004
PG 8
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400014
PM 31491741
DA 2019-10-28
ER

PT J
AU Kim, YH
   Her, AY
   Jeong, MH
   Kim, BK
   Hong, SJ
   Kim, S
   Ahn, CM
   Kim, JS
   Ko, YG
   Choi, D
   Hong, MK
   Jang, Y
AF Kim, Yong Hoon
   Her, Ae-Young
   Jeong, Myung Ho
   Kim, Byeong-Keuk
   Hong, Sung-Jin
   Kim, Seunghwan
   Ahn, Chul-Min
   Kim, Jung-Sun
   Ko, Young-Guk
   Choi, Donghoon
   Hong, Myeong-Ki
   Jang, Yangsoo
TI A comparison between statin with ACE inhibitor or ARB therapy in STEMI
   patients who underwent successful PCI with drug-eluting stents
SO ATHEROSCLEROSIS
LA English
DT Article
DE Myocardial infarction; Statin; Angiotensin converting enzyme inhibitor;
   Angiotensin receptor blocker
ID ACUTE MYOCARDIAL-INFARCTION; ACUTE CORONARY SYNDROMES;
   CARDIOVASCULAR-DISEASES; TASK-FORCE; ANGIOTENSIN; MANAGEMENT;
   GUIDELINES; RISK; ATORVASTATIN; MORBIDITY
AB Background and aims: Studies of the comparative clinical outcomes between statin with angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) in ST-segment elevation myocardial infarction (STEMI) patients are limited. We compared 2-year clinical outcomes between statin with ACEI or ARB therapy in STEMI patients after successful percutaneous coronary intervention (PCI) with drug-eluting stents (DES).
   Methods: A total of 11,706 STEMI patients were enrolled and separated into two groups: the ACEI group (statin + ACEI, n = 8705) and the ARB group (statin + ARB, n = 3001). The primary endpoint was major adverse cardiac events (MACE) defined as all-cause death, recurrent MI (re-MI), and any coronary revascularization. Secondary endpoints were the individual components of MACE and target vessel failure (TVF).
   Results: After propensity score-matched (PSM) analysis, two PSM groups (2729 pairs, n= 5458, C-statistic = 0.675) were generated. The cumulative incidences of MACE, re-MI, and any coronary revascularization were similar between the two groups. However, the cumulative incidences of all-cause death (hazard ratio [HR], 1.548; 95% confidence interval [CI], 1.091-2.197; p= 0.014) and cardiac death (HR, 1.850; 95% CI, 1.218-2.811; p= 0.004) were significantly higher in the ARB group compared with the ACEI group after PSM analysis.
   Conclusions: The combination of statin with ACEI may be the preferred treatment strategy to reduce mortality rates in STEMI patients after successful PCI with DES rather than statin with ARB in this study during a 2-year follow-up period.
C1 [Kim, Yong Hoon; Her, Ae-Young] Kangwon Natl Univ, Sch Med, Dept Internal Med, Div Cardiol, 156 Baengnyeong Rd, Chunchon 24289, Gangwon Provinc, South Korea.
   [Jeong, Myung Ho] Chonnam Natl Univ Hosp, Cardiovasc Ctr, Dept Cardiol, Gwangju, South Korea.
   [Kim, Byeong-Keuk; Hong, Sung-Jin; Ahn, Chul-Min; Kim, Jung-Sun; Ko, Young-Guk; Choi, Donghoon; Hong, Myeong-Ki; Jang, Yangsoo] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea.
   [Kim, Seunghwan] Inje Univ, Coll Med, Haeundae Paik Hosp, Div Cardiol, Busan, South Korea.
RP Kim, YH (reprint author), Kangwon Natl Univ, Sch Med, Dept Internal Med, Div Cardiol, 156 Baengnyeong Rd, Chunchon 24289, Gangwon Provinc, South Korea.
EM yhkim02@kangwon.ac.kr
OI Kim, Jung-Sun/0000-0003-2263-3274; Kim, Seunghwan/0000-0002-2641-9606
FU Research of Korea Centers for Disease Control and Prevention
   [2016-ER6304-02]
FX This research was supported by a fund (2016-ER6304-02) by Research of
   Korea Centers for Disease Control and Prevention.
NR 39
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 109
EP 117
DI 10.1016/j.atherosclerosis.2019.08.018
PG 9
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400015
PM 31491742
DA 2019-10-28
ER

PT J
AU Bainey, KR
   Morais, J
   Zeymer, U
   Welsh, RC
AF Bainey, Kevin R.
   Morais, Joao
   Zeymer, Uwe
   Welsh, Robert C.
TI Atrial fibrillation with percutaneous coronary intervention: Navigating
   the minefield of antithrombotic therapies
SO ATHEROSCLEROSIS
LA English
DT Review
DE Anticoagulation; Antiplatelet therapy; Atrial fibrillation; Percutaneous
   coronary intervention
ID DUAL ANTIPLATELET THERAPY; CARDIOVASCULAR SOCIETY GUIDELINES; ELUTING
   STENT IMPLANTATION; MYOCARDIAL-INFARCTION; FOCUSED UPDATE;
   ANTICOAGULANT-THERAPY; PLATELET INHIBITION; TRIPLE THERAPY;
   DOUBLE-BLIND; 2017 ESC
AB This review aims to provide insights into contemporary therapeutic options for the treatment of patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) and compares current international guidelines. AF is a common cardiac arrhythmia and a major risk factor for stroke. The risk of stroke can be reduced with the use of oral anticoagulant (OAC) therapy. However, for patients with AF, PCI necessitates the use of combined antithrombotic therapies (OAC and antiplatelet therapies) to reduce thrombotic coronary complications. Optimal combinations and durations of OAC and/or antiplatelet therapy remains an area of clinical debate. Nuances exist within the current guidelines regarding duration and combination of antithrombotic therapy for AF patients requiring PCI. However, consensus was found across the following key points: (i) recent evidence supports a preferred role for a dual antithrombotic approach (OAC plus 1 antiplatelet); (ii) limited use of triple antithrombotic therapy is recommended across all guidelines for patients where the ischemic risk outweighs the risk of bleeding, with the duration to be kept as short as possible; and (iii) lifelong management using monotherapy with an OAC from 12 months post PCI is recommended for stable patients across all guidelines.
C1 [Bainey, Kevin R.; Welsh, Robert C.] Univ Alberta, Mazankowski Alberta Heart Inst, 2C2 Walter C Mackenzie, Edmonton, AB T6G 2B7, Canada.
   [Morais, Joao] Leira Hosp Ctr, Leiria, Portugal.
   [Zeymer, Uwe] Klinikum Stadt Ludwigshafen Rhein, Ludwigshafen, Germany.
RP Welsh, RC (reprint author), Univ Alberta, Mazankowski Alberta Heart Inst, 2C2 Walter C Mackenzie, Edmonton, AB T6G 2B7, Canada.
EM Robert.Welsh@albertahealthservices.ca
FU Bayer AGBayer AG
FX In part, this manuscript receiving funding support from Bayer AG.
NR 45
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 118
EP 125
DI 10.1016/j.atherosclerosis.2019.08.021
PG 8
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400016
PM 31494384
DA 2019-10-28
ER

PT J
AU Isiozor, NM
   Kunutsor, SK
   Voutilainen, A
   Kurl, S
   Kauhanen, J
   Laukkanen, JA
AF Isiozor, Nzechukwu M.
   Kunutsor, Setor K.
   Voutilainen, Ari
   Kurl, Sudhir
   Kauhanen, Jussi
   Laukkanen, Jari A.
TI Ideal cardiovascular health and risk of acute myocardial infarction
   among Finnish men
SO ATHEROSCLEROSIS
LA English
DT Article
DE Acute myocardial infarction; Cardiovascular health metrics; Ideal
   cardiovascular health; Risk factor; Men
ID SYSTOLIC BLOOD-PRESSURE; DISEASE; ASSOCIATIONS; MORTALITY; PREVALENCE;
   EXERCISE; EVENTS; IMPACT
AB Background and aims: Acute myocardial infarction (AMI) is associated with high mortality globally and remains a public health burden. We sought to investigate the relation between the American Heart Association's cardiovascular health metrics (CVH) and the risk of AMI among middle-aged Finnish men.
   Methods: We used the ongoing population-based Kuopio Ischaemic Heart Disease cohort study comprising men aged 40-62 years at baseline. The CVH metrics was computed among 2584 participants at baseline with health scores ranging from 0 to 7. This was categorized into three groups of CVH metrics as poor (0-2), intermediate (3-4) and ideal (>= 5). Multivariate Cox regression models were used to estimate the hazard ratios (HR) and 95% confidence intervals (CIs) of CVH metrics for AMI.
   Results: During a median follow-up period of 25.2 years, 513 cases of AMI were recorded. Only one participant was able to achieve all the seven ideal health metrics. The risk of AMI decreased continuously with the increasing number of CVH metrics across the range 2-7 (for non-linearity, p=0.07). Men with ideal CVH metrics had a HR (95% CI) for AMI of 0.28 (CI 0.15-0.55, p < 0.001) compared to those with poor CVH metrics after adjustment for age, alcohol intake and socioeconomic status. The associations remained consistent following further adjustment for history of coronary heart disease and history of type 2 diabetes.
   Conclusions: Ideal CVH metrics was strongly and linearly associated with reduced risk of AMI among middle-aged Finnish men.
C1 [Isiozor, Nzechukwu M.; Voutilainen, Ari; Kurl, Sudhir; Kauhanen, Jussi; Laukkanen, Jari A.] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Yliopistonranta 1, Kuopio 70210, Finland.
   [Kunutsor, Setor K.] Univ Hosp Bristol NHS Fdn Trust, Natl Inst Hlth Res Bristol Biomed Res Ctr, Bristol, Avon, England.
   [Kunutsor, Setor K.] Univ Bristol, Bristol, Avon, England.
   [Kunutsor, Setor K.] Univ Bristol, Musculoskeletal Res Unit, Bristol Med Sch, Translat Hlth Sci, Bristol, Avon, England.
   [Laukkanen, Jari A.] Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla, Finland.
   [Laukkanen, Jari A.] Cent Finland Hlth Care Dist, Dept Internal Med, Jyvaskyla, Finland.
RP Isiozor, NM (reprint author), Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Yliopistonranta 1, Kuopio 70210, Finland.
EM nzechuis@uef.fi
OI Isiozor, Nzechukwu/0000-0001-8699-1025
FU Matti and Vappu Maukonen grant for Heart Disease Research
FX This study was supported in part by Matti and Vappu Maukonen grant for
   Heart Disease Research.
NR 28
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 126
EP 131
DI 10.1016/j.atherosclerosis.2019.08.024
PG 6
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400017
PM 31509777
DA 2019-10-28
ER

PT J
AU Wei, W
   Li, XX
   Xu, M
AF Wei, Wei
   Li, Xiao-Xue
   Xu, Ming
TI Inhibition of vascular neointima hyperplasia by FGF21 associated with
   FGFR1/Syk/NLRP3 inflammasome pathway in diabetic mice
SO ATHEROSCLEROSIS
LA English
DT Article
DE FGF21; Diabetes; Neointima hyperplasia; Vascular smooth muscle cell;
   NLRP3 inflammasome
ID GROWTH-FACTOR 21; SMOOTH-MUSCLE-CELLS; NLRP3 INFLAMMASOME; VSMC
   PROLIFERATION; TYROSINE KINASE; MIGRATION; ATHEROSCLEROSIS; ACTIVATION
AB Background and aims: Neointima hyperplasia is the pathological basis of atherosclerosis and restenosis, which have been associated with diabetes mellitus (DM). Fibroblast growth factor 21 (FGF21) is a potential diabetic drug, however, it has not been investigated whether FGF21 prevents neointima hyperplasia in DM.
   Methods: Vascular neointima hyperplasia was induced in mice fed a high fat diet (HFD) combined with low dose streptozotocin (STZ) administration. In vitro, vascular smooth muscle cells (VSMCs) were incubated with high glucose (HG, 30 mM). VSMC proliferation and migration, as well as formation of NLRP3 inflammasome, were assessed.
   Results: We found that FGF21 significantly inhibited neointima hyperplasia and improved endothelium-independent contraction in the wire-injured common carotid artery (CCA) of diabetic mice. In vitro, the proliferation and migration of HG-treated VSMCs were shown as remarkable increase of PCNA, cyclin D1, MMP2 and MMP9, as well as cell migration through wound healing and transwell migration assays. Such abnormal changes were dramatically reversed by FGF21, which mimicked the role of NLRP3 inflammasome inhibitor MCC950 and caspase-1 inhibitor WEHD. Moreover, along with more NLRP3, ASC oligomer and their colocalization, the release of active caspase-1(p20) and IL-1 beta was significantly inhibited by FGF21 in VSMCs exposed to HG. Furthermore, FGF21 suppressed phosphorylation of spleen tyrosine kinase (Syk) via FGFR1, which regulated NLRP3 inflammasome through ASC phosphorylation and oligomerization.
   Conclusions: We demonstrated that potential protection of FGF21 on VSMCs proliferation and migration was associated with inhibition of FGFR1/Syk/NLRP3 inflammasome, resulting in the improvement of neointima hyperplasia in diabetic mice.
C1 [Wei, Wei; Xu, Ming] China Pharmaceut Univ, Sch Preclin Med & Clin Pharm, Dept Clin Pharm, 24 Tong Jia Lane, Nanjing 210009, Jiangsu, Peoples R China.
   [Li, Xiao-Xue] Southeast Univ, Sch Med, Dept Pharmacol, Nanjing 210009, Jiangsu, Peoples R China.
RP Xu, M (reprint author), China Pharmaceut Univ, Sch Preclin Med & Clin Pharm, Dept Clin Pharm, 24 Tong Jia Lane, Nanjing 210009, Jiangsu, Peoples R China.
EM mingxu@cpu.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81570413, 81773732, 81973509]; Natural Science
   Foundation of JiangsuNatural Science Foundation of Jiangsu Province
   [BK20161461]
FX This work was supported by the National Natural Science Foundation of
   China (No. 81570413 and No.81773732 and No.81973509) and Natural Science
   Foundation of Jiangsu (No. BK20161461).
NR 53
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 132
EP 142
DI 10.1016/j.atherosclerosis.2019.08.017
PG 11
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400018
PM 31513948
DA 2019-10-28
ER

PT J
AU Xie, W
   Li, L
   Gong, D
   Zhang, M
   Lv, YC
   Guo, DM
   Zhao, ZW
   Zheng, XL
   Zhang, DW
   Dai, XY
   Yin, WD
   Tang, CK
AF Xie, Wei
   Li, Liang
   Gong, Duo
   Zhang, Min
   Lv, Yun-Cheng
   Guo, Dong-ming
   Zhao, Zhen-Wang
   Zheng, Xi-Long
   Zhang, Da-Wei
   Dai, Xiao-Yan
   Yin, Wei-Dong
   Tang, Chao-Ke
TI Kruppel-like factor 14 inhibits atherosclerosis via mir-27a-mediated
   down-regulation of lipoprotein lipase expression in vivo
SO ATHEROSCLEROSIS
LA English
DT Article
DE Kruppel-like factor; MicroRNA; Lipoprotein lipase; Inflammation;
   Macrophage; Atherosclerosis
ID ATTENUATES LIPID-ACCUMULATION; AORTIC ATHEROSCLEROSIS; OXIDATIVE STRESS;
   KAPPA-B; GYPENOSIDES; MACROPHAGE; KLF14; ASSOCIATION; VARIANTS; LOCI
AB Background and aims: Kruppel-like factor 14 (KLF14) is known to play a role in atherosclerosis, but the underlying mechanisms are still largely unknown. The aim of our study was to explore the effects of KLF14 on lipid metabolism and inflammatory response, providing a potential target for lowering the risk of atherosclerosiscausing disease.
   Methods and results: mRNA and protein levels of KLF14 were significantly decreased in oxidized low-density lipoprotein (oxLDL)-treated macrophages and in the atherosclerotic lesion area. Chromatin immunoprecipitation (ChIP) and luciferase reporter gene assays were used to confirm that KLF14 positively regulated miR-27a expression by binding to its promoter. We also found that KLF14 could restored appropriate cellular lipid homeostasis and inflammatory responses via negatively regulating lipoprotein lipase (LPL) expression in THP1-derived macrophages through miR-27a. In addition, gypenosides (GP), a KLF14 activator, delayed the development of atherosclerosis in apolipoprotein E deficient (apoE(-/-)) mice.
   Conclusions: KLF14 plays an antiatherogenic role via the miR-27a-dependent down-regulation of LPL and subsequent inhibition of proinflammatory cytokine secretion and lipid accumulation.
C1 [Xie, Wei; Li, Liang; Gong, Duo; Zhang, Min; Zhao, Zhen-Wang; Yin, Wei-Dong; Tang, Chao-Ke] Univ South China, Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Inst Cardiovasc Res, Key Lab Atherosclerol Hunan Prov,Med Res Ctr, Hengyang 421001, Hunan, Peoples R China.
   [Xie, Wei; Lv, Yun-Cheng; Guo, Dong-ming] Univ South China, Clin Anat & Reprod Med Applicat Inst, Hengyang 421001, Hunan, Peoples R China.
   [Li, Liang] Univ South China, Dept Pathophysiol, Hengyang 421001, Hunan, Peoples R China.
   [Zheng, Xi-Long] Univ Calgary, Hlth Sci Ctr, Cumming Sch Med, Dept Biochem & Mol Biol,Libin Cardiovasc Inst Alb, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.
   [Zheng, Xi-Long] Guangzhou Med Univ, Sch Pharmaceut Sci, Key Lab Mol Targets & Clin Pharmacol, Guangzhou 511436, Guangdong, Peoples R China.
   [Zhang, Da-Wei] Univ Alberta, Dept Pediat, Edmonton, AB, Canada.
   [Zhang, Da-Wei] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB, Canada.
   [Dai, Xiao-Yan] Guangzhou Med Univ, Sch Pharmaceut Sci, Guangdong Key Lab Mol Target & Clin Pharmacol, Guangzhou 511436, Guangdong, Peoples R China.
   [Dai, Xiao-Yan] Guangzhou Med Univ, Affiliated Hosp 5, Guangzhou 511436, Guangdong, Peoples R China.
RP Yin, WD; Tang, CK (reprint author), Univ South China, Inst Cardiovasc Res, Hengyang 421001, Hunan, Peoples R China.
EM wdy20042004@126.com; tangchaoke@qq.com
FU National Natural Science Foundation of China of ChinaNational Natural
   Science Foundation of China [81800386]; Hunan Provincial Natural Science
   Foundation of ChinaNatural Science Foundation of Hunan Province
   [2017JJ2234, 2018JJ3453]; start-up funds for Ph.Ds in University of
   South China [2017XQD12, 2017XQD05]
FX The authors gratefully acknowledge the financial supports from the
   National Natural Science Foundation of China of China (81800386), the
   Hunan Provincial Natural Science Foundation of China (2017JJ2234,
   2018JJ3453) and the start-up funds for Ph.Ds in University of South
   China (2017XQD12, 2017XQD05).
NR 54
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 143
EP 161
DI 10.1016/j.atherosclerosis.2019.08.012
PG 19
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400019
PM 31518965
DA 2019-10-28
ER

PT J
AU Sanchez-Hernandez, RM
   Di Taranto, MD
   Benito-Vicente, A
   Uribe, KB
   Lamiquiz-Moneo, I
   Larrea-Sebal, A
   Jebari, S
   Galicia-Garcia, U
   Novoa, FJ
   Boronat, M
   Wagner, AM
   Civeira, F
   Martin, C
   Fortunato, G
AF Sanchez-Hernandez, Rosa M.
   Di Taranto, Maria Donata
   Benito-Vicente, Asier
   Uribe, Kepa B.
   Lamiquiz-Moneo, Itziar
   Larrea-Sebal, Asier
   Jebari, Shifa
   Galicia-Garcia, Unai
   Javier Novoa, F.
   Boronat, Mauro
   Wagner, Ana M.
   Civeira, Fernando
   Martin, Cesar
   Fortunato, Giuliana
TI The Arg499His gain-of-function mutation in the C-terminal domain of
   PCSK9
SO ATHEROSCLEROSIS
LA English
DT Article
DE Dyslipemia; Genetics; Lipids; Cholesterol; Gene expression; Familial
   hypercholesterolemia; Mutations; Functional assay
ID DENSITY-LIPOPROTEIN RECEPTOR; AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA;
   CONVERTASE SUBTILISIN/KEXIN TYPE-9; FAMILIAL HYPERCHOLESTEROLEMIA;
   SECRETED PCSK9; LDL RECEPTOR; PROPROTEIN; GENE; DISEASE; IDENTIFICATION
AB Background and aims: Familial hypercholesterolemia (FH) is a monogenic disease characterized by high levels of low-density lipoprotein cholesterol and premature atherosclerotic cardiovascular disease. FH is caused by loss of function mutations in genes encoding LDL receptor (LDLR), and Apolipoprotein B (APOB) or gain of function (GOF) mutations in proprotein convertase subtilisin/kexin type 9 (PCSK9). In this study, we identified a novel variant in PCSK9, p.(Arg499His), located in the C-terminal domain, in two unrelated FH patients from Spain and Italy.
   Methods: We studied familial segregation and determined variant activity in vitro.
   Results: We determined PCSK9 expression, secretion and activity of the variant in transfected HEK293 cells; extracellular activity of the recombinant p.(Arg499His) PCSK9 variant in HEK 293 and HepG2 cells; PCSK9 affinity to the LDL receptor at neutral and acidic pH; the mechanism of action of the p.(Arg499His) PCSK9 variant by co-transfection with a soluble construct of the LDL receptor and by determining total PCSK9 intracellular accumulation when endosomal acidification is impaired and when an excess of soluble LDLr is present in the culture medium. Our results show high LDL-C concentrations and FH phenotype in p.(Arg499His) carriers. In vitro functional characterization shows that p.(Arg499His) PCSK9 variant causes a reduction in LDLr expression and LDL uptake. An intracellular activity for this variant is also shown when blocking the activity of secreted PCSK9 and by inhibiting endosomal acidification.
   Conclusions: We demonstrated that p.(Arg499His) PCSK9 variant causes a direct intracellular degradation of LDLr therefore causing FH by reducing LDLr availability.
C1 [Sanchez-Hernandez, Rosa M.; Javier Novoa, F.; Boronat, Mauro; Wagner, Ana M.] Univ Las Palmas Gran Canaria, IUIBS, Complejo Hosp Univ Insular Materno Infantil Gran, Secc Endocrinol & Nutr, Las Palmas Gran Canaria, Spain.
   [Di Taranto, Maria Donata; Fortunato, Giuliana] Univ Napoli Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy.
   [Di Taranto, Maria Donata; Fortunato, Giuliana] CEINGE SCarl, Biotecnol Avanzate, Naples, Italy.
   [Benito-Vicente, Asier; Uribe, Kepa B.; Larrea-Sebal, Asier; Jebari, Shifa; Martin, Cesar] Univ Basque Country, CSIC, Inst Biofis, Apdo 644, Bilbao 48080, Spain.
   [Benito-Vicente, Asier; Uribe, Kepa B.; Larrea-Sebal, Asier; Jebari, Shifa; Martin, Cesar] Univ Basque Country, Dept Bioquim, Apdo 644, E-48080 Bilbao, Spain.
   [Lamiquiz-Moneo, Itziar; Civeira, Fernando] Univ Zaragoza, Hosp Univ Miguel Servet, IIS Aragon, CIBERCV, Zaragoza, Spain.
   [Galicia-Garcia, Unai] Univ Basque Country, CSIC, Inst Biofis, Barrio Sarriena S-N, E-48940 Leioa, Bizkaia, Spain.
RP Fortunato, G (reprint author), Univ Napoli Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy.; Fortunato, G (reprint author), CEINGE SCarl, Biotecnol Avanzate, Naples, Italy.; Martin, C (reprint author), Univ Basque Country, CSIC, Inst Biofis, Apdo 644, Bilbao 48080, Spain.; Martin, C (reprint author), Univ Basque Country, Dept Bioquim, Apdo 644, E-48080 Bilbao, Spain.
EM cesar.martin@ehu.eus; fortunat@unina.it
FU Basque GovernmentBasque Government [IT-1264-19]; PIF (2014-2015),
   Gobierno Vasco; DOKBERRI 2019-I; PIF (2017-2018), Gobierno Vasco;
   Fundacion Biofisica Bizkaia; Spanish Atherosclerosis Society
   (Clinico-Epidemiologica 2015); Colegio Oficial de Medicos de Las Palmas
   (Gonzalez-Jaraba 2015)
FX This work was supported by the Basque Government (Grupos Consolidados
   IT-1264-19). A.B.-V. was supported by a grant PIF (2014-2015), Gobierno
   Vasco and DOKBERRI 2019-I. S.J. was supported by a grant PIF
   (2017-2018), Gobierno Vasco. U.G-G was supported by Fundacion Biofisica
   Bizkaia. This work was also supported by a grant of The Spanish
   Atherosclerosis Society (Clinico-Epidemiologica 2015) and a grant of
   Colegio Oficial de Medicos de Las Palmas (Gonzalez-Jaraba 2015).
NR 53
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 162
EP 172
DI 10.1016/j.atherosclerosis.2019.08.020
PG 11
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400020
PM 31518966
DA 2019-10-28
ER

PT J
AU Enkhmaa, B
   Berglund, L
AF Enkhmaa, Byambaa
   Berglund, Lars
TI Statins and Lp(a): The plot thickens
SO ATHEROSCLEROSIS
LA English
DT Editorial Material
DE Lipoproteins; Cardiovascular risk; Cholesterol; Lipids; Drugs
ID COA REDUCTASE INHIBITOR; LOW-DENSITY-LIPOPROTEIN; PRAVASTATIN
C1 [Enkhmaa, Byambaa; Berglund, Lars] Univ Calif Davis, Sch Med, Dept Internal Med, Davis, CA 95616 USA.
RP Berglund, L (reprint author), Univ Calif Davis, Sch Med, Dept Internal Med, Davis, CA 95616 USA.
EM lberglund@ucdavis.edu
FU UC Davis Clinical and Translational Science Center [UL1 TR001860]; NIH
   Building Interdisciplinary Research Careers in Women's Health/K12
   Program [2K12HD051958]
FX We gratefully acknowledge partial support from the UC Davis Clinical and
   Translational Science Center (UL1 TR001860) and the NIH Building
   Interdisciplinary Research Careers in Women's Health/K12 Program
   (2K12HD051958).
NR 20
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 173
EP 175
DI 10.1016/j.atherosclerosis.2019.07.021
PG 3
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400021
PM 31443913
OA Bronze
DA 2019-10-28
ER

PT J
AU Morelli, MB
   Wang, XJ
   Santulli, G
AF Morelli, Marco Bruno
   Wang, Xujun
   Santulli, Gaetano
TI Functional role of gut microbiota and PCSK9 in the pathogenesis of
   diabetes mellitus and cardiovascular disease
SO ATHEROSCLEROSIS
LA English
DT Editorial Material
DE Microbiota; PCSK9; Inflammation; Diabetes mellitus; Cardiovascular
   disease
ID LDL RECEPTORS; INSULIN
C1 [Morelli, Marco Bruno; Wang, Xujun] Albert Einstein Coll Med, Norman Fleischer Inst Diabet & Metab, Einstein Mt Sinai Diabet Res Ctr ES DRC, Dept Med,Wilf Family Cardiovasc Res Inst, New York, NY USA.
   [Wang, Xujun; Santulli, Gaetano] Albert Einstein Coll Med, Norman Fleischer Inst Diabet & Metab, Einstein Mt Sinai Diabet Res Ctr ES DRC, Dept Mol Pharmacol, New York, NY USA.
   [Santulli, Gaetano] Montefiore Univ Hosp, Albert Einstein Coll Med, Wilf Family Cardiovasc Res Inst, Dept Med Cardiol, New York, NY USA.
   [Santulli, Gaetano] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy.
RP Santulli, G (reprint author), Albert Einstein Coll Med, Norman Fleischer Inst Diabet & Metab, Einstein Mt Sinai Diabet Res Ctr ES DRC, Dept Mol Pharmacol, New York, NY USA.; Santulli, G (reprint author), Montefiore Univ Hosp, Albert Einstein Coll Med, Wilf Family Cardiovasc Res Inst, Dept Med Cardiol, New York, NY USA.; Santulli, G (reprint author), Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy.
EM gsantulli001@gmail.com
OI /0000-0001-7231-375X
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 DK123259, R01
   HL146691, R01 DK033823, R00 DK107895]
FX Dr. Gaetano Santulli is supported by the National Institutes of Health
   (R01 DK123259, R01 HL146691, R01 DK033823, R00 DK107895).
NR 20
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 176
EP 178
DI 10.1016/j.atherosclerosis.2019.07.023
PG 3
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400022
PM 31431286
DA 2019-10-28
ER

PT J
AU Zhang, YJ
   Tedgui, A
   Ait-Oufella, H
AF Zhang, Yujiao
   Tedgui, Alain
   Ait-Oufella, Hafid
TI Allograft inflammatory factor-1, a multi-target regulator of
   atherosclerosis
SO ATHEROSCLEROSIS
LA English
DT Editorial Material
ID APOPTOTIC CELL ACCUMULATION; ACTIVATION; CLONING
C1 [Zhang, Yujiao; Tedgui, Alain; Ait-Oufella, Hafid] Univ Paris, INSERM, UMR S 970, Paris Cardiovasc Res Ctr,PARCC, Paris, France.
   [Ait-Oufella, Hafid] Sorbonne Univ, Hop St Antoine, AP HP, Serv Med Intens Reanimat, Paris, France.
RP Ait-Oufella, H (reprint author), PARCC, Paris Cardiovasc Res Ctr, UMR S 970, 56 Rue Leblanc, F-75015 Paris, France.
EM hafid.aitoufella@inserm.fr
NR 15
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 179
EP 180
DI 10.1016/j.atherosclerosis.2019.08.008
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400023
PM 31477235
DA 2019-10-28
ER

PT J
AU Kronenberg, F
   Tsimikas, S
AF Kronenberg, Florian
   Tsimikas, Sotirios
TI The challenges of measuring Lp(a): A fight against Hydra?
SO ATHEROSCLEROSIS
LA English
DT Editorial Material
ID LIPOPROTEIN(A); APOLIPOPROTEIN(A); RISK; DISEASE; SIZE
C1 [Kronenberg, Florian] Med Univ Innsbruck, Dept Genet & Pharmacol, Inst Genet Epidemiol, Schopfstr 41, A-6020 Innsbruck, Austria.
   [Tsimikas, Sotirios] Univ Calif San Diego, Div Cardiovasc Dis, Sulpizio Cardiovasc Ctr, Vasc Med Program, 9500 Gilman Dr, La Jolla, CA 92093 USA.
RP Kronenberg, F (reprint author), Med Univ Innsbruck, Dept Genet & Pharmacol, Inst Genet Epidemiol, Schopfstr 41, A-6020 Innsbruck, Austria.; Tsimikas, S (reprint author), Univ Calif San Diego, Div Cardiovasc Dis, 9500 Gilman Dr, La Jolla, CA 92093 USA.
EM Florian.Kronenberg@i-med.ac.at; stsimikas@ucsd.edu
RI Kronenberg, Florian/B-1736-2008
OI Kronenberg, Florian/0000-0003-2229-1120
NR 20
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 181
EP 183
DI 10.1016/j.atherosclerosis.2019.08.019
PG 3
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400024
PM 31495537
DA 2019-10-28
ER

PT J
AU Egana-Gorrono, L
   Chinnasamy, P
   Casimiro, I
   Almonte, VM
   Parikh, D
   Oliveira-Paula, GH
   Jayakumar, S
   Law, C
   Riascos-Bernal, DF
   Sibinga, NES
AF Egana-Gorrono, Lander
   Chinnasamy, Prameladevi
   Casimiro, Isabel
   Almonte, Vanessa M.
   Parikh, Dippal
   Oliveira-Paula, Gustavo H.
   Jayakumar, Smitha
   Law, Calvin
   Riascos-Bernal, Dario F.
   Sibinga, Nicholas E. S.
TI Allograft inflammatory factor-1 supports macrophage survival and
   efferocytosis and limits necrosis in atherosclerotic plaques
SO ATHEROSCLEROSIS
LA English
DT Article
DE Atherosclerosis; Efferocytosis; Macrophage; Necrosis; NF-kappa B
ID FACTOR-KAPPA-B; MUSCLE-CELL ACTIVATION; OXIDIZED LDL; EXPRESSION;
   INHIBITION; AIF-1; PROLIFERATION; MECHANISMS; RECEPTOR; LESIONS
AB Background and aims: Allograft inflammatory factor-1 (AIF1) has been characterized as a pro-inflammatory molecule expressed primarily in the monocyte/macrophage (MP) lineage and positively associated with various forms of vascular disease, including atherosclerosis. Studies of AIF1 in atherosclerosis have relied on mouse models in which AIF1 was overexpressed in either myeloid or smooth muscle cells, resulting in increased atherosclerotic plaque burden. How physiologic expression of AIF1 contributes to MP biology in atherogenesis is not known.
   Methods: Effects of global AIF1 deficiency on atherosclerosis were assessed by crossing Aif1(-/-) and ApoE(-/-) mice, and provoking hyperlipidemia with high fat diet feeding. Atherosclerotic plaques were studied en face and in cross section. Bone marrow-derived MPs (BMDMs) were isolated from Aif1(-/-) mice for study in culture.
   Results: Atherosclerotic plaques in Aif1(-/-);ApoE(-/-) mice showed larger necrotic cores compared to those in ApoE(-/-) animals, without change in overall lesion burden. In vitro, lack of AIF1 reduced BMDM survival, phagocytosis, and efferocytosis. Mechanistically, AIF1 supported activation of the NF-kappa B pathway and expression of related target genes involved in stress response, inflammation, and apoptosis. Consistent with this in vitro BMDM phenotype, AIF1 deficiency reduced NF-kappa B pathway activity in vivo and increased apoptotic cell number in atherosclerotic lesions from Aif1(-/-) ;ApoE(-/-) mice.
   Conclusions: These findings characterize AIF1 as a positive regulator of the NF-kappa B pathway that supports MP functions such as survival and efferocytosis. In inflammatory settings such as atherosclerosis, these AIF1-dependent activities serve to clear cellular and other debris and limit necrotic core expansion, and may oppose lesion destabilization.
C1 Albert Einstein Coll Med, Wilf Family Cardiovasc Res Inst, Dept Med Cardiol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.
   Albert Einstein Coll Med, Wilf Family Cardiovasc Res Inst, Dept Dev & Mol Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.
   [Egana-Gorrono, Lander] NYU Langone Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Diabet Res Program, New York, NY 10016 USA.
   [Casimiro, Isabel] Univ Chicago, Pritzker Sch Med, Kovler Diabet Ctr, 900 East 57th St, Chicago, IL 60637 USA.
RP Sibinga, NES (reprint author), Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.
EM nicholas.sibinga@einstein.yu.edu
RI Oliveira-Paula, Gustavo H./J-4895-2014
OI Oliveira-Paula, Gustavo H./0000-0002-8248-9713; Sibinga,
   Nicholas/0000-0003-4838-910X; Riascos Bernal, Dario/0000-0002-8790-4699;
   Egana Gorrono, Lander/0000-0002-0378-7844
FU National Institutes of Health (NIH), USAUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [R01HL067944, R01HL128066]; Summer Undergraduate Research Program (SURP,
   2017) of the Graduate Division from Albert Einstein College of Medicine,
   Bronx, NY, USA
FX This work was supported by National Institutes of Health (NIH), USA,
   grants R01HL067944 and R01HL128066 to N.E.S.S. C.L. was supported by the
   Summer Undergraduate Research Program (SURP, 2017) of the Graduate
   Division from Albert Einstein College of Medicine, Bronx, NY, USA.
NR 56
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 184
EP 194
DI 10.1016/j.atherosclerosis.2019.07.022
PG 11
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400025
PM 31439353
OA Other Gold
DA 2019-10-28
ER

PT J
AU Pastori, D
   Ettorre, E
   Carnevale, R
   Nocella, C
   Bartimoccia, S
   Del Sordo, E
   Cammisotto, V
   Violi, F
   Pignatelli, P
   Saliola, M
   Casciaro, MA
   Farcomeni, A
   Rubino, L
   Marchese, C
   Santulli, M
   Vasaturo, F
   Castellani, V
   Menichelli, D
AF Pastori, Daniele
   Ettorre, Evaristo
   Carnevale, Roberto
   Nocella, Cristina
   Bartimoccia, Simona
   Del Sordo, Elisabetta
   Cammisotto, Vittoria
   Violi, Francesco
   Pignatelli, Pasquale
   Saliola, Mirella
   Casciaro, Marco Antonio
   Farcomeni, Alessio
   Rubino, Luca
   Marchese, Cinzia
   Santulli, Maria
   Vasaturo, Fortunata
   Castellani, Valentina
   Menichelli, Danilo
CA Atherosclerosis Atrial
TI Interaction between serum endotoxemia and proprotein convertase
   subtilisin/kexin 9 (PCSK9) in patients with atrial fibrillation: A
   post-hoc analysis from the ATHERO-AF cohort
SO ATHEROSCLEROSIS
LA English
DT Article
DE Atrial fibrillation; PCSK9; LPS; NADPH oxidase
ID CARDIOVASCULAR EVENTS; MEDITERRANEAN DIET; OXIDATIVE STRESS;
   INFLAMMATION; MICROBIOTA
AB Background and aims: Lipopolysaccharides (LPS) is emerging as a novel risk factor for cardiovascular events (CVEs). Furthermore, in vitro evidence suggested that LPS may elicit proprotein convertase subtilisin/kexin 9 (PCSK9) expression, but their relationship in vivo has not been investigated.
   Methods: We conducted a post-hoc analysis of a prospective, single centre cohort study of 907 patients with nonvalvular atrial fibrillation (AF). At baseline, PCSK9, LPS and NADPH oxidase (sNox2-dp) were measured. PCSK9 and LPS were correlated with the incidence of CVEs.
   Results: Median PCSK9 and LPS were 1200 [900-1970] and 49.9 [15.0-108.2] pg/ml, respectively. LPS and PCSK9 were significantly correlated (rS 0.378, p < 0.001). Logistic regression analysis showed that LPS was associated with PCSK9 above the median (odds ratio [OR] 1.727 95% confidence interval [CI] 1.147-2.600 p=0.009). Other factors associated with PCSK9 above the median were sNox2-dp (OR 1.759 C.I. 95% 1.167-2.650, p=0.007), use of antiplatelet drugs (OR 0.437 95%CI 0.219-0.871 p=0.017) and high adherence to Mediterranean diet (OR 0.737 95%CI 0.643-0.845 p=0.001). Olive oil (OR 0.376 95%CI 0.185-0.763, p=0.001) and wine (OR 0.460 95%CI 0.289-0.733 p=0.007) were negatively associated with PCSK9.
   Patients with concomitant high PCSK9 and LPS (LPS=88 pg/ml and PCSK9=1570 pg/ml) had an increased risk of CVEs compared to those with low levels (LPS< 24.3 pg/ml and PCSK9< 1000 pg/ml, Log-Rank test, p = 0.022).
   Conclusions: This study demonstrated, for the first time in vivo, that circulating levels of PCSK9 and LPS are associated with a mechanism possibly involving NADPH oxidase activation. Patients with concomitant increase of PCSK9 and LPS showed a higher risk of CVEs.
C1 [Pastori, Daniele; Bartimoccia, Simona; Del Sordo, Elisabetta; Cammisotto, Vittoria; Violi, Francesco; Pignatelli, Pasquale] Sapienza Univ Rome, Dept Internal Med & Med Specialties, Clin Med 1, Rome, Italy.
   [Ettorre, Evaristo] Sapienza Univ, Div Gerontol, Dept Cardiovasc Resp Nephrol Anesthesiol & Geriat, Rome, Italy.
   [Carnevale, Roberto] Sapienza Univ Rome, Dept Med Surg Sci & Biotechnol, Latina, Italy.
   [Nocella, Cristina] IRCCS Neuromed, I-86077 Pozzilli, IS, Italy.
   [Carnevale, Roberto; Violi, Francesco; Pignatelli, Pasquale] Mediterranea Cardioctr, I-80122 Naples, Italy.
RP Pignatelli, P (reprint author), I Clin Med, Viale Policlin 155, I-00161 Rome, Italy.
EM pasquale.pignatelli@uniroma1.it
RI pignatelli, pasquale/K-2116-2016; Violi, Francesco/K-1509-2016;
   Carnevale, Roberto/K-1472-2016; pastori, daniele/J-7087-2016
OI pignatelli, pasquale/0000-0002-2265-7455; Violi,
   Francesco/0000-0002-6610-7068; Carnevale, Roberto/0000-0002-6216-9595;
   pastori, daniele/0000-0001-6357-5213
NR 29
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 195
EP 200
DI 10.1016/j.atherosclerosis.2019.07.002
PG 6
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400026
PM 31303312
DA 2019-10-28
ER

PT J
AU Yahya, R
   Berk, K
   Verhoeven, A
   Bos, S
   van der Zee, L
   Touw, J
   Erhart, G
   Kronenberg, F
   Timman, R
   Sijbrands, E
   van Lennep, JR
   Mulder, M
AF Yahya, Reyhana
   Berk, Kirsten
   Verhoeven, Adrie
   Bos, Sven
   van der Zee, Leonie
   Touw, Jeanette
   Erhart, Gertraud
   Kronenberg, Florian
   Timman, Reinier
   Sijbrands, Eric
   van Lennep, Jeanine Roeters
   Mulder, Monique
TI Statin treatment increases lipoprotein(a) levels in subjects with low
   molecular weight apolipoprotein(a) phenotype
SO ATHEROSCLEROSIS
LA English
DT Article
DE Statin; Dyslipidemia; lipoprotein(a); KIV2; LPA gene
ID FAMILIAL HYPERCHOLESTEROLEMIA; OXIDIZED PHOSPHOLIPIDS;
   PLASMA-LIPOPROTEIN; LP(A); POLYMORPHISM; CHOLESTEROL; METABOLISM;
   SECRETION; NUMBER; RISK
AB Background and aims: We aimed to evaluate the effect of statin treatment initiation on lipoprotein(a) [Lp(a)] levels in patients with dyslipidemia, and the interactions with the apolipoprotein(a) [apo(a)] phenotype, LPA single nucleotide polymorphisms (SNPs) and change in LDL cholesterol.
   Methods: The study population consisted of patients with dyslipidemia, predominantly familial hypercholesterolemia, who first initiated statin treatment (initiation group; n = 39) or were already on stable statin treatment for at least 4 months (control group; n= 42). Plasma Lp(a) levels were determined with a particle-enhanced immunoturbidimetric assay before and at least 2 months after start of statin treatment in individuals of the initiation group, and at two time points with an interval of at least 2 months in the control group. High and low molecular weight (HMW and LMW, respectively) apo(a) phenotype was determined by immunoblotting, and the common LPA SNPs rs10455872, rs3798220 and rs41272110 by Taqman assay.
   Results: Plasma Lp(a) levels did not increase significantly in the initiation group (median 20.5 (IQR 10.9-80.7) to 23.3 (10.8-71.8) mg/dL; p = 0.09) nor in the control group (30.9 (IQR 9.2-147.0) to 31.7 (IQR 10.9-164.0) mg/dL; p= 0.61). In patients with the LMW apo(a) phenotype, Lp(a) levels increased significantly from 66.4 (IQR 23.5-148.3) to 97.4 (IQR 24.9-160.4) mg/dL (p = 0.026) in the initiation group, but not in the control group and not in patients characterized by the HMW apo(a) phenotype. Interactions with common LPA SNPs and change in LDL cholesterol were not significant.
   Conclusions: Statins affect Lp(a) levels differently in patients with dyslipidemia depending on the apo(a) phenotype. Statins increase Lp(a) levels exclusively in patients with the LMW apo(a) phenotype.
C1 [Yahya, Reyhana; Berk, Kirsten; Verhoeven, Adrie; Bos, Sven; van der Zee, Leonie; Touw, Jeanette; Sijbrands, Eric; van Lennep, Jeanine Roeters; Mulder, Monique] Erasmus MC, Erasmus MC, Div Med Psychol & Psychotherapy, Dept Internal Med,Div Vasc Med & Pharmacol, Rotterdam, Netherlands.
   [Berk, Kirsten] Erasmus MC, Erasmus MC, Dept Dietet, Rotterdam, Netherlands.
   [Berk, Kirsten] Erasmus MC, Erasmus MC, Div Med Psychol & Psychotherapy, Rotterdam, Netherlands.
   [Timman, Reinier] Erasmus MC, Erasmus MC, Dept Psychiat, Div Med Psychol & Psychotherapy, Rotterdam, Netherlands.
   [Erhart, Gertraud; Kronenberg, Florian] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, Innsbruck, Austria.
RP Mulder, M (reprint author), Erasmus MC, Erasmus MC, Dept Internal Med, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands.
EM m.t.mulder@erasmusmc.nl
RI Sijbrands, Eric/A-1065-2009; Kronenberg, Florian/B-1736-2008
OI Sijbrands, Eric/0000-0001-8857-7389; Berk, Kirsten/0000-0003-4097-4785;
   Kronenberg, Florian/0000-0003-2229-1120
FU Erasmus Medical Center Efficiency Research funding program [NL
   42635.078.13]
FX This study was supported in part by a grant from the Erasmus Medical
   Center Efficiency Research funding program (NL 42635.078.13).
NR 38
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 201
EP 205
DI 10.1016/j.atherosclerosis.2019.07.001
PG 5
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400027
PM 31327478
OA Green Published
DA 2019-10-28
ER

PT J
AU Scharnagl, H
   Stojakovic, T
   Dieplinger, B
   Dieplinger, H
   Erhart, G
   Kostner, GM
   Herrmann, M
   Marz, W
   Grammer, TB
AF Scharnagl, Hubert
   Stojakovic, Tatjana
   Dieplinger, Benjamin
   Dieplinger, Hans
   Erhart, Gertraud
   Kostner, Gerhard M.
   Herrmann, Markus
   Maerz, Winfried
   Grammer, Tanja B.
TI Comparison of lipoprotein (a) serum concentrations measured by six
   commercially available immunoassays
SO ATHEROSCLEROSIS
LA English
DT Article
DE Lipoprotein (a) assays; Harmonization; Atherosclerosis; Myocardial
   infarction
ID RISK; APOLIPOPROTEIN(A); STANDARDIZATION; KRINGLE-4; DISEASE
AB Background and aims: Lipoprotein (a) [Lp(a)] is an established causal risk factor for cardiovascular disease (CVD), independently of low-density lipoproteins (LDL) and other risk factors. The recognition of Lp(a) as an atherogenic molecule has raised the demand for reliable quantification methods in the clinical laboratory. The aim of this work is to compare commercial immunochemical assays.
   Methods: We measured Lp(a) serum concentrations using six different assays, providing Lp(a) in mg/dl (Denka Seiken, Abbott Quantia, Beckman, Diasys 21FS, and Siemens N Latex) or in nmol/l (Roche TinaQuant, Diasys 21 FS) in 144 serum samples covering the clinically relevant range of Lp(a) concentrations. All assays relied on fivepoint calibrations using calibrators provided by the manufacturers. Apolipoprotein(a) phenotyping was performed by sodium dodecyl sulfate-agarose gel electrophoresis (SDS-agarose) followed by immunoblotting.
   Results: Most bivariate correlation coefficients were greater than 0.90. Compared to an established IFCC-proposed reference material, the results of the different assays diverged from the target values (43.3 mg/dl or 96.6 nmol/l) by-8% (Siemens N Latex) and +22% (Abbott Quantia). Stratification of the samples into five groups with increasing Lp(a) concentrations and difference plots showed that the differences among assays were concentration-dependent. Some assays overestimated Lp(a) at high concentrations compared to the Denka Seiken assay.
   Conclusions: Current commercial immunological assays for measuring Lp(a) concentrations are differently calibrated. Their biases differ significantly across the clinically relevant concentration range in a non-linear manner. This is not conclusively explained by apolipoprotein (a) phenotypes. Further international efforts to harmonize assays for Lp(a) are needed.
C1 [Scharnagl, Hubert; Stojakovic, Tatjana; Herrmann, Markus; Maerz, Winfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Auenbruggerpl 15, A-8010 Graz, Austria.
   [Dieplinger, Benjamin] Konventhosp Barmherzige Brueder, Dept Lab Med, Linz, Austria.
   [Dieplinger, Hans; Erhart, Gertraud] Med Univ Innsbruck, Dept Genet & Pharmacol, Inst Genet Epidemiol, Innsbruck, Austria.
   [Kostner, Gerhard M.] Med Univ Graz, Gottfried Schatz Res Ctr Cell Signaling Metab & A, Inst Mol Biol & Biochem, Graz, Austria.
   [Maerz, Winfried] Heidelberg Univ, Med Fac Mannheim, Heidelberg, Germany.
   [Maerz, Winfried] SYNLAB Holding Deutschland GmbH, SYNLAB Acad, Mannheim, Germany.
   [Maerz, Winfried] SYNLAB Holding Deutschland GmbH, SYNLAB Acad, Augsburg, Germany.
   [Grammer, Tanja B.] Heidelberg Univ, Med Fac Mannheim, Mannheim Inst Publ Hlth Social & Prevent, Heidelberg, Germany.
RP Scharnagl, H (reprint author), Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Auenbruggerpl 15, A-8010 Graz, Austria.
EM hubert.scharnagl@medunigraz.at
OI Kostner, Gerhard/0000-0002-2615-6017
NR 24
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2019
VL 289
BP 206
EP 213
DI 10.1016/j.atherosclerosis.2019.08.015
PG 8
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA JC4XM
UT WOS:000489281400028
PM 31493849
OA Other Gold
DA 2019-10-28
ER

PT J
AU Breuninger, TA
   Wawro, N
   Meisinger, C
   Artati, A
   Adamski, J
   Peters, A
   Grallert, H
   Linseisen, J
AF Breuninger, Taylor A.
   Wawro, Nina
   Meisinger, Christa
   Artati, Anna
   Adamski, Jerzy
   Peters, Annette
   Grallert, Harald
   Linseisen, Jakob
TI Associations between fecal bile acids, neutral sterols, and serum lipids
   in the KORA FF4 study
SO ATHEROSCLEROSIS
LA English
DT Article
DE Stool metabolites; Lipids; Dyslipidemia; Cholesterol; Triglycerides;
   Population-based; enable-Cluster
ID CHOLESTEROL ABSORPTION; DYSLIPIDEMIA; DISEASE; METABOLISM; RISK;
   PHYTOSTEROLS; MANAGEMENT; EXCRETION; OUTPUT
AB Background and aims: Dyslipidemia is a major risk factor for cardiovascular disease, the leading cause of preventable death worldwide. As a result, a full understanding of the factors influencing dyslipidemia is urgently necessary. Bile acids have been recognized as regulators of lipid metabolism, and neutral sterols may influence serum lipid levels. Therefore, this analysis was conducted to better understand the relationship between bile acids, neutral sterols, and dyslipidemia.
   Methods: We examined cross-sectional associations between selected fecal metabolites and serum lipids or markers of dyslipidemia in 1387 participants of the KORA FF4 study using linear and logistic regression models.
   Results: We found positive associations between fecal bile acids and serum high-density lipoprotein cholesterol, low-density lipoprotein cholesterol (LDL-c), total cholesterol, triglycerides and markers of dyslipidemia, though associations were seen most consistently with triglycerides and hypertriglyceridemia. We also found positive associations between fecal cholesterol and serum LDL-c, total cholesterol, triglycerides, hypertriglyceridemia and high serum total cholesterol, though only associations with triglycerides or hypertriglyceridemia remained significant after applying the Bonferroni correction. Unexpectedly, several fecal plant sterols were positively associated with serum lipids and the associated markers of dyslipidemia. However, many of these associations were no longer statistically significant after adjusting for multiple testing.
   Conclusions: Our results provide insight into the role that bile acids may play in the development or progression of dyslipidemia. However, further confirmation of these results is warranted. Longitudinal and experimental studies are necessary to clarify the mechanisms behind these associations and to determine causality.
C1 [Breuninger, Taylor A.; Wawro, Nina; Meisinger, Christa; Linseisen, Jakob] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth GmbH, Independent Res Unit Clin Epidemiol, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.
   [Breuninger, Taylor A.; Wawro, Nina; Meisinger, Christa; Linseisen, Jakob] Ludwig Maximilians Univ Munchen, Chair Epidemiol, UNIKA T Augsburg, Neusasser Str 47, D-86156 Augsburg, Germany.
   [Artati, Anna; Adamski, Jerzy; Peters, Annette] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth GmbH, Res Unit Mol Endocrinol & Metab, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.
   [Adamski, Jerzy] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, MD 7,8 Med Dr, Singapore 117596, Singapore.
   [Peters, Annette; Grallert, Harald] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth GmbH, Inst Epidemiol, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.
   [Peters, Annette; Grallert, Harald] German Ctr Diabet Res DZD, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.
RP Breuninger, TA (reprint author), German Res Ctr Environm Hlth GmbH, Independent Res Unit Clin Epidemiol, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.
EM taylor.breuninger@helmholtz-muenchen.de
RI Linseisen, Jakob/B-5353-2014
OI Linseisen, Jakob/0000-0002-9386-382X
FU iMED, a research alliance within the Helmholtz Association, Germany;
   Helmholtz Zentrum Munchen -German Research Center for Environmental
   Health - German Federal Ministry of Education and Research (BMBF)Federal
   Ministry of Education & Research (BMBF) [01EA1409E]; State of Bavaria;
   Munich Center of Health Sciences (MC-Health),
   Ludwig-Maximilians-Universitat, as part of LMUinnovativ; German Ministry
   for Education and Research (BMBF)Federal Ministry of Education &
   Research (BMBF) [FK 01EA1409E]
FX Stool sample collection in KORA FF4 was supported by iMED, a research
   alliance within the Helmholtz Association, Germany. The KORA study was
   initiated and financed by the Helmholtz Zentrum Munchen -German Research
   Center for Environmental Health, which is funded by the German Federal
   Ministry of Education and Research (BMBF, grant#01EA1409E) and by the
   State of Bavaria. Furthermore, KORA research was supported within the
   Munich Center of Health Sciences (MC-Health),
   Ludwig-Maximilians-Universitat, as part of LMUinnovativ. The preparation
   of this paper was supported by the enable Cluster and is catalogued by
   the enable Steering Committee as enable 33
   (http://enable-cluster.de).This work was funded by a grant of the German
   Ministry for Education and Research (BMBF) FK 01EA1409E. The funding
   agencies had no role in the design, analysis or writing of this article.
NR 41
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2019
VL 288
BP 1
EP 8
DI 10.1016/j.atherosclerosis.2019.06.911
PG 8
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IW6XN
UT WOS:000485127200001
PM 31277007
OA Other Gold
DA 2019-10-28
ER

PT J
AU Moschonas, IC
   Tselepis, AD
AF Moschonas, Iraklis C.
   Tselepis, Alexandros D.
TI The pathway of neutrophil extracellular traps towards atherosclerosis
   and thrombosis
SO ATHEROSCLEROSIS
LA English
DT Review
DE Atherosclerosis; Neutrophil extracellular traps; Neutrophils; Platelets;
   Thrombosis
ID DEEP-VEIN THROMBOSIS; ACTIVATED PLATELETS; VENOUS THROMBOSIS;
   P-SELECTIN; NETOSIS; DNA; MYELOPEROXIDASE; HMGB1; ELASTASE; RELEASE
AB Neutrophil extracellular traps (NETs) are web-like extrusions of genetic material, which are released upon neutrophil activation. NETs consist of a chromatin substructure, onto which a vast array of proteins with various properties is dispersed. NETs production was initially described as an unrecognized defense mechanism of neutrophils, due to their ability to entrap and possibly eliminate a wide range of pathogens. Nevertheless, growing evidence suggests that NETs are implicated in a multitude of pathophysiological conditions, such as autoimmunity, cancer, diabetes mellitus and Alzheimer's disease. Importantly, NETs may also play a decisive role in atherosclerosis and thrombosis. In this context, it has been demonstrated that NETs are present in atherosclerotic lesions of both humans and animal models and are implicated in various mechanisms leading to atherogenesis. Among others, NETs induce oxidative stress and oxidize high-density lipoprotein particles, thus reducing their beneficial cholesterol efflux capacity. NETs also induce endothelial cell dysfunction and apoptosis and promote the generation of anti-double-stranded-DNA autoantibodies. NETs may also play a prothrombotic role, since they form a fibrin-like base for platelet adhesion, activation and aggregation. Furthermore, NETs promote the accumulation of prothrombotic molecules, like von Willebrand factor and fibrinogen, thus significantly contributing to thrombus formation. Notably, there is vast data linking NETs to arterial and venous thrombosis in animal models, as well as in humans. Future large-scale studies should incorporate NETs and their individual components as disease markers, as well as potential therapeutic targets, to reduce atherosclerosis and to prevent thrombosis.
C1 [Moschonas, Iraklis C.; Tselepis, Alexandros D.] Univ Ioannina, Dept Chem, Lab Biochem, Atherothrombosis Res Ctr, GR-45110 Ioannina, Greece.
RP Tselepis, AD (reprint author), Univ Ioannina, Dept Chem, Lab Biochem, Atherothrombosis Res Ctr, GR-45110 Ioannina, Greece.
EM atselep@uoi.gr
OI Moschonas, Iraklis C./0000-0002-7884-5674
NR 104
TC 1
Z9 1
U1 6
U2 6
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2019
VL 288
BP 9
EP 16
DI 10.1016/j.atherosclerosis.2019.06.919
PG 8
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IW6XN
UT WOS:000485127200002
PM 31280097
DA 2019-10-28
ER

PT J
AU Kobayashi, D
   Noto, H
   Shimbo, T
   Ino, T
   Osugi, Y
   Takahashi, O
   Asai, K
AF Kobayashi, Daiki
   Noto, Hiroshi
   Shimbo, Takuro
   Ino, Teruo
   Osugi, Yasuhiro
   Takahashi, Osamu
   Asai, Kanichi
TI Repeated measures of extremely high levels of high-density lipoprotein
   cholesterol and subsequent all-cause mortality and cardiovascular
   events: A longitudinal study
SO ATHEROSCLEROSIS
LA English
DT Article
DE Extremely high HDL; Mortality; Cardiovascular disease; Longitudinal
   study
ID ISCHEMIC-HEART-DISEASE; HDL-CHOLESTEROL; LDL-CHOLESTEROL; HIGH-RISK;
   TRIGLYCERIDES; INDIVIDUALS; ASSOCIATION; TORCETRAPIB; THERAPY; GENDER
AB Background and aims: Extremely high level high-density lipoprotein (HDL) cholesterol had been cautioned as risk factor for all-cause mortality and cardiovascular disease. However, both the physician and the patient may underestimate the risk due to the emphasis on "good cholesterol", resulting in passive treatment or adoption of a less healthy lifestyle. The aim of this study is to re-evaluate the association with longitudinal data to account for fluctuations in HDL cholesterol and covariates.
   Methods: We conducted a retrospective longitudinal study at a large teaching hospital in Tokyo, Japan, from 2005 to 2016. We included all adults who participated in health check-ups. Outcomes were all-cause mortality and cardiovascular events. HDL cholesterol was repeatedly measured at each visit and categorized into five groups. The time-varying Cox model was applied to longitudinal analyses.
   Results: We included a total of 83,100 participants; the mean age was 45.5 (standard deviation: 12.4) years; 41,013 (49.4%) were male, and 4475 participants belonged to the extremely high level HDL cholesterol group (> 90 mg/dl). During a median follow-up of 1746 (interquartile range: 740-3112.5) days, 382 (0.5%) participants died, and 2023 (2.4%) experienced cardiovascular events. Although the extremely high level HDL cholesterol group had significantly lower hazard ratios (HRs) for all-cause mortality (HR: 0.49, 95% confidence interval (CI): 0.26-0.90) and cardiovascular events (HR: 0.71, 95% CI: 0.54-0.94) compared to the low group (< 40 mg/dl), HRs were higher than in the very high level HDL cholesterol group.
   Conclusions: Our study demonstrated that extremely high level HDL cholesterol has significantly lower risks of all-cause mortality and cardiovascular events compared to low level, but higher risks compared to very high level, as previously reported.
C1 [Kobayashi, Daiki; Takahashi, Osamu] St Lukes Int Hosp, Div Gen Internal Med, Dept Med, Tokyo, Japan.
   [Kobayashi, Daiki; Takahashi, Osamu] St Lukes Int Univ, Dept Epidemiol, Grad Sch Publ Hlth, Tokyo, Japan.
   [Kobayashi, Daiki; Ino, Teruo; Osugi, Yasuhiro; Asai, Kanichi] Fujita Med Univ, Toyoake, Aichi, Japan.
   [Noto, Hiroshi] St Lukes Int Hosp, Dept Endocrinol, Tokyo, Japan.
   [Shimbo, Takuro] Ohta Nishinouchi Hosp, Koriyama, Fukushima, Japan.
   [Asai, Kanichi] Toyota Reg Med Ctr, Toyota, Japan.
RP Kobayashi, D (reprint author), St Lukes Int Hosp, Div Gen Internal Med, Dept Med, Tokyo, Japan.
EM daikoba@luke.ac.jp
NR 43
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2019
VL 288
BP 17
EP 25
DI 10.1016/j.atherosclerosis.2019.06.918
PG 9
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IW6XN
UT WOS:000485127200003
PM 31295627
DA 2019-10-28
ER

PT J
AU Au, JS
   Proudfoot, NA
   Timmons, BW
   MacDonald, MJ
AF Au, Jason S.
   Proudfoot, Nicole A.
   Timmons, Brian W.
   MacDonald, Maureen J.
TI Retrograde shift in carotid artery longitudinal wall motion after
   one-year follow-up in children
SO ATHEROSCLEROSIS
LA English
DT Article
DE Arterial health; Ultrasound; Speckle-tracking; Tracking; Childhood
ID INTIMA-MEDIA THICKNESS; PULSE-WAVE VELOCITY; IDEAL CARDIOVASCULAR
   HEALTH; REFERENCE VALUES; BLOOD-PRESSURE; SHEAR STRAIN; RISK-FACTORS;
   CHILDHOOD; ADULTHOOD; DISPLACEMENT
AB Background and aims: Cross-sectional studies suggest that arterial stiffness increases during childhood; however, this evidence stems from pressure-dependent arterial distension, while longitudinal movement of the arterial wall has not been explored. Carotid artery longitudinal wall motion (CALM) has been identified as a novel biomarker of vascular health in adults and may provide complementary biaxial wall information to vascular changes during childhood development. Accordingly, the purpose of this study was to assess how CALM changes and tracks over a one-year period in young children.
   Methods: Children were recruited from the Health Outcomes and Physical activity in Preschoolers study (n = 114; 65 girls; age: 5.8 +/- 0.9 years-old). CALM was measured at the left common carotid artery using ultrasound with speckle tracking.
   Results: There were increases in CALM magnitudes over one-year follow-up, including systolic retrograde, diastolic, maximum, and total radial-axial displacement (all p < 0.01), with no differences between boys and girls. With the exception of systolic anterograde displacement, all CALM variables tracked better in girls than in boys, both individually (Spearman's. ranges: 0.49-0.61 vs. 0.25-0.47), as well as when split into tertile groups (Cohen's weighted. ranges: 0.43-0.60 vs. 0.16-0.44), indicating overall moderate tracking (kappa > 0.40) in the entire cohort.
   Conclusions: CALM displacements change rapidly during childhood and track into pre-pubescence in a sexspecific manner. These findings suggest that CALM is influenced by individual factors that track consistently, and that similar to arterial stiffness, it may be valuable to examine the age-associated changes in CALM magnitudes to infer changes in child vascular health over time.
C1 [Au, Jason S.; Proudfoot, Nicole A.; Timmons, Brian W.; MacDonald, Maureen J.] McMaster Univ, Dept Kinesiol, 1280 Main St West, Hamilton, ON L8S 4K1, Canada.
   [Proudfoot, Nicole A.; Timmons, Brian W.] McMaster Univ, Dept Pediat, 1280 Main St West, Hamilton, ON L8S 4K1, Canada.
RP MacDonald, MJ (reprint author), McMaster Univ, Dept Kinesiol, Ivor Wynne Ctr, Room E207,1280 Main St West, Hamilton, ON L8S 4K1, Canada.
EM macdonmj@mcmaster.ca
OI MacDonald, Maureen/0000-0001-9851-3610; Au, Jason/0000-0001-8601-323X
FU Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR) [MOP 102560]; Natural Sciences and Engineering Research
   Council of CanadaNatural Sciences and Engineering Research Council of
   Canada [DG 238819-13]; NSERCNatural Sciences and Engineering Research
   Council of Canada [CGSD2-475515-2015]
FX The Healthy Outcomes and Physical activity in Preschoolers (HOPP) study
   is funded by the Canadian Institutes of Health Research (MOP 102560 to
   B.T.). This study was funded by a Natural Sciences and Engineering
   Research Council of Canada Discovery Grant to M.M (DG 238819-13) and a
   NSERC postgraduate scholarship to J.A. (CGSD2-475515-2015). B.T. is a
   Canada Research Chair in Child Health & Exercise Medicine.
NR 47
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2019
VL 288
BP 26
EP 32
DI 10.1016/j.atherosclerosis.2019.07.005
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IW6XN
UT WOS:000485127200004
PM 31310885
DA 2019-10-28
ER

PT J
AU Dyrbus, K
   Gasior, M
   Desperak, P
   Osadnik, T
   Nowak, J
   Banach, M
AF Dyrbus, Krzysztof
   Gasior, Mariusz
   Desperak, Piotr
   Osadnik, Tadeusz
   Nowak, Jolanta
   Banach, Maciej
TI The prevalence and management of familial hypercholesterolemia in
   patients with acute coronary syndrome in the Polish tertiary centre:
   Results from the TERCET registry with 19,781 individuals
SO ATHEROSCLEROSIS
LA English
DT Article
DE Acute coronary syndrome; Familial hypercholesterolemia; Cardiovascular
   outcomes; LDL; TERCET registry
ID ARTERY-DISEASE; GUIDELINES; MUTATIONS; PROGNOSIS; COMMON; RISK
AB Background and aims: The prevalence of familial hypercholesterolemia (FH) is high among patients with stable coronary artery disease (CAD). However, data on FH on admission among patients with acute coronary syndrome (ACS) are still relatively scarce. Therefore, we aimed to assess the prevalence, lipid-lowering therapy and short-and long-term outcomes in patients with FH among ACS patients.
   Methods and results: The investigation was performed in a cohort of 19,781 consecutive patients from the TERCET Registry. There were 7319 patients admitted with ACS: 3085 due to STEMI, 2256 due to NSTEMI, and 1978 due to UA. The stable CAD group (n=12,462) was considered the reference group. Based on the personal and familial history of premature cardiovascular disease and LDL cholesterol concentration, the Dutch Lipid Clinic Network (DLCN) algorithm was used for FH diagnosis.
   The overall occurrence of probable/definite FH and possible FH was 1.2% and 13.5% respectively. Among patients with ACS, 1.6% had probable/definite FH and 17.0% possible FH. The highest occurrence of FH was observed in the STEMI subgroup (20.6%). Patients with definite and probable FH had higher 30-day mortality than patients without FH (8.2% and 3.8% vs. 2.0%, respectively; p=0.0052). No significant differences were observed between the FH groups in the 12-, 36- and 60-month follow-up. Propensity-score matching analysis showed that definite/probable FH patients had significantly higher all-cause mortality at 36- and 60-month follow-up in comparison to non-FH subjects (11.4% vs. 4.8% and 19.2% vs. 7.2%, respectively; p=0.021 for both).
   Conclusions: The prevalence of FH according to the DLCN criteria in the Polish very high-risk population is significantly higher in patients with ACS than in patients with sCAD. FH is a cause of increased all-cause mortality in the long-term follow-up.
C1 [Dyrbus, Krzysztof; Gasior, Mariusz; Desperak, Piotr; Osadnik, Tadeusz; Nowak, Jolanta] Med Univ Silesia, Chair & Dept Cardiol 3, Div Dent Zabrze, Silesian Ctr Heart Dis,Sch Med, Zabrze, Poland.
   [Osadnik, Tadeusz] Med Univ Silesia, Sch Med, Div Dent Zabrze, Chair & Dept Pharmacol, Katowice, Poland.
   [Banach, Maciej] Med Univ Lodz, WAM Univ Hosp Lodz, Dept Hypertens, Zeromskiego 113, Lodz, Poland.
   [Banach, Maciej] PMMHRI, Lodz, Poland.
   [Banach, Maciej] Univ Zielona Gora, Cardiovasc Res Ctr, Zielona Gora, Poland.
RP Dyrbus, K (reprint author), Med Univ Silesia, Chair & Dept Cardiol 3, Div Dent Zabrze, Silesian Ctr Heart Dis,Sch Med, Zabrze, Poland.
EM dyrbusk@gmail.com
RI Banach, Maciej/A-1271-2009; Osadnik, Tadeusz/P-5844-2014
OI Banach, Maciej/0000-0001-6690-6874; Osadnik, Tadeusz/0000-0002-3202-6972
NR 42
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2019
VL 288
BP 33
EP 41
DI 10.1016/j.atherosclerosis.2019.06.899
PG 9
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IW6XN
UT WOS:000485127200005
PM 31319356
DA 2019-10-28
ER

PT J
AU Chen, YL
   Yu, HP
   Zhu, JZ
   Zhang, H
   Zhao, YX
   Dong, YL
   Cui, Y
   Gong, G
   Chai, Q
   Guo, YQ
   Liu, ZD
AF Chen, Yali
   Yu, Huapeng
   Zhu, Jizheng
   Zhang, Hua
   Zhao, Yingxin
   Dong, Yuanli
   Cui, Yi
   Gong, Gary
   Chai, Qiang
   Guo, Yuqi
   Liu, Zhendong
TI Low carotid endothelial shear stress associated with cerebral small
   vessel disease in an older population: A subgroup analysis of a
   population-based prospective cohort study
SO ATHEROSCLEROSIS
LA English
DT Article
DE Cerebral small vessel disease; Hemodynamic; Shear stress; Endothelial
   function
ID WHITE-MATTER HYPERINTENSITIES; ARTERIAL STIFFNESS; SMOKING-CESSATION;
   RISK-FACTORS; BRAIN; ATHEROSCLEROSIS; MECHANISMS; PATHOLOGY; HEALTH
AB Background and aims: The association between carotid wall shear stress (WSS) and cerebral small vessel disease has yet to be fully elucidated. The major purpose of this study was to investigate this association in older subjects.
   Methods: Common carotid artery WSS, endothelial function, white matter hyperintensities (WMH), lacunes, and microbleeds were assessed in 1396 older adults. Participants were followed-up for an average of 69.7 months.
   Results: Mean (M) and peak (P) WSS and changes in endothelial function were independently associated with changes in WMH volume and fraction, lacune counts, and microbleed counts (all p < 0.05). The risks of new-incident Fazekas scale >= 2 [hazard ratio (HR) with 95% confidence interval (CI): 2.141 (1.469-3.119), p=0.005 and 1.731 (1.197-2.505), p=0.004, respectively], lacunes [HR (95% CI): 2.034 (1.369-3.022), p < 0.001 and 1.693 (1.151-2.490), p=0.003, respectively], and microbleeds [HR (95% CI): 2.311 (1.509-3.541), p < 0.001 and 2.208 (1.299-3.751), p < 0.001, respectively] were significantly higher in the lowest quartile group than in the higher quartile group, as classified by either MWSS or PWSS, after adjustment for confounders.
   Conclusions: Low carotid WSS is an independent risk factor for the progression of cerebral small vessel disease in older adults.
C1 [Chen, Yali; Zhang, Hua; Zhao, Yingxin; Chai, Qiang; Liu, Zhendong] Shandong Acad Med Sci, Inst Basic Med, Cardiocerebrovasc Control & Res Ctr, 18877 Jingshi Rd, Jinan 250062, Shandong, Peoples R China.
   [Yu, Huapeng] Fourth Peoples Hosp Jinan, Jinan Inst Cardiovasc Dis, Dept Cardiol, Jinan 250031, Shandong, Peoples R China.
   [Zhu, Jizheng] Fourth Peoples Hosp Jinan, Emergency Dept, Jinan 250031, Shandong, Peoples R China.
   [Dong, Yuanli] Lanshan Dist People Hosp, Dept Community, Linyi 276002, Shandong, Peoples R China.
   [Cui, Yi] Shandong Univ, Qilu Hosp, Dept Radiol, Jinan 250012, Shandong, Peoples R China.
   [Gong, Gary] Johns Hopkins Univ, Sch Med, Russel H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA.
   [Guo, Yuqi] Shandong Acad Med Sci, Inst Basic Med, Key Lab Rare & Uncommon Dis, Jinan 250062, Shandong, Peoples R China.
RP Liu, ZD (reprint author), Shandong Acad Med Sci, Inst Basic Med, Cardiocerebrovasc Control & Res Ctr, 18877 Jingshi Rd, Jinan 250062, Shandong, Peoples R China.; Guo, YQ (reprint author), Shandong Acad Med Sci, Inst Basic Med, Dept Microbiol, Key Lab Rare & Uncommon Dis, 18877 Jingshi Rd, Jinan 250062, Shandong, Peoples R China.
EM guoyuqiyky@126.com; zhendongliu876@126.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81670432, 81202778, 81470489]; Natural Science
   Foundation of Shandong Province, ChinaNatural Science Foundation of
   Shandong Province [ZR2016HM82, ZR2014HM098]; Key Research and
   Development Project of Shandong Province [2018GSF118044, 2017GSF218060];
   Innovation Project of the Shandong Academy of Medical Sciences
FX This work was supported by the National Natural Science Foundation of
   China (grant numbers 81670432, 81202778, and 81470489), the Natural
   Science Foundation of Shandong Province, China (grant numbers ZR2016HM82
   and ZR2014HM098), the Key Research and Development Project of Shandong
   Province (grant numbers 2018GSF118044 and 2017GSF218060), and the
   Innovation Project of the Shandong Academy of Medical Sciences.
NR 36
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2019
VL 288
BP 42
EP 50
DI 10.1016/j.atherosclerosis.2019.07.006
PG 9
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IW6XN
UT WOS:000485127200006
PM 31323461
DA 2019-10-28
ER

PT J
AU Barchuk, M
   Schreier, L
   Lopez, G
   Cevey, A
   Baldi, J
   Tome, MDF
   Goren, N
   Rubio, M
   Miksztowicz, V
   Berg, G
AF Barchuk, Magali
   Schreier, Laura
   Lopez, Graciela
   Cevey, Agata
   Baldi, Julio
   Fernandez Tome, Maria del Carmen
   Goren, Nora
   Rubio, Miguel
   Miksztowicz, Veronica
   Berg, Gabriela
TI Glycosylphosphatidylinositol-anchored high density lipoprotein-binding
   protein 1 and angiopoietin-like protein 4 are associated with the
   increase of lipoprotein lipase activity in epicardial adipose tissue
   from diabetic patients
SO ATHEROSCLEROSIS
LA English
DT Article
DE Epicardial adipose tissue; Lipoprotein lipase;
   Glycosylphosphatidylinositol-anchored high density lipoprotein-binding
   protein 1; Angiopoietin-like protein 4; Coronary artery disease
ID CORONARY-ARTERY-DISEASE; METABOLIC SYNDROME; ENDOTHELIAL-CELLS; FAT;
   EXPRESSION; HYPERGLYCEMIA; TRIGLYCERIDE; TRANSPORTER; MELLITUS; GLUCOSE
AB Background and aims: Epicardial adipose tissue (EAT) is a visceral AT, surrounding myocardium and coronary arteries. Its volume is higher in Type 2 diabetic (DM2) patients, associated with cardiovascular disease risk. Lipoprotein lipase (LPL) hydrolyses triglycerides (TG) from circulating lipoproteins, supplying fatty acids to AT, contributing to its expansion. We aimed to evaluate LPL expression and activity in EAT from DM2 and no DM2 patients, and its regulators ANGPTL4, GPIHBP1 and PPAR gamma levels, together with VLDLR expression and EAT LPL association with VLDL characteristics.
   Methods: We studied patients undergoing coronary by-pass graft (CABG) divided into CABG-DM2 (n=21) and CABG-noDM2 (n=29), and patients without CABG (No CABG, n=30). During surgery, EAT and subcutaneous AT (SAT) were obtained, in which LPL activity, gene and protein expression, its regulators and VLDLR protein levels were determined. Isolated circulating VLDLs were characterized.
   Results: EAT LPL activity was higher in CABG-DM2 compared to CABG-noDM2 and No CABG (p=0.002 and p<0.001) and in CABG-noDM2 compared to No CABG (p=0.02), without differences in its expression. ANGPTL4 levels were higher in EAT from No CABG compared to CABG-DM2 and CABG-noDM2 (p<0.001). GPIHBP1 levels were higher in EAT from CABG-DM2 and CABG-noDM2 compared to No CABG (p=0.04). EAT from CABG-DM2 presented higher PPAR gamma levels than CABG-noDM2 and No CABG (p=0.02 and p=0.03). No differences were observed in VLDL composition between groups, although EAT LPL activity was inversely associated with VLDL-TG and TG/protein index (p<0.05).
   Conclusions: EAT LPL regulation would be mainly post-translational. The higher LPL activity in DM2 could be partly responsible for the increase in EAT volume.
C1 [Barchuk, Magali; Schreier, Laura; Lopez, Graciela; Miksztowicz, Veronica; Berg, Gabriela] Univ Buenos Aires, Inst Fisiopatol & Bioquim Clin INFIBIOC, Lab Lipidos & Aterosclerosis, Fac Farm & Bioquim,Dept Bioquim Clin, Buenos Aires, DF, Argentina.
   [Cevey, Agata; Goren, Nora] Univ Buenos Aires, Inst Invest Biomed Retrovirus & SIDA INBIRS, Fac Med, CONICET, Buenos Aires, DF, Argentina.
   [Baldi, Julio; Rubio, Miguel] Univ Buenos Aires, Hosp Clin Jose de San Martin, Div Cirugia Cardiaca, Buenos Aires, DF, Argentina.
   [Fernandez Tome, Maria del Carmen] Univ Buenos Aires, Inst Quim & Fisicoquim Biol IQUIFIB, Catedra Biol Celular & Mol, Fac Farm & Bioquim,CONICET, Buenos Aires, DF, Argentina.
   [Miksztowicz, Veronica; Berg, Gabriela] Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Buenos Aires, DF, Argentina.
RP Berg, G (reprint author), Junin 956, Buenos Aires, DF, Argentina.
EM gaberg@ffyb.uba.ar
OI Berg, Gabriela/0000-0002-5787-8960
FU Agencia Nacional de Promocion Cientifica y TecnologicaANPCyT [PICT
   0920-2016]; Universidad de Buenos AiresUniversity of Buenos Aires
   [UBACYT 20020150-100042BA]; Sociedad Argentina de Diabetes [SAD
   2017-2018]; Fundacion Roemmers
FX This work was supported by the Agencia Nacional de Promocion Cientifica
   y Tecnologica (Grant number: PICT 0920-2016), the Universidad de Buenos
   Aires (Grant number: UBACYT 20020150-100042BA), the Sociedad Argentina
   de Diabetes (Grant number: SAD 2017-2018) and the Fundacion Roemmers
   (Grant number: Roemmers 2016-2018).
NR 46
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2019
VL 288
BP 51
EP 59
DI 10.1016/j.atherosclerosis.2019.06.915
PG 9
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IW6XN
UT WOS:000485127200007
PM 31323462
DA 2019-10-28
ER

PT J
AU Anholm, C
   Kumarathurai, P
   Pedersen, LR
   Samkani, A
   Walzem, RL
   Nielsen, OW
   Kristiansen, OP
   Fenger, M
   Madsbad, S
   Sajadieh, A
   Haugaard, SB
AF Anholm, Christian
   Kumarathurai, Preman
   Pedersen, Lene Rorholm
   Samkani, Amirsalar
   Walzem, Rosemary L.
   Nielsen, Olav Wendelboe
   Kristiansen, Ole Peter
   Fenger, Mogens
   Madsbad, Sten
   Sajadieh, Ahmad
   Haugaard, Steen Bendix
TI Liraglutide in combination with metformin may improve the atherogenic
   lipid profile and decrease C-reactive protein level in statin treated
   obese patients with coronary artery disease and newly diagnosed type 2
   diabetes: A randomized trial
SO ATHEROSCLEROSIS
LA English
DT Article
DE Lipoprotein; GLP-1; Liraglutide; Low-grade inflammation
ID CARDIOVASCULAR RISK BIOMARKERS; NECROSIS-FACTOR-ALPHA; INSULIN
   SENSITIVITY; EFFICACY; SAFETY; SIZE; ATHEROSCLEROSIS; DYSLIPIDEMIA;
   ASSOCIATION; PREVENTION
AB Background and aims: Atherosclerosis in obesity and type 2 diabetes (T2DM) is associated with low-grade inflammation (LGI) and dyslipidemia, where especially small, dense lipoprotein particles are atherogenic. The glucagon-like peptide-1 receptor agonist, liraglutide, reduces cardiovascular events by poorly understood mechanisms. We investigated the effect of liraglutide combined with metformin on LGI and lipoprotein density profiles in patients with stable coronary artery disease (CAD) and newly diagnosed T2DM.
   Methods: We conducted a randomized, double-blind, placebo-controlled, cross-over trial over a 12 + 12-week period, with >= 2-week wash-out. Intervention: liraglutide/metformin vs. placebo/metformin. Lipoproteins were separated by continuous density gradient ultracentrifugation, and LDL divided into five subfractions between 226 and 270 angstrom, considering particle size <= 255 angstrom as the atherogenic pattern. Plasma C-reactive protein and tumor necrosis factor-alpha were assessed by the enzyme-linked immunosorbent-assay.
   Results: 28 out of 41 randomized patients completed all visits. Intention-to-treat analysis was performed but one patient had statin dosage and was excluded from the analysis. 95% of the patients were on statin therapy. Overall, liraglutide did not affect lipid subfractions or markers of LGI compared to placebo. The combination of liraglutide and metformin reduced the total LDL subfractions, primarily by reducing the most atherogenic subfraction LDL5, and reduced CRP but not TNF-alpha. Explorative analyses suggested that the subfraction LDL5 during the wash-out period rebounded significantly at least in a per-protocol analysis of the sub-group of patients starting the liraglutide therapy.
   Conclusions: In patients with CAD and newly diagnosed T2DM on stable statin therapy, liraglutide combined with metformin may improve the atherogenic LDL lipid profile and CRP.
C1 [Anholm, Christian] Copenhagen Univ Hosp, Dept Internal Med, Nordre Ringvej 57, DK-2600 Glostrup, Denmark.
   [Anholm, Christian; Haugaard, Steen Bendix] Copenhagen Univ Hosp, Dept Internal Med, Amager, Denmark.
   [Kumarathurai, Preman; Pedersen, Lene Rorholm; Nielsen, Olav Wendelboe; Kristiansen, Ole Peter; Sajadieh, Ahmad] Copenhagen Univ Hosp, Dept Cardiol, Bispebjerg, Denmark.
   [Samkani, Amirsalar; Haugaard, Steen Bendix] Copenhagen Univ Hosp, Dept Endocrinol, Bispebjerg, Denmark.
   [Walzem, Rosemary L.] Texas A&M Univ, Dept Poultry Sci, College Stn, TX 77843 USA.
   [Walzem, Rosemary L.] Texas A&M Univ, Fac Nutr, College Stn, TX USA.
   [Fenger, Mogens] Copenhagen Univ Hosp, Dept Clin Biochem, Hvidovre, Denmark.
   [Madsbad, Sten] Copenhagen Univ Hosp, Dept Endocrinol, Hvidovre, Denmark.
RP Anholm, C (reprint author), Copenhagen Univ Hosp, Dept Internal Med, Nordre Ringvej 57, DK-2600 Glostrup, Denmark.
EM canholm@youmail.dk
FU Novo NordiskNovo Nordisk; Danish Heart Foundation; AP Moller Foundation;
   Department of Internal Medicine, Copenhagen University Hospital, Amager;
   Clinical Research Centre, Copenhagen University Hospital, Hvidovre;
   Bispebjerg Hospital Research Foundation
FX The study was funded by Novo Nordisk with an unrestricted grant for
   investigator-initiated studies. Additional funding was provided by: The
   Danish Heart Foundation, The AP Moller Foundation, The Department of
   Internal Medicine, Copenhagen University Hospital, Amager, The Clinical
   Research Centre, Copenhagen University Hospital, Hvidovre and The
   Bispebjerg Hospital Research Foundation.
NR 48
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2019
VL 288
BP 60
EP 66
DI 10.1016/j.atherosclerosis.2019.07.007
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IW6XN
UT WOS:000485127200008
PM 31326727
DA 2019-10-28
ER

PT J
AU Pandey, GK
   Vadivel, S
   Raghavan, S
   Mohan, V
   Balasubramanyam, M
   Gokulakrishnan, K
AF Pandey, Gautam Kumar
   Vadivel, Sangeetha
   Raghavan, Srividhya
   Mohan, Viswanathan
   Balasubramanyam, Muthuswamy
   Gokulakrishnan, Kuppan
TI High molecular weight adiponectin reduces glucolipotoxicity-induced
   inflammation and improves lipid metabolism and insulin sensitivity via
   APPL1-AMPK-GLUT4 regulation in 3T3-L1 adipocytes
SO ATHEROSCLEROSIS
LA English
DT Article
DE Obesity; Type 2 diabetes; Inflammation; Glucolipotoxicity; Lipid
   metabolism; Insulin resistance; High molecular weight adiponectin
ID GLUCOSE-UPTAKE; APPL1; RECEPTORS; BINDING; OBESITY; DIFFERENTIATION;
   INHIBITION; EXPRESSION; RESISTANCE; IMMUNITY
AB Background and aims: Although the importance of adipokines in modulating the disease process of type 2 diabetes is well recognized, there is dearth of data on the specific role of high molecular weight adiponectin (HMW Ad) on insulin resistance and obesity. Therefore, we tested the effects of HMW Ad on glucolipotoxcity-induced inflammation and insulin resistance in 3T3-L1 adipocytes.
   Methods: 3T3-L1 adipocytes were subject to glucolipotoxicity with and without HMW Ad treatment. Real-time PCR and Western-blot experiments were performed to analyse gene and protein expressions, respectively. Lipolysis, adipored staining, and glucose uptake assay were performed to evaluate alterations in lipid and glucose metabolism.
   Results: Adipocytes subject to glucolipotoxicity showed significantly (p < 0.05) decreased mRNA expression of adiponectin, AdipoR2, GLUT4, and increased inflammation, lipid accumulation as well as lipolysis. Treatment with HMW Ad beneficially modulated lipid metabolism, reduced inflammation and improved glucose uptake in adipocytes. HMW Ad also beneficially regulated APPL1 and AMPK signaling in adipocytes. Silencing of APPL1 gene in adipocytes significantly reduced the effects of HMW Ad on pAMPK protein expression, indicating that HMW Ad plays an important role in regulating AMPK phosphorylation via APPL1 in 3T3-L1 adipocytes.
   Conclusions: HMW Ad treatment improved glucose homeostasis and resulted in reduced lipolysis, inflammation and insulin resistance in adipocytes subject to glucolipotoxicity. The beneficial modulation and regulation of APPL1 and AMPK signals by HMW Ad observed in this study represent a novel mechanism. Raising endogenous HMW Ad levels either by pharmacological or lifestyle modification could have a therapeutic value.
C1 [Pandey, Gautam Kumar; Vadivel, Sangeetha; Mohan, Viswanathan; Balasubramanyam, Muthuswamy; Gokulakrishnan, Kuppan] Madras Diabet Res Fdn, Dept Res Biochem, Chennai 600086, Tamil Nadu, India.
   [Raghavan, Srividhya] Madras Diabet Res Fdn, Dept Cell & Mol Biol, Chennai 600086, Tamil Nadu, India.
   [Gokulakrishnan, Kuppan] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurochem, Hosur Rd, Bengaluru 560029, India.
RP Gokulakrishnan, K (reprint author), Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurochem, Inst Natl Importance, Hosur Rd, Bengaluru 560029, India.
EM gokulmdrf@gmail.com
FU Department of Science and Technology (DST), Govt. of IndiaDepartment of
   Science & Technology (India)Government of India [SERC/LS-109/2011];
   Council of Scientific & Industrial Research (CSIR), IndiaCouncil of
   Scientific & Industrial Research (CSIR) - India
FX Authors acknowledge grant support from the Department of Science and
   Technology (DST), Govt. of India for funding this work (Grant No
   SERC/LS-109/2011). Gautam Kumar Pandey acknowledges the Council of
   Scientific & Industrial Research (CSIR), India for his financial
   assistance (Senior Research Fellowship).
NR 40
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2019
VL 288
BP 67
EP 75
DI 10.1016/j.atherosclerosis.2019.07.011
PG 9
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IW6XN
UT WOS:000485127200009
PM 31330381
DA 2019-10-28
ER

PT J
AU Zhang, J
   Chen, J
   Yang, J
   Xu, CW
   Hu, Q
   Wu, H
   Cai, WY
   Guo, Q
   Gao, WQ
   He, C
   Yang, CJ
   Yang, J
AF Zhang, Jing
   Chen, Jing
   Yang, Jun
   Xu, Changwu
   Hu, Qi
   Wu, Hui
   Cai, Wanyin
   Guo, Qing
   Gao, Wenqi
   He, Chao
   Yang, Chaojun
   Yang, Jian
TI Suv39h1 downregulation inhibits neointimal hyperplasia after vascular
   injury
SO ATHEROSCLEROSIS
LA English
DT Article
DE Suv39h1; Neointimal hyperplasia; Id3; p21; p27Kip1
ID SMOOTH-MUSCLE-CELLS; LOOP-HELIX PROTEINS; HISTONE METHYLATION; GENE;
   ID3; PROLIFERATION; TRANSCRIPTION; FIBRONECTIN; P21(WAF1); PROMOTES
AB Background and aims: Neointimal hyperplasia resulting from pathological vascular smooth muscle cells (VSMCs) activation is a common pathophysiological basis for numerous proliferative vascular diseases, such as restenosis. Suv39h1, an important transcription suppressor, may be involved in this process. Herein, we investigated the role of Suv39h1 in pathological intimal hyperplasia and its possible mechanisms in vitro and in vivo.
   Methods: An adenovirus vector for Suv39h1 overexpression and a lentiviral vector for its downregulation were constructed and used to transfect cultured VSMCs in vitro. The functional changes in VSMCs stimulated by angiotensin II (Ang II) were observed and the possible mechanism was investigated. Additionally, rat carotid arteries with balloon injury were locally transfected with these viral vectors and changes in neointima formation, proliferating cell nuclear antigen (Pcna) expression and collagen deposition were examined.
   Results: Upon Ang II stimulation, the expression of Suv39h1 and inhibitor of DNA binding 3 (Id3) was significantly increased. Suv39h1 downregulation inhibited Ang II-stimulated migration and proliferation of VSMCs, antagonized the production of Id3 and promoted p21 and p27Kip1 expression. In contrast, Suv39h1 overexpression had the opposite effects. Suv39h1 regulated the transcription of p21 and p27Kip1 by controlling H3K9me3 in the proximal promoter regions. Consistent with the VSMCs results, Suv39h1 and Id3 expression was significantly increased in blood vessels after balloon injury. Suv39h1 downregulation inhibited intimal hyperplasia, and attenuated Pcna expression and collagen synthesis in the intima, while Suv39h1 overexpression had the opposite effects.
   Conclusions: Suv39h1 downregulation effectively inhibited neointimal hyperplasia after vascular injury.
C1 [Zhang, Jing; Cai, Wanyin; Gao, Wenqi; Yang, Chaojun] China Three Gorges Univ, Coll Clin Med Sci 1, Cent Lab, Yichang 443003, Peoples R China.
   [Zhang, Jing; Yang, Jun; Wu, Hui; Cai, Wanyin; Guo, Qing; Gao, Wenqi; He, Chao; Yang, Chaojun; Yang, Jian] Yichang Cent Peoples Hosp, Yiling Rd, Yichang 443003, Peoples R China.
   [Zhang, Jing; Yang, Jun; Wu, Hui; He, Chao; Yang, Jian] China Three Gorges Univ, Coll Clin Med Sci 1, Dept Cardiol, Yiling Rd, Yichang 443003, Peoples R China.
   [Chen, Jing; Xu, Changwu; Hu, Qi] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430060, Hubei, Peoples R China.
   [Guo, Qing] China Three Gorges Univ, Coll Clin Med Sci 1, Dept Ophthalmol, Yichang 443003, Peoples R China.
RP Yang, J (reprint author), Yichang Cent Peoples Hosp, Yiling Rd, Yichang 443003, Peoples R China.; Yang, J (reprint author), China Three Gorges Univ, Coll Clin Med Sci 1, Dept Cardiol, Yiling Rd, Yichang 443003, Peoples R China.
EM yangjian@ctgu.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81500230, 81470387, 81770360, 81670333, 81770456,
   81600234]; Hubei Province Health and Family Planning Scientific Research
   Project [WJ2019Z004]; Hubei Provincial Natural Science Foundation
   [2018CFA044]
FX This work was supported by the National Natural Science Foundation of
   China (81500230, 81470387, 81770360, 81670333, 81770456, 81600234),
   Hubei Province Health and Family Planning Scientific Research Project
   (WJ2019Z004), and Hubei Provincial Natural Science Foundation
   (2018CFA044).
NR 34
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2019
VL 288
BP 76
EP 84
DI 10.1016/j.atherosclerosis.2019.06.909
PG 9
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IW6XN
UT WOS:000485127200010
PM 31330382
DA 2019-10-28
ER

PT J
AU Vallejo-Vaz, AJ
   Ray, KK
   Ginsberg, HN
   Davidson, MH
   Eckel, RH
   Lee, LV
   Bessac, L
   Pordy, R
   Letierce, A
   Cannon, CP
AF Vallejo-Vaz, Antonio J.
   Ray, Kausik K.
   Ginsberg, Henry N.
   Davidson, Michael H.
   Eckel, Robert H.
   Lee, L. Veronica
   Bessac, Laurence
   Pordy, Robert
   Letierce, Alexia
   Cannon, Christopher P.
TI Associations between lower levels of low-density lipoprotein cholesterol
   and cardiovascular events in very high-risk patients: Pooled analysis of
   nine ODYSSEY trials of alirocumab versus control
SO ATHEROSCLEROSIS
LA English
DT Article
DE PCSK9; Low-density lipoprotein cholesterol; Cardiovascular disease;
   Diabetes mellitus; Renal disease
ID LDL CHOLESTEROL; EFFICACY; SAFETY; EZETIMIBE; DISEASE;
   HYPERCHOLESTEROLEMIA; GUIDELINES; MANAGEMENT; THERAPY
AB Background and aims: Guidelines recommend high-intensity statins for patients with atherosclerotic cardiovascular disease (ASCVD). Subgroups with comorbidities that increase cardiovascular risk, such as diabetes mellitus (DM), chronic kidney disease (CKD) or polyvascular disease (PoVD), may derive greater absolute benefit from addition of non-statin therapies. We assessed the relationship between lower low-density lipoprotein cholesterol (LDL-C) and major adverse cardiovascular events (MACE) risk reduction during alirocumab phase III ODYSSEY trials among these subgroups.
   Methods: Patient data were pooled from nine trials comparing alirocumab with control (placebo/ezetimibe), predominantly on background maximally tolerated statin. Patients with baseline ASCVD were stratified into subgroups with DM, CKD or PoVD, or without comorbidities, and between-group relative and absolute benefits were compared.
   Results: Among 3505 patients with ASCVD, 1573 had no comorbidities, 981 had DM, 660 had CKD and 943 had PoVD, with overlap between comorbidities; mean baseline LDL-C levels were 119 (ASCVD overall), 123, 117, 114 and 113 mg/dL, respectively. Overall, each 39 mg/dL lower on-study LDL-C was associated with a 25% lower MACE risk, hazard ratio 0.75 (95% confidence interval, 0.62-0.90, p = 0.0023), with a similar lower risk observed in each very high-risk subgroup (DM, CKD or PoVD; 30-35%) but not in the subgroup without these comorbidities (9%). Absolute benefits were greater for very high-risk subgroups; lowering LDL-C from 120 to 40 mg/dL would result in 2.76-4.35 fewer MACE/100 patient-years versus 0.3 for no comorbidities.
   Conclusions: Among patients with ASCVD and mean baseline LDL-C > 100 mg/dL, patients with DM, CKD or PoVD appeared to derive greater absolute cardiovascular benefits from further LDL-C reduction than those without.
C1 [Vallejo-Vaz, Antonio J.; Ray, Kausik K.] Imperial Coll London, Imperial Ctr Cardiovasc Dis Prevent, London, England.
   [Ginsberg, Henry N.] Columbia Univ, New York, NY USA.
   [Davidson, Michael H.] Univ Chicago Med, Dept Med, Chicago, IL USA.
   [Eckel, Robert H.] Univ Colorado, Anschutz Med Campus, Aurora, CO USA.
   [Lee, L. Veronica] Sanofi, Bridgewater, NJ USA.
   [Bessac, Laurence] Sanofi, Paris, France.
   [Pordy, Robert] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.
   [Letierce, Alexia] Sanofi, Chilly Mazarin, France.
   [Cannon, Christopher P.] Brigham & Womens Hosp, Cardiovasc Div, 75 Francis St, Boston, MA 02115 USA.
RP Vallejo-Vaz, AJ (reprint author), Imperial Coll, Sch Publ Hlth, Dept Primary Care & Publ Hlth, Imperial Ctr Cardiovasc Dis Prevent, Reynolds Bldg,St Dunstans Rd, London W6 8RP, England.
EM a.vallejo-vaz@imperial.ac.uk
RI Keskin, Kudret/AAB-8198-2019
OI Keskin, Kudret/0000-0002-9049-1530
FU SanofiSanofi-Aventis; Regeneron Pharmaceuticals, Inc.
FX This analysis was funded by Sanofi and Regeneron Pharmaceuticals, Inc.
NR 25
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2019
VL 288
BP 85
EP 93
DI 10.1016/j.atherosclerosis.2019.07.008
PG 9
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IW6XN
UT WOS:000485127200011
PM 31349086
OA Other Gold, Green Published
DA 2019-10-28
ER

PT J
AU Kabootari, M
   Hasheminia, M
   Guity, K
   Ramezankhani, A
   Azizi, F
   Hadaegh, F
AF Kabootari, Maryam
   Hasheminia, Mitra
   Guity, Kamran
   Ramezankhani, Azra
   Azizi, Fereidoun
   Hadaegh, Farzad
TI Gestational diabetes mellitus in mothers and long term cardiovascular
   disease in both parents: Results of over a decade follow-up of the
   Iranian population
SO ATHEROSCLEROSIS
LA English
DT Article
DE Gestational diabetes mellitus; Cardiovascular disease; Spousal
   concordance
ID SPOUSAL CONCORDANCE; INCREASED RISK; HYPERTENSION; WOMEN; COUPLES;
   COHORT
AB Background and aims: We aimed at evaluating whether the presence of gestational diabetes mellitus (GDM) in mothers is associated with increased risk of incident cardiovascular disease (CVD) in both mothers and fathers.
   Methods: In this population-based study, 4308 Iranian women, aged 18-64 years, with at least 1 live-birth delivery, and free of CVD at baseline, were followed. Corresponding spouses were identified in 2547 cases. The association between history of GDM and incident CVD was assessed using multivariate Cox's proportional hazard in 3 models: model 1, unadjusted; model 2, adjusted for age, body mass index, smoking (for men), maternal parity, miscarriage, physical activity, hypertension and hypercholesterolemia, and model 3, further adjusted for diabetes mellitus.
   Results: After a median follow-up of 14.1 years, 314 mothers and 424 fathers experienced CVD. Women with history of GDM had an adjusted hazard ratio (HR), 95% CI of 1.85 (1.38-2.48) and 1.29 (0.96-1.75) for CVD in models 1 and 2, respectively. Furthermore, an independent association with CVD was observed in fathers with an adjusted HR of 1.35 (1.02-1.79) in the confounder adjusted model and even after further controlling for diabetes [1.36 (1.03-1.80)]. Moreover, all traditional risk factors, excluding BMI, showed an independent risk for CVD in both genders.
   Conclusions: Women with prior GDM showed an increased risk of CVD that was not independent of important CVD risk factors. However, among men, spousal history of GDM was an independent risk factor for incident CVD, even after considering important traditional risk factors, including diabetes.
C1 [Kabootari, Maryam] Golestan Univ Med Sci, Metab Disorders Res Ctr, Gorgan, Golestan, Iran.
   [Kabootari, Maryam; Hasheminia, Mitra; Ramezankhani, Azra; Hadaegh, Farzad] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, 24 Yamen St, Tehran 193954763, Iran.
   [Guity, Kamran] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Cellular & Mol Endocrine Res Ctr, Tehran, Iran.
   [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran.
RP Hadaegh, F (reprint author), Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, 24 Yamen St, Tehran 193954763, Iran.
EM fzhadaegh@endocrine.ac.ir
RI azizi, Fereidoun/K-1572-2017
OI azizi, Fereidoun/0000-0002-6470-2517
NR 34
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2019
VL 288
BP 94
EP 100
DI 10.1016/j.atherosclerosis.2019.07.016
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IW6XN
UT WOS:000485127200012
PM 31352273
DA 2019-10-28
ER

PT J
AU Surendran, A
   Zhang, H
   Winter, T
   Edel, A
   Aukema, H
   Ravandi, A
AF Surendran, Arun
   Zhang, Hannah
   Winter, Tanja
   Edel, Andrea
   Aukema, Harold
   Ravandi, Amir
TI Oxylipin profile of human low-density lipoprotein is dependent on its
   extent of oxidation
SO ATHEROSCLEROSIS
LA English
DT Article
DE Oxylipins; LDL; Atherosclerosis; Mass spectrometry; Lipids
ID ARACHIDONIC-ACID; FATTY-ACID; LIPID-PEROXIDATION; ESTERIFIED
   EICOSANOIDS; DOCOSAHEXAENOIC ACID; PROTEIN OXIDATION; COPPER; PRODUCTS;
   LDL; QUANTIFICATION
AB Background and aims: Atherosclerosis is usually the underlying cause of heart attacks, strokes and peripheral vascular diseases - collectively known as cardiovascular diseases. Oxidation of low density lipoprotein (LDL) and its lipid content has an important role in the formation of lipid-laden atherosclerotic plaques. Not much is known about the impact of oxidative stress on bioactive oxylipin molecules present in LDL. The aim of this study is to understand the changes in oxylipin molecules present in LDL characterized by varying degrees of LDL oxidation.
   Methods: LDL was isolated from the pooled plasma of healthy normolipidemic volunteers and was subjected to in vitro copper-catalyzed oxidation for varying time intervals (0 h, 6 h, 12 h, 24 h and 30 h). At each time interval, oxylipins were isolated through solid phase extraction and quantified using a targeted LC/-MS/MS approach employing stable isotope dilution method.
   Results: Our results demonstrate that different forms of oxidized LDL (OxLDL) are characterized by specific oxylipin distribution and concentration. Compared to non-oxidized LDL, there is a significant increase in oxylipin generation (p <= 0.05) in OxLDL subjected to 12 h and 24 h of oxidation. Though linoleate derived oxylipins are the most abundant in OxLDL extracts, the concentration of particular oxylipin species differed with different degrees of oxidation. Specifically, two pro-inflammatory linoleate-derived triols, namely 9,10,13-triHOME and 9,12,13-triHOME, exhibited a concentration increase of similar to 25 fold in 12h-OxLDL compared to non-oxidized LDL. Moreover, Partial least squares Discriminant Analysis (PLS-DA) identified 10 oxylipins, primarily prostaglandins, which could serve as additional biomarkers for oxidative stress or cardiovascular risk assessment.
   Conclusions: Our data suggests that oxidative stress induces profound changes in the oxylipin content of LDL and the pattern of change is based on the extent of oxidation.
C1 [Surendran, Arun; Zhang, Hannah; Edel, Andrea; Ravandi, Amir] Univ Manitoba, St Boniface Hosp, Res Ctr, Inst Cardiovasc Sci, Winnipeg, MB, Canada.
   [Winter, Tanja; Aukema, Harold] Univ Manitoba, Dept Food & Human Nutr Sci, Winnipeg, MB, Canada.
   [Surendran, Arun; Ravandi, Amir] Univ Manitoba, Dept Physiol & Pathophysiol, Winnipeg, MB, Canada.
RP Ravandi, A (reprint author), St Boniface Gen Hosp, 409 Tache Ave, Winnipeg, MB R2H 2A6, Canada.
EM aravandi@sbgh.mb.ca
OI /0000-0001-6663-1225
FU Research Manitoba, Canada; Heart and Stroke Foundation of CanadaHeart &
   Stroke Foundation of Canada
FX This work was supported by Research Manitoba, Canada for Arun Surendran,
   Research Manitoba, Canada for Dr. Amir Ravandi and Heart and Stroke
   Foundation of Canada for Dr. Amir Ravandi.
NR 54
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2019
VL 288
BP 101
EP 111
DI 10.1016/j.atherosclerosis.2019.07.018
PG 11
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IW6XN
UT WOS:000485127200013
PM 31352271
DA 2019-10-28
ER

PT J
AU Lim, DH
   Lee, Y
   Park, GM
   Choi, SW
   Kim, YG
   Lee, SW
   Kim, YH
   Yang, DH
   Kang, JW
   Lim, TH
   Kim, HK
   Choe, J
   Hong, S
   Kim, YG
   Lee, CK
   Yoo, B
AF Lim, Doo-Ho
   Lee, Yongjik
   Park, Gyung-Min
   Choi, Seung Won
   Kim, Yong-Giun
   Lee, Seung-Whan
   Kim, Young-Hak
   Yang, Dong Hyun
   Kang, Joon-Won
   Lim, Tae-Hwan
   Kim, Hong-Kyu
   Choe, Jaewon
   Hong, Seokchan
   Kim, Yong-Gil
   Lee, Chang-Keun
   Yoo, Bin
TI Serum uric acid level and subclinical coronary atherosclerosis in
   asymptomatic individuals: An observational cohort study
SO ATHEROSCLEROSIS
LA English
DT Article
DE Uric acid; Hyperuricemia; Coronary artery disease; Atherosclerosis;
   Coronary computed tomography angiography
ID COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CARDIOVASCULAR-DISEASE; RISK; PLAQUES;
   HYPERURICEMIA; ASSOCIATION; CALCIUM
AB Background and aims: There are limited data on the association between serum uric acid (SUA) level and subclinical coronary atherosclerosis. This study investigated the influence of SUA level on subclinical coronary atherosclerosis, as detected by coronary computed tomography angiography (CCTA), in an asymptomatic population.
   Methods: We evaluated 6431 asymptomatic individuals (mean age 53.6 +/- 7.6 years, 4691 men [72.9%]) with no prior history of coronary artery disease, who voluntarily underwent laboratory tests and CCTA as part of a general health examination. The participants were stratified into quartiles according to their SUA levels. Coronary atherosclerotic plaques (calcified, mixed, and non-calcified plaques) were assessed using CCTA. Logistic regression analysis was used to determine the association between SUA levels and subclinical coronary atherosclerosis.
   Results: The prevalence of any atherosclerotic, calcified, mixed, and non-calcified plaques increased with SUA quartiles (all p < 0.001). After adjustment for cardiovascular risk factors, there were no statistically significant differences in the adjusted odds ratios for calcified plaque (1.19; 95% CI 0.98-1.46; p = 0.080) and mixed plaque (1.25; 95% CI 0.94-1.67; p = 0.132) in the fourth SUA quartile compared to the first quartile. However, the adjusted odds ratios for any atherosclerotic plaque (1.39; 95% CI 1.16-1.68; p < 0.001) and non-calcified plaque (1.38; 95% CI 1.11-1.72; p = 0.004) were significantly higher in the fourth SUA quartile.
   Conclusions: In asymptomatic individuals, high SUA level was an independent predictor of non-calcified plaques, suggesting an increased cardiovascular risk.
C1 [Lim, Doo-Ho; Choi, Seung Won] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Rheumatol, Ulsan, South Korea.
   [Lee, Yongjik] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Thorac & Cardiovasc Surg, Ulsan, South Korea.
   [Park, Gyung-Min; Kim, Yong-Giun] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Cardiol, 877 Bangeojinsunhwando Ro, Ulsan 44033, South Korea.
   [Lee, Seung-Whan; Kim, Young-Hak] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol, Seoul, South Korea.
   [Yang, Dong Hyun; Kang, Joon-Won; Lim, Tae-Hwan] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea.
   [Kim, Hong-Kyu; Choe, Jaewon; Hong, Seokchan] Univ Ulsan, Coll Med, Asan Med Ctr, Hlth Screening & Promot Ctr, Seoul, South Korea.
   [Kim, Yong-Gil; Lee, Chang-Keun; Yoo, Bin] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Rheumatol, Seoul, South Korea.
RP Park, GM (reprint author), Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Cardiol, 877 Bangeojinsunhwando Ro, Ulsan 44033, South Korea.
EM min8684@hanmail.net
OI Lim, Doo-Ho/0000-0002-8012-7364
FU Basic Science Research Program through the National Research Foundation
   of Korea - Ministry of Education [2018R1D1A3B07043344]
FX This research was supported by Basic Science Research Program through
   the National Research Foundation of Korea funded by the Ministry of
   Education (2018R1D1A3B07043344).
NR 19
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2019
VL 288
BP 112
EP 117
DI 10.1016/j.atherosclerosis.2019.07.017
PG 6
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IW6XN
UT WOS:000485127200014
PM 31352272
DA 2019-10-28
ER

PT J
AU Im, E
   Lee, SY
   Hong, SJ
   Ahn, CM
   Kim, JS
   Kim, BK
   Ko, YG
   Choi, D
   Jang, Y
   Hong, MK
AF Im, Eui
   Lee, Seung-Yul
   Hong, Sung-Jin
   Ahn, Chul-Min
   Kim, Jung-Sun
   Kim, Byeong-Keuk
   Ko, Young-Guk
   Choi, Donghoon
   Jang, Yangsoo
   Hong, Myeong-Ki
TI Impact of late stent malapposition after drug-eluting stent implantation
   on long-term clinical outcomes
SO ATHEROSCLEROSIS
LA English
DT Article
DE Drug-eluting stent; Optical coherence tomography; Coronary artery
   disease
ID OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; EARLY
   STRUT COVERAGE; INTRAVASCULAR ULTRASOUND; FOLLOW-UP; EVEROLIMUS;
   ANGIOGRAPHY; BIOLIMUS; MECHANISMS; 3-MONTH
AB Background and aims: The impact of late drug-eluting stent (DES) malapposition detected by optical coherence tomography (OCT) on long-term clinical outcomes has not been clearly established. We evaluated long-term clinical outcomes of late stent malapposition (LSM) detected by OCT in a qualified study population.
   Methods: A total of 428 patients were selected from previous randomized OCT studies that evaluated the degree of strut coverage of different DESs at a 3-12-month follow-up OCT examination. These patients were assigned to one of two groups based on the presence (n = 136) or absence (n = 292) of LSM on follow-up OCT images (performed at 7.0 +/- 3.4 months after DES implantation). The cumulative rates of composite events (cardiac death, target-vessel-related myocardial infarction, target-vessel revascularization, and stent thrombosis) were compared between the two groups.
   Results: During 73.7 +/- 18.3 months of follow-up, cardiac death or (very) late stent thrombosis did not occur in either group. The cumulative rate of composite events was similar among the patients in each group (6.2% in patients with LSM vs. 11.7% in those without LSM) [hazard ratio (HR) = 0.569, 95% confidence interval (CI) = 0.257-1.257, p = 0.163]. Target vessel-related myocardial infarction occurred in 0.7% of patients with LSM vs. 1.5% of those without LSM (HR = 0.521, 95% CI = 0.058-4.670, p = 0.560). Target-vessel revascularization was performed in 5.4% of patients with LSM vs. 10.2% of those without LSM (HR = 0.574, 95% CI = 0.246-1.343, p = 0.201).
   Conclusions: Cardiac death or (very) late stent thrombosis did not occur in patients with OCT-detected LSM during long-term follow-up. The presence of OCT-detected LSM was not associated with adverse clinical events.
C1 [Im, Eui] Yonsei Univ Hlth Syst, Yongin Severance Hosp, Yongin, South Korea.
   [Lee, Seung-Yul] Wonkwang Univ, Coll Med, Sanbon Hosp, Gunpo, South Korea.
   [Hong, Sung-Jin; Ahn, Chul-Min; Kim, Jung-Sun; Kim, Byeong-Keuk; Ko, Young-Guk; Choi, Donghoon; Jang, Yangsoo; Hong, Myeong-Ki] Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Seoul, South Korea.
RP Hong, MK (reprint author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, Yonsei Ro 50-1, Seoul 03722, South Korea.
EM mkhong61@yuhs.ac
OI Kim, Jung-Sun/0000-0003-2263-3274
FU Korea Health Technology Research & Development Project through the Korea
   Health Industry Development Institute - Ministry of Health & Welfare,
   Republic of Korea [HI17C0882, HI16C2211, HI15C2782]; Bio & Medical
   Technology Development Program of the National Research Foundation -
   Korean government [2015M3A9C6031514]; Cardiovascular Research Center,
   Seoul, Korea
FX This work was supported by grants from the Korea Health Technology
   Research & Development Project through the Korea Health Industry
   Development Institute, funded by the Ministry of Health & Welfare,
   Republic of Korea (No. HI17C0882, HI16C2211, and HI15C2782), the Bio &
   Medical Technology Development Program of the National Research
   Foundation funded by the Korean government (No. 2015M3A9C6031514), and
   the Cardiovascular Research Center, Seoul, Korea.
NR 23
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2019
VL 288
BP 118
EP 123
DI 10.1016/j.atherosclerosis.2019.07.014
PG 6
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IW6XN
UT WOS:000485127200015
PM 31357039
DA 2019-10-28
ER

PT J
AU Dai, F
   Qi, Y
   Guan, W
   Meng, GL
   Liu, ZG
   Zhang, T
   Yao, WJ
AF Dai, Fan
   Qi, Yan
   Guan, Wei
   Meng, Guoliang
   Liu, Zhaoguo
   Zhang, Ting
   Yao, Wenjuan
TI RhoGDI stability is regulated by SUMOylation and ubiquitination via the
   AT1 receptor and participates in Ang II-induced smooth muscle
   proliferation and vascular remodeling
SO ATHEROSCLEROSIS
LA English
DT Article
DE RhoGDI; SUMOylation; Ubiquitination; Angiotensin II; Vascular remodeling
ID INDUCED HYPERTROPHIC RESPONSES; ANGIOTENSIN-II; PROTEOMIC ANALYSIS;
   PROGRESSION; SUMO; IDENTIFICATION; ACTIVATION; STRESS; ALPHA; RAT
AB Background and aims: The physiological role of Rho-specific guanine nucleotide dissociation inhibitor (RhoGDI) in vascular remodeling remains unknown. We investigated the function of RhoGDI in angiotensin II (Ang II)-induced vascular remodeling in cultured human aortic vascular smooth muscle cells (HA-VSMCs) and in an Ang II-infusion vascular remodeling mouse model.
   Methods: For in vitro assays of HA-VSMCs, proliferation was assessed by BrdU and EdU assays and immunofluorescence analysis of ki-67 expression. RhoGDI1 and RhoGDI2 function and expression were assessed by RNAi, Western blotting and real-time RT-PCR. RhoGDI ubiquitination and SUMOylation levels were evaluated by co-immunoprecipitation and Western blotting. The functions of proteosomal-mediated degradation, ubiquitination, SUMOylation and Ang II receptors were assessed using specific inhibitors. To evaluate the in vivo effects of Ang II and RhoGDI, H & E staining, Masson's trichrome staining, and immunostaining were employed.
   Results: Ang II treatment of HA-VSMCs for 6 or 48 h promoted RhoGDI1 and RhoGDI2 protein degradation and reduced cell proliferation, which was reversed by proteosome inhibition. In contrast, treatment with Ang II for 12 or 24 h induced dose-dependent cell proliferation without affecting RhoGDI expression. RNA interference of either RhoGDI1 or RhoGDI2 blocked proliferation induced by 12 or 24 h treatment of Ang II. Moreover, Ang II-dependent degradation at 6 and 48 h correlated with RhoGDI ubiquitination and inversely correlated with RhoGDI SUMOylation and cell proliferation. Treatment with specific inhibitors suggests that ubiquitin and SUMO competitively bind to RhoGDI1 and RhoGDI2 to reciprocally regulate RhoGDI stability and HA-VSMC proliferation. Furthermore, inhibition of the Ang II receptor 1 (AT1 receptor), but not the Ang II receptor 2, blocked Ang II-dependent RhoGDI stabilization and proliferation at 12 and 24 h. In mice, Ang II infusion increased the intima-media thickness, collagen and myofiber production and VSMC proliferation, and these effects were shown to be dependent on RhoGDI1, RhoGDI2 and AT1 receptor. Ang II infusion exerted no significant effect on RhoGDI1 and RhoGDI2 protein levels, which were decreased after AT1 receptor inhibition.
   Conclusions: Together, the results of this study reveal a novel mechanism by which Ang II regulates RhoGDI stability by SUMOylation and ubiquitination via AT1 receptor activation and thus affects VSMC proliferation and vascular remodeling.
C1 [Dai, Fan; Qi, Yan; Guan, Wei; Meng, Guoliang; Liu, Zhaoguo; Yao, Wenjuan] Nantong Univ, Sch Pharm, 19 QiXiu Rd, Nantong 226001, Peoples R China.
   [Zhang, Ting] Univ Sydney, Save Sight Inst, Sydney, NSW 2000, Australia.
RP Yao, WJ (reprint author), Nantong Univ, Sch Pharm, Dept Pharmacol, 19 QiXiu Rd, Nantong 226001, Jiangsu, Peoples R China.
EM yaowenjuan0430@aliyun.com
FU National Natures Science Foundation of Nantong City [JC2018059]; Jiangsu
   Planned Projects for Postdoctoral Research FundsJiangsu Planned Projects
   for Postdoctoral Research Funds [1601107C]; Postgraduate Research &
   Practice Innovation Program of Jiangsu Province [KYCX19_2085]
FX This work was supported by a grant from the National Natures Science
   Foundation of Nantong City (No. JC2018059), the Jiangsu Planned Projects
   for Postdoctoral Research Funds (No. 1601107C), and the Postgraduate
   Research & Practice Innovation Program of Jiangsu Province (No.
   KYCX19_2085).
NR 44
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2019
VL 288
BP 124
EP 136
DI 10.1016/j.atherosclerosis.2019.07.010
PG 13
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IW6XN
UT WOS:000485127200016
PM 31362179
DA 2019-10-28
ER

PT J
AU Lin, MS
   Lin, YS
   Chang, ST
   Wang, PC
   Wu, VCC
   Lin, WY
   Chung, CM
AF Lin, Ming-Shyan
   Lin, Yu-Sheng
   Chang, Shih-Tai
   Wang, Po-Chang
   Wu, Victor Chien-Chia
   Lin, Wey-Yil
   Chung, Chang-Min
TI Effect of initiating statin therapy on long-term outcomes of patients
   with dyslipidemia after intracerebral hemorrhage
SO ATHEROSCLEROSIS
LA English
DT Article
DE Statin; Intracerebral hemorrhage; Cerebrovascular; Mortality
ID STROKE; MORTALITY; RISK; HOSPITALIZATION; ATORVASTATIN; METAANALYSIS;
   VALIDATION; DISEASE; EVENTS
AB Background and aims: Intracerebral hemorrhage (ICH) has a higher mortality than ischemic stroke. Statin is beneficial for stroke, but high potency statin treatment has been associated with the risk of hemorrhagic stroke. The aim of this study was to assess the impact of initiating statin therapy after ICH on cardiovascular outcomes.
   Methods: Dyslipidemic patients were retrieved from the ICH population from the National Health Insurance Research Database in Taiwan. We retrospectively compared patients prescribed with and without statin treatment after ICH. Outcomes of interest were mortality, myocardial infarction, ischemic stroke, and hemorrhagic stroke during 5 years of follow-up.
   Results: Of 17,980 adult patients with ICH and dyslipidemia, 8927 were eligible for analysis over the study period, including 1613 patients receiving statin therapy and 7314 patients not taking statins. After propensity score matching, the mean age was 61.2 +/- 12.2 years in the statin group and 61.6 +/- 13.0 years in the non-statin group. Hypertension was dominant, followed by diabetes mellitus, and the mean estimated NIHSS score was 12.9. The patients who received statin therapy were associated with lower risks of all-cause mortality (12.7% vs. 21.3%; hazard ratio [HR], 0.54; 95% confidence interval [CI], 0.45-0.65), cardiovascular death (4.0% vs. 7.1%; HR, 0.54; 95% CI, 0.39-0.75) and ICH (5.4% vs. 8.5%; HR, 0.62; 95% CI, 0.46-0.83) compared to those who did not receive statins.
   Conclusions: Initiating statin therapy after ICH was associated with a decreased risk of recurrent ICH and mortality for dyslipidemia patients.
C1 [Lin, Ming-Shyan; Lin, Yu-Sheng; Chang, Shih-Tai; Wang, Po-Chang; Chung, Chang-Min] Chang Gung Mem Hosp, Div Cardiol, Chiayi, Taiwan.
   [Lin, Yu-Sheng; Chung, Chang-Min] Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taoyuan County, Taiwan.
   [Wu, Victor Chien-Chia] Chang Gung Mem Hosp, Linkou Med Ctr, Taoyuan, Taiwan.
   [Lin, Wey-Yil] Taiwan Landseed Hosp, Dept Neurol, Taoyuan, Taiwan.
RP Chung, CM (reprint author), 6,Sec West Chai Pu Rd, Chiayi 61363, Taiwan.
EM cmchung02@gmail.com
OI Wu, Victor Chien-Chia/0000-0002-9918-4369
FU Chang Gung Memorial Hospital, TaiwanChang Gung Memorial Hospital
   [CMRPG6G0551]
FX This work was supported by research grants from Chang Gung Memorial
   Hospital, Taiwan (grant CMRPG6G0551).
NR 37
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2019
VL 288
BP 137
EP 145
DI 10.1016/j.atherosclerosis.2019.07.009
PG 9
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IW6XN
UT WOS:000485127200017
PM 31374467
DA 2019-10-28
ER

PT J
AU Ruscica, M
   Tokgozoglu, L
   Corsini, A
   Sirtori, CR
AF Ruscica, Massimiliano
   Tokgozoglu, Lale
   Corsini, Alberto
   Sirtori, Cesare R.
TI PCSK9 inhibition and inflammation: A narrative review
SO ATHEROSCLEROSIS
LA English
DT Review
DE High-sensitivity CRP; Inflammation; PCSK9; PCSK9 inhibition
ID C-REACTIVE-PROTEIN; DENSITY-LIPOPROTEIN CHOLESTEROL;
   SMOOTH-MUSCLE-CELLS; STATIN-INTOLERANT PATIENTS; HIGH CARDIOVASCULAR
   RISK; LDL-C; CAROTID ATHEROSCLEROSIS; MYOCARDIAL-INFARCTION;
   MONOCLONAL-ANTIBODIES; VASCULAR INFLAMMATION
AB Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of morbidity and mortality despite excellent pharmacological and revascularization approaches. Low-density lipoproteins (LDL) are undoubtedly the most significant biochemical variables associated with atheroma, however, compelling data identify inflammation as critical for the maintenance of the atherosclerotic process, underlying some of the most feared vascular complications. Although its causal role is questionable, high-sensitivity C-reactive protein (hs-CRP) represents a major biomarker of inflammation and associated risk in CVD. While statin-associated reduced risk may be related to the lowering of both LDL-C and hs-CRP, PCSK9 inhibitors leading to dramatic LDL-C reductions do no alter hs-CRP levels. On the other hand, hs-CRP levels identify groups of patients with a high risk of CV disease achieving better ASCVD prevention in response to PCSK9 inhibition. In the FOURIER study, even in patients with extremely low levels of LDL-C, there was a stepwise risk increment according to the values of hsCRP: +9% (< 1 mg/L), +10.8% (1-3 mg/L) and +13.1% (> 3 mg/L). Likewise, in the SPIRE-1 and -2 studies, bococizumab patients with hs-CRP > 3 mg/L had a 60% greater risk of future CV events. Most of the patients enrolled in the PCSK9 trials were on maximally tolerated statin therapy at baseline, and an elevated hs-CRP may reflect residual inflammatory risk after standard LDL-C lowering therapy. Moreover, data on changes in inflammation markers in carriers of PCSK9 loss-of-function mutations are scanty and not conclusive, thus, evidence from the effects of anti-inflammatory molecules on PCSK9 levels might help unravel this hitherto complex tangle.
C1 [Ruscica, Massimiliano; Corsini, Alberto] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy.
   [Tokgozoglu, Lale] Hacettepe Univ, Dept Cardiol, Ankara, Turkey.
   [Corsini, Alberto] Multimed IRCCS, Milan, Italy.
   [Sirtori, Cesare R.] ASST Grande Osped Metropolitano Niguarda, Ctr Dislipidemie, Milan, Italy.
RP Ruscica, M (reprint author), Dept Pharmacol & Biomol Sci, Via Balzaretti 9, I-20133 Milan, Italy.
EM massimiliano.ruscica@unimi.it
RI Keskin, Kudret/AAB-8198-2019; Ruscica, Massimiliano/K-7133-2012
OI Keskin, Kudret/0000-0002-9049-1530; Ruscica,
   Massimiliano/0000-0002-0195-7061
FU Cariplo FoundationFondazione Cariplo [2015-0552]
FX Cariplo Foundation 2015-0552 (MR).
NR 149
TC 1
Z9 1
U1 6
U2 6
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2019
VL 288
BP 146
EP 155
DI 10.1016/j.atherosclerosis.2019.07.015
PG 10
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IW6XN
UT WOS:000485127200018
PM 31404822
DA 2019-10-28
ER

PT J
AU Quillard, T
AF Quillard, Thibaut
TI Calcification associates with transcriptomic signatures related to
   plaque stability in carotid arteries
SO ATHEROSCLEROSIS
LA English
DT Editorial Material
DE Calcification; Peripheral arteries; CT scan; Transcriptomic analysis;
   Atherosclerosis
C1 [Quillard, Thibaut] Univ Nantes, CHU Nantes, INSERM, UMR1238, Nantes, France.
RP Quillard, T (reprint author), Univ Nantes, CHU Nantes, INSERM, UMR1238, Nantes, France.
EM thibaut.quillard@univ-nantes.fr
NR 20
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2019
VL 288
BP 156
EP 157
DI 10.1016/j.atherosclerosis.2019.06.906
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IW6XN
UT WOS:000485127200019
PM 31280875
OA Bronze
DA 2019-10-28
ER

PT J
AU Al-Mallah, MH
   Sakr, S
AF Al-Mallah, Mouaz H.
   Sakr, Sherif
TI Artificial intelligence for plaque characterization: A scientific
   exercise looking for a clinical application
SO ATHEROSCLEROSIS
LA English
DT Editorial Material
DE Artificial intelligence; Plaque characterization
ID ALL-CAUSE MORTALITY; COMPUTED-TOMOGRAPHY; CORONARY; ANGIOGRAPHY
C1 [Al-Mallah, Mouaz H.] Houston Methodist Hosp, Houston Methodist DeBakey Heart & Vasc Ctr, 6565 Fannin St,Smith 18, Houston, TX 77030 USA.
   [Sakr, Sherif] Univ Tartu, Inst Comp Sci, Data Syst Grp, Tartu, Estonia.
RP Al-Mallah, MH (reprint author), Houston Methodist Hosp, Houston Methodist DeBakey Heart & Vasc Ctr, 6565 Fannin St,Smith 18, Houston, TX 77030 USA.
EM mal-mallah@houstonmethodist.org
OI Al-Mallah, Mouaz/0000-0003-2348-0484
NR 20
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2019
VL 288
BP 158
EP 159
DI 10.1016/j.atherosclerosis.2019.06.914
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IW6XN
UT WOS:000485127200020
PM 31280876
OA Bronze
DA 2019-10-28
ER

PT J
AU Farukhi, Z
   Mora, S
AF Farukhi, Zareen
   Mora, Samia
TI A little more time around the track may go a long way: Implications of
   increasing moderate to vigorous physical activity in pre-adolescents
SO ATHEROSCLEROSIS
LA English
DT Editorial Material
DE Physical activity; Lipids; Lipoproteins; Nuclear magnetic resonance
   spectroscopy; Children
ID CARDIOMETABOLIC RISK-FACTORS; CARDIOVASCULAR-DISEASE RISK; SEDENTARY
   TIME; CHILDREN; ASSOCIATIONS
C1 [Farukhi, Zareen; Mora, Samia] Harvard Med Sch, Brigham & Womens Hosp, Div Prevent Med, Ctr Lipid Metab, Boston, MA 02115 USA.
   [Mora, Samia] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.
   [Mora, Samia] Harvard Med Sch, Boston, MA 02115 USA.
RP Mora, S (reprint author), Ctr Lipid Metab, 900 Commonwealth Ave E, Boston, MA 02215 USA.
EM smora@bwh.harvard.edu
FU National Heart, Lung, and Blood Institute (NHLBI)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Heart Lung & Blood Institute (NHLBI) [T32 HL007575];
   NHLBIUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [R01HL117861, K24HL136852]; National Institute of
   Diabetes and Digestive and Kidney DiseasesUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
   [DK112940]
FX Dr. Farukhi was supported by the National Heart, Lung, and Blood
   Institute (NHLBI, T32 HL007575). Dr. Mora has received institutional
   research grant support from the NHLBI (R01HL117861 and K24HL136852) and
   the National Institute of Diabetes and Digestive and Kidney Diseases
   (DK112940).
NR 19
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2019
VL 288
BP 160
EP 162
DI 10.1016/j.atherosclerosis.2019.06.916
PG 3
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IW6XN
UT WOS:000485127200021
PM 31337493
OA Bronze
DA 2019-10-28
ER

PT J
AU Kronenberg, F
AF Kronenberg, Florian
TI Therapeutic lowering of lipoprotein(a): How much is enough?
SO ATHEROSCLEROSIS
LA English
DT Editorial Material
DE Lipoprotein(a); Lipid-lowering drugs
ID APOLIPOPROTEIN(A); METAANALYSIS; CHOLESTEROL
C1 [Kronenberg, Florian] Med Univ Innsbruck, Dept Genet & Pharmacol, Inst Genet Epidemiol, Schopfstr 41, A-6020 Innsbruck, Austria.
RP Kronenberg, F (reprint author), Med Univ Innsbruck, Dept Genet & Pharmacol, Inst Genet Epidemiol, Schopfstr 41, A-6020 Innsbruck, Austria.
EM Florian.Kronenberg@i-med.ac.at
RI Kronenberg, Florian/B-1736-2008
OI Kronenberg, Florian/0000-0003-2229-1120
NR 21
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2019
VL 288
BP 163
EP 165
DI 10.1016/j.atherosclerosis.2019.07.003
PG 3
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IW6XN
UT WOS:000485127200022
PM 31327477
DA 2019-10-28
ER

PT J
AU Stock, J
AF Stock, Jane
TI Novel therapeutics specific to lipoprotein(a)
SO ATHEROSCLEROSIS
LA English
DT Editorial Material
DE Novel therapeutics; Lipoprotein (a)
ID ELEVATED LIPOPROTEIN(A); CARDIOVASCULAR-DISEASE; RISK
C1 [Stock, Jane] European Atherosclerosis Soc, World Trade Ctr Goteborg, Massans Gata 18, SE-41251 Gothenburg, Sweden.
RP Stock, J (reprint author), European Atherosclerosis Soc, World Trade Ctr Goteborg, Massans Gata 18, SE-41251 Gothenburg, Sweden.
EM office@eas-society.org
NR 14
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2019
VL 288
BP 166
EP 167
DI 10.1016/j.atherosclerosis.2019.06.902
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IW6XN
UT WOS:000485127200023
PM 31280874
OA Bronze
DA 2019-10-28
ER

PT J
AU Bae, Y
   Kang, SJ
   Kim, G
   Lee, JG
   Min, HS
   Cho, H
   Kang, DY
   Lee, PH
   Ahn, JM
   Park, DW
   Lee, SW
   Kim, YH
   Lee, CW
   Park, SW
   Park, SJ
AF Bae, Youngoh
   Kang, Soo-Jin
   Kim, Geena
   Lee, June-Goo
   Min, Hyun-Seok
   Cho, Hyungjoo
   Kang, Do-Yoon
   Lee, Pil Hyung
   Ahn, Jung-Min
   Park, Duk-Woo
   Lee, Seung-Whan
   Kim, Young-Hak
   Lee, Cheol Whan
   Park, Seong-Wook
   Park, Seung-Jung
TI Prediction of coronary thin-cap fibroatheroma by intravascular
   ultrasound-based machine learning
SO ATHEROSCLEROSIS
LA English
DT Article
DE Machine learning; Intravascular ultrasound; Thin-cap fibroatheroma
ID ELUTING STENT IMPLANTATION; PLAQUE MORPHOLOGY; ATHEROSCLEROSIS;
   THROMBOSIS; OUTCOMES; REGRESSION; ELEVATION; INSIGHTS; THERAPY; IMPACT
AB Background and aims: Although grayscale intravascular ultrasound (IVUS) is commonly used for assessing coronary lesion morphology and optimizing stent implantation, detection of vulnerable plaques by IVUS remains challenging. We aimed to develop machine learning (ML) models for predicting optical coherence tomography-derived thin-cap fibroatheromas (OCT-TCFAs).
   Methods: In 517 patients with angina, 414 and 103 coronary lesions were randomized into training vs. test sets. Each of the IVUS-OCT co-registered frames (including 32,807 for training and 8101 for test) was labeled according to the presence vs. absence of OCT-TCFA. Among 1449 computed IVUS features based on two-dimensional geometry and texture, 17 features were finally selected and used in supervised ML with artificial neural network (ANN), support vector machine (SVM), and naive Bayes.
   Results: IVUS sections with (vs. without) OCT-TCFA showed a larger plaque burden, and a smaller and eccentric lumen. TCFA-containing sections were characterized by increased ratios of variance, entropy, and kurtosis; reduced ratio of homogeneity within the superficial to the deeper plaque; and decreased smoothness within the fibrous cap. In addition, OCT-TCFA was associated with low ratios of gamma-beta, Nakagami-mu and Nakagami-omega, and a high ratio of Rayleigh-b within the superficial to the deeper region. With a 5-fold cross-validation, the averaged accuracies were 81 +/- 5% for ANN (area under the curve [AUC] = 0.80 +/- 0.08), 77 +/- 4% for SVM (AUC = 0.74 +/- 0.05), and 78 +/- 2% for naive Bayes (AUC = 0.77 +/- 0.04) for predicting OCT-TCFA. In the test set, ANN and naive Bayes showed the overall accuracies of > 80%.
   Conclusions: Supervised ML algorithms with computed IVUS features predicted the presence of OCT-TCFA. This data-driven approach may help clinicians in recognizing high-risk coronary lesions.
C1 [Bae, Youngoh; Kang, Soo-Jin; Min, Hyun-Seok; Cho, Hyungjoo; Kang, Do-Yoon; Lee, Pil Hyung; Ahn, Jung-Min; Park, Duk-Woo; Lee, Seung-Whan; Kim, Young-Hak; Lee, Cheol Whan; Park, Seong-Wook; Park, Seung-Jung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
   [Kim, Geena] Regis Univ, Coll Comp & Informat Sci, Denver, CO USA.
   [Lee, June-Goo] Asan Inst Life Sci, Biomed Engn Res Ctr, Seoul, South Korea.
RP Kang, SJ (reprint author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM sjkang@amc.seoul.kr
OI Kim, Geena/0000-0002-0212-3181
FU Korea Healthcare Technology R&D Project, Ministry for Health & Welfare
   Affairs, Republic of Korea [HI15C1790, HI17C1080]; Ministry of Science
   and ICT [NRF-2017R1A2B4005886]; Asan Institute for Life Sciences, Asan
   Medical Center, Seoul, Korea [2017-0745]
FX This study was supported by grants from the Korea Healthcare Technology
   R&D Project, Ministry for Health & Welfare Affairs, Republic of Korea
   (HI15C1790 and HI17C1080); the Ministry of Science and ICT
   (NRF-2017R1A2B4005886); and the Asan Institute for Life Sciences, Asan
   Medical Center, Seoul, Korea (2017-0745).
NR 30
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2019
VL 288
BP 168
EP 174
DI 10.1016/j.atherosclerosis.2019.04.228
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IW6XN
UT WOS:000485127200024
PM 31130215
DA 2019-10-28
ER

PT J
AU Karlof, E
   Seime, T
   Dias, N
   Lengquist, M
   Witasp, A
   Almqvist, H
   Kronqvist, M
   Gadin, JR
   Odeberg, J
   Maegdefessel, L
   Stenvinkel, P
   Matic, LP
   Hedin, U
AF Karlof, Eva
   Seime, Till
   Dias, Nuno
   Lengquist, Mariette
   Witasp, Anna
   Almqvist, Hakan
   Kronqvist, Malin
   Gadin, Jesper R.
   Odeberg, Jacob
   Maegdefessel, Lars
   Stenvinkel, Peter
   Matic, Ljubica Perisic
   Hedin, Ulf
TI Correlation of computed tomography with carotid plaque transcriptomes
   associates calcification with lesion-stabilization
SO ATHEROSCLEROSIS
LA English
DT Article
DE Atherosclerosis; Computed tomography; Microarrays; Calcification;
   Carotid stenosis; Smooth muscle cells
ID MUSCLE-CELL PROLIFERATION; VASCULAR CALCIFICATION; STROKE PREVENTION;
   EXPRESSION; GENE; ENDARTERECTOMY; CORONARY; ATHEROSCLEROSIS; STENOSIS;
   BIOLOGY
AB Background and aims: Unstable carotid atherosclerosis causes stroke, but methods to identify patients and lesions at risk are lacking. We recently found enrichment of genes associated with calcification in carotid plaques from asymptomatic patients. Here, we hypothesized that calcification represents a stabilising feature of plaques and investigated how macro-calcification, as estimated by computed tomography (CT), correlates with gene expression profiles in lesions.
   Methods: Plaque calcification was measured in pre-operative CT angiographies. Plaques were sorted into high- and low-calcified, profiled with microarrays, followed by bioinformatic analyses. Immunohistochemistry and qPCR were performed to evaluate the findings in plaques and arteries with medial calcification from chronic kidney disease patients.
   Results: Smooth muscle cell (SMC) markers were upregulated in high-calcified plaques and calcified plaques from symptomatic patients, whereas macrophage markers were downregulated. The most enriched processes in high-calcified plaques were related to SMCs and extracellular matrix (ECM) organization, while inflammation, lipid transport and chemokine signaling were repressed. These findings were confirmed in arteries with high medial calcification. Proteoglycan 4 (PRG4) was identified as the most upregulated gene in association with plaque calcification and found in the ECM, SMA+ and CD68+/TRAP + cells.
   Conclusions: Macro-calcification in carotid lesions correlated with a transcriptional profile typical for stable plaques, with altered SMC phenotype and ECM composition and repressed inflammation. PRG4, previously not described in atherosclerosis, was enriched in the calcified ECM and localized to activated macrophages and smooth muscle-like cells. This study strengthens the notion that assessment of calcification may aid evaluation of plaque phenotype and stroke risk.
C1 [Karlof, Eva; Hedin, Ulf] Karolinska Univ Hosp, Dept Vasc Surg, Stockholm, Sweden.
   [Karlof, Eva; Seime, Till; Lengquist, Mariette; Kronqvist, Malin; Matic, Ljubica Perisic; Hedin, Ulf] Karolinska Inst, Dept Mol Med & Surg, L8 03, SE-17176 Stockholm, Sweden.
   [Dias, Nuno] Skane Univ Hosp, Dept Vasc Surg, Vasc Ctr, Malmo, Sweden.
   [Witasp, Anna; Stenvinkel, Peter] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Renal Med, Stockholm, Sweden.
   [Almqvist, Hakan] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.
   [Gadin, Jesper R.; Maegdefessel, Lars] Karolinska Inst, Dept Med, Ctr Mol Med, Stockholm, Sweden.
   [Odeberg, Jacob] Royal Inst Technol, Sch Biotechnol, Dept Prote, Sci Life Lab, Stockholm, Sweden.
   [Maegdefessel, Lars] Tech Univ Munich, Klinikum Klinikum Rechts Isar Isar, Dept Vasc & Endovasc Surg, Munich, Germany.
RP Matic, LP; Hedin, U (reprint author), Karolinska Inst, Dept Mol Med & Surg, L8 03, SE-17176 Stockholm, Sweden.
EM Ljubica.Matic@ki.se; Ulf.Hedin@ki.se
RI Odeberg, Jacob/I-8314-2016
OI Odeberg, Jacob/0000-0003-0996-1644
FU European UnionEuropean Union (EU) [722609]; Swedish Heart and Lung
   FoundationSwedish Heart-Lung Foundation; Swedish Research CouncilSwedish
   Research Council [K2009-65X-2233-01-3, K201365X-06816-30-4,
   349-2007-8703]; Uppdrag Besegra Stroke [P581/2011-123]; Stockholm County
   CouncilStockholm County Council [ALF2011-0260, ALF-20110279]; Swedish
   Society for Medical Research; Tore Nilsson's Foundation; Magnus
   Bergvall's Foundation; Karolinska Institute FoundationKarolinska
   Institutet
FX The European Union's Horizon 2020/Marie Sklodowska-Curie grant agreement
   No 722609 (INTRICARE); Swedish Heart and Lung Foundation; Swedish
   Research Council (K2009-65X-2233-01-3, K201365X-06816-30-4,
   349-2007-8703); Uppdrag Besegra Stroke (P581/2011-123); Stockholm County
   Council (ALF2011-0260, ALF-20110279); Swedish Society for Medical
   Research; Tore Nilsson's, Magnus Bergvall's and Karolinska Institute
   Foundations.
NR 48
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2019
VL 288
BP 175
EP 185
DI 10.1016/j.atherosclerosis.2019.05.005
PG 11
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IW6XN
UT WOS:000485127200025
PM 31109707
OA Other Gold
DA 2019-10-28
ER

PT J
AU Jones, PR
   Rajalahti, T
   Resaland, GK
   Aadland, E
   Steene-Johannessen, J
   Anderssen, SA
   Bathen, TF
   Andreassen, T
   Kvalheim, OM
   Ekelund, U
AF Jones, Paul Remy
   Rajalahti, Tarja
   Resaland, Geir Kare
   Aadland, Eivind
   Steene-Johannessen, Jostein
   Anderssen, Sigmund Alfred
   Bathen, Tone Frost
   Andreassen, Trygve
   Kvalheim, Olav Martin
   Ekelund, Ulf
TI Associations of physical activity and sedentary time with lipoprotein
   subclasses in Norwegian schoolchildren: The Active Smarter Kids (ASK)
   study
SO ATHEROSCLEROSIS
LA English
DT Article
DE Epidemiology; Physical activity; Sedentary time; Lipoprotein subclasses;
   Lipidomics; Adiposity; Paediatrics
ID CARDIOMETABOLIC RISK-FACTORS; CARDIOVASCULAR RISK; CHILDREN; SERUM;
   PROFILE; PLASMA; EPIDEMIOLOGY; CHOLESTEROL; PERFORMANCE; MODERATE
AB Background and aims: Physical activity is favourably associated with certain markers of lipid metabolism. The relationship of physical activity with lipoprotein particle profiles in children is not known. Here we examine cross-sectional associations between objectively measured physical activity and sedentary time with serum markers of lipoprotein metabolism.
   Methods: Our cohort included 880 children (49.0% girls, mean age 10.2 years). Physical activity intensity and time spent sedentary were measured objectively using accelerometers. 30 measures of lipoprotein metabolism were quantified using nuclear magnetic resonance spectroscopy. Multiple linear regression models adjusted for age, sex, sexual maturity and socioeconomic status were used to determine associations of physical activity and sedentary time with lipoprotein measures. Additional models were adjusted for adiposity. Isotemporal substitution models quantified theoretical associations of replacing 30 min of sedentary time with 30 min of moderate- to vigorous-intensity physical activity (MVPA).
   Results: Time spent in MVPA was associated with a favourable lipoprotein profile independent of sedentary time. There were inverse associations with a number of lipoprotein measures, including most apolipoprotein B-containing lipoprotein subclasses and triglyceride measures, the ratio of total to high-density lipoprotein (HDL) cholesterol, and non-HDL cholesterol concentration. There were positive associations with larger HDL subclasses, HDL cholesterol concentration and particle size. Reallocating 30 min of sedentary time to MVPA had broadly similar associations. Sedentary time was only partly and weakly associated with an unfavourable lipoprotein profile.
   Conclusions: Physical activity of at least moderate-intensity is associated with a favourable lipoprotein profile in schoolchildren, independent of time spent sedentary, adiposity and other confounders.
C1 [Jones, Paul Remy; Steene-Johannessen, Jostein; Anderssen, Sigmund Alfred; Ekelund, Ulf] Norwegian Sch Sport Sci, Dept Sports Med, Post Box 4014, N-0806 Oslo, Norway.
   [Rajalahti, Tarja; Kvalheim, Olav Martin] Univ Bergen, Dept Chem, Bergen, Norway.
   [Rajalahti, Tarja] Forde Hlth Trust, Forde, Norway.
   [Resaland, Geir Kare; Aadland, Eivind; Anderssen, Sigmund Alfred] Western Norway Univ Appl Sci, Dept Sport Food & Nat Sci, Sogndal, Norway.
   [Resaland, Geir Kare] Forde Cent Hosp, Ctr Hlth Res, Forde, Norway.
   [Bathen, Tone Frost; Andreassen, Trygve] Norwegian Univ Sci & Technol NTNU, Dept Circulat & Med Imaging, Trondheim, Norway.
RP Jones, PR (reprint author), Norwegian Sch Sport Sci, Dept Sports Med, Post Box 4014, N-0806 Oslo, Norway.
EM paul.jones@nih.no; tarja.rajalahti@uib.no; geir.kare.resaland@hvl.no;
   eivind.aadland@hvl.no; jostein.steene-johannessen@nih.no;
   s.a.anderssen@nih.no; tone.f.bathen@ntnu.no; trygve.andreassen@ntnu.no;
   olav.kvalheim@uib.no; ulf.ekelund@nih.no
RI Jones, Paul/E-4210-2016
OI Jones, Paul/0000-0002-9770-3938
FU Research Council of NorwayResearch Council of Norway [249932/F20,
   221047/F40]; Gjensidige Foundation [1042294]; Forde Health Trust;
   Faculty of Medicine, NTNU; Central Norway Regional Health Authority
FX This work was supported by the Research Council of Norway [grant numbers
   #249932/F20 and #221047/F40]; and the Gjensidige Foundation [grant
   number #1042294]. TR received funding from Forde Health Trust to perform
   the NMR lipoprotein analysis. The MR Core Facility is funded by the
   Faculty of Medicine, NTNU, and Central Norway Regional Health Authority.
NR 48
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2019
VL 288
BP 186
EP 193
DI 10.1016/j.atherosclerosis.2019.05.023
PG 8
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IW6XN
UT WOS:000485127200026
PM 31200940
DA 2019-10-28
ER

PT J
AU Ray, KK
   Vallejo-Vaz, AJ
   Ginsberg, HN
   Davidson, MH
   Louie, MJ
   Bujas-Bobanovic, M
   Minini, P
   Eckel, RH
   Cannon, CP
AF Ray, Kausik K.
   Vallejo-Vaz, Antonio J.
   Ginsberg, Henry N.
   Davidson, Michael H.
   Louie, Michael J.
   Bujas-Bobanovic, Maja
   Minini, Pascal
   Eckel, Robert H.
   Cannon, Christopher P.
TI Lipoprotein(a) reductions from PCSK9 inhibition and major adverse
   cardiovascular events: Pooled analysis of alirocumab phase 3 trials
SO ATHEROSCLEROSIS
LA English
DT Article
DE PCSK9; Alirocumab; lipoprotein(a); Low-density lipoprotein cholesterol;
   Cardiovascular risk; Cholesterol-lowering drugs
ID STATIN THERAPY; DOUBLE-BLIND; FAMILIAL HYPERCHOLESTEROLEMIA; TARGETING
   APOLIPOPROTEIN(A); RISK PATIENTS; LDL-C; EFFICACY; SAFETY; CHOLESTEROL;
   EZETIMIBE
AB Background and aims: Elevated lipoprotein(a) [Lp(a)] levels are considered a causal factor for cardiovascular disease. In phase 3 ODYSSEY trials, alirocumab reduced levels of low-density lipoprotein cholesterol (LDL-C) and Lp(a), with concomitant reductions in the risk of major adverse cardiovascular events (MACE). We assessed whether lower on-study and greater percentage reductions in Lp(a) are associated with a lower risk of MACE.
   Methods: Post-hoc analysis of data pooled from 10 phase 3 ODYSSEY trials comparing alirocumab with control (placebo or ezetimibe) in patients (n = 4983) with cardiovascular disease and/or risk factors, and hypercholesterolemia despite statin/other lipid-lowering therapies.
   Results: Median (Q1, Q3) baseline Lp(a) levels were 23.5 (8.0, 67.0) mg/dL. Median Lp(a) changes from baseline with alirocumab were -25.6% vs. -2.5% with placebo (absolute reductions 6.8 vs. 0.5 mg/dL) in placebo-controlled trials, and -21.4% vs. 0.0% with ezetimibe (4.5 vs. 0.0 mg/dL) in ezetimibe-controlled trials. During follow-up (6699 patient-years), 104 patients experienced MACE. A 12% relative risk reduction in MACE per 25% reduction in Lp(a) (p = 0.0254) was no longer significant after adjustment for LDL-C changes: hazard ratio per 25% reduction: 0.89 (95% confidence interval, 0.79-1.01; p = 0.0780). In subgroup analysis, the association between Lp(a) reduction and MACE remained significant in a fully adjusted model among participants with baseline Lp(a) >= 50 mg/dL (p-interaction vs. Lp(a) < 50 mg/dL: 0.0549).
   Conclusions: In this population, Lp(a) reductions were not significantly associated with MACE independently of LDL-C reductions. Reducing the risk of MACE by targeting Lp(a) may require greater reductions in Lp(a) with more potent therapies and/or higher initial Lp(a) levels.
C1 [Ray, Kausik K.; Vallejo-Vaz, Antonio J.] Imperial Coll, Sch Publ Hlth, Dept Primary Care & Publ Hlth, Imperial Ctr Cardiovasc Dis Prevent, London, England.
   [Ginsberg, Henry N.] Columbia Univ, New York, NY USA.
   [Davidson, Michael H.] Univ Chicago Med, Dept Med, Chicago, IL USA.
   [Louie, Michael J.] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.
   [Bujas-Bobanovic, Maja] Sanofi, Bridgewater, MA USA.
   [Minini, Pascal] Sanofi, Biostat & Programming, Chilly Mazarin, France.
   [Eckel, Robert H.] Univ Colorado, Anschutz Med Campus, Aurora, CO USA.
   [Cannon, Christopher P.] Brigham & Womens Hosp, Cardiovasc Med Innovat, 75 Francis St, Boston, MA 02115 USA.
RP Vallejo-Vaz, AJ (reprint author), Imperial Coll London, Dept Primary Care & Publ Hlth, Imperial Ctr Cardiovasc Dis Prevent, Reynold Bldg,Imperial Coll Charing Cross Campus, London W6 8RP, England.
EM a.vallejo-vaz@imperial.ac.uk
RI Keskin, Kudret/AAB-8198-2019
OI Keskin, Kudret/0000-0002-9049-1530
FU SanofiSanofi-Aventis; Regeneron Pharmaceuticals, Inc.
FX This analysis was funded by Sanofi and Regeneron Pharmaceuticals, Inc.
   The sponsors were involved in the study design, collection, analysis,
   and interpretation of data, as well as data checking of information
   provided in the manuscript. The authors were responsible for all content
   and editorial decisions, and received no honoraria related to the
   development of this publication.
NR 39
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD SEP
PY 2019
VL 288
BP 194
EP 202
DI 10.1016/j.atherosclerosis.2019.06.896
PG 9
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IW6XN
UT WOS:000485127200027
PM 31253441
OA Other Gold
DA 2019-10-28
ER

PT J
AU Nam, K
   Hur, J
   Han, K
   Im, DJ
   Suh, YJ
   Hong, YJ
   Lee, HJ
   Kim, YJ
   Choi, BW
AF Nam, Kyungsun
   Hur, Jin
   Han, Kyunghwa
   Im, Dong Jin
   Suh, Young Joo
   Hong, Yoo Jin
   Lee, Hye-Jeong
   Kim, Young Jin
   Choi, Byoung Wook
TI Prognostic value of coronary artery disease-reporting and data system
   (CAD-RADS) score for cardiovascular events in ischemic stroke
SO ATHEROSCLEROSIS
LA English
DT Article
DE CAD-RADS; Cardiovascular event; Prognosis; Coronary computed tomography
   angiography; Stroke
ID COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CALCIUM SCORE; CT ANGIOGRAPHY; RISK;
   CARDIOLOGY; ACR
AB Background and aims: The coronary artery disease-reporting and data system (CAD-RADS) was recently developed to standardize CAD classifications and incorporate clinical management. We aimed to investigate the prognostic value and additional risk stratification benefits of CAD-RADS compared to coronary artery calcium scores (CACS) and CAD extent classifications in ischemic stroke patients without cardiac symptoms.
   Methods: From January 2013 to December 2014, 762 ischemic stroke patients with risk factors for CAD and without chest pain underwent coronary computed tomography angiography. CACS, CAD extent classification, and CAD-RADS scores were used to evaluate the computed tomography angiography images. The primary endpoint was major adverse cardiovascular events (MACEs), which were defined as cardiovascular death, nonfatal myocardial infarction, unstable angina requiring hospitalization, and revascularization.
   Results: During the mean follow-up period of 3.36 years, 67 MACEs were recorded. Of the 762 patients, 23.5% were classified as CAD-RADS 0, 19.7% as CAD-RADS 1, 18.2% as CAD-RADS 2, 18.6% as CAD-RADS 3, 15.4% as CAD-RADS 4A, 2.2% as CAD-RADS 4B, and 2.4% as CAD-RADS 5. CACS, CAD extent classification, and CAD-RADS scores independently stratified the risk of future MACEs (all p < 0.05). The C-statistics revealed that both CAD extent classification and CAD-RADS scores improved risk stratification beyond CACS (C-index: 0.767 vs. 0.715; 95% confidence interval [CI] 0.026, 0.105), and 0.781 vs. 0.715; 95% CI 0.015, 0.086).
   Conclusions: In ischemic stroke patients without chest pain, CAD-RADS had prognostic value for future MACEs and better risk discrimination compared with CACS alone.
C1 [Hur, Jin] Yonsei Univ, Coll Med, Severance Hosp, Dept Radiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Hur, Jin] Yonsei Univ, Coll Med, Severance Hosp, Res Inst Radiol Sci, 50-1 Yonsei Ro, Seoul 03722, South Korea.
RP Hur, J (reprint author), Yonsei Univ, Coll Med, Severance Hosp, Dept Radiol, 50-1 Yonsei Ro, Seoul 03722, South Korea.; Hur, J (reprint author), Yonsei Univ, Coll Med, Severance Hosp, Res Inst Radiol Sci, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM khuhz@yuhs.ac
NR 22
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
BP 1
EP 7
DI 10.1016/j.atherosclerosis.2019.05.022
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800893
PM 31176800
OA Bronze
DA 2019-10-28
ER

PT J
AU Iyen, B
   Qureshi, N
   Kai, J
   Akyea, RK
   Leonardi-Bee, J
   Roderick, P
   Humphries, SE
   Weng, S
AF Iyen, Barbara
   Qureshi, Nadeem
   Kai, Joe
   Akyea, Ralph K.
   Leonardi-Bee, Jo
   Roderick, Paul
   Humphries, Steve E.
   Weng, Stephen
TI Risk of cardiovascular disease outcomes in primary care subjects with
   familial hypercholesterolaemia: A cohort study
SO ATHEROSCLEROSIS
LA English
DT Article
DE Familial hypercholesterolaemia; Cardiovascular disease; Coronary heart
   disease; Stroke; Peripheral vascular disease; Epidemiology
ID CORONARY-ARTERY-DISEASE; POPULATION-PREVALENCE; CLINICAL-PRACTICE;
   ALL-CAUSE; CHOLESTEROL; STROKE; MANAGEMENT; MORTALITY; STATINS; CUTOFF
AB Background and aims: Familial hypercholesterolaemia (FH) is a known major cause of premature heart disease. However, the risks of atherosclerotic disease in other vascular regions are less known. We determined the risk of major cardiovascular disease (CVD) outcomes associated with clinical FH.
   Methods: In a retrospective cohort study (1 January, 1999 to 22 July, 2016), we randomly-matched 14,097 UK subjects with clinical FH diagnoses or characteristics (Simon-Broome definite or Dutch Lipid Clinic Score > 8) to 42,506 subjects without FH by age, sex, general practice. We excluded those with CVD at baseline. Incident rates for coronary heart disease (CHD), stroke or transient ischaemic attack (TIA) and peripheral vascular disease (PVD) were estimated. Cox proportional hazards regression, stratified on matched-pairs, determined adjusted hazards ratios (HR) for incident CVD.
   Results: During follow-up (median 13.8 years), incidence rates (95% CI) of CVD (per 1000 person-years) were 25.6 (24.8-26.3) in FH and 2.9 (2.8-3.1) in non-FH subjects. The risk of CHD, stroke/TIA and PVD was higher in FH compared to non-FH subjects: CHD (HR 10.63, 95% CI 9.82-11.49), stroke/TIA (HR 6.74, 95% CI 5.84-7.77), PVD (HR 7.17, 95% CI 6.08-8.46). The risk of CVD was greater in those with FH characteristics (HR 13.52, 95% CI 12.48-14.65) than those with clinical diagnoses (HR 1.66, 95% CI 1.42-1.93).
   Conclusions: In addition to the recognised increased risk of CHD, subjects with FH have greatly elevated risk of stroke/TIA and PVD. This emphasises need for early diagnosis and preventive interventions beyond CHD, to reduce CVD risk in these individuals.
C1 [Iyen, Barbara; Qureshi, Nadeem; Kai, Joe; Akyea, Ralph K.; Weng, Stephen] Univ Nottingham, Div Primary Care, Primary Care Stratified Med Grp, Nottingham, England.
   [Leonardi-Bee, Jo] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham, England.
   [Roderick, Paul] Univ Southampton, Fac Med Primary Care & Populat Sci, Southampton, Hants, England.
   [Humphries, Steve E.] UCL, Inst Cardiovasc Sci, Cardiovasc Genet, London, England.
RP Iyen, B (reprint author), Univ Nottingham, Div Primary Care, Room 1402,Tower Bldg, Nottingham, England.
EM barbara.iyen@nottingham.ac.uk
OI Kai, Joe/0000-0001-9040-9384; Weng, Stephen/0000-0002-5281-9590; Akyea,
   Ralph/0000-0003-4529-8237; Qureshi, Nadeem/0000-0003-4909-0644; Iyen,
   Barbara/0000-0001-9720-1180
FU NIHRNational Institute for Health Research (NIHR) [15/134/02]
FX The authors would like to thank members of the study team and steering
   committee of the Cascade FH study team involved with the NIHR funded
   Health Technology Assessment project 15/134/02.
NR 36
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
BP 8
EP 15
DI 10.1016/j.atherosclerosis.2019.05.017
PG 8
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800894
PM 31181417
OA Green Published, Other Gold, Green Accepted
DA 2019-10-28
ER

PT J
AU Larsen, HG
   Yndigegn, T
   Marinkovic, G
   Grufman, H
   Mares, R
   Nilsson, J
   Goncalves, I
   Schiopu, A
AF Larsen, Helena Grauen
   Yndigegn, Troels
   Marinkovic, Goran
   Grufman, Helena
   Mares, Razvan
   Nilsson, Jan
   Goncalves, Isabel
   Schiopu, Alexandru
TI The soluble receptor for advanced glycation end-products (sRAGE) has a
   dual phase-dependent association with residual cardiovascular risk after
   an acute coronary event
SO ATHEROSCLEROSIS
LA English
DT Article
DE Acute coronary syndrome; S100A12; sRAGE; Inflammation; Cardiovascular
   risk
ID MYOCARDIAL-INFARCTION; RAGE; S100A12; NEUTROPHIL; ATHEROSCLEROSIS;
   ENDPRODUCTS; LYMPHOCYTE; EXPRESSION; MARKER; ROLES
AB Background and aims: The pro-inflammatory alarmin S100A12 (EN-RAGE) and the soluble form of its receptor, the receptor for advanced glycation endproducts (sRAGE), have diverging roles in cardiovascular disease. In experimental studies, S100A12 promoted atherosclerosis while sRAGE treatment was anti-atherogenic and reduced myocardial infarction size by scavenging RAGE ligands. Here, we aimed to explore the links between S100A12, sRAGE, and long-term prognosis after an acute coronary syndrome (ACS).
   Methods: We measured S100A12 and sRAGE in 524 patients within 24 h after an ACS, and again 6 weeks later in a subgroup of 114 patients. This subgroup also completed a follow-up echocardiography after 1 year. The median follow-up time for recurrent major adverse cardiovascular events (MACE), defined as recurrent ACS or cardiovascular death, was 25.7 +/- 12.6 months.
   Results: In Cox proportional hazard analyses, baseline S100A12 and sRAGE were positively associated with the risk of MACE, independently of traditional cardiovascular risk factors. The association between sRAGE and MACE remained significant after additional adjustment for troponin T, NT-proBNP and hsCRP [HR 95%CI for highest versus lowest tertile 3.2 (1.5-6.5), p = 0.002]. High sRAGE was also associated with deteriorating left ventricular function and an increased rate of heart failure hospitalization post-discharge. In contrast, patients with increasing sRAGE at 6 weeks compared to baseline had lower incidence of recurrent ACS.
   Conclusions: Our data suggest that sRAGE has a dual, phase-dependent association with residual cardiovascular risk after ACS. These findings are important for the design and interpretation of future studies on sRAGE as biomarker and potential treatment in ACS patients.
C1 [Larsen, Helena Grauen; Yndigegn, Troels; Marinkovic, Goran; Grufman, Helena; Nilsson, Jan; Goncalves, Isabel; Schiopu, Alexandru] Lund Univ, Dept Clin Sci Malmo, Expt Cardiovasc Res Unit, CRC 91 12 Jan Waldenstroms Gata 35, S-21428 Malmo, Sweden.
   [Larsen, Helena Grauen; Goncalves, Isabel; Schiopu, Alexandru] Skane Univ Hosp Malmo, Dept Cardiol, Malmo, Sweden.
   [Mares, Razvan; Schiopu, Alexandru] Univ Med Pharm Sci & Technol Tirgu Mures, 38 Gh Marinescu Str, Targu Mures, Romania.
RP Schiopu, A (reprint author), Lund Univ, Inst Clin Sci Malmo, Expt Cardiovasc Res Grp, CRC 91 12,Jan Waldenstroms Gata 35, SE-21428 Malmo, Sweden.
EM alexandru.schiopu@med.lu.se
OI Goncalves, Isabel/0000-0002-2935-0181; Nilsson, Jan/0000-0002-9752-7479;
   Schiopu, Alexandru/0000-0002-7587-5050
FU Swedish Research CouncilSwedish Research Council; Marianne and Marcus
   Wallenberg Foundation; Swedish Heart and Lung FoundationSwedish
   Heart-Lung Foundation; Swedish Medical Society; Region Skane Research
   Funds; Malmo University Hospital Funds; Crafoord Foundation; Ernhold
   Lundstrom's Foundation; Royal Physiographic Society in Lund; Bundy
   Academy foundation at Lund University; Swedish Foundation for Strategic
   ResearchSwedish Foundation for Strategic Research; Ministry of Research
   and Innovation of Romania, CNCS - UEFISCDI within PNCDI III
   [PN-III-P4-ID-PCCF-2016-0172]
FX This study was supported by grants from the Swedish Research Council,
   Marianne and Marcus Wallenberg Foundation, Swedish Heart and Lung
   Foundation, Swedish Medical Society, Region Skane Research Funds, Malmo
   University Hospital Funds, the Crafoord Foundation, Ernhold Lundstrom's
   Foundation, the Royal Physiographic Society in Lund, the Bundy Academy
   foundation at Lund University, and the Swedish Foundation for Strategic
   Research. This work was also financed by a grant from the Ministry of
   Research and Innovation of Romania, CNCS - UEFISCDI, project number
   PN-III-P4-ID-PCCF-2016-0172, within PNCDI III.
NR 40
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
BP 16
EP 23
DI 10.1016/j.atherosclerosis.2019.05.020
PG 8
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800895
PM 31181415
DA 2019-10-28
ER

PT J
AU Oudkerk, SF
   Hoesein, FAAM
   Mali, WP
   Oner, FC
   Verlaan, JJ
   de Jong, PA
   Kinney, GL
   Hokanson, J
   Lynch, D
   Silverman, EK
   Budoff, MJ
   Regan, EA
AF Oudkerk, Sytse F.
   Hoesein, Firdaus A. A. Mohamed
   Mali, Willem PThM
   Oner, F. Cumhur
   Verlaan, Jorrit-Jan
   de Jong, Pim A.
   Kinney, Gregory L.
   Hokanson, John
   Lynch, David
   Silverman, Edwin K.
   Budoff, Matthew J.
   Regan, Elizabeth A.
TI Subjects with diffuse idiopathic skeletal hyperostosis have an increased
   burden of coronary artery disease: An evaluation in the COPDGene cohort
SO ATHEROSCLEROSIS
LA English
DT Article
DE Calciumscore; CT; DISH; Coronary artery disease; Atherosclerosis;
   Agatson score
ID ECTOPIC MINERALIZATION; COMPUTED-TOMOGRAPHY; RISK-FACTORS;
   CALCIFICATION; PATHOGENESIS; ETIDRONATE; FEATURES; INSULIN; CHEST
AB Background and aims: Diffuse idiopathic skeletal hyperostosis (DISH) is a common incidental finding on medical imaging and often thought to be benign. Our objective was to investigate whether DISH is associated with coronary artery disease as measured with the coronary artery calcification (CAC) score in a large cohort of current and former smokers.
   Methods: In a subset of subjects from the COPDGene study, DISH was scored by a minimum of two independent readers if there were four adjacent levels of flowing osteophytes and a third reader adjudicated discrepancies. CAC was calculated using a modified Agatston method. Associations of DISH with the presence and extent of CAC were analyzed with and without adjustment for COPD and known atherosclerotic risk factors, including age, sex, race, diabetes, hypertension, high cholesterol, body mass index and smoking.
   Results: DISH was present in 361 subjects (13.2%) from a total group of 2728. Median (interquartile range) Agatston was 81 (0-329) in DISH subjects compared to 0 (0-94 in subjects without DISH (p < 0.001). DISH prevalence was 8.8% in CAC = 0, 12.8% in CAC1-100, 20.0% in CAC100-400 and 24.7% in CAC.400. Subjects with DISH had a significantly higher risk of having coronary artery calcifications; OR [CI95%] 1.37[1.05-1.78] (p = 0.019) after correction for age, gender, race, COPD and atherosclerotic risk factors.
   Conclusions: Subjects with DISH, a common musculoskeletal disorder involving bone formation anterior to the spine, have an increased burden of coronary artery disease, and therefore DISH may be a more relevant incidental finding than commonly thought.
C1 [Oudkerk, Sytse F.; Hoesein, Firdaus A. A. Mohamed; Mali, Willem PThM; de Jong, Pim A.] Univ Med Ctr Utrecht, Utrecht, Netherlands.
   [Oudkerk, Sytse F.; Hoesein, Firdaus A. A. Mohamed; Mali, Willem PThM; de Jong, Pim A.] Univ Utrecht, Dept Radiol & Nucl Med, Utrecht, Netherlands.
   [Oner, F. Cumhur; Verlaan, Jorrit-Jan] Univ Med Ctr Utrecht, Dept Orthoped, Utrecht, Netherlands.
   [Kinney, Gregory L.; Hokanson, John] Univ Colorado, Dept Epidemiol, Colorado Sch Publ Hlth, Denver, CO 80202 USA.
   [Regan, Elizabeth A.] Natl Jewish Hlth, Div Rheumatol, Denver, CO USA.
   [Silverman, Edwin K.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.
   [Budoff, Matthew J.] Harbor UCLA, Los Angeles Biomed Res Inst, Div Cardiol, Torrance, CA USA.
   [Lynch, David] Natl Jewish Hlth, Dept Radiol, Div Oncol, Canc Ctr, Denver, CO USA.
RP de Jong, PA (reprint author), Univ Med Ctr Utrecht, Dept Radiol & Nucl Med, Room E01-132, NL-3508 GA Utrecht, Netherlands.
EM p.dejong-8@umcutrecht.nl
RI Kinney, Gregory/M-4867-2013
OI Kinney, Gregory/0000-0002-5218-4986
FU National Heart, Lung, and Blood InstituteUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung & Blood Institute (NHLBI) [U01 HL089897, U01
   HL089856]; COPD Foundation
FX The project described was supported by Award Number U01 HL089897 and
   Award Number U01 HL089856 from the National Heart, Lung, and Blood
   Institute. The content is solely the responsibility of the authors and
   does not necessarily represent the official views of the National Heart,
   Lung, and Blood Institute or the National Institutes of Health.; The
   COPDGene (R) project is also supported by the COPD Foundation through
   contributions made to an Industry Advisory Board comprised of
   AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis, Pfizer,
   Siemens and Sunovion.
NR 32
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
BP 24
EP 29
DI 10.1016/j.atherosclerosis.2019.05.030
PG 6
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800896
PM 31181416
DA 2019-10-28
ER

PT J
AU Zhu, ZB
   Zhong, CK
   Guo, DX
   Bu, XQ
   Xu, T
   Guo, LB
   Liu, JL
   Zhang, JT
   Li, D
   Zhang, JH
   Ju, Z
   Chen, CS
   Chen, J
   He, J
   Zhang, YH
AF Zhu, Zhengbao
   Zhong, Chongke
   Guo, Daoxia
   Bu, Xiaoqing
   Xu, Tan
   Guo, Libing
   Liu, Jiale
   Zhang, Jintao
   Li, Dong
   Zhang, Jianhui
   Ju, Zhong
   Chen, Chung-Shiuan
   Chen, Jing
   He, Jiang
   Zhang, Yonghong
TI Multiple biomarkers covering several pathways improve predictive ability
   for cognitive impairment among ischemic stroke patients with elevated
   blood pressure
SO ATHEROSCLEROSIS
LA English
DT Article
DE Cognitive impairment; Ischemic stroke; Biomarkers; Risk prediction;
   Prevention
ID MINI-MENTAL-STATE; MECHANISMS; CLASSIFICATION; HOMOCYSTEINE; DEMENTIA;
   DECLINE
AB Background and aims: We aimed to evaluate the ability of multiple novel biomarkers representing several pathophysiological pathways to improve risk prediction of post-stroke cognitive impairment.
   Methods: We conducted a prospective multicenter study in 638 ischemic stroke patients with elevated blood pressure based on a random subsample from China Antihypertensive Trial in Acute Ischemic Stroke and measured 12 circulating biomarkers in these participants. Cognitive impairment was assessed at 3 months after stroke with definitions of Mini-Mental State Examination (MMSE) score < 27 or Montreal Cognitive Assessment (MoCA) score < 25.
   Results: According to MMSE score, 1 SD increase of rheumatoid factor (odds ratio [OR] 1.22, 95% confidence interval [CI] 1.02-1.46), matrix metalloproteinase-9 (OR 1.47, 95% CI 1.22-1.77) and total homocysteine (OR 1.22, 95% CI 1.01-1.49) after log transformation was significantly associated with the risk of post-stroke cognitive impairment. The ORs associated with their simultaneously high levels were 4.89 (95% CI, 2.31-10.35; p(trend) < 0.001) and 3.09 (95% CI, 1.60-5.98; p(trend) < 0.001) for cognitive impairment and the severity of cognitive impairment, respectively. Adding these 3 biomarkers to conventional model significantly improved the risk prediction of cognitive impairment (C statistic 0.729 vs. 0.688, p = 0.004; net reclassification improvement = 33.67%, p < 0.001; integrated discrimination index = 4.61%; p < 0.001). Similar significant findings were observed when cognitive impairment was defined by MoCA score.
   Conclusions: Combination of rheumatoid factor, matrix metalloproteinase-9 and total homocysteine can improve the risk prediction of cognitive impairment among ischemic stroke patients with elevated blood pressure. Further studies are warranted to validate our findings and explore their roles as potential therapeutic targets.
C1 [Zhu, Zhengbao; Zhong, Chongke; Guo, Daoxia; Bu, Xiaoqing; Xu, Tan; Zhang, Yonghong] Soochow Univ, Sch Publ Hlth, Dept Epidemiol, Med Coll, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China.
   [Zhu, Zhengbao; Zhong, Chongke; Guo, Daoxia; Bu, Xiaoqing; Xu, Tan; Zhang, Yonghong] Soochow Univ, Med Coll, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China.
   [Zhu, Zhengbao; Zhong, Chongke; Bu, Xiaoqing; Chen, Chung-Shiuan; Chen, Jing; He, Jiang] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA.
   [Guo, Libing] Siping Cent Hosp, Dept Neurol, Jilin, Jilin, Peoples R China.
   [Liu, Jiale] Jilin Cent Hosp, Dept Neurol, Jilin, Jilin, Peoples R China.
   [Zhang, Jintao] 88th Hosp PLA, Dept Neurol, Tai An, Shandong, Peoples R China.
   [Li, Dong] Feicheng City Peoples Hosp, Dept Internal Med, Feicheng, Shandong, Peoples R China.
   [Zhang, Jianhui] Tongliao Municipal Hosp, Dept Neurol, Tongliao, Inner Mongolia, Peoples R China.
   [Ju, Zhong] Kerqin Dist First Peoples Hosp Tongliao City, Dept Neurol, Tongliao, Inner Mongolia, Peoples R China.
   [Chen, Jing; He, Jiang] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA.
RP Zhang, YH (reprint author), Soochow Univ, Sch Publ Hlth, Dept Epidemiol, Med Coll, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China.; Zhang, YH (reprint author), Soochow Univ, Med Coll, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China.; He, J (reprint author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA.
EM jhe@tulane.edu; yhzhang@suda.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81673263]; Ministry of Science and Technology of
   ChinaMinistry of Science and Technology, China [2016YFC1307300]; China
   Scholarship CouncilChina Scholarship Council [201806920079];
   Postgraduate Research & Practice Innovation Program of Jiangsu Province
   [KYCX18_2539]; Project of the Priority Academic Program Development of
   Jiangsu Higher Education Institutions, China; Tulane University in New
   Orleans, Louisiana; Collins C. Diboll Private Foundation in New Orleans,
   Louisiana
FX This study was supported by the National Natural Science Foundation of
   China (grants: 81673263), Ministry of Science and Technology of China
   (grants: 2016YFC1307300), China Scholarship Council (grants:
   201806920079), Postgraduate Research & Practice Innovation Program of
   Jiangsu Province (grants: KYCX18_2539), and a Project of the Priority
   Academic Program Development of Jiangsu Higher Education Institutions,
   China; and by Tulane University and Collins C. Diboll Private
   Foundation, both in New Orleans, Louisiana.
NR 33
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
BP 30
EP 37
DI 10.1016/j.atherosclerosis.2019.05.028
PG 8
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800897
PM 31185379
DA 2019-10-28
ER

PT J
AU De Silva, GS
   Desai, K
   Darwech, M
   Naim, U
   Jin, X
   Adak, S
   Harroun, N
   Sanchez, LA
   Semenkovich, CF
   Zayed, MA
AF De Silva, Gayan S.
   Desai, Kshitij
   Darwech, Malik
   Naim, Uzma
   Jin, Xiaohua
   Adak, Sangeeta
   Harroun, Nikolai
   Sanchez, Luis A.
   Semenkovich, Clay F.
   Zayed, Mohamed A.
TI Circulating serum fatty acid synthase is elevated in patients with
   diabetes and carotid artery stenosis and is LDL-associated
SO ATHEROSCLEROSIS
LA English
DT Article
DE Fatty acid synthase; Carotid artery stenosis; Serum biomarker; Diabetes;
   Lipoprotein
ID INTIMA-MEDIA THICKNESS; GENE-TRANSCRIPTION; CEREBROVASCULAR-DISEASE;
   INSULIN-RESISTANCE; PPAR-ALPHA; CHOLESTEROL; RISK; ATHEROSCLEROSIS;
   STROKE; HYPERTRIGLYCERIDEMIA
AB Background and aims: Diabetes is an independent risk factor for carotid artery stenosis (CAS). Fatty acid synthase (FAS), an essential de novo lipogenesis enzyme, has increased activity in the setting of diabetes that leads to altered lipid metabolism. Circulating FAS (cFAS) was recently observed in the blood of patients with hyper-insulinemia and cancer. We thought to evaluate the origin of cFAS and its role in diabetes-associated CAS.
   Methods: Patients with diabetes and no diabetes, undergoing carotid endarterectomy (CEA) for CAS, were prospectively enrolled for collection of plaque and fasting serum. FPLC was used to purify lipoprotein fractions, and ELISA was used to quantify cFAS content and activity. Immunoprecipitation (IP) was used to evaluate the affinity of cFAS to LDL-ApoB.
   Results: Patients with CAS had higher cFAS activity (p < 0.01), and patients with diabetes had higher cFAS activity than patients with no diabetes (p < 0.05). cFAS activity correlated with serum glucose (p = 0.03, r(2) = 0.35), and cFAS content trended with plaque FAS content (p = 0.06, r(2) = 0.69). cFAS was predominantly in LDL cholesterol fractions of patients with CAS (p < 0.001), and IP of cFAS demonstrated pulldown of ApoB. Similar to patients with diabetes, db/db mice had highest levels of serum cFAS (p < 0.01), and fasL(-/-) (tissue-specific liver knockdown of FAS) mice had the lowest levels of cFAS (p < 0.001).
   Conclusions: Serum cFAS is higher in patients with diabetes and CAS, appears to originate from the liver, and is LDL cholesterol associated. We postulate that LDL may be serving as a carrier for cFAS that contributes to atheroprogression in carotid arteries of patients with diabetes.
C1 [De Silva, Gayan S.; Desai, Kshitij; Darwech, Malik; Naim, Uzma; Jin, Xiaohua; Harroun, Nikolai; Sanchez, Luis A.; Zayed, Mohamed A.] Washington Univ, Sch Med, Dept Surg, Sect Vasc Surg, St Louis, MO 63110 USA.
   [Adak, Sangeeta; Semenkovich, Clay F.] Washington Univ, Sch Med, Dept Internal Med, Div Endocrinol Lipid & Metab, St Louis, MO 63110 USA.
   [Zayed, Mohamed A.] Vet Affairs St Louis Hlth Care Syst, St Louis, MO USA.
RP Zayed, MA (reprint author), Campus Box 8109,Surg 660 South Euclid Ave, St Louis, MO 63110 USA.
EM zayedm@wustl.edu
FU Vascular Cures Foundation Wylie Scholar Award; American Surgical
   Association Research Fellowship Award; Society for Vascular Surgery
   Foundation Research Investigator Award; Washington University School of
   Medicine Diabetes Research Center NIH/NIDDK [P30 DK020589];
   NIH/NHLBIUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [K08 HL132060]; NIH/NIDDKUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
   [R01 DK101392]
FX This work was supported by grants from the Vascular Cures Foundation
   Wylie Scholar Award (MAZ), American Surgical Association Research
   Fellowship Award (MAZ), Society for Vascular Surgery Foundation Research
   Investigator Award (MAZ), Washington University School of Medicine
   Diabetes Research Center NIH/NIDDK P30 DK020589 (MAZ), NIH/NHLBI K08
   HL132060 (MAZ), and NIH/NIDDK R01 DK101392 (CFS).
NR 45
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
BP 38
EP 45
DI 10.1016/j.atherosclerosis.2019.05.016
PG 8
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800898
PM 31202106
OA Other Gold
DA 2019-10-28
ER

PT J
AU Ong, KL
   Campbell, S
   Wu, B
   McClelland, RL
   Kokkinos, J
   Szklo, M
   Polak, JF
   Allison, MA
   Rye, KA
AF Ong, Kwok Leung
   Campbell, Steven
   Wu, Ben J.
   McClelland, Robyn L.
   Kokkinos, John
   Szklo, Moyses
   Polak, Joseph F.
   Allison, Matthew A.
   Rye, Kerry-Anne
TI Relationship of fibroblast growth factor 21 with subclinical
   atherosclerosis and cardiovascular events: Multi-Ethnic Study of
   Atherosclerosis
SO ATHEROSCLEROSIS
LA English
DT Article
DE Ankle-brachial index; Cardiovascular disease; Carotid intima-media
   thickness; Coronary artery calcification; Fibroblast growth factor 21
ID INTIMA-MEDIA THICKNESS; FENOFIBRATE INTERVENTION; VASCULAR
   CALCIFICATION; SERUM FGF21; PPAR-ALPHA; ASSOCIATION; DISEASE; PREDICTOR;
   INDUCTION
AB Background and aims: Fibroblast growth factor 21 (FGF21) has been suggested as a novel biomarker for cardiovascular disease (CVD), especially in people with high CVD risk. However, it is not known whether FGF21 is a CVD biomarker in an initially healthy cohort. We therefore investigated the relationship of plasma FGF21 levels with measures of subclinical atherosclerosis and cardiovascular events in Multi-Ethnic Study of Atherosclerosis participants without known CVD at baseline.
   Methods: A total of 5788 participants had plasma FGF21 levels measured at the baseline exam (2000-2002). Carotid intima-media thickness (IMT), ankle-brachial index (ABI) and coronary artery calcification (CAC) were measured at baseline. Participants were followed up for incident CVD events over a median period of 14 years.
   Results: In cross-sectional analyses adjusting for socio-demographic variables, participants with higher FGF21 levels had higher carotid IMT, lower ABI, and higher prevalence of CAC (p < 0.001). However, these associations were not significant after simultaneously adjusting for demographic, socioeconomic and lifestyle factors, traditional CVD risk factors, and biomarkers of inflammation and hemostasis. Among 5768 patients with follow-up data, 820 developed incident CVD endpoints. Higher baseline FGF21 levels were not associated with the risk for incident CVD endpoints after adjusting for multiple confounding factors (odds ratio 1.03; 95% confidence interval, 0.94-1.12, per SD increase in In-transformed FGF21 levels).
   Conclusions: Although FGF21 has been suggested as a CVD biomarker for people with high CVD risk, our findings do not support a role of FGF21 as a CVD biomarker in those without a history of CVD.
C1 [Ong, Kwok Leung; Wu, Ben J.; Kokkinos, John; Rye, Kerry-Anne] Univ New South Wales, Sch Med Sci, Lipid Res Grp, Sydney, NSW, Australia.
   [Ong, Kwok Leung; Campbell, Steven; Rye, Kerry-Anne] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.
   [McClelland, Robyn L.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA.
   [Szklo, Moyses] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   [Polak, Joseph F.] Tufts Univ, Sch Med, Dept Radiol, Boston, MA 02111 USA.
   [Allison, Matthew A.] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA.
RP Ong, KL; Rye, KA (reprint author), Univ New South Wales, Sch Med Sci, Sydney, NSW 2052, Australia.
EM oklws@yahoo.com.hk; k.rye@unsw.edu.au
OI Ong, Kwok Leung/0000-0001-7229-7614
FU University of New South Wales [RG134592]; Australian National Health and
   Medical Research CouncilNational Health and Medical Research Council of
   Australia [1122854]; National Heart Foundation of AustraliaNational
   Heart Foundation of Australia [100715]; National Heart, Lung, and Blood
   Institute, United StatesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung
   & Blood Institute (NHLBI) [HHSN268201500003I, N01-HC-95159,
   N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164,
   N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169];
   National Center for Advancing Translational Sciences, United States
   [UL1-TR-000040, UL1-TR-001079, UL1-TR-001420]
FX Kwok Leung Ong was supported by the Vice-Chancellor's Postdoctoral
   Fellowship from the University of New South Wales (RG134592) and the
   Australian National Health and Medical Research Council Career
   Development Fellowship (1122854). The measurement of FGF21 levels in
   MESA samples was supported by the NSW CVRN Research Development Project
   Grant (100715) from the National Heart Foundation of Australia to Dr.
   Kwok Leung Ong. The MESA study was supported by contracts
   HHSN268201500003I, N01-HC-95159, N01-HC-95160, N01-HC-95161,
   N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166,
   N01-HC-95167, N01-HC-95168, and N01-HC-95169 from the National Heart,
   Lung, and Blood Institute, United States, and by grants UL1-TR-000040,
   UL1-TR-001079, and UL1-TR-001420 from National Center for Advancing
   Translational Sciences, United States.
NR 46
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
BP 46
EP 53
DI 10.1016/j.atherosclerosis.2019.06.898
PG 8
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800899
PM 31212234
DA 2019-10-28
ER

PT J
AU Wang, KC
   Chen, PS
   Chao, TH
   Luo, CY
   Chung, HC
   Tseng, SY
   Huang, TY
   Lin, YL
   Shi, GY
   Wu, HL
   Li, YH
AF Wang, Kuan-Chieh
   Chen, Po-Sheng
   Chao, Ting-Hsing
   Luo, Chawn-Yau
   Chung, Hsing-Chun
   Tseng, Shih-Ya
   Huang, Ting-Yu
   Lin, Ying-Li
   Shi, Guey-Yueh
   Wu, Hua-Lin
   Li, Yi-Heng
TI The role of vascular smooth muscle cell membrane-bound thrombomodulin in
   neointima formation
SO ATHEROSCLEROSIS
LA English
DT Article
DE Neointima; Smooth muscle cell; Thrombomodulin
ID LECTIN-LIKE DOMAIN; ENDOTHELIAL-CELLS; PROTEIN-C; EXPRESSION;
   INFLAMMATION; ATHEROSCLEROSIS; ADHESION; RECEPTOR; PATHWAY
AB Background and aims: Thrombomodulin (TM) is an endothelial cell membrane-bound anticoagulant protein expressed in normal arteries. After vascular injury, medial and neointimal smooth muscle cells (SMCs) exhibit large amounts of TM. The purpose of this study was to investigate the physiological significance of vascular SMC-bound TM.
   Methods: The morphology, expression of phenotype markers and cell behaviors of cultured aortic SMCs after knockdown of TM were observed. Transgenic mice with SMC-specific TM deletion were generated, and carotid neointima formation was induced by carotid ligation.
   Results: Cultured human aortic SMCs displayed a synthetic phenotype with a rhomboid-shaped morphology and expressed TM. TM knockdown induced a spindle-shaped change in morphology with an increased expression of contractile phenotype marker and decreased expression of synthetic phenotype marker. TM knockdown not only attenuated the proliferation of SMCs but also reduced tumor necrosis factor-alpha-induced nuclear factor-kappa B activation and interlukin-6 production. In a carotid artery ligation model, transgenic mice with SMC-specific TM deletion (SM22-cre(tg)/TMflox/flox) had significantly less cellular proliferation in arterial walls compared with wild type mice (SM22-cre(tg)/TM+/+). The neointima area and neointima/media area ratio were smaller in SM22-cre(tg)/TMflox/flox mice at 4 weeks after ligation.
   Conclusions: Our results indicate that vascular SMC-bound TM plays a role in changes of the SMC phenotype. It also influences SMC cell behavior and injury-induced neointima formation.
C1 [Wang, Kuan-Chieh; Huang, Ting-Yu; Lin, Ying-Li; Shi, Guey-Yueh; Wu, Hua-Lin] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan, Taiwan.
   [Wang, Kuan-Chieh] Chia Nan Univ Pharm & Sci, Dept Pharm, Tainan, Taiwan.
   [Chen, Po-Sheng; Chao, Ting-Hsing; Chung, Hsing-Chun; Tseng, Shih-Ya; Li, Yi-Heng] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Internal Med, Tainan, Taiwan.
   [Chen, Po-Sheng] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Inst Clin Med, Coll Med, Tainan, Taiwan.
   [Luo, Chawn-Yau] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Surg, Coll Med, Tainan, Taiwan.
RP Li, YH (reprint author), Natl Cheng Kung Univ Hosp, Dept Internal Med, 138 Sheng Li Rd, Tainan 704, Taiwan.
EM heng@mail.ncku.edu.tw
FU Ministry of Science and Technology, Taipei, Taiwan
   [104-2314-B-006-083-MY2, 106-2314-B-006-045-MY3]
FX This work was supported by grants 104-2314-B-006-083-MY2 and
   106-2314-B-006-045-MY3 from the Ministry of Science and Technology,
   Taipei, Taiwan.
NR 35
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
BP 54
EP 63
DI 10.1016/j.atherosclerosis.2019.05.019
PG 10
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800900
PM 31212235
DA 2019-10-28
ER

PT J
AU Proudfoot, NA
   Au, JS
   Timmons, BW
   MacDonald, MJ
AF Proudfoot, Nicole A.
   Au, Jason S.
   Timmons, Brian W.
   MacDonald, Maureen J.
TI Associations between carotid artery longitudinal wall motion and
   arterial stiffness indicators in young children
SO ATHEROSCLEROSIS
LA English
DT Article
DE Pulse wave velocity; Ultrasound imaging; Speckle-tracking; Arterial wall
   motion; Vascular stiffness; Child
ID PULSE-WAVE VELOCITY; CARDIOVASCULAR RISK-FACTORS; NONINVASIVE
   DETERMINATION; BLOOD-PRESSURE; DISTENSIBILITY; DISPLACEMENT;
   DEFINITIONS; MOVEMENT; INDEXES; HEALTH
AB Background and aims: Carotid artery longitudinal wall motion (CALM) is associated with established indicators of arterial stiffness in healthy adults and in adults with cardiovascular disease risk factors. CALM assessment may be more feasible for incorporation into routine clinical examination than traditional assessments of arterial stiffness; however, the relationship between CALM and arterial stiffness in children has not been established.
   Methods: Data were collected from a subset of children participating in the Health Outcomes and Physical activity in Preschoolers study. CALM was characterized by segmental longitudinal wall displacement, velocity, and acceleration. Arterial stiffness was measured using whole-body pulse wave velocity (PWV) and carotid artery beta-stiffness index. Associations between CALM and arterial stiffness and the influence of age, sex, and height on those associations were determined.
   Results: One hundred and ninety-one children (ages 5.0-8.0 years) were included in the analyses. Systolic retrograde (r = -0.20, p = 0.01) and maximum (r = -0.15, p = 0.04) CALM displacements were weakly correlated with PWV while systolic anterograde and diastolic CALM displacements and wall velocities and accelerations were not correlated with PWV (r = -0.12 to -0.03, p = 0.10 to 0.64). There were no significant correlations between any CALM outcome and beta-stiffness index (r = -0.12 to 0.10; p > 0.05). Associations were attenuated after adjusting for age, sex, and height.
   Conclusions: Higher arterial stiffness, measured by PWV, but not beta-stiffness, is weakly associated with less longitudinal movement of the common carotid artery in young, healthy children indicating CALM measurement is not a strong candidate for clinical assessment of arterial stiffness in children.
C1 [Proudfoot, Nicole A.; Timmons, Brian W.] McMaster Univ, Dept Pediat, Child Hlth & Exercise Med Program, Hamilton, ON, Canada.
   [Proudfoot, Nicole A.; Au, Jason S.; Timmons, Brian W.; MacDonald, Maureen J.] McMaster Univ, Dept Kinesiol, IWC E207,1280 Main St West, Hamilton, ON L8S 4K1, Canada.
RP MacDonald, MJ (reprint author), McMaster Univ, Dept Kinesiol, IWC E207,1280 Main St West, Hamilton, ON L8S 4K1, Canada.
EM macdonmj@mcmaster.ca
OI MacDonald, Maureen/0000-0001-9851-3610; Au, Jason/0000-0001-8601-323X
FU Canadian Institutes of Health Research (MOP)Canadian Institutes of
   Health Research (CIHR) [102560]; Natural Sciences and Engineering
   Research Council of Canada (NSERC)Natural Sciences and Engineering
   Research Council of Canada [238819-13]; NSERCNatural Sciences and
   Engineering Research Council of Canada [CGSD2-475515-2015]
FX The HOPP study was funded by the Canadian Institutes of Health Research
   (MOP #102560). This work was also supported by a Natural Sciences and
   Engineering Research Council of Canada (NSERC) Discovery grant to MJM
   (DG No. 238819-13) and a NSERC postgraduate scholarship to JSA
   (CGSD2-475515-2015). BWT holds the Canada Research Chair in Child Health
   & Exercise Medicine.
NR 40
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
BP 64
EP 69
DI 10.1016/j.atherosclerosis.2019.06.895
PG 6
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800901
PM 31220802
DA 2019-10-28
ER

PT J
AU Devarakonda, CV
   Pereira, FE
   Smith, JD
   Shapiro, LH
   Ghosh, M
AF Devarakonda, Charan V.
   Pereira, Flavia E.
   Smith, Jonathan D.
   Shapiro, Linda H.
   Ghosh, Mallika
TI CD13 deficiency leads to increased oxidative stress and larger
   atherosclerotic lesions
SO ATHEROSCLEROSIS
LA English
DT Article
DE CD13; ANPEP; Atherosclerosis; Oxidative stress; oxLDL; Macrophages;
   Reactive oxygen species; Reactive nitrogen species; Nitric oxide;
   L-NMMA; NAC
ID LOW-DENSITY-LIPOPROTEIN; OXIDIZED LDL; PROMOTES ATHEROSCLEROSIS; INDUCED
   INFLAMMATION; NITRIC-OXIDE; RECEPTOR; MACROPHAGES; OXLDL; CD36;
   ACTIVATION
AB Background and aims: Atherosclerosis is an inflammatory cardiovascular disorder characterized by accumulation of lipid-loaded macrophages in the intima. Prolonged accumulation leads to apoptosis of macrophages and eventually to progression of lesion development. Prevention of macrophage accumulation within the intima has been shown to reduce lesion formation. Since CD13 mediates trafficking of macrophages to sites of injury and repair, we tested the role of CD13 in atherosclerosis.
   Methods: CD13(+/+) Ldlr(-/-) and CD13(-/-) Ldlr(-/-) (low density lipoprotein receptor) mice were fed basal or high fat diet (HFD) for 9, 12 and 15 weeks. Mice were euthanized and aortic roots along with innominate arteries were analyzed for atherosclerotic lesions. Cellular mechanisms were determined in vitro using CD13(+/+) and CD13(-/-) bone marrow derived macrophages (BMDMs) incubated with highly oxidized low-density lipoprotein (oxLDL).
   Results: At the 9 and 12 week time points, no differences were observed in the average lesion size, but at the 15 week time point, CD13(-/-) Ldlr(-/-) mice had larger lesions with exaggerated necrotic areas. CD13(+/+) and CD13(-/-) macrophages endocytosed similar amounts of oxLDL, but CD13(-/-) macrophages generated higher amounts of oxidative stressors in comparison to CD13(+/+) macrophages. This increased oxidative stress was due to increased nitric oxide production in oxLDL treated CD13(-/-) macrophages. Accumulated oxidative stress subsequently led to accelerated apoptosis and enhanced necrosis of oxLDL treated CD13(-/-) macrophages.
   Conclusions: Contrary to our prediction, CD13 deficiency led to larger atherosclerotic lesions with increased areas of necrosis. Mechanistically, CD13 deficiency led to increased nitric oxide production and consequently, greater oxidative stress.
C1 [Devarakonda, Charan V.; Pereira, Flavia E.; Shapiro, Linda H.; Ghosh, Mallika] Univ Connecticut, Hlth Ctr, Ctr Vasc Biol, Farmington, CT 06030 USA.
   [Smith, Jonathan D.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA.
RP Shapiro, LH; Ghosh, M (reprint author), 263 Farmington Ave, Farmington, CT 06030 USA.
EM lshapiro@uchc.edu; mghosh@uchc.edu
RI Devarakonda, Charan Kumar/AAB-7003-2019
OI Shapiro, Linda/0000-0003-4590-4671
FU NHLBIUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [P01HL070694, HL127449, P01HL029582]
FX This work was supported by NHLBI grants P01HL070694 and HL127449 (LHS)
   and P01HL029582 (JDS).
NR 50
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
BP 70
EP 80
DI 10.1016/j.atherosclerosis.2019.06.901
PG 11
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800902
PM 31229835
DA 2019-10-28
ER

PT J
AU Feldmann, K
   Grandoch, M
   Kohlmorgen, C
   Valentin, B
   Gerfer, S
   Nagy, N
   Hartwig, S
   Lehr, S
   Fender, AC
   Fischer, JW
AF Feldmann, Kathrin
   Grandoch, Maria
   Kohlmorgen, Christina
   Valentin, Birte
   Gerfer, Stephen
   Nagy, Nadine
   Hartwig, Sonja
   Lehr, Stefan
   Fender, Anke C.
   Fischer, Jens W.
TI Decreased M1 macrophage polarization in dabigatran-treated
   Ldlr-deficient mice: Implications for atherosclerosis and adipose tissue
   inflammation
SO ATHEROSCLEROSIS
LA English
DT Article
DE Inflammation; Macrophage; Thrombin inhibitor; Atherosclerosis; Obesity
ID DIRECT THROMBIN INHIBITOR; DIET-INDUCED OBESITY; FREE FATTY-ACIDS;
   IDENTIFICATION; GENERATION; PHENOTYPE; LESIONS; RATS
AB Background and aims: The non-vitamin K oral anticoagulant dabigatran etexilate (dabigatran) is increasingly prescribed to patients with non-valvular atrial fibrillation and venous thromboembolism. Adipose tissue (AT) inflammation during obesity plays a crucial role in the development of insulin resistance, type II diabetes and atherogenesis. The aim of the present study was to investigate the effects of thrombin inhibition by dabigatran in a combined model of diet-induced obesity and atherosclerosis.
   Methods: Female Low density lipoprotein receptor knockout (Lldr(-/-)) mice were fed a high-fat diet containing 5 mg/g dabigatran or matching control for 20 weeks.
   Results: Dabigatran-treated animals showed increased adipocyte hypertrophy, but reduced numbers of pro-inflammatory M1-polarized macrophages in the adipose tissue. Abundance of pro-inflammatory M1 macrophages was also decreased in the aortic wall of dabigatran-fed mice. Multiple circulating cytokines were reduced, indicating an effect in systemically relevant secretory compartments such as the AT.
   Conclusions: Dabigatran treatment reduces pro-inflammatory M1 macrophages in atherosclerotic lesions, thereby contributing to plaque stabilizing and atheroprotective effects of the thrombin inhibitor. This finding is not restricted to the vascular wall but is also present in AT where dabigatran treatment reduced the release of pro-inflammatory cytokines and accumulation of M1 macrophages.
C1 [Feldmann, Kathrin; Grandoch, Maria; Kohlmorgen, Christina; Valentin, Birte; Gerfer, Stephen; Nagy, Nadine; Fischer, Jens W.] Heinrich Heine Univ Duesseldorf, Univ Hosp, Med Fac, Inst Pharmacol & Clin Pharmacol, Dusseldorf, Germany.
   [Feldmann, Kathrin; Grandoch, Maria; Kohlmorgen, Christina; Valentin, Birte; Gerfer, Stephen; Nagy, Nadine; Fischer, Jens W.] Heinrich Heine Univ Duesseldorf, Univ Hosp, Cardiovasc Res Inst Duesseldorf CARID, Dusseldorf, Germany.
   [Hartwig, Sonja; Lehr, Stefan] Heinrich Heine Univ Duesseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Biochem & Pathobiochem, Dusseldorf, Germany.
   [Hartwig, Sonja; Lehr, Stefan] German Ctr Diabet Res DZD, D-85764 Munich, Germany.
   [Fender, Anke C.] Univ Hosp, West German Heart & Vasc Ctr, Inst Pharmacol, Essen, Germany.
RP Fischer, JW (reprint author), Heinrich Heine Univ Dusseldorf, Univ Klinikum, Inst Pharmakol & Klin Pharmakol, Moorenstr 5, D-40225 Dusseldorf, Germany.
EM jens.fischer@uni-duesseldorf.de
FU Boehringer IngelheimBoehringer Ingelheim
FX Boehringer Ingelheim supported this work by supplying a research grant
   and providing the animal chow. No author has relevant conflict of
   interest to disclose.
NR 37
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
BP 81
EP 88
DI 10.1016/j.atherosclerosis.2019.06.897
PG 8
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800903
PM 31233979
DA 2019-10-28
ER

PT J
AU Masana, L
   Ibarretxe, D
   Rodriguez-Borjabad, C
   Plana, N
   Valdivielso, P
   Pedro-Botet, J
   Civeira, F
   Lopez-Miranda, J
   Guijarro, C
   Mostaza, J
   Pinto, X
AF Masana, Luis
   Ibarretxe, Daiana
   Rodriguez-Borjabad, Celia
   Plana, Nuria
   Valdivielso, Pedro
   Pedro-Botet, Juan
   Civeira, Fernando
   Lopez-Miranda, Jose
   Guijarro, Carlos
   Mostaza, Jose
   Pinto, Xavier
CA Spanish Arteriosclerosis Soc
TI Toward a new clinical classification of patients with familial
   hypercholesterolemia: One perspective from Spain
SO ATHEROSCLEROSIS
LA English
DT Review
DE Familial hypercholesterolemia; Diagnosis; Polygenic familial
   hypercholesterolemia classification; Familial combined hyperlipidaemia;
   PCSK9 inhibitors
ID HYPERLIPIDEMIA; MUTATIONS; DIAGNOSIS; GUIDANCE; DISEASE; SCORE
AB The introduction of singular therapies, such as proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i), to lower high cholesterol levels requires better classification of patients eligible for intensive lipid lowering therapy. According to the European Medicines Administration, PCSK9i are recommended in primary prevention only in familial hypercholesterolemia (FH) patients. Therefore, an FH diagnosis is not simply an academic issue, because it has many clinical implications. The bases of a diagnosis of FH are not entirely clear. The availability of genetic testing, including large genome-wide association analyses and whole genome studies, has shown that some patients with a clinical diagnosis of definite FH have no mutations in the genes associated with the disease. This fact does not exclude the very high cardiovascular risk of these patients, and an early and intensive lipid lowering therapy is recommended in all FH patients. Because an FH diagnosis is a cornerstone for decisions about therapies, a precise definition of FH is urgently required. This is an expert consensus document from the Spanish Atherosclerosis Society. We propose the following classification: familial hypercholesterolemia syndrome integrated by (1) heterozygous familial hypercholesterolemia: patients with clinically definite FH and a functional mutation in one allele of the LDLR, ApoB: 100, and PCSK9 genes; (2) homozygous familial hypercholesterolemia: mutations affect both alleles; (3) polygenic familial hypercholesterolemia: patients with clinically definite FH but no mutations associated with FH are found (to be distinguished from non-familial, multifactorial hypercholesterolemia); (4) familial hypercholesterolemia combined with hypertriglyceridemia: a subgroup of familial combined hyperlipidaemia patients fulfilling clinically definite FH with associated hypertriglyceridemia.
C1 [Masana, Luis; Ibarretxe, Daiana; Rodriguez-Borjabad, Celia; Plana, Nuria] Univ Rovira & Virgili, IISPV, Hosp Univ Sant Joan, Unitat Med Vasc & Metab, Reus, Spain.
   [Valdivielso, Pedro] Univ Malaga, Virgen Victoria Univ Hosp, CIMES,IBIMA, Lipids & Atherosclerosis Lab,Dept Med & Dermatol, Malaga, Spain.
   [Pedro-Botet, Juan] Univ Autonoma Barcelona, Dept Med, Hosp Mar, Unitat Lipids & Risc Vasc, Barcelona, Spain.
   [Civeira, Fernando] Univ Zaragoza, CIBERCV, IIS Aragon, Hosp Univ Miguel Servet,Unidad Lipidos, Zaragoza, Spain.
   [Lopez-Miranda, Jose] Univ Cordoba, CIBEROBN, Reina Sofia Univ Hosp,IMIBIC, Dept Internal Med,Lipid & Atherosclerosis Unit, Cordoba, Spain.
   [Guijarro, Carlos] Rey Juan Carlos Univ, Univ Hosp Alcorcon Fdn, Internal Med Unit, Madrid, Spain.
   [Mostaza, Jose] Hosp Carlos III, Internal Med Serv, Madrid, Spain.
   [Pinto, Xavier] Hosp Llobregat, Hosp Univ Bellvitge, Internal Med, Lipids & Vasc Risk Unit, Barcelona, Spain.
RP Masana, L (reprint author), Univ Rovira & Virgili, Fac Med, C St Llorenc 21, Reus 43007, Spain.
EM luis.masana@urv.cat
RI Lopez-Miranda, Jose/Y-8306-2019
OI Lopez-Miranda, Jose/0000-0002-8844-0718; Plana,
   Nuria/0000-0002-4231-7618; Masana, Luis/0000-0002-0789-4954
NR 18
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
BP 89
EP 92
DI 10.1016/j.atherosclerosis.2019.06.905
PG 4
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800904
PM 31238171
OA Green Published, Bronze
DA 2019-10-28
ER

PT J
AU de Gonzalo-Calvo, D
   Elosua, R
   Vea, A
   Subirana, I
   Sayols-Baixeras, S
   Marrugat, J
   Llorente-Cortes, V
AF de Gonzalo-Calvo, David
   Elosua, Roberto
   Vea, Angela
   Subirana, Isaac
   Sayols-Baixeras, Sergi
   Marrugat, Jaume
   Llorente-Cortes, Vicenta
TI Soluble low-density lipoprotein receptor-related protein 1 as a
   biomarker of coronary risk: Predictive capacity and association with
   clinical events
SO ATHEROSCLEROSIS
LA English
DT Article
DE Biomarker; Cardiovascular risk; Coronary artery disease; REGICOR;
   Soluble LRP1
ID SMOOTH-MUSCLE-CELLS; ABDOMINAL AORTIC-ANEURYSM; CARDIOVASCULAR-DISEASE;
   GENE POLYMORPHISMS; CIRCULATING LEVELS; HEART-DISEASE; AMYLOID-BETA;
   LRP1; LDL; EXPRESSION
AB Background and aims: We aimed to determine whether circulating sLRP1 levels are associated with future coronary events and improve the predictive capacity of the REGICOR (Registre Gironi del Cor) risk function.
   Methods: We conducted a case-cohort study based on the follow-up of the REGICOR population-based cohort. Of the 5,404 participants aged between 35 and 74 years, without previous history of cardiovascular disease, 117 subjects with angina or fatal or non-fatal myocardial infarction were included, and 512 individuals were randomly selected as a subcohort (including 14 patients who presented coronary events). sLRP1 levels were measured in basal plasma samples by commercial ELISA. Hazard ratio (HR) was estimated with Cox models adjusted for potential confounding factors. Discrimination and reclassification were analyzed with the c-index and the net reclassification index (NRI), respectively. A Mendelian randomization approach was used to explore the causality of the association between sLRP1 and coronary artery disease (CAD).
   Results: The group of participants who presented a CAD event showed higher levels of sLRP1 than the subcohort (2.45 [0.43; 8.31] vs. 2.07 [0.40; 6.65] mu g/mL, p < 0.001). sLRP1 was significantly associated with CAD events even after adjustment for confounding factors (adjusted HR per standard deviation= 1.30, 95% CI: 1.01-1.67, p= 0.039). sLRP1 did not increase the predictive capacity or improve cardiovascular risk stratification of the REGICOR function. The LRP1 genetic variants associated with CAD risk were not related to sLRP1 concentration.
   Conclusions: Plasma sLRP1 is independently associated with the incidence of coronary events, but it does not improve the predictive capacity of the REGICOR risk function.
C1 [de Gonzalo-Calvo, David; Vea, Angela; Llorente-Cortes, Vicenta] Biomed Res Inst Sant Pau IIB Sant Pau, Lipids & Cardiovasc Pathol Grp, Barcelona, Spain.
   [de Gonzalo-Calvo, David; Llorente-Cortes, Vicenta] CSIC, Inst Biomed Res Barcelona IIBB, Barcelona, Spain.
   [de Gonzalo-Calvo, David; Elosua, Roberto; Sayols-Baixeras, Sergi; Marrugat, Jaume; Llorente-Cortes, Vicenta] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain.
   [Elosua, Roberto; Subirana, Isaac; Sayols-Baixeras, Sergi] Hosp Mar, Med Res Inst IMIM, Cardiovasc Epidemiol & Genet Grp, Barcelona, Spain.
   [Elosua, Roberto] Univ Vic, Med Sch, Cent Univ Catalonia, Vic, Spain.
   [Subirana, Isaac] Ctr Invest Biomed Red Epidemiol Salud Publ CIBERE, Barcelona, Spain.
   [Marrugat, Jaume] Hosp Mar, Med Res Inst IMIM, REGICOR Grp, Barcelona, Spain.
RP Llorente-Cortes, V (reprint author), Biomed Res Inst Sant Pau IIB Sant Pau, Lipids & Cardiovasc Pathol Grp, Barcelona, Spain.; Marrugat, J (reprint author), Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain.
EM jaume@imim.es; cllorente@santpau.cat
OI de Gonzalo Calvo, David/0000-0003-2240-3532; Sayols Baixeras,
   Sergi/0000-0002-1181-6262; ELOSUA, ROBERTO/0000-0001-8235-0095
FU PERIS from Agencia de Gestio d'Ajuts Universitaris i de Recerca
   [SLT002/16/00088]; Instituto Salud Carlos III - European Fund for
   Regional Development [FIS 94/0540, FIS 99/0013-01, FIS 99/9342, FIS
   PI020471, FIS PI08/1327, INTRASALUD PI11/01801, CP 06/00100, CES12/025,
   CP12/03287, ECA07/060, FIS PI14/01729, FIS PI18/01584,
   RD12/0042/0010/0011/0013/0061]; Fundacio MARATO TV3 [201521-10; 081630];
   Government of Catalonia through the Agency for Management of University
   and Research Grants [2009SGR1195, 2014SGR240, 2017SGR946]; Juan de la
   Cierva-Incorporacion from the Ministerio de Economia y Competitividad
   [IJCI-2016-29393]; Instituto de Salud Carlos IIIInstituto de Salud
   Carlos III [CB16/11/00403, CB16/11/00229, CB16/11/00246, CB06/02/0029]
FX This work was funded by PERIS from Agencia de Gestio d'Ajuts
   Universitaris i de Recerca [Grant SLT002/16/00088], the Instituto Salud
   Carlos III, which is co-financed by the European Fund for Regional
   Development [Grants FIS 94/0540, FIS 99/0013-01, FIS 99/9342, FIS
   PI020471, FIS PI08/1327, INTRASALUD PI11/01801, CP 06/00100, CES12/025,
   CP12/03287, ECA07/060, FIS PI14/01729, FIS PI18/01584,
   RD12/0042/0010/0011/0013/0061], and by the Fundacio MARATO TV3 [Grant
   201521-10; 081630], and the Government of Catalonia through the Agency
   for Management of University and Research Grants [2009SGR1195,
   2014SGR240 and 2017SGR946]. DdG-C was a recipient of a Juan de la
   Cierva-Incorporacion from the Ministerio de Economia y Competitividad
   [Grant IJCI-2016-29393]. CIBERCV and CIBERESP (CB16/11/00403 to DdG-C
   and VLl-C; CB16/11/00229 to JM; CB16/11/00246 to RE; CB06/02/0029 to IS)
   are projects of the Instituto de Salud Carlos III.
NR 44
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
BP 93
EP 99
DI 10.1016/j.atherosclerosis.2019.06.904
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800905
PM 31247347
DA 2019-10-28
ER

PT J
AU Baumer, Y
   McCurdy, S
   Jin, XT
   Weatherby, TM
   Dey, AK
   Mehta, NN
   Yap, JK
   Kruth, HS
   Boisvert, WA
AF Baumer, Yvonne
   McCurdy, Sara
   Jin, Xueting
   Weatherby, Tina M.
   Dey, Amit K.
   Mehta, Nehal N.
   Yap, Jonathan K.
   Kruth, Howard S.
   Boisvert, William A.
TI Ultramorphological analysis of plaque advancement and cholesterol
   crystal formation in Ldlr knockout mouse atherosclerosis
SO ATHEROSCLEROSIS
LA English
DT Article
DE Cholesterol crystal; Atherosclerosis; Inflammation; Endothelial cells;
   Macrophages; Necrotic core; Atherogenesis
ID NLRP3 INFLAMMASOME ACTIVATION; SMOOTH-MUSCLE-CELLS; HUMAN MACROPHAGES;
   CORE REGION; CRYSTALLIZATION; ENDOTHELIUM; GENERATION; MORPHOLOGY;
   EXPRESSION; DOMAINS
AB Backgound and aims: The low-density lipoprotein receptor-deficient (Ldlr(-/-)) mouse has been utilized by cardiovascular researchers for more than two decades to study atherosclerosis. However, there has not yet been a systematic effort to document the ultrastructural changes that accompany the progression of atherosclerotic plaque in this model.
   Methods: Employing several different staining and microscopic techniques, including immunohistochemistry, as well as electron and polarized microscopy, we analyzed atherosclerotic lesion development in Ldlr(-/-) mice fed an atherogenic diet over time.
   Results: Lipid-like deposits occurred in the subendothelial space after only one week of atherogenic diet. At two weeks, cholesterol crystals (CC) formed and increased thereafter. Lipid, CC, vascular smooth muscles cells, and collagen progressively increased over time, while after 4 weeks, relative macrophage content decreased. Accelerated accumulation of plate-and needle-shaped CC accompanied plaque core necrosis. Lastly, CC were surrounded by cholesterol microdomains, which co-localized with CC through all stages of atherosclerosis, indicating that the cholesterol microdomains may be a source of CC.
   Conclusions: Here, we have documented, for the first time in a comprehensive way, atherosclerotic plaque morphology and composition from early to advanced stages in the Ldlr(-/-) mouse, one of the most commonly used animal models utilized in atherosclerosis research.
C1 [Baumer, Yvonne; McCurdy, Sara; Yap, Jonathan K.; Boisvert, William A.] Univ Hawaii, John A Burns Sch Med, Cardiovasc Res Ctr, 651 Ilalo St, Honolulu, HI 96813 USA.
   [Jin, Xueting; Kruth, Howard S.] NHLBI, Sect Expt Atherosclerosis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Weatherby, Tina M.] Univ Hawaii, Biol Electron Microscope Facil, Pacific Biosci Res Ctr, 2538 Mall,Snyder Hall, Honolulu, HI 96822 USA.
   [Dey, Amit K.; Mehta, Nehal N.] NHLBI, Sect Inflammat & Cardiometab Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Boisvert, William A.] Kazan Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia.
   [Baumer, Yvonne] NHLBI, Social Determinants Obes & Cardiovasc Risk Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [McCurdy, Sara] Univ Calif San Diego, Dept Med, 9500 Gilman Dr 0726, La Jolla, CA 92093 USA.
RP Boisvert, WA (reprint author), Univ Hawaii, John A Burns Sch Med, Cardiovasc Res Ctr, 651 Ilalo St, Honolulu, HI 96813 USA.
EM wab@hawaii.edu
OI McCurdy, Sara/0000-0001-7854-8808; Boisvert, William/0000-0003-2574-9176
FU NSFNational Science Foundation (NSF) [DBI-1040548]; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01HL075677, R01HL081863]; American Heart AssociationAmerican
   Heart Association [16IRG27540027, 16GRNT30810007]; Ingeborg v. F. McKee
   Fund of the Hawaii Community Foundation [17ADVC-86287]; Intramural
   Research Program of the National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA; Binational Science FoundationUS-Israel Binational Science
   Foundation [2013045]
FX The Hitachi HT7700 TEM was acquired with NSF grant DBI-1040548. This
   project was funded by NIH grants R01HL075677 and R01HL081863, by
   Innovative Research Grant 16IRG27540027 and Grant-in-Aid 16GRNT30810007
   from the American Heart Association, and by the Ingeborg v. F. McKee
   Fund of the Hawaii Community Foundation 17ADVC-86287 to WAB. Additional
   support for this project was from the Intramural Research Program of the
   National Institutes of Health and the Binational Science Foundation
   (Grant 2013045).
NR 75
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
BP 100
EP 111
DI 10.1016/j.atherosclerosis.2019.05.029
PG 12
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800906
PM 31247346
DA 2019-10-28
ER

PT J
AU Wang, YT
   Liu, XK
   Wu, X
   Degnan, AJ
   Malhotra, A
   Zhu, CC
AF Wang, Yuting
   Liu, Xinke
   Wu, Xiao
   Degnan, Andrew J.
   Malhotra, Ajay
   Zhu, Chengcheng
TI Culprit intracranial plaque without substantial stenosis in acute
   ischemic stroke on vessel wall MRI: A systematic review
SO ATHEROSCLEROSIS
LA English
DT Review
DE Vessel wall imaging; Intracranial stenosis; Atherosclerosis; Ischemic
   stroke
ID HIGH-RESOLUTION MRI; ARTERY ATHEROSCLEROTIC PLAQUES; SUBCORTICAL
   INFARCTION; CRYPTOGENIC STROKE; ENHANCEMENT; PATTERNS; SUBTYPE
AB Background and aims: Intracranial atherosclerotic plaque is associated with ischemic strokes without substantial stenosis, and needs better characterization. We aim to investigate the clinical significance of intracranial plaque without substantial stenosis by high resolution vessel wall MRI (vwMRI) through a systematic review of existing studies.
   Methods: Studies investigating intracranial arterial atherosclerotic plaques without substantial stenosis in acute ischemic stroke patients using vwMRI were systematically identified by searching the PubMed and Medline database and article reference lists. Study characteristics were recorded, the methodological quality of eligible studies was assessed, relevant clinical data were extracted, and collective data was analyzed.
   Results: Twenty-one studies were identified as eligible. 463 patients were included without stenosis of the intracranial arteries, and 651 patients were included with stenosis< 50%. The prevalence of intracranial plaque revealed by vwMRI among acute/subacute ischemic stroke patients with non-stenotic Magnetic Resonance Angiography (MRA) was 50.6% (95% confidence interval (CI), 46.1%-55.1%). The prevalence of< 50% MRA stenotic culprit plaque among acute/subacute ischemic stroke patients with a clinical diagnosis of intracranial atherosclerosis was 51.2% (95% CI, 38.4%-64.0%). Plaques features, including wall enhancement, positive remodeling, intraplaque hemorrhage, plaque location and eccentricity, were associated with acute stroke, progressive motor deficits and unfavorable overall functional outcomes.
   Conclusions: Intracranial high-risk plaque with zero or mild degree of stenosis is more prevalent than previously acknowledged, and is associated with ischemic stroke and unfavorable outcome. VwMRI can identify the high-risk plaque features, which may act as a promising tool to better risk stratify these patients.
C1 [Wang, Yuting] Sichuan Acad Med Sci, Dept Radiol, Chengdu, Sichuan, Peoples R China.
   [Wang, Yuting] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China.
   [Wang, Yuting; Liu, Xinke; Zhu, Chengcheng] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.
   [Liu, Xinke] Capital Med Univ, Beijing Neurosurg Inst, Dept Intervent Neuroradiol, Beijing, Peoples R China.
   [Liu, Xinke] Capital Med Univ, Beijing Tiantan Hosp, Beijing, Peoples R China.
   [Wu, Xiao; Malhotra, Ajay] Yale Sch Med, Dept Radiol & Biomed Imaging, New Haven, CT USA.
   [Wu, Xiao; Malhotra, Ajay] Yale Univ, New Haven, CT USA.
   [Degnan, Andrew J.] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Degnan, Andrew J.] Childrens Hosp Philadelphia, Dept Radiol, Philadelphia, PA 19104 USA.
RP Zhu, CC (reprint author), 4150 Clement St, San Francisco, CA 94112 USA.; Wang, YT (reprint author), 32,Section 2,1st Ring Rd West, Chengdu 610072, Sichuan, Peoples R China.
EM wangyuting_330@163.com; Chengcheng.Zhu@ucsf.edu
OI Liu, Xinke/0000-0003-3918-0814; Zhu, Chengcheng/0000-0001-6898-549X
FU United States National Institutes of Health (NIH)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [K99HL136883]
FX This study is supported by United States National Institutes of Health
   (NIH) grant K99HL136883.
NR 46
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
BP 112
EP 121
DI 10.1016/j.atherosclerosis.2019.06.907
PG 10
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800907
PM 31254918
OA Bronze
DA 2019-10-28
ER

PT J
AU Ulleryd, MA
   Mjornstedt, F
   Panagaki, D
   Yang, LJ
   Engevall, K
   Gutierrez, S
   Wang, YX
   Gan, LM
   Nilsson, H
   Michaelsson, E
   Johansson, ME
AF Ulleryd, Marcus A.
   Mjornstedt, Filip
   Panagaki, Dimitra
   Yang, Li Jin
   Engevall, Kajsa
   Gutierrez, Saray
   Wang, Yixin
   Gan, Li-Ming
   Nilsson, Holger
   Michaelsson, Erik
   Johansson, Maria E.
TI Stimulation of alpha 7 nicotinic acetylcholine receptor (alpha 7nAChR)
   inhibits atherosclerosis via immunomodulatory effects on myeloid cells
SO ATHEROSCLEROSIS
LA English
DT Article
DE Alpha 7 nicotinic acetylcholine receptor alpha 7nAChR; Chrna7;
   Cholinergic signaling; Atherosclerosis; Immune responses; Phagocytosis;
   Inflammation; alpha 7nAChR agonists; Cardiovascular disease
ID HEART-RATE-VARIABILITY; MONOCYTE SUBSETS; WHOLE-BLOOD; P-SELECTIN;
   IN-VITRO; ATHEROGENESIS; INFLAMMATION; PROGRESSION; CHEMOKINE; AGONISTS
AB Background and aims: Alpha 7 nicotinic acetylcholine receptor (alpha 7nAChR) stimulation can regulate acute inflammation, and lack of alpha 7nAChR accelerates atherosclerosis in mice. In this study, we aimed to investigate the effects of the novel alpha 7nAChR agonist, AZ6983, on atherosclerosis and assess its possible immunomodulating effects.
   Methods: AZ6983 was tested in vitro in LPS-challenged mouse and human blood and in vivo using the acute inflammatory air pouch model. Thereafter, long-term effects of AZ6983 treatment on atherosclerosis and immune responses were assessed in apoE-/-mice after 8 and 12 weeks. Atherosclerosis was investigated in the aortic root and thoracic aorta, serum levels of cytokines were analysed and RNAseq was used to study aortic gene expression. Further, bone-marrow-derived macrophages were used to assess phagocytosis in vitro.
   Results: alpha 7nAChR activation by AZ6983 decreased pro-inflammatory cytokines in acute stimulations of human and mouse blood in vitro, as well as in vivo using the air pouch model. Treating apoE(-/-) mice with AZ6983 decreased atherosclerosis by 37-49% and decreased serum cytokine levels. RNAseq analysis of aortae suggested the involvement of several specific myeloid cell functions, including phagocytosis. In line with this, AZ6983 significantly increased phagocytosis in bone marrow-derived macrophages.
   Conclusions: This study demonstrates that activation of alpha 7nAChR with AZ6983 inhibits atherosclerosis in apoE(-/-) mice and that immunomodulating effects on myeloid cells, such as enhanced phagocytosis and suppression of inflammatory cytokines, could be part of the athero-protective mechanisms. The observed anti-inflammatory effect in human blood supports the idea that AZ6983 may decrease disease also in humans.
C1 [Ulleryd, Marcus A.; Mjornstedt, Filip; Panagaki, Dimitra; Yang, Li Jin; Engevall, Kajsa; Gutierrez, Saray; Nilsson, Holger; Johansson, Maria E.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol, Gothenburg, Sweden.
   [Wang, Yixin] Crown Biosci Inc, Shanghai, Peoples R China.
   [Gan, Li-Ming] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden.
   [Gan, Li-Ming; Michaelsson, Erik] AstraZeneca, R&D BioPharmaceut, Early Cardiovasc Renal & Metab, Gothenburg, Sweden.
RP Johansson, ME (reprint author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol, Gothenburg, Sweden.
EM maria.e.johansson@neuro.gu.se
OI Johansson, Maria/0000-0002-2569-2977
FU Swedish Heart Lung foundationSwedish Heart-Lung Foundation; Swedish
   Research CouncilSwedish Research Council; Swedish Society of Medicine;
   Magnus Bergvall foundation; Stiftelsen Langmanska kulturfonden;
   Stiftelsen Gamla tjanarinnor; Lars Hiertas foundation; Ake Wiberg
   foundation; OE and Edla Johanssons vetenskapliga stiftelse; Stiftelsen
   Tornspiran; Emil and Wera Cornells foundation; Dr. Felix Neuberghs
   Foundation; Emelle Foundation; Wilhelm and Martina Lundgren foundation;
   Swedish government [ALF GBG-723131]
FX Our work was supported by grants from The Swedish Heart Lung foundation,
   The Swedish Research Council, The Swedish Society of Medicine, Magnus
   Bergvall foundation, Stiftelsen Langmanska kulturfonden, Stiftelsen
   Gamla tjanarinnor, Lars Hiertas foundation, Ake Wiberg foundation, OE
   and Edla Johanssons vetenskapliga stiftelse, Stiftelsen Tornspiran, Emil
   and Wera Cornells foundation, Dr. Felix Neuberghs Foundation, Emelle
   Foundation, Wilhelm and Martina Lundgren foundation and grants from the
   Swedish state under the agreement between the Swedish government and the
   county councils, the ALF-agreement (ALF GBG-723131).
NR 58
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
BP 122
EP 133
DI 10.1016/j.atherosclerosis.2019.06.903
PG 12
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800908
PM 31260875
DA 2019-10-28
ER

PT J
AU Liu, XX
   Sun, CB
   Gu, X
   Liu, XL
   Wang, XD
   Wang, XY
   Xie, ZL
   Tian, JW
   Yu, B
AF Liu, Xinxin
   Sun, Changbin
   Gu, Xia
   Liu, Xianglan
   Wang, Xuedong
   Wang, Xueyu
   Xie, Zulong
   Tian, Jinwei
   Yu, Bo
TI Intraplaque neovascularization attenuated statin benefit on
   atherosclerotic plaque in CAD patients: A follow-up study with combined
   imaging modalities
SO ATHEROSCLEROSIS
LA English
DT Article
DE Neovascularization; Plaque progression; Thin-cap fibroatheroma; Optical
   coherence tomography; Intravascular ultrasound
ID OPTICAL COHERENCE TOMOGRAPHY; VASA VASORUM; INTRAVASCULAR ULTRASOUND;
   PROGRESSION; ANGIOGENESIS; VULNERABILITY; INFLAMMATION; ACQUISITION;
   STANDARDS; CONSENSUS
AB Background and aims: Plaque progression increases the risk of a cardiovascular event. This study aims to determine whether intraplaque neovascularization (NV) associates with a greater risk of plaque progression.
   Methods: Baseline and 12-month follow-up IVUS was used in combination with baseline OCT to assess 164 non-culprit plaques in 118 CAD patients. A generalized estimating equation approach with exchangeable correlation structure was used to correct for the dependency of repeated measurements.
   Results: Patients were divided into two groups according to NV (52 patients with 62 NV plaques, 66 patients with 102 non-NV plaques). Non-culprit plaques in the NV group exhibited a more frequent occurrence of TCFA (p= 0.004), macrophage (p= 0.005), cholesterol crystal (p= 0.012), calcification (p= 0.030), thinner fibrous cap thickness (FCT) [(86.8 +/- 55.1) vs. (127.4 +/- 70.1) mu m, p= 0.015], larger lipid arc [(219.5 +/- 66.9) vs. (179.8 +/- 61.4), p= 0.002] compared to the non-NV group. A large change in percent atheroma volume (PAV), plaque plus media cross-sectional area (P&M CSA), plaque volume, and plaque burden was observed from baseline to follow-up in the NV group. Changes in P&M CSA, plaque volume, and plaque burden showed significant differences in fibroatheroma with NV. Intraplaque NV could predict a high risk of plaque progression despite statin therapy [OR 6.521 (95% CI 2.457-17.308), p < 0.001].
   Conclusions: NV might attenuate the benefits of statin therapy in plaque progression. This study may provide a new basis for anti-angiogenic strategies to prevent atherosclerotic plaque progression.
C1 [Liu, Xinxin; Sun, Changbin; Gu, Xia; Liu, Xianglan; Wang, Xuedong; Wang, Xueyu; Tian, Jinwei; Yu, Bo] Harbin Med Univ, Affiliated Hosp 2, Dept Cardiol, Harbin 150086, Heilongjiang, Peoples R China.
   [Liu, Xinxin; Sun, Changbin; Gu, Xia; Liu, Xianglan; Wang, Xuedong; Wang, Xueyu; Tian, Jinwei; Yu, Bo] Harbin Med Univ, Minist Educ, Key Lab Myocardial Ischemia, Harbin 150086, Heilongjiang, Peoples R China.
   [Xie, Zulong] Chongqing Med Univ, Affiliated Hosp 2, Dept Cardiol, Chongqing 400010, Peoples R China.
RP Yu, B (reprint author), Harbin Med Univ, Affiliated Hosp 2, Dept Cardiol, Harbin 150086, Heilongjiang, Peoples R China.; Tian, JW (reprint author), Harbin Med Univ, Minist Educ, Key Lab Myocardial Ischemia, Harbin 150086, Heilongjiang, Peoples R China.
EM tianjinweidr2009@163.com; dryu_hmu@163.com
FU National Key R&D Program of China [2016YFC1301100]; National Natural
   Science Foundation of ChinaNational Natural Science Foundation of China
   [81571749, 91739113, 81703502]; China Postdoctoral Science
   FoundationChina Postdoctoral Science Foundation [2018M630376];
   Heilongjiang Postdoctoral Science Foundation [LBH-Z17120]
FX This study was supported by grants from the National Key R&D Program of
   China (to B.Y., Grant No. 2016YFC1301100), National Natural Science
   Foundation of China (to J.W.T., Grant No. 81571749, 91739113 and to
   X.X.L., Grant No. 81703502), China Postdoctoral Science Foundation
   (2018M630376) and Heilongjiang Postdoctoral Science Foundation
   (LBH-Z17120).
NR 34
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
BP 134
EP 139
DI 10.1016/j.atherosclerosis.2019.06.912
PG 6
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800909
PM 31272069
DA 2019-10-28
ER

PT J
AU Wisloff, T
   Mundal, LJ
   Retterstol, K
   Igland, J
   Kristiansen, IS
AF Wisloff, Torbjorn
   Mundal, Liv J.
   Retterstol, Kjetil
   Igland, Jannicke
   Kristiansen, Ivar Sonbo
TI Economic evaluation of lipid lowering with PCSK9 inhibitors in patients
   with familial hypercholesterolemia: Methodological aspects
SO ATHEROSCLEROSIS
LA English
DT Article
DE Health economic evaluation; PCSK9 inhibitors; Cholesterol
ID COST-EFFECTIVENESS; CHOLESTEROL; PREVALENCE; CHILDREN; HEALTH; IMPACT
AB Background and aims: Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors have proved to reduce low density lipoprotein cholesterol levels in numerous clinical trials. In two large clinical trials, PCSK9 inhibitor treatment reduced the risk of cardiovascular disease. Our aim was to explore the impact of varying assumptions about clinical effectiveness on health and economic outcomes for patients with familial hypercholesterolemia.
   Methods: We used a previously published and validated Norwegian model for cardiovascular disease. The model was updated with recent data from the world's second largest registry of patients with genetically confirmed familial hypercholesterolemia. We performed analyses for 24 different subgroups of patients based on age, gender, statin tolerance and previous history of cardiovascular disease.
   Results: In 1 out of 24 subgroups, PCSK9 inhibitors were cost-effective when effectiveness was modelled using direct relative efficacy as reported in the FOURIER trial. When using assumptions, as suggested in a recent consensus statement from the European Atherosclerosis Society, 14 subgroups were cost-effective.
   Conclusions: Cost-effectiveness of PCSK9 inhibitors depends highly on assumptions regarding effectiveness. Basing assumptions only on randomised controlled trials, and not taking into account varying effects based on baseline cholesterol level, results in much fewer groups being cost-effective.
C1 [Wisloff, Torbjorn; Kristiansen, Ivar Sonbo] Univ Oslo, Dept Hlth Management & Hlth Econ, Oslo, Norway.
   [Wisloff, Torbjorn] Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol & Modelling, Oslo, Norway.
   [Mundal, Liv J.; Retterstol, Kjetil] Oslo Univ Hosp, Dept Endocrinol Morbid Obes & Prevent Med, Lipid Clin, Oslo, Norway.
   [Mundal, Liv J.; Retterstol, Kjetil] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway.
   [Igland, Jannicke] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.
RP Wisloff, T (reprint author), Norwegian Inst Publ Hlth, Postboks 222, N-0213 Oslo, Norway.
EM torbjorn.wisloff@medisin.uio.no
RI Keskin, Kudret/AAB-8198-2019
OI Keskin, Kudret/0000-0002-9049-1530; Retterstol,
   Kjetil/0000-0002-1309-7556; Wisloff, Torbjorn/0000-0002-7539-082X
NR 36
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
BP 140
EP 146
DI 10.1016/j.atherosclerosis.2019.06.900
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800910
PM 31280039
DA 2019-10-28
ER

PT J
AU Qiu, SH
   Cai, X
   Liu, JN
   Yang, BQ
   Zugel, M
   Steinacker, JM
   Sun, ZL
   Schumann, U
AF Qiu, Shanhu
   Cai, Xue
   Liu, Jianing
   Yang, Bingquan
   Zuegel, Martina
   Steinacker, Juergen Michael
   Sun, Zilin
   Schumann, Uwe
TI Association between circulating cell adhesion molecules and risk of type
   2 diabetes: A meta-analysis
SO ATHEROSCLEROSIS
LA English
DT Article
DE Endothelial dysfunction; Cell adhesion molecules; Type 2 diabetes;
   Meta-analysis
ID ENDOTHELIAL DYSFUNCTION; INSULIN-RESISTANCE; INFLAMMATORY MARKERS;
   ATHEROSCLEROSIS RISK; PHYSICAL-ACTIVITY; BIOMARKERS; PREDICTION;
   MELLITUS; DISEASE; WOMEN
AB Background and aims: Cell adhesion molecules (CAMs) are implicated in the initiation and progression of atherosclerosis, but their association with risk of type 2 diabetes remains inconsistent. This meta-analysis aimed to quantify this association with dose-response analysis in the general population without type 2 diabetes at baseline.
   Methods: Prospective studies, investigating the association of circulating (plasma/serum) CAMs, such as intercellular adhesion molecule-1 (ICAM-1), E-selectin, vascular cell adhesion molecule-1 (VCAM-1), and P-selectin, with risk of type 2 diabetes, were included. The overall relative risks (RRs) with 95% confidence intervals (CIs) were calculated using a random-effects model.
   Results: Sixteen datasets from 15 studies were included. The overall RR was 1.88 (95% CI 1.59 to 2.23) per 1-ln mu g/ml increase in ICAM-1, and 2.44 (95% CI 1.90 to 3.12) per 1-ln mu g/ml increase in E-selectin. These associations were log-linearly shaped (both pnon-linearity> 0.05) and independent of traditional cardiovascular risk factors (all p < 0.05). ICAM-1 had comparable predictive ability as E-selectin (2.22 versus 2.66, p = 0.40). However, no significant association was observed for VCAM-1 (RR 1.20, 95% CI 0.73 to 1.98) or P-selectin (RR 1.01, 95% CI 0.64 to 1.59), and the added predictive value of circulating CAMs assessed by Integrated Discrimination Improvement to the basic prediction models was small (0.01 for ICAM-1, 0.003 for E-selectin, and 0.007 for VCAM-1).
   Conclusions: Elevated circulating CAMs, especially ICAM-1 and E-selectin, led to increased risk of type 2 diabetes in a dose-dependent manner, supporting the assumption that endothelial dysfunction contributes to the development of diabetes.
C1 [Qiu, Shanhu; Liu, Jianing; Yang, Bingquan; Sun, Zilin] Southeast Univ, Sch Med, Inst Diabet, Zhongda Hosp,Dept Endocrinol, Dingjiaqiao St 87, Nanjing, Jiangsu, Peoples R China.
   [Qiu, Shanhu] Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing 210009, Jiangsu, Peoples R China.
   [Qiu, Shanhu; Zuegel, Martina; Steinacker, Juergen Michael; Schumann, Uwe] Univ Ulm, Med Ctr, Div Sports & Rehabil Med, Ulm, Germany.
   [Cai, Xue] Peking Univ, Sch Nursing, Beijing, Peoples R China.
RP Sun, ZL (reprint author), Southeast Univ, Sch Med, Inst Diabet, Zhongda Hosp,Dept Endocrinol, Dingjiaqiao St 87, Nanjing, Jiangsu, Peoples R China.
EM sunzilin1963@126.com
FU Diabetes Fund from Chinese Society of Microcirculation [TW-2018H005];
   Nanjing Special Fund for Health Science and Technology Development
   [YKK18261]; National Key R&D Program of China [2016YFC1305700]
FX This study was funded by the Diabetes Fund from Chinese Society of
   Microcirculation (No. TW-2018H005), the Nanjing Special Fund for Health
   Science and Technology Development (No. YKK18261), and the National Key
   R&D Program of China (No. 2016YFC1305700). The funders had no roles in
   the design of the study and collection, analysis, and interpretation of
   data or manuscript writing.
NR 47
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
BP 147
EP 154
DI 10.1016/j.atherosclerosis.2019.06.908
PG 8
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800911
PM 31280040
DA 2019-10-28
ER

PT J
AU Tanaka, T
   Kishi, S
   Ninomiya, K
   Tomii, D
   Koseki, K
   Sato, Y
   Okuno, T
   Sato, K
   Koike, H
   Yahagi, K
   Komiyama, K
   Aoki, J
   Tanabe, K
AF Tanaka, Tetsu
   Kishi, Satoru
   Ninomiya, Kai
   Tomii, Daijiro
   Koseki, Keita
   Sato, Yu
   Okuno, Taishi
   Sato, Kei
   Koike, Hideki
   Yahagi, Kazuyuki
   Komiyama, Kota
   Aoki, Jiro
   Tanabe, Kengo
TI Impact of abdominal fat distribution, visceral fat, and subcutaneous fat
   on coronary plaque scores assessed by 320-row computed tomography
   coronary angiography
SO ATHEROSCLEROSIS
LA English
DT Article
DE Computed tomography; Obesity; Plaque score; Coronary artery disease;
   Imaging; Atherosclerosis
ID ADIPOSE-TISSUE; CARDIOVASCULAR-DISEASE; ARTERY-DISEASE; BODY-FAT;
   ASSOCIATION; OBESITY; MORTALITY; CT; ATHEROSCLEROSIS
AB Background and aims: Obesity is a risk factor for coronary artery disease (CAD), but the association between fat distribution, i.e., visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT), and coronary artery plaque morphology remains unclear. This study explored the association between abdominal fat distribution and coronary artery plaques.
   Methods: We retrospectively evaluated 4327 consecutive patients without CAD history, undergoing coronary computed tomography (CT) angiography. Plaques were assessed using segment stenosis score (SSS) and segment involvement score (SIS). We evaluated abdominal VAT and SAT areas using CT images. Patients were categorized into four groups: low VAT (< median)/low SAT (< median); low VAT/high SAT (>= median); high VAT (>= median)/low SAT; and high VAT/high SAT.
   Results: Mean age was 65 years (men, 66.4%). VAT area correlated with SSS (beta-coefficient = 0.11, p < 0.001) and SIS (beta-coefficient= 0.006, p < 0.001), whereas SAT area was inversely correlated with SSS (beta-coefficient =- 0.007, p < 0.001) and SIS (beta-coefficient=-0.004, p < 0.001). The low VAT/high SAT group had the lowest risk of higher SSS (>= 5) and SIS (>= 5) (odds ratio [OR] using low VAT/low SAT group as the reference category, 0.76, 95% confidence interval [CI], 0.61-0.95, p < 0.05; OR, 0.68, 95% CI, 0.53-0.88, p < 0.01, respectively) in multivariate analysis adjusted for age, sex, and traditional CAD risk factors. In the obese population (body mass index >= 25, n = 1694), the low VAT/high SAT group had the lowest risk of higher coronary plaque scores.
   Conclusions: Higher SAT and lower VAT were inversely correlated with the extent and severity of coronary artery plaques. Fat distribution may be useful for evaluating risk and prognosis of CAD.
C1 [Tanaka, Tetsu; Kishi, Satoru; Ninomiya, Kai; Tomii, Daijiro; Koseki, Keita; Sato, Yu; Okuno, Taishi; Sato, Kei; Koike, Hideki; Yahagi, Kazuyuki; Komiyama, Kota; Aoki, Jiro; Tanabe, Kengo] Mitsui Mem Hosp, Div Cardiol, Tokyo, Japan.
RP Kishi, S (reprint author), Mitsui Mem Hosp, Div Cardiol, Chiyoda Ku, Kanda Izumicho 1, Tokyo 1018643, Japan.
EM m980287@gmail.com
OI Kishi, Satoru/0000-0001-6741-787X; tanaka, tetsu/0000-0003-0780-8689
NR 32
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
BP 155
EP 161
DI 10.1016/j.atherosclerosis.2019.06.910
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800912
PM 31295672
DA 2019-10-28
ER

PT J
AU Merz, CNB
   Cheng, S
   Raggi, P
   Wei, J
AF Merz, C. Noel Bairey
   Cheng, Susan
   Raggi, Paolo
   Wei, Janet
TI End-organ ischemia in the absence of proximal obstructive arterial
   disease: Deja vu or jamais vu?
SO ATHEROSCLEROSIS
LA English
DT Editorial Material
DE White matter hyperintense lesions; Microvascular disease; Ischemia;
   Hypercholesterolemia; Women health
ID SUSPECTED ISCHEMIA; WOMEN; REACTIVITY; DEMENTIA; PLAQUES; RISK
C1 [Merz, C. Noel Bairey; Cheng, Susan; Wei, Janet] Cedars Sinai Smidt Heart Inst, Barbra Streisand Womens Heart Ctr, Los Angeles, CA USA.
   [Raggi, Paolo] Univ Alberta, Div Cardiol, Edmonton, AB, Canada.
   [Raggi, Paolo] Univ Alberta, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada.
RP Merz, CNB (reprint author), 127 S San Vicente Blvd,Suite A3600, Los Angeles, CA 90048 USA.
EM Noel.BaireyMerz@cshs.org
FU Gilead SciencesGilead Sciences; National Heart, Lung, and Blood
   InstituteUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [N01-HV-68161, N01-HV-68162, N01-HV-68163,
   N01-HV-68164]; National Institute on AgingUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute on Aging (NIA) [U01-64829, U01-HL649141,
   U01-HL649241, K23-HL105787, K23-HL125941, T32-HL69751, R01-HL090957,
   R01-HL134168, R01-HL131532, R01-HL143227, R01-HL1429831, R03AG032631];
   GCRC from the National Center for Research Resources [MO1-RR00425];
   National Center for Advancing Translational SciencesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Center for Advancing Translational Sciences (NCATS)
   [UL1TR000124]; Edythe L. Broad and the Constance Austin Women's Heart
   Research Fellowships; Cedars-Sinai Medical Center, Los Angeles,
   California; Barbra Streisand Women's Cardiovascular Research and
   Education Program; Cedars-Sinai Medical Center, Los Angeles; Society for
   Women's Health Research (SWHR), Washington, D. C.; Linda Joy Pollin
   Women's Heart Health Program; Erika Glazer Women's Heart Health Project;
   Adelson Family Foundation, Cedars-Sinai Medical Center, Los Angeles,
   California
FX This work was supported by an unrestricted research grant from Gilead
   Sciences, and contracts from the National Heart, Lung, and Blood
   Institute nos. N01-HV-68161, N01-HV-68162, N01-HV-68163, N01-HV-68164,
   grants U01-64829, U01-HL649141, U01-HL649241, K23-HL105787,
   K23-HL125941, T32-HL69751, R01-HL090957, R01-HL134168, R01-HL131532,
   R01-HL143227, R01-HL1429831, and R03AG032631 from the National Institute
   on Aging, GCRC grant MO1-RR00425 from the National Center for Research
   Resources, the National Center for Advancing Translational Sciences
   Grant UL1TR000124, the Edythe L. Broad and the Constance Austin Women's
   Heart Research Fellowships, Cedars-Sinai Medical Center, Los Angeles,
   California, the Barbra Streisand Women's Cardiovascular Research and
   Education Program, Cedars-Sinai Medical Center, Los Angeles, The Society
   for Women's Health Research (SWHR), Washington, D. C., the Linda Joy
   Pollin Women's Heart Health Program, the Erika Glazer Women's Heart
   Health Project, and the Adelson Family Foundation, Cedars-Sinai Medical
   Center, Los Angeles, California.
NR 15
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
BP 162
EP 164
DI 10.1016/j.atherosclerosis.2019.05.021
PG 3
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800913
PM 31213292
OA Bronze
DA 2019-10-28
ER

PT J
AU Styczynski, G
   Kalinowski, P
   Michalowski, L
   Paluszkiewicz, R
   Ziarkiewicz-Wroblewska, B
   Zieniewicz, K
   Tataj, E
   Szmigielski, C
   Jedrusik, P
AF Styczynski, Grzegorz
   Kalinowski, Piotr
   Michalowski, Lukasz
   Paluszkiewicz, Rafal
   Ziarkiewicz-Wroblewska, Bogna
   Zieniewicz, Krzysztof
   Tataj, Emanuel
   Szmigielski, Cezary
   Jedrusik, Piotr
TI No association between aortic stiffness and liver steatosis in morbidly
   obese patients
SO ATHEROSCLEROSIS
LA English
DT Article
DE Aortic stiffness; Aortic pulse wave velocity; Liver steatosis;
   Non-alcoholic fatty liver disease; Liver biopsy; Obesity; Doppler
   echocardiography
ID INCREASED ARTERIAL STIFFNESS; PULSE-WAVE VELOCITY; FATTY LIVER;
   HEART-RATE; DISEASE; RISK; ATHEROSCLEROSIS; DEPENDENCY; VALIDATION;
   ULTRASOUND
AB Background and aims: Patients with non-alcoholic fatty liver disease are characterized by increased aortic stiffness, but it is unclear whether this is related to non-alcoholic fatty liver disease itself or concomitant metabolic syndrome components, including hypertension and diabetes. Previous studies were methodologically limited by ultrasound-based assessment of liver steatosis or performing liver biopsy in patients with more severe disease. Therefore, we prospectively measured aortic pulse wave velocity (aPWV) in non-selected obese subjects admitted for bariatric surgery with liver biopsy, allowing assessment of the association between aortic stiffness and biopsy-confirmed liver steatosis.
   Methods: We evaluated 120 consecutive severely obese patients (79 females; mean age 42 +/- 10 years, mean body mass index 45.0 +/- 5.3 kg/m(2)) without cardiac disease or alcohol-induced liver disease, who were admitted for bariatric surgery. The presence or absence of liver steatosis was defined by wedge liver biopsy. aPWV was measured with the Doppler method at the time of preoperative transthoracic echocardiography.
   Results: Based on liver biopsy results, 82 patients (68%) had liver steatosis and 38 (32%) had no steatosis. Univariate linear regression analysis showed that age, mean arterial pressure, liver steatosis, heart rate, female gender, and diabetes were significantly associated with aPWV. However, only age, mean arterial pressure, heart rate, and diabetes remained significant in the multivariate model (p <= 0.001).
   Conclusions: We found no independent association between biopsy-confirmed liver steatosis and aortic stiffness measured by Doppler aPWV in morbidly obese individuals. Aortic stiffness in these subjects is related to comorbidities and not to non-alcoholic fatty liver disease itself.
C1 [Styczynski, Grzegorz; Szmigielski, Cezary; Jedrusik, Piotr] Med Univ Warsaw, Dept Internal Med Hypertens & Angiol, Banacha 1a, PL-02097 Warsaw, Poland.
   [Kalinowski, Piotr; Paluszkiewicz, Rafal; Zieniewicz, Krzysztof] Med Univ Warsaw, Dept Gen Transplant & Liver Surg, Banacha 1a, PL-02097 Warsaw, Poland.
   [Michalowski, Lukasz; Ziarkiewicz-Wroblewska, Bogna] Med Univ Warsaw, Ctr Biostruct Res, Dept Pathol, Banacha 1a, PL-02097 Warsaw, Poland.
   [Tataj, Emanuel] Med Univ Warsaw, Dept Med Informat & Telemed, Banacha 1a, PL-02097 Warsaw, Poland.
RP Jedrusik, P (reprint author), Med Univ Warsaw, Dept Internal Med Hypertens & Angiol, Banacha 1a, PL-02097 Warsaw, Poland.
EM pjedrusik@wum.edu.pl
NR 33
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
BP 165
EP 170
DI 10.1016/j.atherosclerosis.2019.04.206
PG 6
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800914
PM 31040024
DA 2019-10-28
ER

PT J
AU Ammirati, E
   Moroni, F
   Magnoni, M
   Rocca, MA
   Anzalone, N
   Cacciaguerra, L
   Di Terlizzi, S
   Villa, C
   Sizzano, F
   Palini, A
   Scotti, I
   Besana, F
   Spagnolo, P
   Rimoldi, OE
   Chiesa, R
   Falini, A
   Filippi, M
   Camici, PG
AF Ammirati, Enrico
   Moroni, Francesco
   Magnoni, Marco
   Rocca, Maria A.
   Anzalone, Nicoletta
   Cacciaguerra, Laura
   Di Terlizzi, Simona
   Villa, Chiara
   Sizzano, Federico
   Palini, Alessio
   Scotti, Isabella
   Besana, Francesca
   Spagnolo, Pietro
   Rimoldi, Ornella E.
   Chiesa, Roberto
   Falini, Andrea
   Filippi, Massimo
   Camici, Paolo G.
TI Progression of brain white matter hyperintensities in asymptomatic
   patients with carotid atherosclerotic plaques and no indication for
   revascularization
SO ATHEROSCLEROSIS
LA English
DT Article
DE Carotid plaque; Atherosclerosis; White matter hyperintensities; Ischemic
   stroke; Brain magnetic resonance imaging
ID SMALL VESSEL DISEASE; INTRAPLAQUE NEOVASCULARIZATION; STROKE; RISK;
   LESIONS; ASSOCIATION; STENOSIS; ATROPHY; TRIAL; FOCUS
AB Background and aims: Brain white matter hyperintensities (WMHs) have been associated with an increased risk of ischemic stroke and considered as markers of brain ischemia. Progression of WMHs in asymptomatic patients with non-hemodynamically significant carotid plaque could represent a putative marker of plaque vulnerability. We prospectively evaluate progression and determinants of WMHs in this population.
   Methods: This prospective study included 51 asymptomatic patients with carotid stenosis < 70% that underwent brain magnetic resonance imaging scans at baseline and after a median follow up of 595 days (interquartile range 553-641 days). Patients (mean age of 69 years and 45% females) underwent baseline carotid computed tomography angiography, contrast-enhanced ultrasound for carotid plaque characterization and analysis of subsets of circulating lymphocytes and monocytes by flow cytometry.
   Results: Seventeen subjects (33.3%) had carotid stenoses of 50-70% (Doppler flow velocity) while the rest had stenoses of < 50%. In 25 (49.0%) patients, new WMHs, with 5 new lesions on average and a median volume of 134 mm(3), were detected at follow-up. None of the plaque characteristics or of the circulating cellular biomarkers investigated were associated with the global and ipsilateral occurrence of new WMHs whereas, at multivariate analysis, female sex, hypercholesterolemia, and lower glomerular filtration rate (GFR) emerged as independent variables associated with new WMHs.
   Conclusions: Half of the patients with carotid plaques of intermediate severity had evidence of WMH progression at follow up. Female gender and systemic factors such as hypercholesterolemia, and lower GFR, but not plaque characteristics or circulating cellular biomarkers, are associated with WMH progression.
C1 [Ammirati, Enrico; Moroni, Francesco; Magnoni, Marco; Rocca, Maria A.; Anzalone, Nicoletta; Cacciaguerra, Laura; Chiesa, Roberto; Falini, Andrea; Filippi, Massimo; Camici, Paolo G.] Univ Vita Salute San Raffaele, Via Olgettina 60, I-20132 Milan, Italy.
   [Ammirati, Enrico; Moroni, Francesco; Magnoni, Marco; Chiesa, Roberto; Camici, Paolo G.] IRCCS San Raffaele Hosp, Via Olgettina 60, I-20132 Milan, Italy.
   [Ammirati, Enrico] Osped Niguarda Ca Granda, De Gasperis Cardio Ctr, Piazza Osped Maggiore 3, I-20162 Milan, Italy.
   [Rocca, Maria A.; Cacciaguerra, Laura; Filippi, Massimo] Ist Sci San Raffaele, Inst Expt Neurol, Div Neurosci, Neuroimaging Res Unit, Milan, Italy.
   [Anzalone, Nicoletta; Falini, Andrea] Ist Sci San Raffaele, Dept Neuroradiol, Milan, Italy.
   [Di Terlizzi, Simona; Villa, Chiara] Ist Sci San Raffaele, FRACTAL Flow Cytometry Resource Adv Cytometry Tec, Milan, Italy.
   [Sizzano, Federico; Palini, Alessio] Ecole Polytech Fed Lausanne, Biobanking & Flow Cytometry Core, Nestle Inst Hlth Sci, Innovat Pk,Batiment H, Lausanne, Switzerland.
   [Scotti, Isabella] Ist Ortoped Gaetano Pini, Dept Rheumatol, Milan, Italy.
   [Besana, Francesca; Spagnolo, Pietro] San Raffaele Inst, Cardiovasc Prevent Ctr, Milan, Italy.
   [Rimoldi, Ornella E.] CNR, IBFM, Segrate, Italy.
RP Camici, PG (reprint author), Univ Vita Salute San Raffaele, Via Olgettina 60, I-20132 Milan, Italy.; Camici, PG (reprint author), IRCCS San Raffaele Hosp, Via Olgettina 60, I-20132 Milan, Italy.; Ammirati, E (reprint author), Osped Niguarda Ca Granda, De Gasperis Cardio Ctr, Piazza Osped Maggiore 3, I-20162 Milan, Italy.; Ammirati, E (reprint author), San Raffaele Sci Inst & Univ, Cardiothorac Dept, Via Olgettina 60, I-20132 Milan, Italy.
EM enrico.ammirati@ospedaleniguarda.it; camici.paolo@hsr.it
RI Filippi, Massimo/K-1755-2018; Rocca, Maria A/K-1619-2018
OI Filippi, Massimo/0000-0002-5485-0479; Moroni,
   Francesco/0000-0002-6101-1403; Ammirati, Enrico/0000-0002-1676-5257;
   Rocca, Maria A/0000-0003-2358-4320
FU Italian Health MinistryMinistry of Health, Italy [GR-2009-1608780]
FX Dr. Enrico Ammirati received the "Giovane Ricercatore 2009 Grant" from
   Italian Health Ministry (project code GR-2009-1608780) to conduct the
   present study.
NR 44
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
BP 171
EP 178
DI 10.1016/j.atherosclerosis.2019.04.230
PG 8
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800915
PM 31101367
DA 2019-10-28
ER

PT J
AU Spence, JD
AF Spence, J. David
TI Coronary calcium is not all we need: Carotid plaque burden measured by
   ultrasound is better
SO ATHEROSCLEROSIS
LA English
DT Letter
DE Atherosclerosis; Ultrasound measurement; Cardiovascular risk; Coronary
   calcium; Carotid plaque burden
ID ATHEROSCLEROSIS; RISK; TOOL
C1 [Spence, J. David] Western Univ, Robarts Res Inst, Stroke Prevent & Atherosclerosis Res Ctr, 1400 Western Rd, London, ON N6G 2V4, Canada.
RP Spence, JD (reprint author), Western Univ, Robarts Res Inst, Stroke Prevent & Atherosclerosis Res Ctr, 1400 Western Rd, London, ON N6G 2V4, Canada.
EM dspence@robarts.ca
RI Spence, J. David/K-6396-2013
OI Spence, J. David/0000-0001-7478-1098
NR 10
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
BP 179
EP 180
DI 10.1016/j.atherosclerosis.2019.04.214
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800916
PM 31047640
DA 2019-10-28
ER

PT J
AU Rampidis, GP
   Benetos, G
   Benz, DC
   Giannopoulos, AA
   Buechel, RR
AF Rampidis, Georgios P.
   Benetos, Georgios
   Benz, Dominik C.
   Giannopoulos, Andreas A.
   Buechel, Ronny R.
TI A guide for Gensini Score calculation
SO ATHEROSCLEROSIS
LA English
DT Letter
DE Gensini score; Coronary artery disease; Atherosclerosis; Angiographic
   severity scoring system
C1 [Rampidis, Georgios P.; Benetos, Georgios; Benz, Dominik C.; Giannopoulos, Andreas A.; Buechel, Ronny R.] Univ Hosp Zurich, Dept Nucl Med, Cardiac Imaging, Zurich, Switzerland.
RP Rampidis, GP (reprint author), Univ Hosp Zurich, Dept Nucl Med, Cardiac Imaging, Zurich, Switzerland.
EM Georgios.Rampidis@usz.ch
NR 4
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
BP 181
EP 183
DI 10.1016/j.atherosclerosis.2019.05.012
PG 3
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800917
PM 31104809
DA 2019-10-28
ER

PT J
AU Wu, VCC
   Chen, TH
   Wu, M
   Cheng, CW
   Chen, SW
   Chang, CW
   Cheng, CC
   Chang, SH
   Hung, KC
   Chern, MS
   Lin, FC
   Chu, PH
   Wu, CS
AF Wu, Victor Chien-Chia
   Chen, Tien-Hsing
   Wu, Michael
   Cheng, Chun-Wen
   Chen, Shao-Wei
   Chang, Chun-Wei
   Cheng, Ching-Chang
   Chang, Shang-Hung
   Hung, Kuo-Chun
   Chern, Ming-Shyan
   Lin, Fen-Chiung
   Chu, Pao-Hsien
   Wu, Cheng-Shyong
TI Comparison of cardiovascular outcomes and all-cause mortality in
   patients with chronic hepatitis B and C: A 13-year nationwide
   population-based study in Asia (vol 269, pg 178, 2018)
SO ATHEROSCLEROSIS
LA English
DT Correction
C1 [Wu, Victor Chien-Chia; Chang, Shang-Hung; Hung, Kuo-Chun; Chern, Ming-Shyan; Lin, Fen-Chiung; Chu, Pao-Hsien] Chang Gung Mem Hosp, Linkou Med Ctr, Div Cardiol, Taoyuan, Taiwan.
   [Chen, Tien-Hsing] Chang Gung Mem Hosp, Dept Cardiol, Keelung, Taiwan.
   [Wu, Michael] Brown Univ, Miriam & Rhode Isl Hosp, Warren Alpert Sch Med, Div Cardiovasc Med, Providence, RI 02912 USA.
   [Cheng, Chun-Wen] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Infect Dis, Taoyuan, Taiwan.
   [Chen, Shao-Wei] Chang Gung Mem Hosp, Linkou Med Ctr, Cardiothorac & Vasc Surg, Taoyuan, Taiwan.
   [Chang, Chun-Wei] Chang Gung Mem Hosp, Dept Neurol, Linkou Med Ctr, Taoyuan, Taiwan.
   [Cheng, Ching-Chang] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Neurosurg, Taoyuan, Taiwan.
   [Wu, Cheng-Shyong] Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Chiayi, Taiwan.
RP Wu, VCC (reprint author), Chang Gung Mem Hosp, Linkou Med Ctr, Div Cardiol, Taoyuan, Taiwan.
EM victorcwu@hotmail.com
NR 1
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
BP 184
EP 185
DI 10.1016/j.atherosclerosis.2019.05.025
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800918
PM 31160040
DA 2019-10-28
ER

PT J
AU Stock, JK
AF Stock, Jane K.
TI Highlights from the 87th EAS congress, 26-29th May 2019
SO ATHEROSCLEROSIS
LA English
DT Editorial Material
DE Congress; Maastricht; Highlights; FHSC; Lipoprotein(a)
ID HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; ACHIEVEMENT; PREVALENCE;
   THERAPY; TARGET
C1 [Stock, Jane K.] European Atherosclerosis Soc, World Trade Ctr Goteborg, Massans Gata 18, SE-41251 Gothenburg, Sweden.
RP Stock, JK (reprint author), European Atherosclerosis Soc, World Trade Ctr Goteborg, Massans Gata 18, SE-41251 Gothenburg, Sweden.
EM office@eas-society.org
NR 26
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
BP 186
EP 188
DI 10.1016/j.atherosclerosis.2019.06.913
PG 3
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800919
PM 31326112
OA Bronze
DA 2019-10-28
ER

PT J
AU Aarts, S
   Reiche, M
   den Toom, M
   Beckers, L
   Gijbels, M
   Lutgens, E
AF Aarts, S.
   Reiche, M.
   den Toom, M.
   Beckers, L.
   Gijbels, M.
   Lutgens, E.
TI CD40 DEPLETION ON CD11C+CELLS WORSENS DIET INDUCED OBESITY BUT
   AMELIORATES LIVER INFLAMMATION DURING NASH
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Aarts, S.; Reiche, M.; den Toom, M.; Beckers, L.; Lutgens, E.] Amsterdam UMC Locat AMC, Med Biochem, Amsterdam, Netherlands.
   [Gijbels, M.] Maastricht Univ, Biochem, Maastricht, Netherlands.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0404
BP E2
EP E2
DI 10.1016/j.atherosclerosis.2019.06.005
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800005
DA 2019-10-28
ER

PT J
AU Aaty, TA
   Rezk, M
   Amin, N
   Zohdy, A
AF Aaty, T. Abdel
   Rezk, M.
   Amin, N.
   Zohdy, A.
TI ASSOCIATION OF SERUM LEVEL OF NESFATIN-1 AND EARLY ATHEROSCLEROSIS IN
   PATIENTS WITH TYPE 2 DIABETES
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Aaty, T. Abdel; Amin, N.; Zohdy, A.] Alexandria Univ, Fac Med, Internal Med Diabet & Metab Unit, Alexandria, Egypt.
   [Rezk, M.] Alexandria Univ, Clin Pathol, Fac Med, Alexandria, Egypt.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0333
BP E244
EP E244
DI 10.1016/j.atherosclerosis.2019.06.751
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800749
DA 2019-10-28
ER

PT J
AU Abbing, RLR
   Slijepcevic, D
   Donkers, JM
   Lutgens, E
   Elferink, RPJO
   Van de Graaf, S
AF Abbing, R. L. Roscam
   Slijepcevic, D.
   Donkers, J. M.
   Lutgens, E.
   Elferink, R. P. J. Oude
   Van de Graaf, S.
TI INHIBITION OF HEPATIC BILE SALT UPTAKE TARGETS THE MAIN DRIVERS OF
   ATHEROGENESIS, INFLAMMATION AND HYPERCHOLESTEROLEMIA
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Abbing, R. L. Roscam; Slijepcevic, D.; Donkers, J. M.; Elferink, R. P. J. Oude; Van de Graaf, S.] Amsterdam UMC, Tytgat Inst Liver & Intestinal Res, Amsterdam, Netherlands.
   [Lutgens, E.] Amsterdam UMC, Med Biochem, Amsterdam, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0680
BP E11
EP E11
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800031
DA 2019-10-28
ER

PT J
AU Abduzhamalova, N
   Tereschenko, A
   Masenko, V
   Merkulov, E
   Naumov, V
AF Abduzhamalova, N.
   Tereschenko, A.
   Masenko, V.
   Merkulov, E.
   Naumov, V.
TI THE DYNAMICS OF INFLAMMATORY MARKERS AFTER CORONARY STENT IMPLANTATION
   COMPARED TO PLAQUE MORPHOLOGY IN PATIENTS WITH CORONARY ARTERY DISEASE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Abduzhamalova, N.; Naumov, V.] Minist Hlth Russian Federat, FSBO Natl Cardiol Res Ctr, Dept Atherosclerosis, Moscow, Russia.
   [Tereschenko, A.; Merkulov, E.] Minist Hlth Russian Federat, FSBO Natl Cardiol Res Ctr, Dept Endovasc Methods Diagnost & Treatment, Moscow, Russia.
   [Masenko, V.] Minist Hlth Russian Federat, FSBO Natl Cardiol Res Ctr, Dept Neurohumoral & Immunol Res, Moscow, Russia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0036
BP E241
EP E241
DI 10.1016/j.atherosclerosis.2019.06.741
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800739
DA 2019-10-28
ER

PT J
AU Abrantes, LB
   Alves, AC
   Medeiros, AM
   Correia, S
   Cruz, A
   Ferreira, A
   Lobarinhas, G
   Garcia, P
   Guerra, A
   Mansilha, H
   Martins, E
   Martins, P
   Salgado, J
   Bourbon, M
AF Abrantes, L. B.
   Alves, A. C.
   Medeiros, A. M.
   Correia, S.
   Cruz, A.
   Ferreira, A.
   Lobarinhas, G.
   Garcia, P.
   Guerra, A.
   Mansilha, H.
   Martins, E.
   Martins, P.
   Salgado, J.
   Bourbon, M.
TI PEDIATRIC FAMILIAL HYPERCHOLESTEROLAEMIA
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Abrantes, L. B.; Alves, A. C.; Medeiros, A. M.; Bourbon, M.] Inst Nacl Saude Dr Ricardo Jorge, Dept Promocao Saude & Prevencao Doencas Nao Trans, Lisbon, Portugal.
   [Alves, A. C.; Medeiros, A. M.; Bourbon, M.] Univ Lisbon, Fac Ciencias, BioISI Biosyst & Integrat Sci Inst, Lisbon, Portugal.
   [Correia, S.] Ctr Hosp Barreiro Montijo EPE, Hosp Dia Pediat, Consulta Risco Cardiovasc Pediat, Barreiro, Portugal.
   [Cruz, A.] Hosp de Sto Andre, Ctr Hosp Leiria EPE, Serv Pediat, Leiria, Portugal.
   [Ferreira, A.] Hosp D Estefania, Unidade Doencas Metab, Lisbon, Portugal.
   [Lobarinhas, G.] Hosp de Sta Maria Maior, Serv Pediat, Lisbon, Portugal.
   [Garcia, P.] Ctr Hosp & Univ Coimbra, Doencas Hereditarias Metab Serv, Ctr Desenvolvimento Hosp Pediat, Coimbra, Portugal.
   [Guerra, A.] Hosp S Joao EPE, Serv Pediat, Porto, Portugal.
   [Mansilha, H.] Hosp Sto Antonio, Ctr Hosp Porto EPE, Serv Pediat, Porto, Portugal.
   [Martins, E.] Hosp S Joao EPE, Serv Cardiol, Porto, Portugal.
   [Martins, P.] Ctr Hosp & Univ Coimbra EPE, Hosp Pediat da Carmona Mota, Serv Cardiol Pediat, Coimbra, Portugal.
   [Salgado, J.] Hosp Senhora da Oliveira, EPE, Serv Pediat, Guimaraes, Portugal.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0724
BP E216
EP E216
DI 10.1016/j.atherosclerosis.2019.06.658
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800656
DA 2019-10-28
ER

PT J
AU Abu-Bakar, L
   Ismail, N
   Vigneswary, S
   Jaafar, H
   Tengku-Muhammad, TS
AF Abu-Bakar, L.
   Ismail, N.
   Vigneswary, S.
   Jaafar, H.
   Tengku-Muhammad, T. S.
TI METHYL BENZOATE INCREASES HIGH DENSITY LIPOPROTEIN LEVEL IN DIET-INDUCED
   HYPERCHOLESTEROLEMIA IN ANIMAL MODEL OF SPRAGUE-DAWLEY RAT
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Abu-Bakar, L.; Ismail, N.; Tengku-Muhammad, T. S.] Univ Malaysia Terengganu, Inst Marine Biotechnol, Kuala Nerus, Malaysia.
   [Vigneswary, S.] Univ Malaysia Terengganu, Sch Fundamental Sci, Kuala Nerus, Malaysia.
   [Jaafar, H.] Univ Sains Malaysia, Sch Med Sci, Kota Baharu, Kelantan, Malaysia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0975
BP E224
EP E224
DI 10.1016/j.atherosclerosis.2019.06.685
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800683
DA 2019-10-28
ER

PT J
AU Ackermann, K
   Bonaterra, GA
   Kinscherf, R
   Schwarz, A
AF Ackermann, K.
   Bonaterra, G. A.
   Kinscherf, R.
   Schwarz, A.
TI GROWTH DIFFERENTIATION FACTOR-15 (GDF-15) REGULATES AUTOPHAGIC PROCESSES
   IN OXLDL-TREATED HUMAN MACROPHAGES
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0995
BP E46
EP E46
DI 10.1016/j.atherosclerosis.2019.06.133
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800132
DA 2019-10-28
ER

PT J
AU Afanasieva, O
   Klesareva, E
   Sherstyuk, E
   Afanasieva, M
   Razova, O
   Tmoyan, N
   Ezhov, M
   Pokrovsky, S
AF Afanasieva, O.
   Klesareva, E.
   Sherstyuk, E.
   Afanasieva, M.
   Razova, O.
   Tmoyan, N.
   Ezhov, M.
   Pokrovsky, S.
TI ELEVATED LEVELS OF LIPOPROTEIN(A) AND C-REACTIVE PROTEIN AS RISK FACTORS
   OF SEVERE ATHEROSCLEROSIS IN WOMEN
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Afanasieva, O.; Klesareva, E.; Sherstyuk, E.; Afanasieva, M.; Razova, O.; Tmoyan, N.; Pokrovsky, S.] Hlth Minist RF, Natl Med Res Ctr Cardiol, Lab Problems Atherosclerosis, Inst Expt Cardiol, Moscow, Russia.
   [Ezhov, M.] Hlth Minist RF, Natl Med Res Ctr Cardiol, Lab Problems Atherosclerosis, Inst Clin Cardiol, Moscow, Russia.
RI Klesareva, Elena Aleksandrovna/M-2852-2018
OI Klesareva, Elena Aleksandrovna/0000-0002-0682-8699
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0239
BP E229
EP E229
DI 10.1016/j.atherosclerosis.2019.06.703
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800701
DA 2019-10-28
ER

PT J
AU Afanasieva, O
   Ezhov, M
   Egiazaryan, M
   Klesareva, E
   Utkina, E
   Pokrovsky, S
AF Afanasieva, O.
   Ezhov, M.
   Egiazaryan, M.
   Klesareva, E.
   Utkina, E.
   Pokrovsky, S.
TI DYNAMICS OF PLASMA LEVELS OF LIPOPROTEIN(A), PCSK9, AND THEIR COMPLEX
   AFTER A SINGLE INJECTION OF EVOLOCUMAB
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Afanasieva, O.; Ezhov, M.; Egiazaryan, M.; Klesareva, E.; Utkina, E.; Pokrovsky, S.] Hlth Minist RF, Natl Med Res Ctr Cardiol, Lab Problems Atherosclerosis, Inst Expt Cardiol, Moscow, Russia.
RI Klesareva, Elena Aleksandrovna/M-2852-2018
OI Klesareva, Elena Aleksandrovna/0000-0002-0682-8699
NR 0
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0244
BP E198
EP E198
DI 10.1016/j.atherosclerosis.2019.06.601
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800599
DA 2019-10-28
ER

PT J
AU Perez, MA
   Martinez, PJ
   Heredero, A
   Santiago-Hernandez, A
   Martin-Lorenzo, M
   Molero, D
   Garcia-Segura, JM
   Aldamiz-Echevarria, G
   Alvarez-Llamas, G
AF Agudiez Perez, M.
   Martinez, P. J.
   Heredero, A.
   Santiago-Hernandez, A.
   Martin-Lorenzo, M.
   Molero, D.
   Garcia-Segura, J. M.
   Aldamiz-Echevarria, G.
   Alvarez-Llamas, G.
TI THE URINARY EXOSOMAL METABOLISM REVEALS A CARDIOVASCULAR RISK SIGNATURE
   OF ADDED VALUE TO URINE ANALYSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Agudiez Perez, M.; Martinez, P. J.; Santiago-Hernandez, A.; Martin-Lorenzo, M.; Alvarez-Llamas, G.] UAM, IIS Fdn Jimenez Diaz, Immunol, Madrid, Spain.
   [Heredero, A.; Aldamiz-Echevarria, G.] UAM, Fdn Jimenez Diaz, Cardiac Surg, Madrid, Spain.
   [Molero, D.] Univ Complutense Madrid, Cai Rmn, Madrid, Spain.
   [Garcia-Segura, J. M.] Univ Complutense Madrid, Biochem & Mol Biol 1, Madrid, Spain.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0515
BP E163
EP E164
DI 10.1016/j.atherosclerosis.2019.06.493
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800491
DA 2019-10-28
ER

PT J
AU Ahmad, F
   Leake, D
AF Ahmad, F.
   Leake, D.
TI INHIBITION OF LYSOSOMAL OXIDATION OF LDL PREVENTS LYSOSOMAL DYSFUNCTION,
   CELLULAR SENESCENCE, SECRETION OF PRO-INFLAMMATORY CYTOKINES IN HUMAN
   MACROPHAGES AND REDUCES ATHEROSCLEROSIS IN MICE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Ahmad, F.; Leake, D.] Univ Reading, Inst Cardiovasc & Metab Res, Reading, Berks, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0450
BP E16
EP E16
DI 10.1016/j.atherosclerosis.2019.06.043
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800043
DA 2019-10-28
ER

PT J
AU Ahmad, S
   Demler, O
   Sun, Q
   Moorthy, MV
   Li, C
   Lee, IM
   Ridker, PM
   Manson, JE
   Hu, FB
   Fall, T
   Chasman, DI
   Cheng, S
   Pradhan, AD
   Mora, S
AF Ahmad, S.
   Demler, O.
   Sun, Q.
   Moorthy, M. V.
   Li, C.
   Lee, I. M.
   Ridker, P. M.
   Manson, J. E.
   Hu, F. B.
   Fall, T.
   Chasman, D. I.
   Cheng, S.
   Pradhan, A. D.
   Mora, S.
TI MEDITERRANEAN DIET AND REDUCED RISK OF DIABETES: POTENTIAL MEDIATING
   MECHANISMS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Ahmad, S.; Sun, Q.; Hu, F. B.] Harvard TH Chan Sch Publ Hlth, Nutr, Boston, MA USA.
   [Demler, O.; Moorthy, M. V.; Li, C.; Lee, I. M.; Ridker, P. M.; Manson, J. E.; Chasman, D. I.; Cheng, S.; Pradhan, A. D.; Mora, S.] Harvard Med Sch, Boston, MA 02115 USA.
   [Demler, O.; Moorthy, M. V.; Li, C.; Lee, I. M.; Ridker, P. M.; Manson, J. E.; Chasman, D. I.; Cheng, S.; Pradhan, A. D.; Mora, S.] Brigham & Womens Hosp, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA.
   [Fall, T.] Uppsala Univ Sweden, Med Sci, Uppsala, Sweden.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0814
BP E43
EP E44
DI 10.1016/j.atherosclerosis.2019.06.124
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800123
DA 2019-10-28
ER

PT J
AU Aizaz, SMM
   Moonen, RPM
   Wierts, R
   van der Pol, JAJ
   Zwart, H
   van der Werf, AJ
   Wildberger, JE
   Bucerius, JA
   Kooi, ME
AF Aizaz, S. M. M.
   Moonen, R. P. M.
   Wierts, R.
   van der Pol, J. A. J.
   Zwart, H.
   van der Werf, A. J.
   Wildberger, J. E.
   Bucerius, J. A.
   Kooi, M. E.
TI EVALUATION OF ATTENUATION REDUCTION OF A DEDICATED CAROTID PET/MRI COIL
   FOR CAROTID PLAQUE IMAGING
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Aizaz, S. M. M.; Moonen, R. P. M.; Wierts, R.; van der Pol, J. A. J.; Wildberger, J. E.; Bucerius, J. A.; Kooi, M. E.] Maastricht Univ, Med Ctr, Radiol & Nucl Med, Maastricht, Netherlands.
   [Aizaz, S. M. M.; Moonen, R. P. M.; Wildberger, J. E.; Bucerius, J. A.; Kooi, M. E.] CARIM, Sch Cardiovasc Dis, Maastricht, Netherlands.
   [Zwart, H.; van der Werf, A. J.] Machnet BV, Prod & Proc Dev, Roden, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0394
BP E51
EP E52
DI 10.1016/j.atherosclerosis.2019.06.145
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800144
DA 2019-10-28
ER

PT J
AU Akers, E
   Mulangala, J
   Wilsdon, L
   Psaltis, P
   Bursill, C
   Nicholls, S
   Di Bartolo, B
AF Akers, E.
   Mulangala, J.
   Wilsdon, L.
   Psaltis, P.
   Bursill, C.
   Nicholls, S.
   Di Bartolo, B.
TI LIPOPROTEINS AND THEIR MODIFIED FORMS REGULATE EARLY STAGE VASCULAR
   SMOOTH MUSCLE CELL CALCIFICATION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Akers, E.; Mulangala, J.; Wilsdon, L.; Psaltis, P.; Bursill, C.; Nicholls, S.; Di Bartolo, B.] South Australian Hlth & Med Res Inst, Heart Hlth, Adelaide, SA, Australia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1077
BP E73
EP E74
DI 10.1016/j.atherosclerosis.2019.06.211
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800210
DA 2019-10-28
ER

PT J
AU Akra, S
   Opstad, TB
   Aksnes, TA
   Seljeflot, I
AF Akra, S.
   Opstad, T. B.
   Aksnes, T. A.
   Seljeflot, I.
TI MARKERS OF REMODELING IN SUBCUTANEOUS ADIPOSE TISSUE ARE ASSOCIATED WITH
   THE AMOUNT OF ABDOMINAL ADIPOSE TISSUE, OVERWEIGHT AND INSULIN
   SENSITIVITY IN HEALTHY MIDDLE AGED MEN
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Akra, S.; Opstad, T. B.; Seljeflot, I.] Oslo Univ Hosp Ullevaal, Ctr Clin Heart Res, Dept Cardiol, Oslo, Norway.
   [Opstad, T. B.; Seljeflot, I.] Univ Oslo, Fac Med, Oslo, Norway.
   [Aksnes, T. A.] Oslo Univ Hosp Ullevaal, Dept Acute Med, Sect Cardiovasc & Renal Res, Oslo, Norway.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0603
BP E257
EP E257
DI 10.1016/j.atherosclerosis.2019.06.791
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800789
DA 2019-10-28
ER

PT J
AU Al Helali, S
   Abid, MH
   Al Majed, A
   Al Shugair, N
   Qahtani, HAL
   Belfageih, A
   Al Dulikan, S
   Al Ahmari, S
   Al Zahrani, G
   Al Ahmadi, S
   Nouri, FAL
AF Al Helali, S.
   Abid, M. Hanif
   Al Majed, A.
   Al Shugair, N.
   Qahtani, H. A. L.
   Belfageih, A.
   Al Dulikan, S.
   Al Ahmari, S.
   Al Zahrani, G.
   Al Ahmadi, S.
   Nouri, F. A. L.
TI GENDER-SPECIFIC CORONARY ARTERY CALCIUM SCORE AND ITS ASSOCIATION WITH
   BLOOD LIPIDS AMONG SAUDI PATIENTS REFERRED TO COMPUTED TOMOGRAPHY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Al Helali, S.] Prince Sultan Cardiac Ctr, Adult Cardiol, Adv Imaging Unit, Riyadh, Saudi Arabia.
   [Abid, M. Hanif; Al Majed, A.; Al Shugair, N.; Qahtani, H. A. L.; Belfageih, A.; Al Dulikan, S.; Al Ahmari, S.; Al Ahmadi, S.; Nouri, F. A. L.] Prince Sultan Cardiac Ctr, Adult Cardiol, Riyadh, Saudi Arabia.
   [Al Zahrani, G.] Prince Sultan Cardiac Ctr, Riyadh, Saudi Arabia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1137
BP E274
EP E275
DI 10.1016/j.atherosclerosis.2019.06.850
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800848
DA 2019-10-28
ER

PT J
AU Al-Laho, R
   Al-Muhanna, Z
   Hussain, J
   Alsarraf, A
AF Al-Laho, R.
   Al-Muhanna, Z.
   Hussain, J.
   Alsarraf, A.
TI PREVALENCE OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN KUWAIT
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Al-Laho, R.; Al-Muhanna, Z.; Hussain, J.; Alsarraf, A.] Minist Hlth, Biochem Lab, Kuwait, Kuwait.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0971
BP E208
EP E209
DI 10.1016/j.atherosclerosis.2019.06.635
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800633
DA 2019-10-28
ER

PT J
AU Al-sharea, A
   Flynn, M
   Whillas, A
   Hamilton, J
   Chin-Dusting, J
   Murphy, A
AF Al-sharea, A.
   Flynn, M.
   Whillas, A.
   Hamilton, J.
   Chin-Dusting, J.
   Murphy, A.
TI RHEUMATOID ARTHRITIS INCREASES SYMPATHETIC NERVOUS SYSTEM DRIVEN
   HEMATOPOIETIC STEM CELL MOBILIZATION AND ATHEROGENESIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Al-sharea, A.; Flynn, M.; Whillas, A.; Murphy, A.] Baker Heart & Diabet Inst, Hameatopoiesis & Leukocyte Biol, Melbourne, Vic, Australia.
   [Hamilton, J.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia.
   [Chin-Dusting, J.] Monash Univ, Pharmacol, Melbourne, Vic, Australia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0658
BP E23
EP E23
DI 10.1016/j.atherosclerosis.2019.06.065
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800064
DA 2019-10-28
ER

PT J
AU Al-Sharea, A
   Lee, MKS
   Dragoljevic, D
   Flynn, M
   Frings-Meuthen, P
   Kraakman, M
   Pernes, G
   Nagareddy, P
   Naik, S
   Hamilton, J
   Bobik, A
   Purton, L
   Baldock, P
   Masters, S
   Murphy, A
AF Al-Sharea, A.
   Lee, M. K. S.
   Dragoljevic, D.
   Flynn, M.
   Frings-Meuthen, P.
   Kraakman, M.
   Pernes, G.
   Nagareddy, P.
   Naik, S.
   Hamilton, J.
   Bobik, A.
   Purton, L.
   Baldock, P.
   Masters, S.
   Murphy, A.
TI A HIGH SALT DIET ACCELERATES ATHEROSCLEROSIS BY MODULATING HEMATOPOIESIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Al-Sharea, A.; Lee, M. K. S.; Dragoljevic, D.; Flynn, M.; Pernes, G.; Bobik, A.; Murphy, A.] Baker Heart & Diabet Inst, Vasc Biol, Melbourne, Vic, Australia.
   [Frings-Meuthen, P.] German Aerosp Ctr DLR, Inst Aerosp Med, Cologne, Germany.
   [Kraakman, M.] Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY USA.
   [Nagareddy, P.] Univ Alabama Birmingham, Med, Birmingham, AL USA.
   [Naik, S.] WEHI, Div Mol Med, Melbourne, Vic, Australia.
   [Hamilton, J.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia.
   [Purton, L.] St Vincents Inst Med Res, Bone Biol, Melbourne, Vic, Australia.
   [Baldock, P.] Garvan Inst, Skeletal Metab, Sydney, NSW, Australia.
   [Masters, S.] WEHI, Immunol, Melbourne, Vic, Australia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0651
BP E22
EP E22
DI 10.1016/j.atherosclerosis.2019.06.064
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800063
DA 2019-10-28
ER

PT J
AU Albuquerque, J
   Alves, AC
   Bourbon, M
   Antunes, M
AF Albuquerque, J.
   Alves, A. C.
   Bourbon, M.
   Antunes, M.
TI CLASSIFICATION METHODS APPLIED TO THE DIAGNOSIS OF PEDIATRIC PATIENTS
   WITH FAMILIAL HYPERCHOLESTEROLEMIA: COMPARISON OF SIMON BROOME CRITERIA
   WITH LOGISTIC REGRESSION AND MODIFIED DECISION TREE MODELS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Albuquerque, J.; Antunes, M.] Univ Lisbon, Fac Ciencias, Ctr Estatist Aplicacoes, CEAUL, Lisbon, Portugal.
   [Albuquerque, J.] Univ Porto, Fac Med, Dept Bioquim, Porto, Portugal.
   [Albuquerque, J.; Alves, A. C.; Bourbon, M.] Inst Nacl Saude Doutor Ricardo Jorge, Grp Invest Cardiovasc, Dept Promocao Saude Doencas Nao Transmissiveis, Lisbon, Portugal.
   [Alves, A. C.; Bourbon, M.] Univ Lisbon, Fac Ciencias, Biosyst & Integrat Sci Inst BioISI, Lisbon, Portugal.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0720
BP E216
EP E216
DI 10.1016/j.atherosclerosis.2019.06.657
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800655
DA 2019-10-28
ER

PT J
AU Alexandra, L
   Cosac, MT
   Vlad, ML
   Manea, A
   Manea, SA
AF Alexandra, L.
   Cosac, M. T.
   Vlad, M. L.
   Manea, A.
   Manea, S. A.
TI CROSS-COMMUNICATION BETWEEN HISTONE ACETYLTRANSFERASE AND HISTONE
   DEACETYLASE EPIGENETIC ENZYMES AUGMENTS OXIDATIVE STRESS AND FIBROSIS IN
   THE KIDNEY OF DIABETIC MICE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Alexandra, L.; Cosac, M. T.; Vlad, M. L.; Manea, A.; Manea, S. A.] Inst Cellular Biol & Pathol Nicolae Simionescu, Funct Genom Lab, Bucharest, Romania.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0686
BP E26
EP E26
DI 10.1016/j.atherosclerosis.2019.06.077
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800076
DA 2019-10-28
ER

PT J
AU Alexanova, A
   Viiri, L
   Laaksonen, R
   Kiamehr, M
   Aalto-Setala, K
AF Alexanova, A.
   Viiri, L.
   Laaksonen, R.
   Kiamehr, M.
   Aalto-Setala, K.
TI MODELING LIPID METABOLISM OF CORONARY ARTERY DISEASE PATIENTS WITH
   INDUCED PLURIPOTENT STEM CELL DERIVED HEPATOCYTES
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Alexanova, A.; Viiri, L.; Laaksonen, R.; Kiamehr, M.; Aalto-Setala, K.] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0210
BP E118
EP E119
DI 10.1016/j.atherosclerosis.2019.06.344
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800343
DA 2019-10-28
ER

PT J
AU Ali, L
   Zheng, KH
   Schnitzler, JG
   Hjortnaes, J
   Stroes, ESG
   Kroon, J
AF Ali, L.
   Zheng, K. H.
   Schnitzler, J. G.
   Hjortnaes, J.
   Stroes, E. S. G.
   Kroon, J.
TI LP(A)-INDUCED METABOLIC ACTIVITY IN VALVE INTERSTITIAL CELLS DRIVES
   INFLAMMATION AND ULTIMATELY CALCIFICATION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Ali, L.; Schnitzler, J. G.; Kroon, J.] Amsterdam UMC, Locat AMC, Dept Expt Vasc Med, Amsterdam, Netherlands.
   [Zheng, K. H.; Stroes, E. S. G.] Amsterdam UMC, Locat AMC, Dept Vasc Med, Amsterdam, Netherlands.
   [Hjortnaes, J.] UMC Utrecht, Dept Cardiothorac Surg, Utrecht, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0943
BP E74
EP E74
DI 10.1016/j.atherosclerosis.2019.06.212
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800211
DA 2019-10-28
ER

PT J
AU Ali, S
AF Ali, S.
TI ANTHROPOMETRIC MEASUREMENTS - PREDICTORS OF MAJOR ADVERSE EVENTS IN
   NON-ST ELEVATION MYOCARDIAL INFARCTION PATIENTS AND THEIR SURVIVAL - A
   COHORT STUDY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Ali, S.] Nawshehra Med Complex Kpk, Dept Cardiol, Mardan 25000, Kpk, Pakistan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0034
BP E161
EP E161
DI 10.1016/j.atherosclerosis.2019.06.484
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800482
DA 2019-10-28
ER

PT J
AU Alieva, A
   Boyarinova, M
   Erina, A
   Kolesova, E
   Saulina, E
   Rotar, O
   Konradi, A
AF Alieva, A.
   Boyarinova, M.
   Erina, A.
   Kolesova, E.
   Saulina, E.
   Rotar, O.
   Konradi, A.
TI EARLY SUBCLINICAL ATHEROSCLEROSIS AND LP(A): IS THERE AN ASSOCIATION IN
   RUSSIAN POPULATION?
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Alieva, A.; Boyarinova, M.; Erina, A.; Kolesova, E.; Rotar, O.] Almazov Natl Med Res Ctr, Dept Epidemiol Noncommunicable Dis, St Petersburg, Russia.
   [Saulina, E.] Pavlov First St Petersburg State Med Univ, St Petersburg, Russia.
   [Konradi, A.] Almazov Natl Med Res Ctr, Dept Hypertens, St Petersburg, Russia.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0186
BP E228
EP E229
DI 10.1016/j.atherosclerosis.2019.06.701
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800699
DA 2019-10-28
ER

PT J
AU Alieva, R
   Shek, A
   Kurbanov, R
   Nizamov, U
   Hochimov, S
AF Alieva, R.
   Shek, A.
   Kurbanov, R.
   Nizamov, U.
   Hochimov, S.
TI STRUCTURAL CHANGES BRACHIOCEPHALIC ARTERIES IN PATIENTS WITH CHD AND
   HEFH TAKING INTO ACCOUNT THE LEVEL OF PCSK9 AND GENETIC POLYMORPHISM
   E670G OF THE PCSK9 GENE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Alieva, R.; Shek, A.; Nizamov, U.; Hochimov, S.] Ctr Cardiol Uzbekistan, Dept CHD & Atherosclerosis, Tashkent, Uzbekistan.
   [Kurbanov, R.] Ctr Cardiol Uzbekistan, Arrhytmol, Tashkent, Uzbekistan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0086
BP E252
EP E252
DI 10.1016/j.atherosclerosis.2019.06.776
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800774
DA 2019-10-28
ER

PT J
AU Almaghraby, A
   Saleh, Y
   Abdelnabi, M
   Abdelkarim, O
   Badran, H
AF Almaghraby, A.
   Saleh, Y.
   Abdelnabi, M.
   Abdelkarim, O.
   Badran, H.
TI PATIENTS WITH NEWLY DIAGNOSED DIABETES HAVE WORSE LONG-TERM OUTCOMES
   THAN KNOWN DIABETICS AFTER ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Almaghraby, A.; Abdelkarim, O.] Univ Alexandria, Cardiol, Alexandria, Egypt.
   [Saleh, Y.] Michigan State Univ, Internal Med, E Lansing, MI 48824 USA.
   [Abdelnabi, M.] Med Res Inst, Internal Med Cardiol Unit, Alexandria, Egypt.
   [Badran, H.] Ain Shams Univ, Cardiol, Cairo, Egypt.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0129
BP E113
EP E114
DI 10.1016/j.atherosclerosis.2019.06.330
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800329
DA 2019-10-28
ER

PT J
AU Almaghraby, A
   Abdelnabi, M
   Abdelkarim, O
   Saleh, Y
   Badran, H
AF Almaghraby, A.
   Abdelnabi, M.
   Abdelkarim, O.
   Saleh, Y.
   Badran, H.
TI FREQUENCY AND OUTCOME OF UNDIAGNOSED HYPERCHOLESTEROLEMIA IN PATIENTS
   PRESENTED WITH ST-ELEVATION MYOCARDIAL INFARCTION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Almaghraby, A.; Abdelkarim, O.] Univ Alexandria, Cardiol, Alexandria, Egypt.
   [Abdelnabi, M.] Med Res Inst, Cardiol Unit, Internal Med, Alexandria, Egypt.
   [Saleh, Y.] Michigan State Univ, Internal Med, E Lansing, MI 48824 USA.
   [Badran, H.] Ain Shams Univ, Cardiol, Cairo, Egypt.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0122
BP E180
EP E181
DI 10.1016/j.atherosclerosis.2019.06.547
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800545
DA 2019-10-28
ER

PT J
AU Altmann, S
AF Altmann, S.
TI PROTEOME-DENSE LIPOPROTEIN (PDL) PARTICLE DIVERSITY: A THEORETICAL
   APPROACH TO APPROXIMATING AND MODELING THE EXTENT OF PARTICLE
   VARIABILITY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Altmann, S.] HDL Apom, Res, Allenhurst, NJ USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0746
BP E227
EP E227
DI 10.1016/j.atherosclerosis.2019.06.696
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800694
DA 2019-10-28
ER

PT J
AU Alves, AC
   Alonso, R
   Cuevas, A
   Margarida, AM
   Pereira, CA
   Jannes, EC
   Krieger, EJ
   Arroyo, R
   Schreier, L
   Corral, P
   Banares, GV
   Araujo, M
   Asenjo, S
   Stoll, M
   Dell'Oca, N
   Reyes, X
   Ressia, A
   Campo, R
   Merchan, A
   Teresa, MMT
   Vasques-Cardenas, NA
   Mata, P
   Santos, R
   Bourbon, M
AF Alves, A. C.
   Alonso, R.
   Cuevas, A.
   Medeiros Margarida, A.
   Pereira, A. C.
   Jannes, C. E.
   Krieger, E. J.
   Arroyo, R.
   Schreier, L.
   Corral, P.
   Banares, V. G.
   Araujo, M.
   Asenjo, S.
   Stoll, M.
   Dell'Oca, N.
   Reyes, X.
   Ressia, A.
   Campo, R.
   Merchan, A.
   Teresa, M. Magana-Torres
   Vasques-Cardenas, A. N.
   Mata, P.
   Santos, R.
   Bourbon, M.
TI MOLECULAR ASPECTS OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN
   IBERO-AMERICAN COUNTRIES
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Alves, A. C.; Medeiros Margarida, A.; Bourbon, M.] Inst Nacl Saude Doutor Ricardo Jorge, Dept Promocao Saude & Prevencao Doencas Nao Trans, Unidade I&D, Grp Invest Cardiovasc, Lisbon, Portugal.
   [Alves, A. C.; Medeiros Margarida, A.; Bourbon, M.] Univ Lisbon, Fac Ciencias, BioISI Biosyst & Integrat Sci Inst, Lisbon, Portugal.
   [Alonso, R.; Cuevas, A.] Clin Las Condes, Dept Nutr, Santiago, Chile.
   [Pereira, A. C.; Jannes, C. E.; Krieger, E. J.] Univ Sao Paulo, Med Sch Hosp, Lab Genet & Mol Cardiol, Heart Inst InCor, Sao Paulo, Brazil.
   [Arroyo, R.; Mata, P.] Fdn Hipercolesterolemia Familiar, Madrid, Spain.
   [Schreier, L.] Univ Buenos Aires, Fac Farm & Bioquim, Dept Bioquim Clin, Lab Lipidos & Aterosclerosis, Buenos Aires, DF, Argentina.
   [Corral, P.; Araujo, M.] Univ FASTA, Fac Med, Dept Invest, Buenos Aires, DF, Argentina.
   [Banares, V. G.] Adm Nacl Labs & Inst Salud Dr Carlos Malbran, Ctr Nacl Genet Med, Buenos Aires, DF, Argentina.
   [Asenjo, S.] Univ Concepcion, Fac Med, Chacabuco S-N, Concepcion, Chile.
   [Stoll, M.; Dell'Oca, N.; Reyes, X.; Ressia, A.] Comis Honoraria Salud Cardiovasc, Programa GENYCO, Lab Genet Mol, Montevideo, Uruguay.
   [Campo, R.] Fdn Cardiovasc Colombia, Cardiol, Bogota, Colombia.
   [Merchan, A.] Fdn Clin SHAIO, Cardiol, Bogota, Colombia.
   [Teresa, M. Magana-Torres] Inst Mexicano Seguro Socia, Ctr Invest Biomed Occidente, Guadalajara, Jalisco, Mexico.
   [Vasques-Cardenas, A. N.] Univ Autonoma Guadalajara, Fac Med Zapopan, Guadalajara, Jalisco, Mexico.
   [Santos, R.] Univ Sao Paulo, Med Sch Hosp, Lipid Clin, Heart Inst InCor, Sao Paulo, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0705
BP E215
EP E215
DI 10.1016/j.atherosclerosis.2019.06.654
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800652
DA 2019-10-28
ER

PT J
AU Alves, AC
   Graca, R
   Abrantes, L
   Medeiros, AM
   Fernandes, R
   Menezes, J
   Romao, L
   Bourbon, M
AF Alves, A. C.
   Graca, R.
   Abrantes, L.
   Medeiros, A. M.
   Fernandes, R.
   Menezes, J.
   Romao, L.
   Bourbon, M.
TI FUNCTIONAL CHARACTERIZATION OF LDL RECEPTOR GENE VARIANTS FOUND IN
   PATIENTS WITH CLINICAL DIAGNOSIS OF FAMILIAL HYPERCHOLESTEROLEMIA
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Alves, A. C.; Graca, R.; Abrantes, L.; Medeiros, A. M.; Bourbon, M.] Inst Nacl Saude Doutor Ricardo Jorge, Dept Promocao Saude & Prevencao Doencas Nao Trans, Unidade I&D, Grp Invest Cardiovasc, Lisbon, Portugal.
   [Alves, A. C.; Graca, R.; Medeiros, A. M.; Fernandes, R.; Menezes, J.; Romao, L.; Bourbon, M.] Univ Lisbon, Fac Ciencias, BioISI Biosyst & Integrat Sci Inst, Lisbon, Portugal.
   [Fernandes, R.; Menezes, J.; Romao, L.] Inst Nacl Saude Doutor Ricardo Jorge, Dept Genet Humana, Lisbon, Portugal.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0870
BP E217
EP E217
DI 10.1016/j.atherosclerosis.2019.06.661
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800659
DA 2019-10-28
ER

PT J
AU Amerikanou, C
   Papada, E
   Tanaini, A
   Valsamidou, E
   Dimas, I
   Gioxari, A
   Forbes, A
   Kaliora, A
AF Amerikanou, C.
   Papada, E.
   Tanaini, A.
   Valsamidou, E.
   Dimas, I.
   Gioxari, A.
   Forbes, A.
   Kaliora, A.
TI INCREASED CARDIOVASCULAR RISK IN PATIENTS WITH CROHN'S DISEASE AND
   ULCERATIVE COLITIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Amerikanou, C.; Papada, E.; Tanaini, A.; Valsamidou, E.; Dimas, I.; Gioxari, A.; Kaliora, A.] Harokopio Univ, Nutr Dietet, Athens, Greece.
   [Forbes, A.] Univ East Anglia, Norwich Med Sch, Norwich, Greece.
NR 1
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0199
BP E162
EP E162
DI 10.1016/j.atherosclerosis.2019.06.487
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800485
DA 2019-10-28
ER

PT J
AU Amor, AJ
   Vinagre, I
   Valverde, M
   Pane, A
   Urquizu, X
   Meler, E
   Lopez, E
   Quiros, C
   Gimenez, M
   Codina, L
   Alonso, N
   Conget, I
   Barahona, MJ
   Perea, V
AF Amor, A. J.
   Vinagre, I.
   Valverde, M.
   Pane, A.
   Urquizu, X.
   Meler, E.
   Lopez, E.
   Quiros, C.
   Gimenez, M.
   Codina, L.
   Alonso, N.
   Conget, I.
   Barahona, M. J.
   Perea, V.
TI PREECLAMPSIA: A RISK FACTOR ON PRECLINICAL CAROTID ATHEROSCLEROSIS WITH
   SIMILAR IMPACT TO TYPE 1 DIABETES
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Amor, A. J.; Vinagre, I.; Pane, A.; Gimenez, M.; Conget, I.] Hosp Clin Barcelona, Endocrinol & Nutr Dept, Barcelona, Spain.
   [Amor, A. J.] Inst Salud Carlos III, Ciber Fisiopatol Obesidad & Nutr, Madrid, Spain.
   [Valverde, M.; Quiros, C.; Alonso, N.; Barahona, M. J.; Perea, V.] Hosp Univ Mutua Terrassa, Endocrinol & Nutr Dept, Terrassa, Spain.
   [Urquizu, X.; Lopez, E.; Codina, L.] Hosp Univ Mutua Terrassa, Dept Obstet & Gynecol, Terrassa, Spain.
   [Meler, E.] Hosp Clin Barcelona, Dept Obstet & Gynecol, Barcelona, Spain.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0952
BP E87
EP E88
DI 10.1016/j.atherosclerosis.2019.06.255
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800254
DA 2019-10-28
ER

PT J
AU Anastasaki, M
   Linardakis, M
   Katsiki, N
   Papadakis, S
   Anastasaki, EV
   Duijker, G
   Anyfantakis, D
   Symvoulakis, E
   Lionis, C
AF Anastasaki, M.
   Linardakis, M.
   Katsiki, N.
   Papadakis, S.
   Anastasaki, E. Vasilaki
   Duijker, G.
   Anyfantakis, D.
   Symvoulakis, E.
   Lionis, C.
TI ASSOCIATION BETWEEN BEHAVIORAL RISK FACTORS AND PRESENCE OF
   CARDIOVASCULAR DISEASE IN PRIMARY HEALTHCARE PATIENTS IN CRETE, GREECE.
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Anastasaki, M.; Linardakis, M.; Papadakis, S.; Anastasaki, E. Vasilaki; Duijker, G.; Anyfantakis, D.; Symvoulakis, E.; Lionis, C.] Univ Crete, Sch Med, Clin Social & Family Med, Iraklion, Greece.
   [Katsiki, N.] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Propaedeut Dept Internal Med 1, Thessaloniki, Greece.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0052
BP E178
EP E179
DI 10.1016/j.atherosclerosis.2019.06.541
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800539
DA 2019-10-28
ER

PT J
AU Andersen, JW
   Dahl, M
   Lindholt, JS
   Hoegh, A
AF Andersen, J. Winkler
   Dahl, M.
   Lindholt, J. S.
   Hoegh, A.
TI CHANGES IN THE USE OF CARDIOVASCULAR PREVENTIVE DRUGS ONE YEAR AFTER
   SCREENING FOR CAROTID PLAQUE, PERIPHERAL ARTERIAL DISEASE AND DIABETES
   AMONG 67-YEAR-OLD DANES.
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Andersen, J. Winkler; Dahl, M.; Hoegh, A.] Reg Hosp Cent Jutland, Dept Vasc Surg, Vasc Surg Res Unit, Viborg, Denmark.
   [Lindholt, J. S.] Odense Univ Hosp, Elitary Res Ctr Individualized Med Arterial Dis, Dept Cardiothorac & Vasc Surg, Odense, Denmark.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0617
BP E188
EP E189
DI 10.1016/j.atherosclerosis.2019.06.570
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800568
DA 2019-10-28
ER

PT J
AU Angkananard, T
   Changsirikulchai, S
   Janma, J
AF Angkananard, T.
   Changsirikulchai, S.
   Janma, J.
TI CLINICAL AND LABORATORY ASSOCIATIONS OF LEFT VENTRICULAR SYSTOLIC
   DYSFUNCTION AMONG PATIENTS ON PERITONEAL DIALYSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Angkananard, T.] Srinakharinwirot Univ, Div Cardiovasc Med, HRH Princess Maha Chakri Sirindhorn Med Ctr, Fac Med,Med, Ongkarak, Nakhon Nayok, Thailand.
   [Changsirikulchai, S.; Janma, J.] Srinakharinwirot Univ, Div Nephrol, HRH Princess Maha Chakri Sirindhorn Med Ctr, Fac Med,Med, Nakhon Nayok, Thailand.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0136
BP E123
EP E123
DI 10.1016/j.atherosclerosis.2019.06.359
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800357
DA 2019-10-28
ER

PT J
AU Antza, C
   Doundoulakis, I
   Natsis, M
   Sfikas, G
   Stabouli, S
   Kotsis, V
AF Antza, C.
   Doundoulakis, I.
   Natsis, M.
   Sfikas, G.
   Stabouli, S.
   Kotsis, V.
TI MDRD VERSUS CKD-EPI GLOMERULAR FILTRATION RATE: WHICH CAN BE BETTER
   CORRELATED WITH ARTERIAL STIFFNESS?
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Antza, C.; Natsis, M.; Kotsis, V.] Papageorgiou Gen Hosp, Dept Internal Med 3, Thessaloniki, Greece.
   [Doundoulakis, I.; Sfikas, G.] Mil Hosp, Dept Internal Med, Thessaloniki, Greece.
   [Stabouli, S.] Hippokrateion Hosp, Dept Pediat 1, Thessaloniki, Greece.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0153
BP E271
EP E272
DI 10.1016/j.atherosclerosis.2019.06.840
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800838
DA 2019-10-28
ER

PT J
AU Ariff, AM
   Abu Bakar, NA
   Abd Muid, S
   Abd Rahman, EO
   Ismail, NH
   Ali, AM
   Kasim, NAM
   Nawawi, HM
AF Ariff, A. Mohd
   Abu Bakar, N. A.
   Abd Muid, S.
   Abd Rahman, E. Omar
   Ismail, N. H.
   Ali, A. M.
   Kasim, N. A. Mohd
   Nawawi, H. Mohd
TI FICUS DELTOIDEA SUPPRESSES GENE EXPRESSION OF ENDOTHELIAL ACTIVATION
   BIOMARKERS IN LPS-STIMULATED HUMAN CORONARY ARTERY ENDOTHELIAL CELLS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Ariff, A. Mohd; Abu Bakar, N. A.; Abd Muid, S.; Abd Rahman, E. Omar; Nawawi, H. Mohd] Univ Teknol MARA UiTM, Inst Pathol Lab & Forens Med I PPerForM, Selangor, Malaysia.
   [Ariff, A. Mohd; Abd Muid, S.; Abd Rahman, E. Omar; Kasim, N. A. Mohd; Nawawi, H. Mohd] Univ Teknol MARA UiTM, Fac Med, Selangor, Malaysia.
   [Ismail, N. H.] Univ Teknol MARA UiTM, Atta Ur Rahman Inst, Selangor, Malaysia.
   [Ali, A. M.] Univ Sultan Zainal Abidin UniSZA, Fac Bioresources & Food Ind, Terengganu, Malaysia.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1019
BP E272
EP E272
DI 10.1016/j.atherosclerosis.2019.06.842
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800840
DA 2019-10-28
ER

PT J
AU Arokiaraj, MC
   Menesson, E
AF Arokiaraj, M. C.
   Menesson, E.
TI ROSE - A NOVEL VASCULAR ANTI-INFLAMMATORY AGENT
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Arokiaraj, M. C.] Pondicherry Inst Med Sci, Cardiol, Pondicherry, India.
   [Menesson, E.] TebuBio, Lab Serv, Paris, France.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1130
BP E275
EP E275
DI 10.1016/j.atherosclerosis.2019.06.851
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800849
DA 2019-10-28
ER

PT J
AU Aslan, G
   Polat, V
   Bozcali, E
   Sahin, MH
   Ural, D
   Baysal, K
AF Aslan, G.
   Polat, V.
   Bozcali, E.
   Sahin, M. H.
   Ural, D.
   Baysal, K.
TI ASSESSMENT OF INFLAMMATORY MARKERS IN MICROVASCULAR ANGINA
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Aslan, G.; Bozcali, E.; Ural, D.; Baysal, K.] Koc Univ Hosp, Cardiol, Istanbul, Turkey.
   [Polat, V.; Sahin, M. H.] Bakirkoy Dr Sadi Konuk Educ & Res Hosp, Cardiol, Istanbul, Turkey.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0517
BP E206
EP E207
DI 10.1016/j.atherosclerosis.2019.06.628
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800626
DA 2019-10-28
ER

PT J
AU Asmis, R
   Nguyen, HN
   Ahn, YJ
   Medina, EA
AF Asmis, R.
   Nguyen, H. N.
   Ahn, Y. J.
   Medina, E. A.
TI DIETARY 23-HYDROXY URSOLIC ACID PROTECTS AGAINST ATHEROSCLEROSIS AND
   OBESITY BY PREVENTING DYSLIPIDEMIA-INDUCED MONOCYTE PRIMING AND
   DYSFUNCTION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Asmis, R.; Ahn, Y. J.] Wake Forest Sch Med, Internal Med, Winston Salem, NC USA.
   [Nguyen, H. N.] Univ Texas Hlth San Antonio, Biochem, San Antonio, TX USA.
   [Medina, E. A.] Univ Texas Hlth San Antonio, Pathol, San Antonio, TX USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0466
BP E45
EP E45
DI 10.1016/j.atherosclerosis.2019.06.129
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800128
DA 2019-10-28
ER

PT J
AU Atzeni, IM
   Abdulle, AE
   van Roon, AM
   Smit, AJ
   Westra, J
   Mulder, DJ
AF Atzeni, I. M.
   Abdulle, A. Eman
   van Roon, A. M.
   Smit, A. J.
   Westra, J.
   Mulder, D. J.
TI THE HMGB-1/AGE-RAGE AXIS IN PATIENTS WITH SYSTEMIC SCLEROSIS: A
   POTENTIAL ROLE IN ITS VASCULOPATHY?
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Atzeni, I. M.; Abdulle, A. Eman; van Roon, A. M.; Smit, A. J.; Mulder, D. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands.
   [Westra, J.] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0456
BP E262
EP E262
DI 10.1016/j.atherosclerosis.2019.06.808
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800806
DA 2019-10-28
ER

PT J
AU Aurelian, SM
   Zamfirescu, A
   Dascalescu, R
   Capisizu, A
AF Aurelian, S. M.
   Zamfirescu, A.
   Dascalescu, R.
   Capisizu, A.
TI IS ABDOMINAL AORTIC ANEURYSM TREATABLE IN FRAIL ELDERLY? CLINICAL CASE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Aurelian, S. M.; Zamfirescu, A.; Dascalescu, R.; Capisizu, A.] Univ Med & Pharm Carol Davila, Chron Hosp Sf Luca, Geriatr Clin, Bucharest, Romania.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0198
BP E160
EP E160
DI 10.1016/j.atherosclerosis.2019.06.481
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800479
DA 2019-10-28
ER

PT J
AU Avdeeva, K
   Petelina, T
   Gapon, L
   Musikhina, N
   Leonovich, S
   Lystsova, N
   Polivtseva, N
AF Avdeeva, K.
   Petelina, T.
   Gapon, L.
   Musikhina, N.
   Leonovich, S.
   Lystsova, N.
   Polivtseva, N.
TI CORRELATION OF VASCULAR WALL RIGIDITY WITH INFLAMMATION MARKERS, TARGET
   ORGANS INJURY IN FEMALES WITH ARTERIAL HYPERTENSION IN POSTMENOPAUSE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Avdeeva, K.; Petelina, T.; Musikhina, N.] Russian Acad Sci, Arterial Hypertens Dept, Tyumen Cardiol Res Ctr, Tomsk Natl Res Med Ctr, Tyumen, Russia.
   [Gapon, L.] Russian Acad Sci, Div Clin Cardiol, Tyumen Cardiol Res Ctr, Tomsk Natl Res Med Ctr, Tyumen, Russia.
   [Leonovich, S.] Russian Acad Sci, Clin Diagnost Lab, Tyumen Cardiol Res Ctr, Tomsk Natl Res Med Ctr, Tyumen, Russia.
   [Lystsova, N.; Polivtseva, N.] Russian Acad Sci, Clin Diagnost Dept, Tyumen Cardiol Res Ctr, Tomsk Natl Res Med Ctr, Tyumen, Russia.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0633
BP E247
EP E248
DI 10.1016/j.atherosclerosis.2019.06.761
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800759
DA 2019-10-28
ER

PT J
AU Awoyemi, AO
   Troseid, M
   Arnesen, H
   Solheim, S
   Seljeflot, I
AF Awoyemi, A. O.
   Troseid, M.
   Arnesen, H.
   Solheim, S.
   Seljeflot, I.
TI MARKERS OF GUT-RELATED INFLAMMATION ARE ASSOCIATED WITH CARDIOVASCULAR
   OUTCOME, HOWEVER NOT MODIFIABLE BY DIET OR N-3 PUFA INTERVENTION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Awoyemi, A. O.; Arnesen, H.; Solheim, S.; Seljeflot, I.] Oslo Univ Hosp, Dept Cardiol, Ctr Clin Heart Res, Oslo, Norway.
   [Troseid, M.] Natl Hosp Norway, Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, Oslo, Norway.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0523
BP E246
EP E247
DI 10.1016/j.atherosclerosis.2019.06.758
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800756
DA 2019-10-28
ER

PT J
AU Baardman, J
   van der Velden, S
   Gijbels, M
   van Roomen, C
   Verberk, S
   Griffith, G
   Prange, K
   Wellen, K
   Lutgens, E
   Van den Bossche, J
   de Winther, M
AF Baardman, J.
   van der Velden, S.
   Gijbels, M.
   van Roomen, C.
   Verberk, S.
   Griffith, G.
   Prange, K.
   Wellen, K.
   Lutgens, E.
   Van den Bossche, J.
   de Winther, M.
TI MACROPHAGE ATP-CITRATE LYASE (ACLY) DEFICIENCY AFFECTS CELLULAR
   CHOLESTEROL HOMEOSTASIS AND STABILIZES ATHEROSCLEROTIC LESIONS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Baardman, J.; van der Velden, S.; Gijbels, M.; van Roomen, C.; Griffith, G.; Prange, K.; Lutgens, E.; de Winther, M.] Univ Amsterdam, Dept Med Biochem Expt Vasc Biol, Amsterdam UMC, Amsterdam, Netherlands.
   [Verberk, S.; Van den Bossche, J.] Vrije Univ Amsterdam, Amsterdam UMC, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands.
   [Wellen, K.] Univ Penn, Dept Canc Biol, Perelman Sch Med, Philadelphia, PA 19104 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0978
BP E46
EP E46
DI 10.1016/j.atherosclerosis.2019.06.132
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800131
DA 2019-10-28
ER

PT J
AU Baardman, J
   Verberk, S
   de Winther, M
   Van den Bossche, J
AF Baardman, J.
   Verberk, S.
   de Winther, M.
   Van den Bossche, J.
TI A DEFECTIVE PENTOSE PHOSPHATE PATHWAY REDUCES INFLAMMATORY MACROPHAGE
   RESPONSES DURING HYPERCHOLESTEROLEMIA
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Baardman, J.; de Winther, M.; Van den Bossche, J.] Amsterdam UMC, AMC, Dept Med Biochem, Expt Vasc Biol, Amsterdam, Netherlands.
   [Verberk, S.; Van den Bossche, J.] Vrije Univ Amsterdam Med Ctr, Amsterdam UMC, Dept Mol Cell Biol & Immunolgy, Amsterdam, Netherlands.
   [de Winther, M.] Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0946
BP E103
EP E103
DI 10.1016/j.atherosclerosis.2019.06.300
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800299
OA Green Published
DA 2019-10-28
ER

PT J
AU Baek, S
   Park, S
   Kim, C
AF Baek, S.
   Park, S.
   Kim, C.
TI BLTR1 IN MONOCYTES MEDIATES MONOCYTE-TO-MACROPHAGE DIFFERENTIATION
   LEADING TO VASCULAR INFLAMMATION IN THE INJURED VASCULATURES
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 Pusan Natl Univ, Dept Pharmacol, PNU BK21 Plus Biomed Sci Educ Ctr, Sch Med, Yangsan, Gyeongnam, South Korea.
   Pusan Natl Univ, Dept Pharmacol, Gene & Cell Therapy Res Ctr Vessel Associated Dis, Sch Med, Yangsan, Gyeongnam, South Korea.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0920
BP E249
EP E249
DI 10.1016/j.atherosclerosis.2019.06.766
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800764
DA 2019-10-28
ER

PT J
AU Baila-Rueda, L
   Lamiquiz-Moneo, I
   Bea, AM
   Marco-Benedi, V
   Mateo-Gallego, R
   Jarauta, E
   Laclaustra, M
   Cenarro, A
   Civeira, F
AF Baila-Rueda, L.
   Lamiquiz-Moneo, I.
   Bea, A. M.
   Marco-Benedi, V.
   Mateo-Gallego, R.
   Jarauta, E.
   Laclaustra, M.
   Cenarro, A.
   Civeira, F.
TI ASSOCIATION BETWEEN SNVS IN APOB, APOE, LDLR, NR5A2, PCSK9, PPARGC1A AND
   SREBF2 GENES WITH DESMOSTEROL CONCENTRATIONS IN PATIENTS WITH
   HYPERCHOLESTEROLEMIA WITHOUT MUTATIONS IN CANDIDATE GENES
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Baila-Rueda, L.; Lamiquiz-Moneo, I.; Bea, A. M.; Marco-Benedi, V.; Mateo-Gallego, R.; Jarauta, E.; Laclaustra, M.; Cenarro, A.; Civeira, F.] Inst Invest Sanitaria Aragon CIBERCV, Unidad Clin & Invest Lipidos & Arteriosclerosis, Zaragoza, Spain.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0796
BP E110
EP E110
DI 10.1016/j.atherosclerosis.2019.06.321
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800320
DA 2019-10-28
ER

PT J
AU Bajaj, A
   Vitali, C
   Cuchel, M
   Rader, D
AF Bajaj, A.
   Vitali, C.
   Cuchel, M.
   Rader, D.
TI LITERATURE SURVEY OF LCAT DEFICIENCY: NATURAL HISTORY AND BIOMARKER
   IDENTIFICATION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Bajaj, A.; Vitali, C.; Cuchel, M.; Rader, D.] Univ Penn, Translat Med & Human Genet, Philadelphia, PA 19104 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0968
BP E227
EP E227
DI 10.1016/j.atherosclerosis.2019.06.697
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800695
DA 2019-10-28
ER

PT J
AU Bakker, IBI
   Mijenikman, S
   Brauw, M
   Spijkerman, J
   IMangaliyev, S
   Herrema, H
   Nieuwdorp, M
   Groen, A
   Levels, J
AF Bakker, I. B. Ivo
   Mijenikman, S.
   Brauw, M.
   Spijkerman, J.
   IMangaliyev, S.
   Herrema, H.
   Nieuwdorp, M.
   Groen, A.
   Levels, J.
TI SYSTEMIC AND PORTAL VEIN PLASMA PROTEOME ANALYSIS REVEALS DIFFERENCES IN
   METABOLIC PROTEINS IN PATIENTS ELIGIBLE FOR BARIATRIC SURGERY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Bakker, I. B. Ivo] Amsterdam UMC, Expt Vasc Med G1 114, Amsterdam, Netherlands.
   [Mijenikman, S.] Amsterdam UMC, Expt Vasc Med G1 105, Amsterdam, Netherlands.
   [Brauw, M.] Spaarne Ziekenhuis, Chirurg, Hoofddorp, Netherlands.
   [Spijkerman, J.; Levels, J.] Amsterdam UMC, Expt Vasc Med G1 142, Amsterdam, Netherlands.
   [IMangaliyev, S.; Herrema, H.] Amsterdam UMC, Expt Vasc Med G1 144, Amsterdam, Netherlands.
   [Nieuwdorp, M.] Amsterdam UMC, Expt Vasc Med F4 159 2, Amsterdam, Netherlands.
   [Groen, A.] Amsterdam UMC, Expt Vasc Med G1 145, Amsterdam, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1014
BP E117
EP E118
DI 10.1016/j.atherosclerosis.2019.06.341
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800340
DA 2019-10-28
ER

PT J
AU Ballantyne, C
   Laufs, U
   Ray, KK
   Leiter, LA
   Bays, HE
   Goldberg, AC
   Stroes, ESG
   MacDougall, D
   Zhao, X
   Catapano, AL
AF Ballantyne, C.
   Laufs, U.
   Ray, K. K.
   Leiter, L. A.
   Bays, H. E.
   Goldberg, A. C.
   Stroes, E. S. G.
   MacDougall, D.
   Zhao, X.
   Catapano, A. L.
TI EFFICACY AND SAFETY OF BEMPEDOIC ACID plus EZETIMIBE FIXED-DOSE
   COMBINATION IN PATIENTS AT HIGH CVD RISK AND WITH ELEVATED LDL-C
   RECEIVING MAXIMALLY TOLERATED STATIN THERAPY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Ballantyne, C.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA.
   [Laufs, U.] Univ Leipzig, Dept Cardiol, Leipzig, Germany.
   [Ray, K. K.] Imperial Coll London, Dept Primary Care & Publ Hlth, London, England.
   [Leiter, L. A.] St Michaels Hosp, Div Endocrinol & Metab, Toronto, ON, Canada.
   [Bays, H. E.] Louisville Metab & Atherosclerosis Res Ctr, Louisville, KY USA.
   [Goldberg, A. C.] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, St Louis, MO USA.
   [Stroes, E. S. G.] Acad Med Ctr Amsterdam, Dept Vasc Med, Netherlands Antilles, Amsterdam, Neth Antilles.
   [MacDougall, D.; Zhao, X.] Esper Therapeut, Clin Dev, Ann Arbor, MI USA.
   [Catapano, A. L.] Univ Milan, Milan, Italy.
   [Catapano, A. L.] IRCCS Multimed, Dept Pharmacol & Biomol Sci, Milan, Italy.
RI Ray, Kausik/Z-2055-2019
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1133
BP E7
EP E8
DI 10.1016/j.atherosclerosis.2019.06.020
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800020
DA 2019-10-28
ER

PT J
AU Balogh, E
   Toth, A
   Paragh, G
   Jeney, V
AF Balogh, E.
   Toth, A.
   Paragh, G.
   Jeney, V.
TI INTERPLAY BETWEEN REACTIVE OXYGEN SPECIES AND HIF-1 ACTIVATION DRIVES
   HYPOXIA MEDIATED OSTEOCHONDROGENIC REPROGRAMMING OF VASCULAR SMOOTH
   MUSCLE CELLS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Balogh, E.; Toth, A.; Jeney, V.] Univ Debrecen, Fac Med, Res Ctr Mol Med, Debrecen, Hungary.
   [Paragh, G.] Univ Debrecen, Fac Med, Internal Med, Debrecen, Hungary.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0619
BP E274
EP E274
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800845
DA 2019-10-28
ER

PT J
AU Baragetti, A
   Pellegatta, F
   Cicolari, S
   Danilo, GN
   Grigore, L
   Zampoleri, V
   Luigi, AC
AF Baragetti, A.
   Pellegatta, F.
   Cicolari, S.
   Danilo, G. Norata
   Grigore, L.
   Zampoleri, V.
   Luigi, A. Catapano
TI LEUKOCYTES TELOMERE LENGTH SHORTENING IN FAMILIAL HYPERCHOLESTEROLEMIA
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Baragetti, A.; Cicolari, S.; Danilo, G. Norata] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy.
   [Pellegatta, F.; Grigore, L.; Luigi, A. Catapano] IRCCS Multimed Hosp, Ctr Study Atherosclerosis, Milan, Italy.
   [Zampoleri, V.] Bassini Hosp, SISA Ctr Study Atherosclerosis, Milan, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0914
BP E41
EP E41
DI 10.1016/j.atherosclerosis.2019.06.118
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800117
DA 2019-10-28
ER

PT J
AU Baragetti, A
   Zampoleri, V
   Grigore, L
   Redaelli, L
   Uboldi, P
   Danilo, GN
   Luigi, AC
AF Baragetti, A.
   Zampoleri, V.
   Grigore, L.
   Redaelli, L.
   Uboldi, P.
   Danilo, G. Norata
   Luigi, A. Catapano
TI TRIGLYCERIDES RICH LIPOPROTEINS ELICIT CELLULAR AND ENDOTHELIAL
   INFLAMMATION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Baragetti, A.; Uboldi, P.; Danilo, G. Norata] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy.
   [Zampoleri, V.; Redaelli, L.] Bassini Hosp, SISA Ctr Study Atherosclerosis, Milan, Italy.
   [Grigore, L.; Luigi, A. Catapano] IRCCS Multimed Hosp, Ctr Study Atherosclerosis, Milan, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0916
BP E61
EP E61
DI 10.1016/j.atherosclerosis.2019.06.173
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800172
DA 2019-10-28
ER

PT J
AU Baratta, F
   Pastori, D
   Tozzi, G
   Corradini, SG
   Violi, F
   Angelico, F
   Del Ben, M
AF Baratta, F.
   Pastori, D.
   Tozzi, G.
   Corradini, S. Ginanni
   Violi, F.
   Angelico, F.
   Del Ben, M.
TI LYSOSOMAL ACID LIPASE ACTIVITY AND HEPATIC FIBROSIS IN NONALCOHOLIC
   FATTY LIVER DISEASE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Baratta, F.; Pastori, D.; Violi, F.; Angelico, F.; Del Ben, M.] Sapienza Univ Rome, Internal Med & Med Specialties, Rome, Italy.
   [Tozzi, G.] Childrens Hosp & Res Inst Bambino Gesu, Unit Neuromuscular & Neurodegenerat Dis, Rome, Italy.
   [Corradini, S. Ginanni] Sapienza Univ Rome, Dept Clin Med, Rome, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1076
BP E122
EP E122
DI 10.1016/j.atherosclerosis.2019.06.356
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800355
DA 2019-10-28
ER

PT J
AU Barbalata, T
   Carnuta, MG
   Deleanu, M
   Raileanu, M
   Sima, AV
   Stancu, CS
AF Barbalata, T.
   Carnuta, M. G.
   Deleanu, M.
   Raileanu, M.
   Sima, A. V.
   Stancu, C. S.
TI MECHANISMS OF FUNCTIONAL HDL PRODUCTION AND CHOLESTEROL EFFLUX IN THE
   SMALL INTESTINE OF HYPERLIPIDEMIC HAMSTER; STIMULATION BY GINGER
   ADMINISTRATION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Barbalata, T.; Carnuta, M. G.; Deleanu, M.; Raileanu, M.; Sima, A. V.; Stancu, C. S.] Inst Cellular Biol & Pathol Nicolae Simionescu, Lipid, Bucharest, Romania.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0605
BP E226
EP E227
DI 10.1016/j.atherosclerosis.2019.06.694
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800692
DA 2019-10-28
ER

PT J
AU Barkas, F
   Elisaf, M
   Filippas-Ntekouan, S
   Klouras, E
   Milionis, H
AF Barkas, F.
   Elisaf, M.
   Filippas-Ntekouan, S.
   Klouras, E.
   Milionis, H.
TI GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS PROTECT AGAINST STROKE IN
   PATIENTS WITH DIABETES: A SYSTEMATIC REVIEW AND META-ANALYSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Barkas, F.; Elisaf, M.; Filippas-Ntekouan, S.; Klouras, E.; Milionis, H.] Univ Ioannina, Sch Med, Internal Med, Ioannina, Greece.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0093
BP E116
EP E116
DI 10.1016/j.atherosclerosis.2019.06.336
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800335
DA 2019-10-28
ER

PT J
AU Barkas, F
   Elisaf, M
   Liamis, G
   Anastasiou, G
   Christopoulou, E
   Rizos, E
   Liberopoulos, E
AF Barkas, F.
   Elisaf, M.
   Liamis, G.
   Anastasiou, G.
   Christopoulou, E.
   Rizos, E.
   Liberopoulos, E.
TI METABOLICALLY HEALTHY OBESITY AND RISK OF INCIDENT DIABETES IN PATIENTS
   TREATED WITH STATINS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Barkas, F.; Elisaf, M.; Liamis, G.; Anastasiou, G.; Christopoulou, E.; Liberopoulos, E.] Univ Ioannina, Sch Med, Internal Med, Ioannina, Greece.
   [Rizos, E.] European Univ Cyprus, Sch Med, Nikosia, Cyprus.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0096
BP E129
EP E129
DI 10.1016/j.atherosclerosis.2019.06.379
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800377
DA 2019-10-28
ER

PT J
AU Barkas, F
   Klouras, E
   Liontos, A
   Megapanou, E
   Liamis, G
   Milionis, H
AF Barkas, F.
   Klouras, E.
   Liontos, A.
   Megapanou, E.
   Liamis, G.
   Milionis, H.
TI HYPONATREMIA IS ASSOCIATED WITH INCREASED THE MORTALITY IN PATIENTS WITH
   ACUTE STROKE: A SYSTEMATIC REVIEW AND META-ANALYSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Barkas, F.; Klouras, E.; Liontos, A.; Megapanou, E.; Liamis, G.; Milionis, H.] Univ Ioannina, Sch Med, Internal Med, Ioannina, Greece.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0094
BP E87
EP E87
DI 10.1016/j.atherosclerosis.2019.06.252
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800251
DA 2019-10-28
ER

PT J
AU Barkas, F
   Elisaf, M
   Dimitriou, T
   Liamis, G
   Rizos, E
   Liberopoulos, E
AF Barkas, F.
   Elisaf, M.
   Dimitriou, T.
   Liamis, G.
   Rizos, E.
   Liberopoulos, E.
TI DISTANCE TO TARGETS OF LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND
   ELIGIBILITY FOR TREATMENT WITH PCSK9 INHIBITORS IN PATIENTS AT HIGH
   CARDIOVASCULAR RISK
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Barkas, F.; Elisaf, M.; Dimitriou, T.; Liamis, G.; Liberopoulos, E.] Univ Ioannina, Sch Med, Internal Med, Ioannina, Greece.
   [Rizos, E.] European Univ Cyprus, Sch Med, Nicosia, Cyprus.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0316
BP E185
EP E186
DI 10.1016/j.atherosclerosis.2019.06.561
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800559
DA 2019-10-28
ER

PT J
AU Barkas, F
   Elisaf, M
   Filippatos, T
   Ntekouan, SF
   Sakkas, N
   Liberopoulos, E
AF Barkas, F.
   Elisaf, M.
   Filippatos, T.
   Ntekouan, S. Filippas
   Sakkas, N.
   Liberopoulos, E.
TI LIPID AND GLYCEMIC PROFILE OF OVERWEIGHT AND OBESE PATIENTS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Barkas, F.; Elisaf, M.; Ntekouan, S. Filippas; Sakkas, N.; Liberopoulos, E.] Univ Ioannina, Sch Med, Internal Med, Ioannina, Greece.
   [Filippatos, T.] Univ Crete, Sch Med, Internal Med, Iraklion, Greece.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0095
BP E134
EP E134
DI 10.1016/j.atherosclerosis.2019.06.395
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800393
DA 2019-10-28
ER

PT J
AU Basaran, O
   Dogan, V
   Mert, GO
   Mert, KU
   Ozlek, B
   Celik, O
   Ozlek, E
   Cil, C
   Bekar, L
   Aktas, M
   Resulzade, M
   Kalcik, M
   Aksan, G
   Cinier, G
   Akay, K
   Senol, U
   Demir, V
   Inci, S
   Biteker, M
   Kayikciolu, M
AF Basaran, O.
   Dogan, V.
   Mert, G. O.
   Mert, K. U.
   Ozlek, B.
   Celik, O.
   Ozlek, E.
   Cil, C.
   Bekar, L.
   Aktas, M.
   Resulzade, M.
   Kalcik, M.
   Aksan, G.
   Cinier, G.
   Akay, K.
   Senol, U.
   Demir, V.
   Inci, S.
   Biteker, M.
   Kayikciolu, M.
TI LIPID LOWERING THERAPY USE IN SECONDARY PREVENTION: AN ANALYSIS OF
   EPHESUS STUDY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Basaran, O.; Ozlek, B.; Celik, O.; Ozlek, E.; Cil, C.] Mugla Sitki Kocman Univ, Educ & Res Hosp, Cardiol, Mugla, Turkey.
   [Dogan, V.; Biteker, M.] Mugla Sitki Kocman Univ, Fac Med, Cardiol, Mugla, Turkey.
   [Mert, G. O.] Eskisehir Yunus Emre State Hosp, Cardiol, Eskisehir, Turkey.
   [Mert, K. U.] Eskisehir Osmangazi Univ, Fac Med, Cardol, Eskisehir, Turkey.
   [Bekar, L.; Kalcik, M.] Corum Hitit Univ, Fac Med, Cardiol, Corum, Turkey.
   [Aktas, M.] Kocaeli Univ, Fac Med, Cardiol, Kocaeli, Turkey.
   [Resulzade, M.] Kocaeli Hospitalpk Hosp, Cardiol, Kocaeli, Turkey.
   [Aksan, G.] Sisli Etfal Educ & Res Hosp, Cardiol, Istanbul, Turkey.
   [Cinier, G.] Siyami Ersek Heart Educ & Res Hosp, Cardiol, Istanbul, Turkey.
   [Akay, K.] Kocaeli State Hosp, Cardiol, Kocaeli, Turkey.
   [Senol, U.; Demir, V.] Yozgat Bozok Univ, Fac Med, Cardiol, Yozgat, Turkey.
   [Inci, S.] Aksaray Univ, Fac Med, Cardiol, Aksaray, Turkey.
   [Kayikciolu, M.] Ege Univ, Fac Med, Cardiol, Izmir, Turkey.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0090
BP E203
EP E203
DI 10.1016/j.atherosclerosis.2019.06.618
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800616
DA 2019-10-28
ER

PT J
AU Basu, D
   Josefs, T
   Fisher, EA
   Goldberg, IJ
AF Basu, D.
   Josefs, T.
   Fisher, E. A.
   Goldberg, I. J.
TI EFFECT OF LIPOPROTEIN LIPASE (LPL) DELETION ON ATHEROSCLEROSIS
   REGRESSION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Basu, D.; Josefs, T.; Fisher, E. A.; Goldberg, I. J.] NYU, Sch Med, Med, New York, NY USA.
OI Fisher, Edward/0000-0001-9802-143X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0947
BP E61
EP E61
DI 10.1016/j.atherosclerosis.2019.06.174
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800173
DA 2019-10-28
ER

PT J
AU Bauer, S
   Maegdefessel, L
   Pelisek, J
   Eckstein, HH
AF Bauer, S.
   Maegdefessel, L.
   Pelisek, J.
   Eckstein, H. H.
TI EPIGENETIC LINK BETWEEN HISTONE MODIFICATION, LONG NON-CODING RNAS AND
   EXPRESSION OF MATRIX METALLOPROTEINASES IN ATHEROSCLEROTIC LESIONS OF
   THE EXTRACRANIAL CAROTID ARTERY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Bauer, S.; Maegdefessel, L.; Pelisek, J.; Eckstein, H. H.] Klinikum Rechts Der Isar, Dept Vasc & Endovasc Surg, Munich, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0145
BP E47
EP E47
DI 10.1016/j.atherosclerosis.2019.06.135
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800134
DA 2019-10-28
ER

PT J
AU Baysal, SS
   Koc, S
   Gunes, A
   Altiparmak, IH
AF Baysal, S. S.
   Koc, S.
   Gunes, A.
   Altiparmak, I. H.
TI ENDOTHELIUM BIOMARKERS ENDOCAN AND THROMBOMODULIN LEVELS IN ISOLATED
   CORONARY ARTERY ECTASIA
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Baysal, S. S.; Gunes, A.] Sanliurfa Mehmet Akif Inan Training & Res Hosp, Cardiol, Sanliurfa, Turkey.
   [Koc, S.] Ankara Kecioren Training & Res Hosp, Cardiolgy, Ankara, Turkey.
   [Altiparmak, I. H.] Harran Univ, Fac Med, Cardiol, Sanliurfa, Turkey.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0493
BP E262
EP E262
DI 10.1016/j.atherosclerosis.2019.06.809
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800807
DA 2019-10-28
ER

PT J
AU Bea, AM
   Lamiquiz-Moneo, I
   Marco-Benedi, V
   Mateo-Gallego, R
   Perez-Calahorra, S
   Jarauta, E
   Martin, C
   Cenarro, A
   Civeira, F
AF Bea, A. M.
   Lamiquiz-Moneo, I.
   Marco-Benedi, V.
   Mateo-Gallego, R.
   Perez-Calahorra, S.
   Jarauta, E.
   Martin, C.
   Cenarro, A.
   Civeira, F.
TI LIPID-LOWERING RESPONSE IN SUBJECTS WITH THE P.(LEU167DEL) MUTATION IN
   APOE GENE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Bea, A. M.; Lamiquiz-Moneo, I.; Marco-Benedi, V.; Mateo-Gallego, R.; Perez-Calahorra, S.; Jarauta, E.; Cenarro, A.; Civeira, F.] Hosp Univ Miguel Servet, IIS Aragon CIBERCV, Unidad Clin & Invest Lipidos & Arteriosclerosis, Zaragoza, Spain.
   [Martin, C.] Univ Basque Country, Dept Bioquim & Biol Mol, Bilbao, Spain.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0388
BP E109
EP E109
DI 10.1016/j.atherosclerosis.2019.06.319
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800318
DA 2019-10-28
ER

PT J
AU Begic, N
AF Begic, N.
TI NEDIM BEGIC1, ZIJO BEGIC1, EDIN BEGIC2 DHCR7 GENE MUTATION - BOSNIAN AND
   HERZEGOVINIAN EXPERIENCE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Begic, N.] Clin Ctr Univ Sarajevo, Pediat Clin, Dept Cardiol, Sarajevo, Bosnia & Herceg.
OI Begic, Edin/0000-0001-6842-262X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0527
BP E223
EP E223
DI 10.1016/j.atherosclerosis.2019.06.683
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800681
DA 2019-10-28
ER

PT J
AU Begic, N
   Karahusic, AB
   Kostic, T
AF Begic, N.
   Karahusic, A. Botonjic
   Kostic, T.
TI 3D SIMULATION OF BLOOD FLOW THROUGH NEW DESIGNED STENT GRAFT IN
   ABDOMINAL AORTA
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Begic, N.] Univ Tuzla, Med Fac, Tuzla, Bosnia & Herceg.
   [Begic, N.] Univ Sarajevo, Pediat Clin, Ctr Clin, Sarajevo, Bosnia & Herceg.
   [Karahusic, A. Botonjic] Univ Sarajevo, Fac Architecture, Sarajevo, Bosnia & Herceg.
   [Kostic, T.] Univ Kassel, Dept Hydraul Engn & Water Resources Management, Kassel, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0250
BP E160
EP E160
DI 10.1016/j.atherosclerosis.2019.06.482
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800480
DA 2019-10-28
ER

PT J
AU Beheshti, S
   Madsen, C
   Varbo, A
   Nordestgaard, B
AF Beheshti, S.
   Madsen, C.
   Varbo, A.
   Nordestgaard, B.
TI HOW TO IDENTIFY FAMILIAL PREMATURE MYOCARDIAL INFARCTION: COMPARING
   APPROACHES TO IDENTIFY FAMILIAL HYPERCHOLESTEROLEMIA
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Beheshti, S.; Madsen, C.; Varbo, A.; Nordestgaard, B.] Herlev & Gentofte Hosp, Dept Clin Biochem, Herlev, Denmark.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0289
BP E66
EP E67
DI 10.1016/j.atherosclerosis.2019.06.190
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800189
DA 2019-10-28
ER

PT J
AU Beka, V
   Alimehmeti, I
   Gjergo, H
   Siqeca, M
   Shirka, E
   Goda, A
AF Beka, V.
   Alimehmeti, I.
   Gjergo, H.
   Siqeca, M.
   Shirka, E.
   Goda, A.
TI CORONARY CALCIUM SCORE ASSOCIATION WITH CORONARY ARTERY DISEASE PRESENCE
   AND SEVERITY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Beka, V.; Gjergo, H.; Shirka, E.; Goda, A.] Univ Hosp Ctr Mother Theresa Tirana, Dept Cardiol, Tirana, Albania.
   [Alimehmeti, I.] Univ Med Tirana, Fac Med, Dept Family & Occupat Hlth, Tirana, Albania.
   [Siqeca, M.] Univ Hosp Shefqet Ndroqi Tirana, Dept Cardiol, Tirana, Albania.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0791
BP E253
EP E254
DI 10.1016/j.atherosclerosis.2019.06.780
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800778
DA 2019-10-28
ER

PT J
AU Belhassen, M
   Van Ganse, E
   Ginoux, M
   Nolin, M
   Bada, H
   Bruckert, E
   Krempf, M
   Rebours, V
   Valero, R
   Moulin, P
AF Belhassen, M.
   Van Ganse, E.
   Ginoux, M.
   Nolin, M.
   Bada, H.
   Bruckert, E.
   Krempf, M.
   Rebours, V.
   Valero, R.
   Moulin, P.
TI IDENTIFICATION OF MEDICAL COMPLICATIONS AND REAL-LIFE CARE OF FAMILIAL
   AND MULTIFACTORIAL CHYLOMICRONAEMIA SYNDROMES: THE ESTHYM STUDY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Belhassen, M.; Ginoux, M.; Nolin, M.] PELyon PharmacoEpidemiol Lyon, Lyon, France.
   [Van Ganse, E.] Claude Bernard Lyon 1 Univ, PELyon PharmacoEpidemiol Lyon, Croix Rousse Univ Hosp,Pneumol Dept, HESPER 7425,Hlth Serv & Performance Res, Lyon, France.
   [Bada, H.; Moulin, P.] Claude Bernard Lyon 1 Univ, Louis Pradel Univ Hosp, Hosp Civils Lyon, INSERM,UMR 1060 Carmen, Lyon, France.
   [Bruckert, E.] Pitie Salpetriere Univ Hosp, APHP Paris, Paris, France.
   [Krempf, M.] Nantes Univ Hosp, Nantes, France.
   [Rebours, V.] BEAUJON Univ Hosp, APHP Clichy, Clichy, France.
   [Valero, R.] APHM Univ Hosp, Marseille, France.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0164
BP E60
EP E60
DI 10.1016/j.atherosclerosis.2019.06.170
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800169
DA 2019-10-28
ER

PT J
AU Bellosta, S
   Baci, D
   De Dominicis, C
   Zanda, M
   Gelmi, ML
   Corsini, A
   Abdali, A
AF Bellosta, S.
   Baci, D.
   De Dominicis, C.
   Zanda, M.
   Gelmi, M. L.
   Corsini, A.
   Abdali, A.
TI GLYCOLYSIS INHIBITION SUPPRESSES ANGIOGENESIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Bellosta, S.; Corsini, A.; Abdali, A.] Univ Milan, Pharmacol & Biomol Sci, Milan, Italy.
   [Baci, D.] IRCCS, Multimed, Milan, Italy.
   [De Dominicis, C.; Zanda, M.] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland.
   [Gelmi, M. L.] Univ Milan, Pharmaceut Sci, Milan, Italy.
FU European Union's Horizon 2020 Marie Sklodowska-Curie grant [67552]
FX This project has been funded by the European Union's Horizon 2020 Marie
   Sklodowska-Curie grant (#67552).
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0716
BP E96
EP E96
DI 10.1016/j.atherosclerosis.2019.06.279
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800278
DA 2019-10-28
ER

PT J
AU Beltowski, J
   Wojtak, A
AF Beltowski, J.
   Wojtak, A.
TI DIVERGENT EFFECTS OF HYDROGEN SULFIDE AND POLYSULFIDES ON INFLAMMATORY
   PHENOTYPE OF PERIVASCULAR ADIPOSE TISSUE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Beltowski, J.] Med Univ Lublin, Dept Pathophysiol, Lublin, Poland.
   [Wojtak, A.] Med Univ Lublin, Dept Vasc Surg, Lublin, Poland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0229
BP E243
EP E244
DI 10.1016/j.atherosclerosis.2019.06.748
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800746
DA 2019-10-28
ER

PT J
AU Benne, N
   van Duijn, J
   Vigario, FL
   Leboux, R
   van Veelen, P
   Jiskoot, W
   Kuiper, J
   Slutter, B
AF Benne, N.
   van Duijn, J.
   Vigario, F. Lozano
   Leboux, R.
   van Veelen, P.
   Jiskoot, W.
   Kuiper, J.
   Slutter, B.
TI VACCINATION WITH A REGULATORY T-CELL INDUCING VACCINE FORMULATION
   CONTAINING APOB100 PEPTIDES, REDUCES ATHEROSCLEROSIS IN MICE.
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Benne, N.; van Duijn, J.; Vigario, F. Lozano; Leboux, R.; Jiskoot, W.; Kuiper, J.; Slutter, B.] Leiden Univ, LACDR, BioTherapeut, Leiden, Netherlands.
   [van Veelen, P.] Leiden Univ, Med Ctr, Ctr Prote & Metabol, Leiden, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0413
BP E99
EP E100
DI 10.1016/j.atherosclerosis.2019.06.289
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800288
DA 2019-10-28
ER

PT J
AU Bensaaud, A
   Tawfick, W
   Jordan, F
AF Bensaaud, A.
   Tawfick, W.
   Jordan, F.
TI A TELEPHONE REMINDER TO ENHANCE ADHERENCE TO INTERVENTIONS IN
   CARDIOVASCULAR RANDOMISED TRIALS: A STUDY WITHIN A TRIAL (SWAT)
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Bensaaud, A.] Univ Hosp Galway Ireland, Western Vasc Inst, Dept Vasc & Endovasc Surg, Galway, Ireland.
   [Tawfick, W.] Natl Univ Ireland Galway, Sch Med, Galway, Ireland.
   [Jordan, F.] Natl Univ Ireland Galway, Sch Nursing & Midwifery, Galway, Ireland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0332
BP E186
EP E186
DI 10.1016/j.atherosclerosis.2019.06.563
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800561
DA 2019-10-28
ER

PT J
AU Bensaaud, A
   Tawfick, W
   Sultan, S
AF Bensaaud, A.
   Tawfick, W.
   Sultan, S.
TI MULTIDISCIPLINARY CARDIOVASCULAR DISEASE PREVENTION PROGRAMME VERSUS
   STANDARD CARE FOR RISK REDUCTION IN PATIENTS WITH CAROTID ARTERY
   STENOSIS: STUDY PROTOCOL FOR A RANDOMISED CONTROLLED TRIAL
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Bensaaud, A.; Sultan, S.] Univ Hosp Galway Ireland, Western Vasc Inst, Dept Vasc & Endovasc Surg, Galway, Ireland.
   [Tawfick, W.] Natl Univ Ireland Galway, Sch Med, Galway, Ireland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0280
BP E184
EP E184
DI 10.1016/j.atherosclerosis.2019.06.558
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800556
DA 2019-10-28
ER

PT J
AU Bernal, DR
   Dunaway, C
   deMayo, C
   Cao, L
   Chinnasamy, P
   Jayakumar, S
   Sibinga, N
AF Bernal, D. Riascos
   Dunaway, C.
   deMayo, C.
   Cao, L.
   Chinnasamy, P.
   Jayakumar, S.
   Sibinga, N.
TI THE ATYPICAL CADHERIN FAT1 MODULATES SMOOTH MUSCLE CELL METABOLIC
   PLASTICITY AND LIMITS ATHEROSCLEROSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Bernal, D. Riascos; Dunaway, C.; deMayo, C.; Cao, L.; Chinnasamy, P.; Jayakumar, S.; Sibinga, N.] Albert Einstein Coll Med, Med Cardiol, New York, NY USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0972
BP E5
EP E5
DI 10.1016/j.atherosclerosis.2019.06.014
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800014
DA 2019-10-28
ER

PT J
AU Bijnen, M
   Josefs, T
   van de Gaar, J
   Vroomen, M
   Wijnands, E
   Rensen, S
   Greve, JW
   Hofker, M
   Biessen, E
   de Winther, M
   Stehouwer, C
   Schalkwijk, C
   Wouters, K
AF Bijnen, M.
   Josefs, T.
   van de Gaar, J.
   Vroomen, M.
   Wijnands, E.
   Rensen, S.
   Greve, J. W.
   Hofker, M.
   Biessen, E.
   de Winther, M.
   Stehouwer, C.
   Schalkwijk, C.
   Wouters, K.
TI ADIPOSE TISSUE MACROPHAGES INDUCE HEPATIC NEUTROPHIL RECRUITMENT AND
   MACROPHAGE ACCUMULATION WITHOUT AFFECTING ATHEROSCLEROSIS DEVELOPMENT IN
   MICE.
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Bijnen, M.; van de Gaar, J.; Vroomen, M.; Stehouwer, C.; Schalkwijk, C.; Wouters, K.] Maastricht Univ, Med Ctr, Internal Med, Maastricht, Netherlands.
   [Josefs, T.] NYUMC, Sch Med, New York, NY USA.
   [Wijnands, E.; Biessen, E.] Maastricht Univ, Med Ctr, Pathol, Maastricht, Netherlands.
   [Rensen, S.] Maastricht Univ, Med Ctr, Surg, Maastricht, Netherlands.
   [Greve, J. W.] Zyuderland Hosp, Surg, Heerlen, Netherlands.
   [Hofker, M.] Univ Med Ctr Groningen, Pediat, Groningen, Netherlands.
   [de Winther, M.] AMC, Med Biochem, Amsterdam, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0382
BP E13
EP E13
DI 10.1016/j.atherosclerosis.2019.06.036
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800036
DA 2019-10-28
ER

PT J
AU Bikulciene, I
   Golubevaite, O
   Zekas, V
   Radzevicius, M
   Karciauskaite, D
   Matuzeviciene, R
   Kaminskas, A
   Ausrele, ZK
AF Bikulciene, I.
   Golubevaite, O.
   Zekas, V.
   Radzevicius, M.
   Karciauskaite, D.
   Matuzeviciene, R.
   Kaminskas, A.
   Ausrele, Z. Kucinskiene
TI THE INTERFACE BETWEEN FATTY ACID COMPOSITION OF PLATELET MEMBRANE AND
   PLATELET-LEUKOCYTE AGGREGATES FORMATION IN HEALTHY MEN
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Bikulciene, I.; Golubevaite, O.; Zekas, V.; Radzevicius, M.; Karciauskaite, D.; Matuzeviciene, R.; Kaminskas, A.; Ausrele, Z. Kucinskiene] Vilnius Univ, Inst Biomed Sci, Dept Physiol Biochem Microbiol & Lab Med, Fac Med, Vilnius, Lithuania.
   [Zekas, V.; Radzevicius, M.; Karciauskaite, D.; Matuzeviciene, R.; Ausrele, Z. Kucinskiene] Vilnius Univ Hosp Santaros Klinikos, Ctr Lab Med, Vilnius, Lithuania.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0061
BP E241
EP E242
DI 10.1016/j.atherosclerosis.2019.06.742
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800740
DA 2019-10-28
ER

PT J
AU Bittar, R
   Carrie, A
   Nouadje, G
   Cherfils, C
   Melki, MT
   Giral, P
   Bonnefont-Rousselot, D
AF Bittar, R.
   Carrie, A.
   Nouadje, G.
   Cherfils, C.
   Melki, M. T.
   Giral, P.
   Bonnefont-Rousselot, D.
TI EVALUATION OF A SEMI-AUTOMATIC ISOFOCUSING METHOD FOR APOLIPOPROTEIN E
   PHENOTYPING
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Bittar, R.; Cherfils, C.; Bonnefont-Rousselot, D.] Hop Univ Pitie Salpetriere Charles Foix, AP HP, UF Biochim Malad Metab, Serv Biochim Metab, Paris, France.
   [Bittar, R.; Carrie, A.; Giral, P.] Hop Univ Pitie Salpetriere Charles Foix, AP HP, UMR S1166 ICAN, Paris, France.
   [Carrie, A.] Hop Univ Pitie Salpetriere Charles Foix, AP HP, Serv Biochim Endocrinienne & Oncol, UF Genet Obes & Dyslipidemies, Paris, France.
   [Nouadje, G.; Melki, M. T.] SEBIA, F-91008 Evry, France.
   [Giral, P.] Univ Paris 05, Serv Endocrinol Metab, Paris, France.
   [Bonnefont-Rousselot, D.] Univ Paris 05, Fac Pharm, INSERM U1022, CNRS UMR8258, Paris, France.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0631
BP E235
EP E235
DI 10.1016/j.atherosclerosis.2019.06.722
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800720
DA 2019-10-28
ER

PT J
AU Bittar, R
   Giral, P
   Couvert, P
   Cherfils, C
   Fesel-Fouquier, V
   Koujah, N
   Borgel, A
   Lacorte, JM
   Alibay, N
   Delestre, F
   Bonnefont-Rousselot, D
AF Bittar, R.
   Giral, P.
   Couvert, P.
   Cherfils, C.
   Fesel-Fouquier, V.
   Koujah, N.
   Borgel, A.
   Lacorte, J. M.
   Alibay, N.
   Delestre, F.
   Bonnefont-Rousselot, D.
TI HYPERTRIGLYCERIDEMIA AND SENSIBILITY TO EXOGENOUS FAT
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Bittar, R.; Cherfils, C.; Fesel-Fouquier, V.; Koujah, N.; Borgel, A.; Alibay, N.; Bonnefont-Rousselot, D.] Hop Univ Pitie Salpetriere Charles Foix, AP HP, UF Biochim Malad Metab, Serv Biochim Metab, Paris, France.
   [Bittar, R.; Giral, P.; Couvert, P.; Lacorte, J. M.] Hop Univ Pitie Salpetriere Charles Foix, AP HP, UMR S1166 ICAN, Paris, France.
   [Giral, P.; Delestre, F.] Hop Univ Pitie Salpetriere Charles Foix, AP HP, Serv Endocrinol Metab, Paris, France.
   [Couvert, P.; Lacorte, J. M.] Hop Univ Pitie Salpetriere Charles Foix, AP HP, Serv Biochim Endocrinienne & Oncol, UF Genet Obes & Dyslipidemies, Paris, France.
   [Bonnefont-Rousselot, D.] Univ Paris 05, Fac Pharm, CNRS UMR8258, INSERM U1022, Paris, France.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0185
BP E234
EP E234
DI 10.1016/j.atherosclerosis.2019.06.720
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800718
DA 2019-10-28
ER

PT J
AU Blaha, M
   Andrys, C
   Blaha, V
   Lanska, M
   Zak, P
AF Blaha, M.
   Andrys, C.
   Blaha, V.
   Lanska, M.
   Zak, P.
TI IMPORTANCE OF DECREASE OF THE LEVEL OF PROPROTEIN CONVERTASE SUBTILISIN
   KEXIN 9 (PCSK9) FOLLOWING LIPID APHERESIS IN FAMILIAL
   HYPERCHOLESTEROLEMIA
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Blaha, M.; Andrys, C.; Blaha, V.; Lanska, M.; Zak, P.] Charles Univ Prague, Fac Med, Hradec Kralove, Czech Republic.
   [Blaha, M.; Lanska, M.; Zak, P.] Charles Univ Prague, Teachnig Hosp, Dpt Med 4, Hradec Kralove, Czech Republic.
   [Andrys, C.] Charles Univ Prague, Teachnig Hosp, Inst Immunol & Allergol, Hradec Kralove, Czech Republic.
   [Blaha, V.] Charles Univ Prague, Teachnig Hosp, Dpt Med 3, Hradec Kralove, Czech Republic.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0899
BP E217
EP E218
DI 10.1016/j.atherosclerosis.2019.06.663
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800661
DA 2019-10-28
ER

PT J
AU Bliznyuk, S
   Chubykina, U
   Rozhkova, T
   Ezhov, M
AF Bliznyuk, S.
   Chubykina, U.
   Rozhkova, T.
   Ezhov, M.
TI NON-ACHIEVEMENT OF LDL-CHOLESTEROL GOALS FROM THE RUSSIAN FAMILIAL
   HYPERCHOLESTEROLEMIA REGISTRY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Bliznyuk, S.; Chubykina, U.; Rozhkova, T.; Ezhov, M.] Natl Med Res Ctr Cardiol, Dept Atherosclerosis, Moscow, Russia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0674
BP E220
EP E220
DI 10.1016/j.atherosclerosis.2019.06.671
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800669
DA 2019-10-28
ER

PT J
AU Boffa, M
   Marar, T
   Borrelli, M
   Yeang, C
   Viney, N
   Xia, S
   Witztum, J
   Koschinsky, M
   Tsimikas, S
AF Boffa, M.
   Marar, T.
   Borrelli, M.
   Yeang, C.
   Viney, N.
   Xia, S.
   Witztum, J.
   Koschinsky, M.
   Tsimikas, S.
TI REDUCTION OF PLASMA LIPOPROTEIN(A) WITH ANTISENSE OLIGONUCLEOTIDES IN
   HUMAN SUBJECTS DOES NOT AFFECT FIBRINOLYSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Boffa, M.; Marar, T.] Univ Western Ontario, Biochem, London, ON, Canada.
   [Borrelli, M.; Koschinsky, M.] Univ Western Ontario, Physiol & Pharmacol, London, ON, Canada.
   [Yeang, C.; Witztum, J.; Tsimikas, S.] Univ Calif San Diego, Med, La Jolla, CA 92093 USA.
   [Viney, N.; Xia, S.; Tsimikas, S.] Ionis Pharmaceut, Carlsbad, CA USA.
   [Koschinsky, M.] Univ Western Ontario, Robarts Res Inst, London, ON, Canada.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0730
BP E59
EP E59
DI 10.1016/j.atherosclerosis.2019.06.167
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800166
DA 2019-10-28
ER

PT J
AU Bogsrud, M
   Oyri, L
   Halvorsen, S
   Atar, D
   Leren, T
   Holven, K
AF Bogsrud, M.
   Oyri, L.
   Halvorsen, S.
   Atar, D.
   Leren, T.
   Holven, K.
TI PREVALENCE OF GENETICALLY VERIFIED FAMILIAL HYPERCHOLESTEROLEMIA AMONG
   YOUNG NORWEGIAN PATIENTS (45 YEARS) HOSPITALIZED WITH ACUTE MYOCARDIAL
   INFARCTION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Bogsrud, M.] Oslo Univ Hosp, Unit Cardiac & Cardiovasc Genet, Natl Advisory Unit FH, Oslo, Norway.
   [Oyri, L.; Holven, K.] Univ Oslo, Dept Nutr, Oslo, Norway.
   [Halvorsen, S.; Atar, D.] Univ Oslo, Inst Clin Med, Oslo, Norway.
   [Halvorsen, S.; Atar, D.] Oslo Univ Hosp Ulleval, Dept Cardiol, Oslo, Norway.
   [Leren, T.] Oslo Univ Hosp, Unit Cardiac & Cardiovasc Genet, Oslo, Norway.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0097
BP E209
EP E210
DI 10.1016/j.atherosclerosis.2019.06.638
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800636
DA 2019-10-28
ER

PT J
AU Bonacina, F
   Martini, E
   Garetto, S
   Roselli, G
   Pellegatta, F
   Locatelli, S
   Cremonesi, M
   Catapano, AL
   Kallikourdis, M
   Norata, GD
AF Bonacina, F.
   Martini, E.
   Garetto, S.
   Roselli, G.
   Pellegatta, F.
   Locatelli, S.
   Cremonesi, M.
   Catapano, A. L.
   Kallikourdis, M.
   Norata, G. D.
TI ENGINEERED REGULATORY T CELL ADOPTIVE THERAPY AS A NOVEL TOOL FOR THE
   TREATMENT OF ATHEROSCLEROSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Bonacina, F.; Locatelli, S.; Catapano, A. L.; Norata, G. D.] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy.
   [Martini, E.; Garetto, S.; Roselli, G.; Cremonesi, M.; Kallikourdis, M.] Humanitas Hosp, Humanitas Clin & Res Ctr, Milan, Italy.
   [Pellegatta, F.] Bassini Hosp, SISA Ctr Fo Study Atherosclerosis, Milan, Italy.
RI Kallikourdis, Marinos/AAA-5593-2019; Norata, Giuseppe
   Danilo/AAC-2863-2019
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0940
BP E18
EP E18
DI 10.1016/j.atherosclerosis.2019.06.050
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800050
DA 2019-10-28
ER

PT J
AU Bonaiti, F
   Casula, M
   Olmastroni, E
   Averna, M
   Arca, M
   Catapano, AL
AF Bonaiti, F.
   Casula, M.
   Olmastroni, E.
   Averna, M.
   Arca, M.
   Catapano, A. L.
TI DIAGNOSIS OF FAMILIAL HYPERCHOLESTEROLEMIA IN THE CLINICAL PRACTICE:
   PERFORMANCE OF DUTCH LIPID CLINIC NETWORK SCORE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Bonaiti, F.; Casula, M.; Olmastroni, E.; Catapano, A. L.] Univ Milan, Epidemiol & Prevent Pharmacol Ctr SEFAP, Dept Pharmacol & Biomol Sci, Milan, Italy.
   [Averna, M.] Univ Palermo, Dept Internal Med, Palermo, Italy.
   [Arca, M.] Sapienza Univ Rome, Dept Internal Med & Med Specialties, Rome, Italy.
   [Catapano, A. L.] IRCCS MultiMed, Sesto San Giovanni, MI, Italy.
RI Casula, Manuela/AAC-4470-2019
OI Casula, Manuela/0000-0002-5124-5361
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0983
BP E69
EP E69
DI 10.1016/j.atherosclerosis.2019.06.196
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800195
DA 2019-10-28
ER

PT J
AU Bork, C
   Veno, SK
   Lasota, AN
   Lundbye-Christensen, S
   Overvad, K
   Schmidt, EB
AF Bork, C.
   Veno, S. K.
   Lasota, A. N.
   Lundbye-Christensen, S.
   Overvad, K.
   Schmidt, E. B.
TI ALPHA-LINOLENIC ACID INTAKE AND THE RISK OF ATHEROSCLEROTIC
   CARDIOVASCULAR DISEASE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Bork, C.; Veno, S. K.; Schmidt, E. B.] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark.
   [Lasota, A. N.] Aalborg Univ Hosp, Dept Vasc Surg, Aalborg, Denmark.
   [Lundbye-Christensen, S.] Aalborg Univ Hosp, Unit Clin Biostat, Aalborg, Denmark.
   [Overvad, K.] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0506
BP E83
EP E83
DI 10.1016/j.atherosclerosis.2019.06.240
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800239
DA 2019-10-28
ER

PT J
AU Borkhalenko, Y
   Zharinov, O
   Yepanchintseva, O
   Todurov, B
AF Borkhalenko, Y.
   Zharinov, O.
   Yepanchintseva, O.
   Todurov, B.
TI CHANGES IN THE QUALITY OF LIFE IN PATIENTS WITH STABLE ISCHEMIC CORONARY
   DISEASE AFTER REVASCULARIZATOIN AT 6-MONTH FOLLOW-UP
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Borkhalenko, Y.; Yepanchintseva, O.; Todurov, B.] Minist Healthcare Ukraine, Inst Heart, Pathol Myocardium & Transplant Dept, Kiev, Ukraine.
   [Zharinov, O.] Natl Med Acad Postgrad Educ, Dept Functoinal Diagnost, Kiev, Ukraine.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0039
BP E150
EP E151
DI 10.1016/j.atherosclerosis.2019.06.449
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800447
DA 2019-10-28
ER

PT J
AU Borowczyk, C
   Laroche-traineau, J
   Brevier, J
   Marais, S
   Gerbaud, E
   Clofent-sanchez, G
   Ottones, F
AF Borowczyk, C.
   Laroche-traineau, J.
   Brevier, J.
   Marais, S.
   Gerbaud, E.
   Clofent-sanchez, G.
   Ottones, F.
TI AUTOFLUORESCENT INTRACELLULAR NADH AND FAD MAY BE USED TO DETECT
   ATHEROMATOUS PLAQUE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Borowczyk, C.; Laroche-traineau, J.; Clofent-sanchez, G.; Ottones, F.] Crmsb, Cnrs Umr 5536, Bordeaux, France.
   [Brevier, J.] Xlim, Cnrs Umr 7252, Limoges, France.
   [Marais, S.] BIC, Bordeaux, France.
   [Gerbaud, E.] INSERM, Crct, Bordeaux, France.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1135
BP E282
EP E283
DI 10.1016/j.atherosclerosis.2019.06.875
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800873
DA 2019-10-28
ER

PT J
AU Boshku, AA
   Panova, DI
AF Boshku, A. Atanasova
   Panova, D. Ivanova
TI LIPID PROFILE IN RELATION TO ANTROPOMETRIC INDICES AND INSULIN
   RESISTANCE IN OVERWEINGT WOMEN WITH POLYCYSTIC OVARY SYNDROME
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Boshku, A. Atanasova] Ss Cyril & Methodius Univ, Fac Med, Univ Clin Obstet & Gynecol, Clin Chem, Skopje, Macedonia.
   [Panova, D. Ivanova] Ss Cyril & Methodius Univ, Fac Med, Univ Clin Obstet & Gynecol, Endocrinol, Skopje, Macedonia.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0843
BP E135
EP E135
DI 10.1016/j.atherosclerosis.2019.06.398
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800396
DA 2019-10-28
ER

PT J
AU Bot, I
   Kritikou, E
   van der Heijden, T
   Swart, M
   van Duijn, J
   Slutter, B
   Wezel, A
   Smeets, H
   Maffia, P
   Kuiper, J
AF Bot, I.
   Kritikou, E.
   van der Heijden, T.
   Swart, M.
   van Duijn, J.
   Slutter, B.
   Wezel, A.
   Smeets, H.
   Maffia, P.
   Kuiper, J.
TI HYPERCHOLESTEROLEMIA PROMOTES A MAST CELL-CD4+T-CELL INTERACTION IN
   ATHEROSCLEROSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Bot, I.; Kritikou, E.; van der Heijden, T.; Swart, M.; van Duijn, J.; Slutter, B.; Kuiper, J.] Leiden Univ, LACDR, BioTherapeut, Leiden, Netherlands.
   [Wezel, A.; Smeets, H.] HMC Westeinde, Surg, The Hague, Netherlands.
   [Maffia, P.] Univ Glasgow, Ctr Immunobiol, Immun & Inflammat, Glasgow, Lanark, Scotland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0209
BP E17
EP E17
DI 10.1016/j.atherosclerosis.2019.06.048
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800048
DA 2019-10-28
ER

PT J
AU Boulet, MM
   Cheillan, D
   Di Filippo, M
   Michalski, MC
   Moulin, P
   Calzada, C
AF Boulet, M. M.
   Cheillan, D.
   Di Filippo, M.
   Michalski, M. C.
   Moulin, P.
   Calzada, C.
TI TRIGLYCERIDE RICH LIPOPROTEINS FROM TYPE 2 DIABETIC PATIENTS ACTIVATE
   PLATELETS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Boulet, M. M.; Cheillan, D.; Di Filippo, M.; Michalski, M. C.; Moulin, P.; Calzada, C.] Univ Lyon 1, Hosp Civils Lyon, CarMeN Lab, INSA Lyon,INSERM,U1060,INRA,U1397, Villeurbanne, France.
   [Cheillan, D.; Di Filippo, M.] Hosp Civils Lyon, Ctr Biol Est, Bron, France.
   [Moulin, P.] Hosp Civils Lyon, Hop Louis Pradel, Fed Endocrinol Malad Metab Diabet & Nutr, Bron, France.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0214
BP E108
EP E109
DI 10.1016/j.atherosclerosis.2019.06.317
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800316
DA 2019-10-28
ER

PT J
AU Bourgeois, R
   Despres, AA
   Guertin, J
   Perrot, N
   Mitchell, P
   Gotti, C
   Bourassa, S
   Scipione, CA
   Couture, P
   Droit, A
   Koschinsky, ML
   Mathieu, P
   Arsenault, B
AF Bourgeois, R.
   Despres, A. A.
   Guertin, J.
   Perrot, N.
   Mitchell, P.
   Gotti, C.
   Bourassa, S.
   Scipione, C. A.
   Couture, P.
   Droit, A.
   Koschinsky, M. L.
   Mathieu, P.
   Arsenault, B.
TI A COMPARATIVE PROTEOMIC ANALYSIS OF LIPOPROTEIN(A) AND LOW-DENSITY
   LIPOPROTEINS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Bourgeois, R.; Despres, A. A.; Guertin, J.; Perrot, N.; Mitchell, P.; Mathieu, P.; Arsenault, B.] IUCPQ, Cardiol, Quebec City, PQ, Canada.
   [Gotti, C.; Bourassa, S.; Droit, A.] CHU Quebec, Prote, Quebec City, PQ, Canada.
   [Scipione, C. A.; Koschinsky, M. L.] Robarts Res Inst, Chem & Biochem, London, ON, Canada.
   [Couture, P.] Univ Laval, Fac Med, Med, Quebec City, PQ, Canada.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0105
BP E58
EP E58
DI 10.1016/j.atherosclerosis.2019.06.163
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800162
DA 2019-10-28
ER

PT J
AU Bourgeois, T
   Thomas, C
   Jalil, A
   Masson, D
   Grober, J
AF Bourgeois, T.
   Thomas, C.
   Jalil, A.
   Masson, D.
   Grober, J.
TI MYELOID LPCAT3 DEFICIENCY PROMOTES HEPATIC STEATOSIS IN HIGH-FAT DIET
   FED MICE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Bourgeois, T.; Thomas, C.; Jalil, A.; Masson, D.; Grober, J.] INSERM, UMR1231, Lipness Team, Dijon, France.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0169
BP E1
EP E1
DI 10.1016/j.atherosclerosis.2019.06.002
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800002
DA 2019-10-28
ER

PT J
AU Boutari, C
   Tziomalos, K
   Doumas, M
   Lefkos, P
   Pappas, P
   Athyros, V
   Karagiannis, A
AF Boutari, C.
   Tziomalos, K.
   Doumas, M.
   Lefkos, P.
   Pappas, P.
   Athyros, V.
   Karagiannis, A.
TI EFFECT OF HIGH AND LOW DOSE OF ROSUVASTATIN ON FATTY LIVER DISEASE AND
   24-HOUR ARTERIAL STIFFNESS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER
   DISEASE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Boutari, C.; Doumas, M.; Pappas, P.; Athyros, V.; Karagiannis, A.] Aristotle Univ Thessaloniki, Sch Med, Hippokrat Hosp, Propedeut Dept Internal Med 2, Thessaloniki, Greece.
   [Tziomalos, K.] Univ Thessaloniki, Sch Med, Propedeut Dept Internal Med 1, AHEPA Hosp, Thessaloniki, Greece.
   [Lefkos, P.] Hippokrateion Hosp, Thessaloniki, Greece.
   [Lefkos, P.] Hippokrateion Hosp, Dept Radiol, Thessaloniki, Greece.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0088
BP E203
EP E203
DI 10.1016/j.atherosclerosis.2019.06.617
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800615
DA 2019-10-28
ER

PT J
AU Boyle, J
   Seneviratne, A
   Han, Y
   Jiang, L
   Walter, E
   Cave, L
   Shaikh, A
   Long, NJ
   Carling, D
   Mason, JC
   Haskard, DO
AF Boyle, J.
   Seneviratne, A.
   Han, Y.
   Jiang, L.
   Walter, E.
   Cave, L.
   Shaikh, A.
   Long, N. J.
   Carling, D.
   Mason, J. C.
   Haskard, D. O.
TI VERTEBRATE HEMATOMA RESOLUTION IS DIRECTED BY ACTIVATING TRANSCRIPTION
   FACTOR 1 (ATF1) AND ADENOSINE-MONOPHOSPHATE-ACTIVATED-PROTEIN-KINASE
   (AMPK)
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Boyle, J.; Seneviratne, A.; Han, Y.; Walter, E.; Cave, L.; Shaikh, A.; Mason, J. C.; Haskard, D. O.] Imperial Coll London, NHLI, London, England.
   [Jiang, L.; Long, N. J.] Imperial Coll London, Mol Sci Res Hub, London, England.
   [Carling, D.] MRC, London Med Sci Inst, London, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0497
BP E246
EP E246
DI 10.1016/j.atherosclerosis.2019.06.755
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800753
DA 2019-10-28
ER

PT J
AU Boyle, J
   Seneviratne, A
   Tsao, A
   Shaikh, A
   Carling, D
   Haskard, DO
   Justin, CM
   Cave, L
AF Boyle, J.
   Seneviratne, A.
   Tsao, A.
   Shaikh, A.
   Carling, D.
   Haskard, D. O.
   Justin, M. C.
   Cave, L.
TI SMARCA4 REDIRECTS BINDING OF MACROPHAGE ACTIVATING TRANSCRIPTION FACTOR
   1 (ATF1) FROM GENES FOR INFLAMMATION RESOLUTION TO GENES FOR ERYTHROCYTE
   RESOLUTION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Boyle, J.; Seneviratne, A.; Tsao, A.; Shaikh, A.; Haskard, D. O.; Justin, M. C.; Cave, L.] Imperial Coll London, NHLI, London, England.
   [Carling, D.] Med Res Council London Med Inst, London, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0491
BP E78
EP E78
DI 10.1016/j.atherosclerosis.2019.06.226
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800225
DA 2019-10-28
ER

PT J
AU Boyle, J
   Seneviratne, A
   Hyde, G
   Moestrup, SK
   Carling, D
   Mason, JC
   Haskard, DO
AF Boyle, J.
   Seneviratne, A.
   Hyde, G.
   Moestrup, S. K.
   Carling, D.
   Mason, J. C.
   Haskard, D. O.
TI METFORMIN DIRECTLY SUPPRESSES ATHEROSCLEROSIS IN NORMOGLYCEMIC MICE VIA
   HAEMATOPOIETIC ADENOSINE MONOPHOSPHATE-ACTIVATED PROTEIN KINASE (AMPK)
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Boyle, J.; Seneviratne, A.; Hyde, G.; Mason, J. C.; Haskard, D. O.] Imperial Coll London, NHLI, London, England.
   [Moestrup, S. K.] Aarhus Univ, Biomed, Aarhus, Denmark.
   [Carling, D.] Med Res Council London Med Sci Inst, London, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0504
BP E45
EP E46
DI 10.1016/j.atherosclerosis.2019.06.130
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800129
DA 2019-10-28
ER

PT J
AU Bratset, V
   Heier, M
   Margeirsdottir, HD
   Solheim, S
   Arnesen, H
   Jorgensen, KD
   Seljeflot, I
AF Bratset, V.
   Heier, M.
   Margeirsdottir, H. Dis
   Solheim, S.
   Arnesen, H.
   Jorgensen, K. Dahl
   Seljeflot, I.
TI MARKERS OF PROCOAGULANT ACTIVITY IN CHILDREN/ADOLESCENTS WITH TYPE 1
   DIABETES - A CASE CONTROL STUDY.
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Bratset, V.; Solheim, S.; Arnesen, H.; Seljeflot, I.] Oslo Univ Hosp Ullevaal, Ctr Clin Heart Res, Cardiol, Oslo, Norway.
   [Bratset, V.; Heier, M.; Margeirsdottir, H. Dis; Arnesen, H.; Jorgensen, K. Dahl; Seljeflot, I.] Fac Med, Med Clin, Oslo, Norway.
   [Heier, M.; Margeirsdottir, H. Dis; Jorgensen, K. Dahl] Oslo Univ Hosp, Oslo Diabet Res Ctr, Endocrinol, Oslo, Norway.
   [Heier, M.; Jorgensen, K. Dahl] Oslo Univ Hosp Ullevaal, Pediat, Oslo, Norway.
   [Margeirsdottir, H. Dis] Akershus Univ Hosp, Pediat, Oslo, Norway.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0684
BP E141
EP E142
DI 10.1016/j.atherosclerosis.2019.06.421
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800419
DA 2019-10-28
ER

PT J
AU Brett, T
   Arnold-Reed, D
   Ping-Delfos, WCS
   Condon, C
   Watts, GF
AF Brett, T.
   Arnold-Reed, D.
   Ping-Delfos, W. Chan She
   Condon, C.
   Watts, G. F.
TI FAMILIAL HYPERCHOLESTEROLAEMIA - TIME FOR A GREATER ROLE FOR PRIMARY
   CARE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Brett, T.; Arnold-Reed, D.; Ping-Delfos, W. Chan She; Condon, C.] Univ Notre Dame Australia, Gen Practice & Primary Hlth Care Res, Fremantle, WA, Australia.
   [Watts, G. F.] Univ Western Australia, Lipid Disorders Clin, Dept Cardiol, Royal Perth Hosp, Perth, WA, Australia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0078
BP E209
EP E209
DI 10.1016/j.atherosclerosis.2019.06.637
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800635
DA 2019-10-28
ER

PT J
AU Bruikman, C
   Vreeken, D
   Zhang, H
   van Zonneveld, AJ
   Hovingh, K
   van Gils, J
AF Bruikman, C.
   Vreeken, D.
   Zhang, H.
   van Zonneveld, A. J.
   Hovingh, K.
   van Gils, J.
TI FUNCTION AND MUTATION OF NETRIN-1 IN PREMATURE ATHEROSCLEROSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Bruikman, C.; Hovingh, K.] Amsterdam UMC, AMC, Vasc Med, Amsterdam, Netherlands.
   [Vreeken, D.; Zhang, H.; van Zonneveld, A. J.; van Gils, J.] Leiden Univ, Med Ctr, Internal Med, Einthoven Lab Vasc & Regenerat Med, Leiden, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1090
BP E13
EP E13
DI 10.1016/j.atherosclerosis.2019.06.037
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800037
DA 2019-10-28
ER

PT J
AU Bubnova, M
   Aronov, D
AF Bubnova, M.
   Aronov, D.
TI INFLUENCE OF EZETIMIBE AND CO-ADMINISTRATION OF EZETIMIBE/SIMVASTATIN ON
   POSTPRANDIAL HYPERLIPIDEMIA IN PATIENTS WITH PRIMARY HYPERLIPIDEMIA.
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Bubnova, M.] Natl Med Res Ctr Prevent Med, Rehabil & Secondary Prevent Comorbid Dis, Prevent Atherosclerosis & Trombosis, Moscow, Russia.
   [Aronov, D.] Natl Med Res Ctr Prevent Med, Cardiorehabil, Moscow, Russia.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0420
BP E205
EP E205
DI 10.1016/j.atherosclerosis.2019.06.623
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800621
DA 2019-10-28
ER

PT J
AU Bubnova, M
   Aronov, D
AF Bubnova, M.
   Aronov, D.
TI EFFECTS OF ORAL FAT LOAD ON THE POSTPRANDIAL MYOCARDIAL ISCHEMIA,
   ACTIVITY OF ENDOTHELIAL FUNCTION, PLATELET AGGREGATION, LEVELS OF
   LACTATE IN PATIENTS WITH STABLE ANGINA PECTORIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Bubnova, M.] Natl Med Res Ctr Prevent Med, Rehabil & Secondary Prevent Comorbid Dis, Prevent Atherosclerosis & Trombosis, Moscow, Russia.
   [Aronov, D.] Natl Med Res Ctr Prevent Med, Cardiologyl Rehabil, Moscow, Russia.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0929
BP E167
EP E167
DI 10.1016/j.atherosclerosis.2019.06.504
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800502
DA 2019-10-28
ER

PT J
AU Burggraaf, B
   van der Meulen, N
   van der Geijn, GJ
   Cabezas, MC
AF Burggraaf, B.
   van der Meulen, N.
   van der Geijn, G. J.
   Cabezas, M. Castro
TI SYSTEMIC ERYTHROCYTE-BOUND APOLIPOPROTEIN B IN DIABETES
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Burggraaf, B.; van der Meulen, N.; Cabezas, M. Castro] Franciscus Gasthuis, Internal Med, Rotterdam, Netherlands.
   [van der Geijn, G. J.] Franciscus Gasthuis, Clin Chem, Rotterdam, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0895
BP E128
EP E128
DI 10.1016/j.atherosclerosis.2019.06.376
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800374
DA 2019-10-28
ER

PT J
AU Burggraaf, B
   Pouw, N
   Arroyo, SF
   van Vark-van der Zee, L
   van de Geijn, GJ
   Birnie, E
   Huisbrink, J
   van der Zwan, E
   Mulder, M
   Rensen, P
   de Herder, W
   Cabezas, MC
AF Burggraaf, B.
   Pouw, N.
   Arroyo, S. Fernandez
   van Vark-van der Zee, L.
   van de Geijn, G. J.
   Birnie, E.
   Huisbrink, J.
   van der Zwan, E.
   Mulder, M.
   Rensen, P.
   de Herder, W.
   Cabezas, M. Castro
TI REDUCED FASTING AND POSTPRANDIAL TRIGLYCERIDE LEVELS BY ALIROCUMAB IN
   MALE DIABETES PATIENTS ON INTENSIVE INSULIN TREATMENT BY IMPROVED
   CHYLOMICRON METABOLISM
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Burggraaf, B.; Cabezas, M. Castro] Franciscus Gasthuis, Internal Med, Rotterdam, Netherlands.
   [Pouw, N.; van de Geijn, G. J.; van der Zwan, E.] Franciscus Gasthuis, Clin Chem, Rotterdam, Netherlands.
   [Arroyo, S. Fernandez] Univ Rovira & Virgili, Dept Med & Cirurgia, Tarragona, Spain.
   [van Vark-van der Zee, L.; Mulder, M.; de Herder, W.] Erasmus MC, Internal Med, Rotterdam, Netherlands.
   [Birnie, E.] Franciscus Gasthuis, Stat & Educ, Rotterdam, Netherlands.
   [Huisbrink, J.] Franciscus Gasthuis, Pharmacol, Rotterdam, Netherlands.
   [Rensen, P.] Leiden Univ, Med Ctr, Internal Med, Leiden, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0939
BP E44
EP E44
DI 10.1016/j.atherosclerosis.2019.06.126
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800125
DA 2019-10-28
ER

PT J
AU Buriakovska, O
   Isayeva, G
AF Buriakovska, O.
   Isayeva, G.
TI SLEEP QUALITY AND PLASMA LIPIDS IN PATIENTS WITH HYPERTENSION AND
   DIABETES MELLITUS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Buriakovska, O.; Isayeva, G.] LT Malaya Natl Ukrainian Acad Med Sci, Govt Inst Natl Inst Therapy, Dept Chron Noncommunicable Dis Prevent, Kharkov, Ukraine.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0326
BP E186
EP E186
DI 10.1016/j.atherosclerosis.2019.06.562
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800560
DA 2019-10-28
ER

PT J
AU Burja, B
   Topalovic, D
   Kuret, T
   Zivkovic, L
   Mrak-Poljsak, K
   Janko, T
   Spremo-Potparevic, B
   Zigon, P
   Cucnik, S
   Sodin-Semrl, S
   Lakota, K
   Frank-Bertoncelj, M
AF Burja, B.
   Topalovic, D.
   Kuret, T.
   Zivkovic, L.
   Mrak-Poljsak, K.
   Janko, T.
   Spremo-Potparevic, B.
   Zigon, P.
   Cucnik, S.
   Sodin-Semrl, S.
   Lakota, K.
   Frank-Bertoncelj, M.
TI PROTECTIVE EFFECTS OF OLIVE LEAF EXTRACT ON INFLAMMATORY ACTIVATION OF
   ENDOTHELIAL CELLS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Burja, B.; Kuret, T.; Mrak-Poljsak, K.; Zigon, P.; Cucnik, S.; Sodin-Semrl, S.; Lakota, K.] Univ Med Ctr Ljubljana, Dept Rheumatol, Ljubljana, Slovenia.
   [Burja, B.; Frank-Bertoncelj, M.] Univ Hosp Zurich, Ctr Expt Rheumatol, Zurich, Switzerland.
   [Topalovic, D.; Zivkovic, L.; Spremo-Potparevic, B.] Univ Belgrade, Fac Pharm, Belgrade, Serbia.
   [Kuret, T.; Cucnik, S.] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia.
   [Janko, T.; Sodin-Semrl, S.; Lakota, K.] Univ Primorska, Fac Math Nat Sci & Informat Technol, Koper, Slovenia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0403
BP E95
EP E95
DI 10.1016/j.atherosclerosis.2019.06.276
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800275
DA 2019-10-28
ER

PT J
AU Busnelli, M
   Manzini, S
   Conti, M
   Chiesa, G
AF Busnelli, M.
   Manzini, S.
   Conti, M.
   Chiesa, G.
TI IMPACT OF DIETARY CHOLINE ON ATHEROSCLEROSIS DEVELOPMENT IN
   CONVENTIONALLY RAISED APOE-KO MICE EXPRESSING DIFFERENT LEVELS OF APOA-I
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Busnelli, M.; Manzini, S.; Conti, M.; Chiesa, G.] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1027
BP E20
EP E20
DI 10.1016/j.atherosclerosis.2019.06.057
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800057
DA 2019-10-28
ER

PT J
AU Calmarza, P
   Ramos-Caceres, M
   Civeira-Marin, M
   Marco-Benedi, V
   Bea, AM
   Lamiquiz-Moneo, I
   Baila-Rueda, L
   Cenarro, A
   Civeira, F
AF Calmarza, P.
   Ramos-Caceres, M.
   Civeira-Marin, M.
   Marco-Benedi, V.
   Bea, A. M.
   Lamiquiz-Moneo, I.
   Baila-Rueda, L.
   Cenarro, A.
   Civeira, F.
TI CHANGES IN TRIGLYCERIDES CONCENTRATION ARE NEGATIVELY ASSOCIATED WITH
   LIPOPROTEIN (A) CONCENTRATION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Calmarza, P.; Ramos-Caceres, M.; Civeira-Marin, M.; Marco-Benedi, V.; Bea, A. M.; Lamiquiz-Moneo, I.; Baila-Rueda, L.; Cenarro, A.; Civeira, F.] Hosp Univ Miguel Servet, IIS Aragon, CIBERCV, Unidad Lipidos & Arteriosclerosis, Zaragoza, Spain.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0587
BP E59
EP E59
DI 10.1016/j.atherosclerosis.2019.06.166
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800165
DA 2019-10-28
ER

PT J
AU Cantin, C
   Pasten, V
   Hormazabal, N
   Garchitorena, MJ
   Fuenzalida, B
   Carvajal, L
   Contreras, S
   Leiva, A
AF Cantin, C.
   Pasten, V.
   Hormazabal, N.
   Garchitorena, M. J.
   Fuenzalida, B.
   Carvajal, L.
   Contreras, S.
   Leiva, A.
TI SUPRAPHYSIOLOGICAL MATERNAL HYPERCHOLESTEROLEMIA ASSOCIATES WITH
   INCREASED MATERNAL LEVELS OF PCSK9 AND WITH CHANGES IN THE MATERNAL AND
   NEONATAL LDL AND HDL PROFILE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Cantin, C.; Pasten, V.; Hormazabal, N.; Garchitorena, M. J.; Fuenzalida, B.; Carvajal, L.; Contreras, S.; Leiva, A.] Pontificia Univ Catolica Chile, Div Obstet & Gynecol, Sch Med, Fac Med, Santiago, Chile.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0558
BP E81
EP E82
DI 10.1016/j.atherosclerosis.2019.06.236
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800235
DA 2019-10-28
ER

PT J
AU Cao, J
   Goossens, P
   Martin-Lorenzo, M
   Scupakova, K
   Dewez, F
   Biessen, EAL
   Heeren, RMA
   Balluff, B
AF Cao, J.
   Goossens, P.
   Martin-Lorenzo, M.
   Scupakova, K.
   Dewez, F.
   Biessen, E. A. L.
   Heeren, R. M. A.
   Balluff, B.
TI THREE-DIMENSIONAL MASS SPECTROMETRY IMAGING OF LIPIDS IN MOUSE AORTIC
   ATHEROSCLEROTIC PLAQUE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Cao, J.; Martin-Lorenzo, M.; Scupakova, K.; Dewez, F.; Heeren, R. M. A.; Balluff, B.] Maastricht Univ, Maastricht MultiModal Mol Imaging Inst M4I, Maastricht, Netherlands.
   [Goossens, P.; Biessen, E. A. L.] MUMC, Dept Pathol, Maastricht, Netherlands.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0628
BP E29
EP E29
DI 10.1016/j.atherosclerosis.2019.06.085
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800084
DA 2019-10-28
ER

PT J
AU Caradio, F
   Di Monte, D
   De Flaviis, C
   D'Ardes, D
   Pierdomenico, A
   Cipollone, F
   Bucci, M
AF Caradio, F.
   Di Monte, D.
   De Flaviis, C.
   D'Ardes, D.
   Pierdomenico, A.
   Cipollone, F.
   Bucci, M.
TI PERFORMANCE OF DUTCH LIPID CLINIC NETWORK SCORE IN ITALIAN PATIENTS: THE
   EXPERIENCE OF THE CENTER FOR DYSLIPIDAEMIAS OF CHIETI (LIPIGEN STUDY*)
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Caradio, F.; Di Monte, D.; De Flaviis, C.; D'Ardes, D.; Cipollone, F.; Bucci, M.] SS Annunziata Hosp, Ctr Diag & Therapy Dyslipidemia, Chieti, Italy.
   [Pierdomenico, A.] Univ G dAnnunzio, Clin Res Ctr CeSI MeT, Chieti, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0871
BP E217
EP E217
DI 10.1016/j.atherosclerosis.2019.06.662
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800660
DA 2019-10-28
ER

PT J
AU Maurici, JC
   Cuello, E
   Pardina, E
   Betriu, A
   Baena-Fustegueras, JA
   Peinado-Onsurbe, J
AF Carmona Maurici, J.
   Cuello, E.
   Pardina, E.
   Betriu, A.
   Baena-Fustegueras, J. A.
   Peinado-Onsurbe, J.
TI ATHEROSCLEROTIC PLAQUE IN MORBIDLY OBESE PATIENTS DETERMINES THE
   IMPROVEMENT IN ENDOTHELIAL AND VASCULAR PROFILE AND THE REMISSION OF
   COMORBIDITIES ONE YEAR AFTER BARIATRIC SURGERY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Carmona Maurici, J.; Pardina, E.; Peinado-Onsurbe, J.] Barcelona Univ, Biol Fac, Dept Biochem & Mol Biomed, Barcelona, Spain.
   [Cuello, E.; Baena-Fustegueras, J. A.] UdL, Arnau de Vilanova Univ Hosp, Endocrinol Surg Unit, Lleida, Spain.
   [Betriu, A.] Univ Lleida, Arnau de Vilanova Univ Hosp, Unit Detect & Treatment Atherothrombot Dis, UDETMAV&R Vasc & Renal Translat Res Grp,IRBLleida, Lleida, Spain.
RI Pardina, Eva/AAA-8222-2019
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0211
BP E139
EP E140
DI 10.1016/j.atherosclerosis.2019.06.414
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800412
DA 2019-10-28
ER

PT J
AU Casula, M
   Olmastroni, E
   Taddeo, MB
   Tragni, E
   Pirillo, A
   Luigi, AC
AF Casula, M.
   Olmastroni, E.
   Taddeo, M. Boccalari
   Tragni, E.
   Pirillo, A.
   Luigi, A. Catapano
TI SAFETY AND CARDIOVASCULAR EFFICACY OF ANTI-PCSK9 MONOCLONAL ANTIBODIES:
   A META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Casula, M.] Univ Milan, Dept Pharmacol & Biomol Sci DiSFeB, Milan, Italy.
   [Olmastroni, E.; Taddeo, M. Boccalari; Tragni, E.; Luigi, A. Catapano] Univ Milan, Dept Pharmacol & Biomol Sci DiSFeB, Milan, Italy.
   [Pirillo, A.] E Bassini Hosp, Ctr Study Atherosclerosis, Cinisello Balsamo, MI, Italy.
   [Pirillo, A.; Luigi, A. Catapano] IRCCS MultiMed, Sesto San Giovanni, MI, Italy.
RI Pirillo, Angela/C-4228-2014; Casula, Manuela/AAC-4470-2019
OI Pirillo, Angela/0000-0002-2948-6257; Casula, Manuela/0000-0002-5124-5361
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0692
BP E39
EP E39
DI 10.1016/j.atherosclerosis.2019.06.113
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800112
DA 2019-10-28
ER

PT J
AU Caunite, L
   Trusinskis, K
   Kamzola, G
AF Caunite, L.
   Trusinskis, K.
   Kamzola, G.
TI IMPROVEMENT OF MYOCARDIAL STRAIN AFTER REVASCULARIZATION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Caunite, L.; Trusinskis, K.; Kamzola, G.] Pauls Stradins Clin Univ Hosp, Cardiol, Riga, Latvia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0841
BP E262
EP E263
DI 10.1016/j.atherosclerosis.2019.06.811
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800809
DA 2019-10-28
ER

PT J
AU Ceasovschih, A
   Sorodoc, V
   Aursulesei, V
   Tesloianu, D
   Jaba, IM
   Cozma, CD
   Mihai, B
   Statescu, C
   Lionte, C
   Sirbu, O
   Stoica, A
   Vata, LG
   Coman, A
   Bologa, C
   Haliga, R
   Puha, G
   Dumitrescu, G
   Constantin, M
   Simionov, L
   Sorodoc, L
AF Ceasovschih, A.
   Sorodoc, V.
   Aursulesei, V.
   Tesloianu, D.
   Jaba, I. M.
   Cozma, C. Dima
   Mihai, B.
   Statescu, C.
   Lionte, C.
   Sirbu, O.
   Stoica, A.
   Vata, L. G.
   Coman, A.
   Bologa, C.
   Haliga, R.
   Puha, G.
   Dumitrescu, G.
   Constantin, M.
   Simionov, L.
   Sorodoc, L.
TI STUDY OF CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH PERIPHERAL ARTERY
   DISEASE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Ceasovschih, A.; Sorodoc, V.; Lionte, C.; Sirbu, O.; Stoica, A.; Vata, L. G.; Coman, A.; Bologa, C.; Haliga, R.; Puha, G.; Dumitrescu, G.; Constantin, M.; Sorodoc, L.] Grigore T Popa Univ Med & Pharm, Internal Med, Iasi, Romania.
   [Aursulesei, V.; Cozma, C. Dima; Statescu, C.] Grigore T Popa Univ Med & Pharm, Cardiol, Iasi, Romania.
   [Tesloianu, D.; Simionov, L.] Emergency Clin Hosp Sfantul Spiridon, Cardiol, Iasi, Romania.
   [Jaba, I. M.] Grigore T Popa Univ Med & Pharm, Stat, Iasi, Romania.
   [Mihai, B.] Grigore T Popa Univ Med & Pharm, Diabet, Iasi, Romania.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0834
BP E190
EP E190
DI 10.1016/j.atherosclerosis.2019.06.575
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800573
DA 2019-10-28
ER

PT J
AU Ceasovschih, A
   Sorodoc, V
   Tesloianu, D
   Aursulesei, V
   Jaba, E
   Jaba, IM
   Petris, A
   Cozma, CD
   Mihai, B
   Statescu, C
   Lionte, C
   Petris, OR
   Stoica, A
   Sirbu, O
   Tuchilus, C
   Vata, L
   Bologa, C
   Obreja, M
   Alexa, R
   Sorodoc, L
AF Ceasovschih, A.
   Sorodoc, V.
   Tesloianu, D.
   Aursulesei, V.
   Jaba, E.
   Jaba, I. M.
   Petris, A.
   Cozma, C. Dima
   Mihai, B.
   Statescu, C.
   Lionte, C.
   Petris, O. R.
   Stoica, A.
   Sirbu, O.
   Tuchilus, C.
   Vata, L.
   Bologa, C.
   Obreja, M.
   Alexa, R.
   Sorodoc, L.
TI LIFE QUALITY AND PSYCHOLOGICAL GENDER PARTICULARITIES IN PATIENTS WITH
   PERIPHERAL ARTERY DISEASE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Ceasovschih, A.; Sorodoc, V.; Lionte, C.; Petris, O. R.; Stoica, A.; Sirbu, O.; Vata, L.; Bologa, C.; Obreja, M.; Alexa, R.; Sorodoc, L.] Grigore T Popa Univ Med & Pharm, Internal Med, Iasi, Romania.
   [Tesloianu, D.] Emergency Clin Hosp Sf Spiridon Iasi, Cardiol, Iasi, Romania.
   [Aursulesei, V.; Petris, A.; Cozma, C. Dima; Statescu, C.] Grigore T Popa Univ Med & Pharm, Cardiol, Iasi, Romania.
   [Jaba, E.] Alexandru Ioan Cuza Univ, Stat, Iasi, Romania.
   [Jaba, I. M.] Grigore T Popa Univ Med & Pharm, Stat, Iasi, Romania.
   [Mihai, B.] Grigore T Popa Univ Med & Pharm, Diabet, Iasi, Romania.
   [Tuchilus, C.] Grigore T Popa Univ Med & Pharm, Lab Med, Iasi, Romania.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1092
BP E275
EP E275
DI 10.1016/j.atherosclerosis.2019.06.852
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800850
DA 2019-10-28
ER

PT J
AU Cedo, L
   Fernandez-Castillejo, S
   Rubio, L
   Metso, J
   Santos, D
   Munoz, D
   Rivas-Urbina, A
   Mendez-Lara, KA
   Farras, M
   Jauhiainen, M
   Motilva, MJ
   Fito, M
   Blanco-Vaca, F
   Sola, R
   Escola-Gil, JC
AF Cedo, L.
   Fernandez-Castillejo, S.
   Rubio, L.
   Metso, J.
   Santos, D.
   Munoz, D.
   Rivas-Urbina, A.
   Mendez-Lara, K. A.
   Farras, M.
   Jauhiainen, M.
   Motilva, M. J.
   Fito, M.
   Blanco-Vaca, F.
   Sola, R.
   Escola-Gil, J. C.
TI THE INTAKE OF OLIVE OIL PHENOLIC COMPOUNDS PROMOTES MACROPHAGE-SPECIFIC
   REVERSE CHOLESTEROL TRANSPORT IN VIVO
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Cedo, L.; Santos, D.; Rivas-Urbina, A.; Mendez-Lara, K. A.; Farras, M.; Blanco-Vaca, F.; Escola-Gil, J. C.] Inst Invest Biomed IIB St Pau, Biochem, Barcelona, Spain.
   [Cedo, L.; Santos, D.; Farras, M.; Blanco-Vaca, F.; Escola-Gil, J. C.] CIBER Diabet & Enfermedades Metab Asociadas CIBER, Metab Bases Cardiovasc Risk Grp, Madrid, Spain.
   [Fernandez-Castillejo, S.; Rubio, L.; Sola, R.] Univ Rovira & Virgili, Fac Med & Hlth Sci, Dept Med & Surg, Funct Nutr Oxidat & CVD Res Grp,NFOC Salut, Reus, Spain.
   [Rubio, L.; Motilva, M. J.] Univ Lleida, Agrotecnio Ctr, Dept Food Technol, Lleida, Spain.
   [Metso, J.; Jauhiainen, M.] Minerva Fdn, Helsinki, Finland.
   [Metso, J.; Jauhiainen, M.] Natl Inst Hlth & Welf, Genom & Biomarkers Unit, Helsinki, Finland.
   [Munoz, D.; Fito, M.] IMIM Hosp del Mar Med Res Inst, Grp Risc Cardiovasc & Nutr, Barcelona, Spain.
   [Munoz, D.; Fito, M.] CIBER Physiopathol Obes & Nutr CIBEROBN, Grp Risc Cardiovasc & Nutr, Madrid, Spain.
   [Rivas-Urbina, A.; Mendez-Lara, K. A.; Blanco-Vaca, F.; Escola-Gil, J. C.] Univ Autonoma Barcelona, Bioquim Biol Mol & Biomed, Barcelona, Spain.
   [Motilva, M. J.] Univ La Rioja, Gobierno La Rioja, CSIC, ICVV,Finca La Grajera, Logrono, Spain.
   [Sola, R.] HUSJR, NFOC Salut, Reus, Spain.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0487
BP E223
EP E223
DI 10.1016/j.atherosclerosis.2019.06.682
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800680
DA 2019-10-28
ER

PT J
AU Cejkova, S
   Kubatova, H
   Thieme, F
   Janousek, L
   Fronek, J
   Poledne, R
   Lesna, IK
AF Cejkova, S.
   Kubatova, H.
   Thieme, F.
   Janousek, L.
   Fronek, J.
   Poledne, R.
   Lesna, I. Kralova
TI DOES INFLAMMATION IN PERIVASCULAR ADIPOSE TISSUE AFFECT THE ADJACENT
   ARTERIAL WALL?
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Cejkova, S.; Kubatova, H.; Poledne, R.; Lesna, I. Kralova] Inst Clin & Expt Med, Lab Atherosclerosis Res, Prague, Czech Republic.
   [Thieme, F.; Janousek, L.; Fronek, J.] Inst Clin & Expt Med, Dept Transplant Surg, Prague, Czech Republic.
FU project Ministry of Health CZ for development of research organization
   [00023001]; Czech Science FoundationGrant Agency of the Czech Republic
   [17-28103A]
FX Supported by the project Ministry of Health CZ for development of
   research organization 00023001- institutional support and by the Czech
   Science Foundation, project No. 17-28103A
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0355
BP E244
EP E245
DI 10.1016/j.atherosclerosis.2019.06.752
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800750
DA 2019-10-28
ER

PT J
AU Cenarro, A
   Lamiquiz-Moneo, I
   Bea, AM
   Mateo-Gallego, R
   Laclaustra, M
   Osaba, L
   Martin, C
   Civeira, F
AF Cenarro, A.
   Lamiquiz-Moneo, I.
   Bea, A. M.
   Mateo-Gallego, R.
   Laclaustra, M.
   Osaba, L.
   Martin, C.
   Civeira, F.
TI SENSITIVITY OF THE CLINICAL CRITERIA FOR SUSPECTED FAMILIAL
   HYPERCHOLESTEROLEMIA IN THE DETECTION OF DIAGNOSTIC MUTATIONS OF THE
   DISEASE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Cenarro, A.; Lamiquiz-Moneo, I.; Bea, A. M.; Mateo-Gallego, R.; Laclaustra, M.; Civeira, F.] IIS Aragon, CIBERCV, Lab Invest Mol, Zaragoza, Spain.
   [Osaba, L.] Progenika Biopharma, Progenika, Derio, Spain.
   [Martin, C.] Univ Basque Country, UPV EHU, CSIC, Inst Biofis,Dept Bioquim, Bilbao, Spain.
NR 0
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0783
BP E68
EP E68
DI 10.1016/j.atherosclerosis.2019.06.194
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800193
DA 2019-10-28
ER

PT J
AU Cesaro, A
   Gragnano, F
   Fimiani, F
   Moscarella, E
   Pariggiano, I
   Diana, V
   Carfora, V
   Conte, M
   Falato, S
   Cesarano, M
   Di Maio, D
   Calabro, P
AF Cesaro, A.
   Gragnano, F.
   Fimiani, F.
   Moscarella, E.
   Pariggiano, I.
   Diana, V.
   Carfora, V.
   Conte, M.
   Falato, S.
   Cesarano, M.
   Di Maio, D.
   Calabro, P.
TI QUALITY OF LIFE IMPROVEMENT IN HIGH AND VERY HIGH CARDIOVASCULAR RISK
   PATIENTS TREATED WITH PCSK9 INHIBITORS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Cesaro, A.; Gragnano, F.; Fimiani, F.; Moscarella, E.; Pariggiano, I.; Diana, V.; Carfora, V.; Conte, M.; Falato, S.; Cesarano, M.; Di Maio, D.; Calabro, P.] Univ Campania L Vanvitelli, Dept Med Translat Sci, Naples, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1062
BP E199
EP E199
DI 10.1016/j.atherosclerosis.2019.06.605
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800603
DA 2019-10-28
ER

PT J
AU Charach, L
   Charach, G
AF Charach, L.
   Charach, G.
TI STRONG CORRELATION OF STROKE AND MORTALITY WITH LOW BILE ACID OUTPUT
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Charach, L.] Tel Aviv Univ, Internal Med B, Rabin Med Ctr, Petah Tiqwa, Israel.
   [Charach, G.] Tel Aviv Univ, Internal Med B, Meir Med Ctr Kfar Saba, Kefar Sava, Israel.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1102
BP E275
EP E276
DI 10.1016/j.atherosclerosis.2019.06.853
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800851
DA 2019-10-28
ER

PT J
AU Chen, HJ
   Hoeksema, M
   Kuznetsova, T
   van der Velden, S
   de Winther, M
AF Chen, H. J.
   Hoeksema, M.
   Kuznetsova, T.
   van der Velden, S.
   de Winther, M.
TI LYSINE DEMETHYLASE 3A (KDM3A) DEFICIENCY AFFECTS MACROPHAGE INFLAMMATORY
   RESPONSES AND REDUCES ATHEROGENESIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Chen, H. J.; Kuznetsova, T.; van der Velden, S.; de Winther, M.] AMC, Amsterdam UMC, Med Biochem, Amsterdam, Netherlands.
   [Hoeksema, M.] Univ Calif San Diego, Cellular & Mol Med, San Diego, CA 92103 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1032
BP E46
EP E47
DI 10.1016/j.atherosclerosis.2019.06.134
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800133
DA 2019-10-28
ER

PT J
AU Chen, Y
   Waqar, AB
   Shiomi, M
   Ning, B
   Fan, J
AF Chen, Y.
   Waqar, A. B.
   Shiomi, M.
   Ning, B.
   Fan, J.
TI HYPERTENSION DESTABILIZES ATHEROSCLEROTIC LESIONS AND INDUCES CARDIAC
   DEATH IN WHHL RABBITS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Chen, Y.] Univ Yamanashi, Dept Mol Pathol, Kofu, Yamanashi, Japan.
   [Waqar, A. B.; Fan, J.] Univ Yamanashi, Fac Med, Grad Sch Med Sci, Dept Mol Pathol, Kofu, Yamanashi, Japan.
   [Shiomi, M.] Kobe Univ, Sch Med, Ctr Expt Anim, Kobe, Hyogo, Japan.
   [Ning, B.] Xian Med Univ, Dept Pathol, Xian, Shaanxi, Peoples R China.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0687
BP E270
EP E270
DI 10.1016/j.atherosclerosis.2019.06.836
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800834
DA 2019-10-28
ER

PT J
AU Chiesa, G
   Busnelli, M
   Capparini, L
   Manzini, S
AF Chiesa, G.
   Busnelli, M.
   Capparini, L.
   Manzini, S.
TI RUPATADINE DOES NOT AFFECT ATHEROSCLEROSIS DEVELOPMENT IN APOE-KO MICE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Chiesa, G.; Busnelli, M.; Capparini, L.; Manzini, S.] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1029
BP E250
EP E251
DI 10.1016/j.atherosclerosis.2019.06.771
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800769
DA 2019-10-28
ER

PT J
AU Choi, J
   Baek, S
   Jang, E
   Park, S
   Kim, C
AF Choi, J.
   Baek, S.
   Jang, E.
   Park, S.
   Kim, C.
TI HMGB1 INCREASES 5-LO-DERIVED LTB4 PRODUCTION LEADING TO AN INCREASED
   MCP-1 EXPRESSION IN VASCULAR SMOOTH MUSCLE CELLS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Choi, J.; Baek, S.; Jang, E.; Park, S.; Kim, C.] Pusan Natl Univ, Dept Pharmacol, PNU BK21 Plus Biomed Sci Educ Ctr,Sch Med, Gene & Cell Therapy Res Ctr Vessel Associated Dis, Yangsan, South Korea.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0921
BP E259
EP E259
DI 10.1016/j.atherosclerosis.2019.06.800
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800798
DA 2019-10-28
ER

PT J
AU Chora, JR
   Iacocca, MA
   Carrie, A
   Leigh, SE
   Tichy, L
   Kurtz, CL
   Freiberger, T
   Sijbrands, EJ
   Hegele, RA
   Knowles, JW
   Bourbon, M
AF Chora, J. R.
   Iacocca, M. A.
   Carrie, A.
   Leigh, S. E.
   Tichy, L.
   Kurtz, C. L.
   Freiberger, T.
   Sijbrands, E. J.
   Hegele, R. A.
   Knowles, J. W.
   Bourbon, M.
TI SPECIFICATION OF ACMG/AMP GUIDELINES FOR VARIANT INTERPRETATION IN
   FAMILIAL HYPERCHOLESTEROLEMIA
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Chora, J. R.; Bourbon, M.] Inst Nacl Saude Doutor Ricardo Jorge, Dept Promocao Saude & Prevencao Doencas Nao Trans, Lisbon, Portugal.
   [Chora, J. R.; Bourbon, M.] Univ Lisbon, Biosyst & Integrat Sci Inst, Fac Ciencias, Lisbon, Portugal.
   [Iacocca, M. A.; Hegele, R. A.] Western Univ, Robarts Res Inst, London, ON, Canada.
   [Carrie, A.] Hop Univ Pitie Salpetriere Charles Foix, Mol & Chromosomal Genet Ctr, Obes & Dyslipidemia Genet Unit, Paris, France.
   [Carrie, A.] Sorbonne Univ, Hop Pitie, Inst Cardiometab & Nutr, INSERM, Paris, France.
   [Leigh, S. E.] Queen Mary Univ London, Genom England, London, England.
   [Tichy, L.] Univ Hosp Brno, Ctr Mol Biol & Gene Therapy, Brno, Czech Republic.
   [Kurtz, C. L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA.
   [Freiberger, T.] Ctr Cardiovasc Surg & Transplantat, Mol Genet Lab, Brno, Czech Republic.
   [Freiberger, T.] Masaryk Univ, Ceitec, Brno, Czech Republic.
   [Freiberger, T.] Med Fac, Brno, Czech Republic.
   [Sijbrands, E. J.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands.
   [Knowles, J. W.] Stanford Univ, Ctr Inherited Cardiovasc Dis, Palo Alto, CA 94304 USA.
   [Knowles, J. W.] FH Fdn, Pasadena, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0811
BP E68
EP E68
DI 10.1016/j.atherosclerosis.2019.06.195
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800194
DA 2019-10-28
ER

PT J
AU Christoffersen, M
   Nordestgaard, BG
   Tybjaerg-Hansen, A
AF Christoffersen, M.
   Nordestgaard, B. G.
   Tybjaerg-Hansen, A.
TI PLASMA TRANSTHYRETIN AND RISK OF ALL-CAUSE AND CARDIOVASCULAR MORTALITY
   IN THE GENERAL POPULATION: TWO PROSPECTIVE COHORT STUDIES
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Christoffersen, M.; Tybjaerg-Hansen, A.] Rigshosp, Dept Clin Biochem, Copenhagen, Denmark.
   [Nordestgaard, B. G.] Herlev Hosp, Dept Clin Biochem, Herlev, Denmark.
   [Nordestgaard, B. G.; Tybjaerg-Hansen, A.] Herlev Hosp, Copenhagen Gen Populat Study, Herlev, Denmark.
   [Nordestgaard, B. G.; Tybjaerg-Hansen, A.] Frederiksberg Univ Hosp, Copenhagen City Heart Study, Frederiksberg, Denmark.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0696
BP E9
EP E9
DI 10.1016/j.atherosclerosis.2019.06.024
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800024
DA 2019-10-28
ER

PT J
AU Chua, SXS
   Seneviratna, A
   Goh, LL
   Toh, LXG
   Liew, H
   Seow, CJ
   Lian, X
   Chew, EKD
   Boehm, BO
   Dalan, R
AF Chua, S. X. S.
   Seneviratna, A.
   Goh, L. L.
   Toh, L. X. G.
   Liew, H.
   Seow, C. J.
   Lian, X.
   Chew, E. K. D.
   Boehm, B. O.
   Dalan, R.
TI THE CHOLESTEROL EFFLUX CAPACITY (CEC) CORRELATES WITH OXIDATIVE STRESS
   IN TYPE 2 DIABETES MELLITUS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Chua, S. X. S.; Seneviratna, A.; Goh, L. L.; Toh, L. X. G.] Tan Tock Seng Hosp, Clin Res & Innovat Off, Singapore, Singapore.
   [Liew, H.; Seow, C. J.; Chew, E. K. D.; Boehm, B. O.; Dalan, R.] Tan Tock Seng Hosp, Endocrinol, Singapore, Singapore.
   [Lian, X.] Tan Tock Seng Hosp, Nursing, Singapore, Singapore.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0350
BP E222
EP E223
DI 10.1016/j.atherosclerosis.2019.06.680
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800678
DA 2019-10-28
ER

PT J
AU Chulaievska, N
   Mitchenko, O
   Romanov, V
   Yakuschko, L
AF Chulaievska, N.
   Mitchenko, O.
   Romanov, V.
   Yakuschko, L.
TI ANALYSIS OF UKRAINIAN REGISTRY OF PATIENTS WITH FAMILIAL
   HYPERCHOLESTEROLEMIA
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Chulaievska, N.; Mitchenko, O.; Romanov, V.; Yakuschko, L.] Natl Acad Med Sci Ukraine, State Inst Natl Sci Ctr, MD Strazhesko Inst Cardiol, Dept Dyslipidemia, Kiev, Ukraine.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0223
BP E207
EP E208
DI 10.1016/j.atherosclerosis.2019.06.631
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800629
DA 2019-10-28
ER

PT J
AU Cicero, A
   Sahebkar, A
   Fogacci, F
   Bove, M
   Giovannini, M
   Borghi, C
AF Cicero, A.
   Sahebkar, A.
   Fogacci, F.
   Bove, M.
   Giovannini, M.
   Borghi, C.
TI EFFECTS PHYTOSOMAL CURCUMIN ON ANTHROPOMETRIC PARAMETERS,
   INSULIN-RESISTANCE, CORTISOLEMIA AND NON-ALCOHOLIC FATTY LIVER DISEASE
   INDEXES: A DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Cicero, A.; Fogacci, F.; Bove, M.; Giovannini, M.; Borghi, C.] Alma Mater Studiorum Univ Bologna, Med & Surg Sci Dept, Bologna, Italy.
   [Sahebkar, A.] Mashhad Univ Med Sci, Biotechnol Res Ctr, Pharmaceut Technol Inst, Mashhad, Razavi Khorasan, Iran.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0919
BP E149
EP E149
DI 10.1016/j.atherosclerosis.2019.06.443
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800441
DA 2019-10-28
ER

PT J
AU Cicero, A
   Fogacci, F
   Bove, M
   Giovannini, M
   Borghi, C
AF Cicero, A.
   Fogacci, F.
   Bove, M.
   Giovannini, M.
   Borghi, C.
TI THREE-ARM, PLACEBO CONTROLLED, RANDOMIZED CLINICAL TRIAL EVALUATING THE
   METABOLIC EFFECT OF A BERGAMOT STANDARDIZED FLAVONOID EXTRACT IN
   DYSLIPIDEMIC OVERWEIGHT SUBJECTS.
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Cicero, A.; Fogacci, F.; Bove, M.; Giovannini, M.; Borghi, C.] Alma Mater Studiorum Univ Bologna, Med & Surg Sci Dept, Bologna, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0900
BP E32
EP E33
DI 10.1016/j.atherosclerosis.2019.06.096
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800095
DA 2019-10-28
ER

PT J
AU Cala, CMC
   Quintela, JC
   Minano, J
   Perez-Montero, M
   Casals, N
   de Sotomayor, MA
   Herrera, MD
   Rodriguez-Rodriguez, R
AF Claro Cala, C. M.
   Quintela, J. C.
   Minano, J.
   Perez-Montero, M.
   Casals, N.
   Alvarez de Sotomayor, M.
   Herrera, M. D.
   Rodriguez-Rodriguez, R.
TI POMACE OLIVE OIL ENRICHED IN OLEANOLIC ACID IMPROVES DIET-INDUCED
   OBESITY AND EXERTS PROTECTIVE EFFECTS IN VASCULAR DYSFUNCTION AND
   METABOLIC PARAMETERS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Claro Cala, C. M.; Minano, J.] Univ Seville, Dept Pharmacol Pediat & Radiol, Seville, Spain.
   [Quintela, J. C.] Natac Biotech SL, Madrid, Spain.
   [Perez-Montero, M.; Casals, N.; Rodriguez-Rodriguez, R.] Univ Int Catalunya, Dept Basic Sci, Fac Med & Hlth Sci, Barcelona, Spain.
   [Alvarez de Sotomayor, M.; Herrera, M. D.] Univ Seville, Pharmacol, Seville, Spain.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0762
BP E132
EP E132
DI 10.1016/j.atherosclerosis.2019.06.388
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800386
DA 2019-10-28
ER

PT J
AU Coassin, S
   Schonherr, S
   Weissensteiner, H
   Erhart, G
   Di Maio, S
   Forer, L
   Lamina, C
   Peters, A
   Thorand, B
   Eckardt, KU
   Kottgen, A
   Utermann, G
   Specht, G
   Kronenberg, F
AF Coassin, S.
   Schoenherr, S.
   Weissensteiner, H.
   Erhart, G.
   Di Maio, S.
   Forer, L.
   Lamina, C.
   Peters, A.
   Thorand, B.
   Eckardt, K. U.
   Koettgen, A.
   Utermann, G.
   Specht, G.
   Kronenberg, F.
TI A COMPREHENSIVE MAP OF THE VARIABILITY IN THE LIPOPROTEIN(A) KIV 2
   REPEAT REGION AND FOLLOW-UP OF THE KIV-2 ARG20TER MUTATION IN 11,000
   INDIVIDUALS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Coassin, S.; Schoenherr, S.; Weissensteiner, H.; Erhart, G.; Di Maio, S.; Forer, L.; Lamina, C.; Kronenberg, F.] Med Univ Innsbruck, Div Genet Epidemiol, Innsbruck, Austria.
   [Peters, A.; Thorand, B.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Munich, Germany.
   [Eckardt, K. U.] Charite Univ Med Berlin, Dept Nephrol & Med Intens Care, Berlin, Germany.
   [Koettgen, A.] Univ Freiburg, Fac Med, Inst Genet Epidemiol, Freiburg, Germany.
   [Koettgen, A.] Univ Freiburg, Med Ctr, Freiburg, Germany.
   [Utermann, G.] Med Univ Innsbruck, Div Human Genet, Innsbruck, Austria.
   [Specht, G.] Univ Innsbruck, Inst Comp Sci, Innsbruck, Austria.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0446
BP E58
EP E58
DI 10.1016/j.atherosclerosis.2019.06.164
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800163
DA 2019-10-28
ER

PT J
AU Coban, N
   Gulec, C
   Ozuynuk, AS
   Erginel-Unaltuna, N
   Erkan, AF
AF Coban, N.
   Gulec, C.
   Ozuynuk, A. S.
   Erginel-Unaltuna, N.
   Erkan, A. F.
TI CORONARY ARTERY DISEASE RELATED MIR-19A AND MIR-26A ARE SENSITIVE TO
   SIMVASTATIN AND ROR-ALPHA LIGANDS IN MACROPHAGE CELLS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Coban, N.; Gulec, C.; Ozuynuk, A. S.; Erginel-Unaltuna, N.] Istanbul Univ, Aziz Sancar Inst Expt Med, Dept Genet, Istanbul, Turkey.
   [Erkan, A. F.] Ufuk Univ, Dept Cardiol, Fac Med, Ankara, Turkey.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0671
BP E239
EP E240
DI 10.1016/j.atherosclerosis.2019.06.735
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800733
DA 2019-10-28
ER

PT J
AU Coban, N
   Ozuynuk, AS
   Erginel-Unaltuna, N
AF Coban, N.
   Ozuynuk, A. S.
   Erginel-Unaltuna, N.
TI AMPK ACTIVATION DECREASES EXPRESSION OF MIR-130B IN ENDOTHELIAL CELLS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Coban, N.; Ozuynuk, A. S.; Erginel-Unaltuna, N.] Istanbul Univ, Aziz Sancar Inst Expt Med, Genet, Istanbul, Turkey.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0679
BP E266
EP E266
DI 10.1016/j.atherosclerosis.2019.06.822
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800820
DA 2019-10-28
ER

PT J
AU Cobbaert, C
   Ruhaak, R
   van der Laarse, A
AF Cobbaert, C.
   Ruhaak, R.
   van der Laarse, A.
TI APOLIPOPROTEIN PROFILING AS A PERSONALIZED APPROACH TO THE DIAGNOSIS AND
   TREATMENT OF DYSLIPIDEMIA
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Cobbaert, C.; Ruhaak, R.; van der Laarse, A.] Leiden Univ, Med Ctr, Clin Chem & Lab Med, Leiden, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0669
BP E165
EP E165
DI 10.1016/j.atherosclerosis.2019.06.499
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800497
DA 2019-10-28
ER

PT J
AU Cohen, H
   Harats, D
   Shaish, A
   Roitelman, J
AF Cohen, H.
   Harats, D.
   Shaish, A.
   Roitelman, J.
TI WHY SHOULD WE MEASURE LOW DENSITY LIPOPROTEIN CHOLESTEROL DIRECTLY?
   COMPARISON BETWEEN PLASMA LDL-CHOLESTEROL ASSESSMENT BY FRIEDEWALD
   EQUATION AND DIRECT MEASUREMENT
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Cohen, H.; Harats, D.; Roitelman, J.] Tel Aviv Univ Israel, Sackler Fac Med, Chaim Sheba Med Ctr, Bert W Strassburger Lipid Ctr, Tel Hashomer, Israel.
   [Shaish, A.] Beer Tuvia Reg Council Arugot, Achva Acad Coll, Chaim Sheba Med Ctr, Bert W Strassburger Lipid Ctr, Ramat Gan, Israel.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0091
BP E108
EP E108
DI 10.1016/j.atherosclerosis.2019.06.315
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800314
DA 2019-10-28
ER

PT J
AU Cohen, H
   Sheinin, R
   Amital, H
   Bitzur, R
AF Cohen, H.
   Sheinin, R.
   Amital, H.
   Bitzur, R.
TI THE LINK BETWEEN STATIN ASSOCIATED MUSCLE PAIN AND CHRONIC PAIN
   SYNDROMES: A CROSS-SECTION STUDY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Cohen, H.; Bitzur, R.] Tel Aviv Univ Israel, Sackler Fac Med, Chaim Sheba Med Ctr, Bert W Strassburger Lipid Ctr, Ramat Gan, Israel.
   [Sheinin, R.; Amital, H.] Tel Aviv Univ Israel, Sackler Fac Med, Sheba Med Ctr, Dept Internal Med B,Ctr Autoimmune Dis, Tel Hashomer, Israel.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0137
BP E273
EP E273
DI 10.1016/j.atherosclerosis.2019.06.845
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800843
DA 2019-10-28
ER

PT J
AU Colonna, R
   Miselli, MA
   Sanz, JM
   Nora, ED
   Zuliani, G
   Passaro, A
AF Colonna, R.
   Miselli, M. A.
   Sanz, J. M.
   Nora, E. Dalla
   Zuliani, G.
   Passaro, A.
TI IL-18 AS A POSSIBLE LINK BETWEEN PHYSICAL INACTIVITY AND INSULIN
   RESISTANCE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Colonna, R.; Miselli, M. A.; Sanz, J. M.; Nora, E. Dalla; Zuliani, G.; Passaro, A.] Univ Ferrara, Sect Internal & Cardioresp Med, Dept Med Sci, Ferrara, Italy.
RI Nora, Edoardo Dalla/AAA-8938-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0755
BP E131
EP E132
DI 10.1016/j.atherosclerosis.2019.06.387
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800385
DA 2019-10-28
ER

PT J
AU Perez, MC
   Navas-Madronal, M
   Martinez-Gonzalez, J
   Rodriguez, C
   Galan, M
AF Consegal Perez, M.
   Navas-Madronal, M.
   Martinez-Gonzalez, J.
   Rodriguez, C.
   Galan, M.
TI INHIBITION OF ENDOPLASMIC RETICULUM STRESS AS A POTENTIAL THERAPY TO
   LIMIT THE PROGRESSION OF AAA AND HYPERTENSIVE HEART DISEASE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Consegal Perez, M.; Navas-Madronal, M.; Galan, M.] Hosp Santa Creu & Sant Pau, Inst Recerca, IIB St Pau, Barcelona, Spain.
   [Martinez-Gonzalez, J.; Rodriguez, C.] Hosp Santa Creu & Sant Pau, Inst Recerca, IIB St Pau, Programa ICCC, Barcelona, Spain.
   [Martinez-Gonzalez, J.; Rodriguez, C.; Galan, M.] CIBER Enfermedades Cardiovasc, Madrid, Spain.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0998
BP E19
EP E19
DI 10.1016/j.atherosclerosis.2019.06.054
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800054
DA 2019-10-28
ER

PT J
AU Corral, P
   Banares, V
   Lopez, G
   Berg, G
   Polisecki, E
   Schaefer, EJ
   Geller, AS
   Schreier, L
AF Corral, P.
   Banares, V.
   Lopez, G.
   Berg, G.
   Polisecki, E.
   Schaefer, E. J.
   Geller, A. S.
   Schreier, L.
TI PHENOTYPE OF DEFINITE FAMILIAL HYPERCHOLESTEROLEMIA WITH NEGATIVE
   GENETIC STUDY IN ARGENTINA
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Corral, P.] Univ FASTA, Fac Med, Dept Invest, Mar Del Plata, Buenos Aires, Argentina.
   [Banares, V.] Ctr Nacl Genet Med, ANLIS Dr Carlos Malbran, Dept Genet Expt, Buenos Aires, DF, Argentina.
   [Lopez, G.; Berg, G.; Schreier, L.] Univ Buenos Aires, Lab Lipidos & Aterosclerosis, Dept Bioquim Clin, Buenos Aires, DF, Argentina.
   [Polisecki, E.; Schaefer, E. J.; Geller, A. S.] Boston Heart Diagnost, Dept Genet, Boston, MA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0459
BP E213
EP E213
DI 10.1016/j.atherosclerosis.2019.06.649
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800647
DA 2019-10-28
ER

PT J
AU de Faria, EC
   Teixeira, LS
   Corozolla, W
   Avila, AMH
   Costa, PDP
   Coelho, RP
   Bezerra, LM
AF Cotta de Faria, E.
   Teixeira, L. S.
   Corozolla, W.
   Avila, A. M. H.
   Costa, P. D. P.
   Coelho, R. P.
   Bezerra, L. M.
TI INFLUENCE OF CLIMATIC VARIABLES ON DEATHS AND HOSPITALIZATIONS FOR
   CARDIOVASCULAR DISEASES IN THE CITY OF CAMPINAS, SAO PAULO.
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Cotta de Faria, E.] Univ Estadual Campinas, Dept Clin Pathol, Campinas, SP, Brazil.
   [Teixeira, L. S.; Corozolla, W.; Coelho, R. P.] Univ Estadual Campinas, Fac Med Sci, Clin Pathol, Campinas, SP, Brazil.
   [Avila, A. M. H.] Univ Estadual Campinas, Cepagri, Campinas, SP, Brazil.
   [Costa, P. D. P.] Univ Estadual Campinas, Sch Elect & Comp Engn, Campinas, SP, Brazil.
   [Bezerra, L. M.] Fac Med Sci, Campinas, SP, Brazil.
   [Bezerra, L. M.] Cepagri, Clin Pathol, Campinas, SP, Brazil.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1113
BP E276
EP E276
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800852
DA 2019-10-28
ER

PT J
AU de Faria, EC
   Corozolla, W
   Teixeira, LS
   de Avila, AMH
   Costa, PDP
   Coelho, RP
   Gomes, EIL
   Zago, VHS
AF Cotta de Faria, E.
   Corozolla, W.
   Teixeira, L. S.
   de Avila, A. M. H.
   Costa, P. D. P.
   Coelho, R. P.
   Gomes, E. I. L.
   Zago, V. H. S.
TI SEASONAL RHYTHMS IN SERUM LIPIDS AND LIPOPROTEINS AND THEIR MODULATION
   BY AGE: A LARGE POPULATION STUDY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Cotta de Faria, E.] Univ Estadual Campinas, Dept Clin Pathol, Campinas, SP, Brazil.
   [Corozolla, W.; Teixeira, L. S.; Coelho, R. P.] Univ Estadual Campinas, Fac Med Sci, Clin Pathol, Campinas, SP, Brazil.
   [de Avila, A. M. H.] Univ Estadual Campinas, Cepagri, Campinas, SP, Brazil.
   [Costa, P. D. P.] Univ Estadual Campinas, Sch Elect & Comp Engn, Campinas, SP, Brazil.
   [Gomes, E. I. L.] Fac Med Sci, Clin Pathol, Campinas, SP, Brazil.
   [Zago, V. H. S.] Pontificia Univ Catolica Campinas, Campinas, SP, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1114
BP E276
EP E276
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800853
DA 2019-10-28
ER

PT J
AU Cramb, R
   George, E
   Bellaby, J
   Day, S
   Dhillon, R
   Dyer, K
   Williams, M
   Patel, K
   Whitmore, J
   Fanning, H
   Millward, V
AF Cramb, R.
   George, E.
   Bellaby, J.
   Day, S.
   Dhillon, R.
   Dyer, K.
   Williams, M.
   Patel, K.
   Whitmore, J.
   Fanning, H.
   Millward, V.
TI THE WEST MIDLANDS SCREENING SERVICE FOR FAMILIAL HYPERCHOLESTEROLAEMIA:
   A FIRST YEAR REVIEW
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Cramb, R.; George, E.; Bellaby, J.; Day, S.; Dhillon, R.; Dyer, K.] West Midlands Clin Network NHS England, West Midlands FH Serv, 2nd Floor St Chads Court,213 Hagley Rd, Birmingham B16 9RG, W Midlands, England.
   [Williams, M.] Pathol Sci Southmead Hosp, Bristol Genet Lab, Bristol, Avon, England.
   [Patel, K.; Millward, V.] West Midlands Clin Network NHS England, St Chads Court,213 Hagley Rd, Birmingham B16 9RG, W Midlands, England.
   [Whitmore, J.] British Heart Fdn, Greater London House,180 Hampstead Rd, London, England.
   [Fanning, H.] Univ Hosp Birmingham NHS Trust, Res & Dev, Birmingham B15 2SW, W Midlands, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0988
BP E218
EP E218
DI 10.1016/j.atherosclerosis.2019.06.665
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800663
DA 2019-10-28
ER

PT J
AU Croll, P
   Bos, D
   Vernooij, M
   Arshi, B
   Lin, FR
   de Jong, RJB
   Ikram, MA
   Goedegebure, A
   Kavousi, M
AF Croll, P.
   Bos, D.
   Vernooij, M.
   Arshi, B.
   Lin, F. R.
   de Jong, R. J. Baatenburg
   Ikram, M. A.
   Goedegebure, A.
   Kavousi, M.
TI CAROTID ATHEROSCLEROSIS IS ASSOCIATED WITH AGE-RELATED HEARING LOSS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Croll, P.] Erasmus Univ, Med Ctr, Otorhinolaryngol Radiol & Nucl Med & Epidemiol, Rotterdam, Netherlands.
   [Bos, D.] Erasmus Univ, Med Ctr, Radiol & Nucl Med & Epidemiol, Rotterdam, Netherlands.
   [Vernooij, M.] Erasmus Univ, Med Ctr, Radiol & Nucl Med, Rotterdam, Netherlands.
   [Arshi, B.; Ikram, M. A.; Kavousi, M.] Erasmus Univ, Med Ctr, Epidemiol, Rotterdam, Netherlands.
   [Lin, F. R.] Johns Hopkins Sch Med, Baltimore, MD USA.
   [Lin, F. R.] Bloomberg Sch Publ Hlth, Otolaryngol Head & Neck Surg & Epidemiol, Baltimore, MD USA.
   [de Jong, R. J. Baatenburg; Goedegebure, A.] Erasmus Univ, Med Ctr, Otorhinolaryngol & Head & Neck Surg, Rotterdam, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0303
BP E114
EP E114
DI 10.1016/j.atherosclerosis.2019.06.331
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800330
DA 2019-10-28
ER

PT J
AU Crombag, G
   Liem, IM
   Koornstra, E
   Schreuder, HBMF
   van Dam-Nolen, HKD
   Lucci, C
   van der Geest, JR
   Daemen, JAPM
   van der Steen, FA
   Hendrikse, J
   Mess, HW
   van der Lugt, A
   Wildberger, EJ
   van Oostenbrugge, JR
   Nederkoorn, JP
   Kooi, ME
AF Crombag, G.
   Liem, M., I
   Koornstra, E.
   Schreuder, F. H. B. M.
   van Dam-Nolen, D. H. K.
   Lucci, C.
   van der Geest, R. J.
   Daemen, M. J. A. P.
   van der Steen, A. F.
   Hendrikse, J.
   Mess, W. H.
   van der Lugt, A.
   Wildberger, J. E.
   van Oostenbrugge, R. J.
   Nederkoorn, P. J.
   Kooi, M. E.
TI START OF ANTIPLATELET THERAPY INCREASES THE PREVALENCE OF INTRAPLAQUE
   HEMORRHAGE IN PATIENTS WITH ADVANCED CAROTID ARTERY LESIONS: A
   LONGITUDINAL MR IMAGING STUDY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Crombag, G.] Cardiovasc Res Inst Maastricht, Radiol & Nucl Med, Maastricht, Netherlands.
   [Liem, M., I; Nederkoorn, P. J.] Univ Amsterdam, Med Ctr, Neurol, Amsterdam, Netherlands.
   [Koornstra, E.; Wildberger, J. E.; Kooi, M. E.] Maastricht Univ, Med Ctr, Radiol & Nucl Med, Maastricht, Netherlands.
   [Schreuder, F. H. B. M.] Radboud Univ Nijmegen, Med Ctr, Neurol, Nijmegen, Netherlands.
   [van Dam-Nolen, D. H. K.; van der Lugt, A.] Erasmus MC, Radiol & Nucl Med, Rotterdam, Netherlands.
   [Lucci, C.; Hendrikse, J.] Univ Med Ctr Utrecht, Radiol, Utrecht, Netherlands.
   [van der Geest, R. J.] Leiden Univ, Med Ctr, Radiol, Leiden, Netherlands.
   [Daemen, M. J. A. P.] Univ Amsterdam, Med Ctr, Pathol, Amsterdam, Netherlands.
   [van der Steen, A. F.] Erasmus MC, Biomed Engn, Rotterdam, Netherlands.
   [Mess, W. H.] Maastricht Univ, Med Ctr, Clin Neurophysiol, Maastricht, Netherlands.
   [van Oostenbrugge, R. J.] Maastricht Univ, Med Ctr, Neurol, Maastricht, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0612
BP E104
EP E105
DI 10.1016/j.atherosclerosis.2019.06.305
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800304
DA 2019-10-28
ER

PT J
AU Crombag, G
   Schreuder, HBMF
   Benali, F
   van Dam-Nolen, HKD
   Lucci, C
   van der Steen, FA
   Daemen, JAPM
   Mess, HW
   van der Lugt, A
   Nederkoorn, JP
   Hofman, AMP
   van Oostenbrugge, JR
   Wildberger, EJ
   Kooi, ME
AF Crombag, G.
   Schreuder, F. H. B. M.
   Benali, F.
   van Dam-Nolen, D. H. K.
   Lucci, C.
   van der Steen, A. F.
   Daemen, M. J. A. P.
   Mess, W. H.
   van der Lugt, A.
   Nederkoorn, P. J.
   Hofman, P. A. M.
   van Oostenbrugge, R. J.
   Wildberger, J. E.
   Kooi, M. E.
TI UPSTREAM REGION OF CAROTID PLAQUE SHOWS MORE INTRAPLAQUE HEMORRHAGE IN
   STROKE PATIENTS: THE PLAQUE AT RISK (PARISK) STUDY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Crombag, G.] Cardiovasc Res Inst Maastricht, Radiol & Nucl Med, Maastricht, Netherlands.
   [Schreuder, F. H. B. M.] Radboud Univ Nijmegen, Med Ctr, Neurol, Nijmegen, Netherlands.
   [Benali, F.; Hofman, P. A. M.; Wildberger, J. E.; Kooi, M. E.] Maastricht Univ, Med Ctr, Radiol & Nucl Med, Maastricht, Netherlands.
   [van Dam-Nolen, D. H. K.; van der Lugt, A.] Erasmus MC, Radiol & Nucl Med, Rotterdam, Netherlands.
   [Lucci, C.] Univ Med Ctr Utrecht, Radiol, Utrecht, Netherlands.
   [van der Steen, A. F.] Erasmus MC, Biomed Engn, Rotterdam, Netherlands.
   [Daemen, M. J. A. P.] Univ Amsterdam, Med Ctr, Pathol, Amsterdam, Netherlands.
   [Mess, W. H.] Maastricht Univ, Med Ctr, Clin Neurophysiol, Maastricht, Netherlands.
   [Nederkoorn, P. J.] Univ Amsterdam, Med Ctr, Neurol, Amsterdam, Netherlands.
   [van Oostenbrugge, R. J.] Maastricht Univ, Med Ctr, Neurol, Maastricht, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0362
BP E50
EP E51
DI 10.1016/j.atherosclerosis.2019.06.144
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800143
DA 2019-10-28
ER

PT J
AU Curley, S
   Dillon, E
   Byrne, R
   McGillicuddy, F
AF Curley, S.
   Dillon, E.
   Byrne, R.
   McGillicuddy, F.
TI THE HDL PROTEOME - CHALLENGES TO ANALYSING HDL-ASSOCIATED PROTEINS AND
   DISENTANGLING ASSOCIATED PROTEINS FROM CONTAMINATING PROTEINS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Curley, S.; Byrne, R.; McGillicuddy, F.] Univ Coll Dublin, Sch Med, Dublin, Ireland.
   [Dillon, E.] Univ Coll Dublin, Mass Spectrometry Core, UCD Conway Inst, Dublin, Ireland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0392
BP E226
EP E226
DI 10.1016/j.atherosclerosis.2019.06.692
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800690
DA 2019-10-28
ER

PT J
AU D'erasmo, L
   Di Costanzo, A
   Minicocci, I
   Polito, L
   Maranghi, M
   Montali, A
   Ceci, F
   Stitziel, N
   Arca, M
AF D'erasmo, L.
   Di Costanzo, A.
   Minicocci, I.
   Polito, L.
   Maranghi, M.
   Montali, A.
   Ceci, F.
   Stitziel, N.
   Arca, M.
TI EVALUATION OF INDICES OF GLUCOSE AND INSULIN METABOLISM IN A COORT
   PATIENTS WITH ANGPTL3 DEFICIENCY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [D'erasmo, L.; Di Costanzo, A.; Minicocci, I.; Polito, L.; Montali, A.; Arca, M.] Sapienza, Dept Internal Med & Clin Specialties, Rome, Italy.
   [Maranghi, M.] Sapienza, Dept Traslat & Precis Med, Rome, Italy.
   [Ceci, F.] Sapienza, Cellular Biotechnol & Hematol, Rome, Italy.
   [Stitziel, N.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0898
BP E44
EP E44
DI 10.1016/j.atherosclerosis.2019.06.125
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800124
DA 2019-10-28
ER

PT J
AU Da Dalt, L
   Perego, C
   Ruscica, M
   Bonacina, F
   Catapano, AL
   Norata, GD
AF Da Dalt, L.
   Perego, C.
   Ruscica, M.
   Bonacina, F.
   Catapano, A. L.
   Norata, G. D.
TI ROLE OF PCSK9 ON PANCREATIC FUNCTION AND INSULIN RELEASE; EVIDENCE FROM
   MICE MODELS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Da Dalt, L.; Perego, C.; Ruscica, M.; Bonacina, F.; Catapano, A. L.; Norata, G. D.] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy.
RI Norata, Giuseppe Danilo/AAC-2863-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1021
BP E44
EP E45
DI 10.1016/j.atherosclerosis.2019.06.127
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800126
DA 2019-10-28
ER

PT J
AU Dalan, R
   Goh, LL
   Seneviratna, A
   Liew, H
   Seow, CJ
   Lian, X
   Chew, EKD
   Leow, KSM
   Boehm, B
AF Dalan, R.
   Goh, L. L.
   Seneviratna, A.
   Liew, H.
   Seow, C. J.
   Lian, X.
   Chew, D. E. K.
   Leow, M. K. S.
   Boehm, B.
TI IMPACT OF VITAMIN E SUPPLEMENTATION ON VASCULAR FUNCTION IN PATIENTS
   WITH TYPE 2 DIABETES MELLITUS STRATIFIED BY HAPTOGLOBIN GENOTYPE (EVAS
   TRIAL): A RANDOMIZED CONTROLLED TRIAL
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Dalan, R.; Liew, H.; Seow, C. J.; Lian, X.; Chew, D. E. K.; Leow, M. K. S.; Boehm, B.] Tan Tock Seng Hosp, Endocrinol, Singapore, Singapore.
   [Goh, L. L.] Tan Tock Seng Hosp, Clin Res, Singapore, Singapore.
   [Seneviratna, A.] Tan Tock Seng Hosp, Clin Res Unit, Singapore, Singapore.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0138
BP E147
EP E147
DI 10.1016/j.atherosclerosis.2019.06.437
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800435
DA 2019-10-28
ER

PT J
AU Dalan, R
   Chee, YJ
   Seneviratna, A
   Chew, EKD
AF Dalan, R.
   Chee, Y. J.
   Seneviratna, A.
   Chew, D. E. K.
TI RED CELL DISTRIBUTION WIDTH IS PREDICTIVE OF MORTALITY AND MAJOR ADVERSE
   CARDIAC AND CEREBROVASCULAR EVENTS IN DIABETES
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Dalan, R.; Chee, Y. J.; Seneviratna, A.; Chew, D. E. K.] Tan Tock Seng Hosp, Endocrinol, Singapore, Singapore.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0343
BP E126
EP E126
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800367
DA 2019-10-28
ER

PT J
AU Dalan, R
   Chua, SXS
   Seneviratna, A
   Chew, EKD
AF Dalan, R.
   Chua, S. S. X.
   Seneviratna, A.
   Chew, D. E. K.
TI CAROTID ARTERY INTIMA-MEDIA THICKNESS IS ASSOCIATED WITH CARDIOMETABOLIC
   RISK FACTORS IN DIABETES
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Dalan, R.; Chua, S. S. X.; Seneviratna, A.; Chew, D. E. K.] Tan Tock Seng Hosp, Endocrinol, Singapore, Singapore.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0344
BP E126
EP E126
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800368
DA 2019-10-28
ER

PT J
AU Dalila, N
   Frikke-Schmidt, R
   Nordestgaard, BG
   Tybjaerg-Hansen, A
AF Dalila, N.
   Frikke-Schmidt, R.
   Nordestgaard, B. G.
   Tybjaerg-Hansen, A.
TI PLASMA TSH CONCENTRATION AND RISK OF CARDIOVASCULAR DISEASE IN THE
   GENERAL POPULATION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Dalila, N.; Frikke-Schmidt, R.; Tybjaerg-Hansen, A.] Copenhagen Univ Hosp, Rigshosp, Clin Biochem KB3011, Copenhagen, Denmark.
   [Nordestgaard, B. G.] Univ Copenhagen, Herlev Hosp, Clin Biochem, Herlev, Denmark.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0979
BP E35
EP E35
DI 10.1016/j.atherosclerosis.2019.06.103
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800102
DA 2019-10-28
ER

PT J
AU Dallinga, GM
   van Capelleveen, J
   Dalila, N
   Bruikman, C
   Peter, J
   Havik, S
   Hovingh, K
   Tybjaerg-Hansen, A
AF Dallinga, G. M.
   van Capelleveen, J.
   Dalila, N.
   Bruikman, C.
   Peter, J.
   Havik, S.
   Hovingh, K.
   Tybjaerg-Hansen, A.
TI A COMMON AND A RARE TRUNCATING VARIANT IN SUSD2 AND RISK OF ISCHEMIC
   HEART DISEASE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Dallinga, G. M.; van Capelleveen, J.; Bruikman, C.; Hovingh, K.] Amsterdam UMC, Vasc Med, Amsterdam, Netherlands.
   [Dalila, N.; Tybjaerg-Hansen, A.] Copenhagen Univ Hosp, Clin Biochem, Copenhagen, Denmark.
   [Peter, J.; Havik, S.] Amsterdam UMC, Expt Vasc Med, Amsterdam, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0880
BP E71
EP E71
DI 10.1016/j.atherosclerosis.2019.06.203
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800202
DA 2019-10-28
ER

PT J
AU Damasceno, NRT
   Cartolano, FDC
   Dias, GD
   Ventura, AOC
   Mello, APDQ
AF Damasceno, N. R. T.
   Cartolano, F. D. C.
   Dias, G. D.
   Ventura, A. O. C.
   Mello, A. P. D. Q.
TI CAN A NUTRITIONAL FACTOR MODULATE THE HDL FUNCTIONALITY: ROLE OF OMEGA-3
   FATTY ACID
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Damasceno, N. R. T.; Cartolano, F. D. C.; Dias, G. D.; Ventura, A. O. C.; Mello, A. P. D. Q.] Publ Hlth Sch, Nutr, Sao Paulo, Brazil.
   [Mello, A. P. D. Q.] Ctr Univ Sao Camilo, Nutr, Sao Paulo, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0534
BP E226
EP E226
DI 10.1016/j.atherosclerosis.2019.06.693
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800691
DA 2019-10-28
ER

PT J
AU Dawczynski, C
   Rieke, AC
   Kiehntopf, M
   Lorkowski, S
AF Dawczynski, C.
   Rieke, A. C.
   Kiehntopf, M.
   Lorkowski, S.
TI MODULATION OF CARDIOVASCULAR RISK FACTORS BY THE MOKARI DIET
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Dawczynski, C.; Rieke, A. C.] Friedrich Schiller Univ Jena, Competence Cluster Nutr & Cardiovasc Hlth nutriCA, Inst Nutr, Jr Res Grp Nutr Concepts, Jena, Germany.
   [Kiehntopf, M.] Friedrich Schiller Univ, Univ Hosp, Inst Clin Chem & Lab Med Jena, Jena, Germany.
   [Lorkowski, S.] Friedrich Schiller Univ Jena, Competence Cluster Nutr & Cardiovasc Hlth nutriCA, Inst Nutr, Dept Biochem & Physiol, Jena, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1065
BP E176
EP E177
DI 10.1016/j.atherosclerosis.2019.06.535
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800533
DA 2019-10-28
ER

PT J
AU De Boer, JF
   de Vries, HD
   Palmiotti, A
   Li, R
   Mulder, NL
   Hovingh, MV
   Koehorst, M
   Kloosterhuis, NJ
   Bloks, VW
   van de Sluis, B
   Kuipers, F
AF De Boer, J. F.
   de Vries, H. D.
   Palmiotti, A.
   Li, R.
   Mulder, N. L.
   Hovingh, M. V.
   Koehorst, M.
   Kloosterhuis, N. J.
   Bloks, V. W.
   van de Sluis, B.
   Kuipers, F.
TI A HUMAN-LIKE COMPOSITION OF THE CIRCULATING BILE ACID POOL IMPACTS ON
   PLASMA LDL CHOLESTEROL IN MICE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [De Boer, J. F.; de Vries, H. D.] Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands.
   [Palmiotti, A.; Li, R.; Mulder, N. L.; Hovingh, M. V.; Koehorst, M.; Kloosterhuis, N. J.; Bloks, V. W.; van de Sluis, B.; Kuipers, F.] Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands.
NR 0
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1127
BP E14
EP E14
DI 10.1016/j.atherosclerosis.2019.06.038
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800038
DA 2019-10-28
ER

PT J
AU De Boer, L
   Hutten, B
   Wiegman, A
   Kastelein, J
   Hof, M
AF De Boer, L.
   Hutten, B.
   Wiegman, A.
   Kastelein, J.
   Hof, M.
TI LIPOPROTEIN(A) LEVELS OVER TIME: A LONG-TERM FOLLOW-UP STUDY OF A LARGE
   COHORT OF CHILDREN
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [De Boer, L.; Hutten, B.; Hof, M.] Amsterdam UMC AMC, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands.
   [De Boer, L.; Wiegman, A.] Amsterdam UMC AMC, Dept Pediat, Amsterdam, Netherlands.
   [De Boer, L.; Kastelein, J.] Amsterdam UMC AMC, Dept Vasc Med, Amsterdam, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0935
BP E59
EP E59
DI 10.1016/j.atherosclerosis.2019.06.168
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800167
DA 2019-10-28
ER

PT J
AU De Bruijn, J
   van Kuijk, K
   Bijnen, M
   Gijbels, M
   Wouters, K
   Carmeliet, P
   Sluimer, J
AF De Bruijn, J.
   van Kuijk, K.
   Bijnen, M.
   Gijbels, M.
   Wouters, K.
   Carmeliet, P.
   Sluimer, J.
TI PARTIAL INHIBITION OF THE KEY GLYCOLYTIC ENZYME PFKFB3 IN MYELOID CELLS
   IMPACTS WHOLE-BODY IMMUNE CELL AND LIVER METABOLISM, BUT NOT
   ATHEROGENESIS.
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [De Bruijn, J.; van Kuijk, K.; Gijbels, M.; Sluimer, J.] Maastricht UMC, Pathol, Maastricht, Netherlands.
   [Bijnen, M.; Wouters, K.] Maastricht UMC, Internal Med, Maastricht, Netherlands.
   [Carmeliet, P.] Katholieke Univ Leuven, Angiogenesis & Vasc Metab, Leuven, Belgium.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0681
BP E19
EP E20
DI 10.1016/j.atherosclerosis.2019.06.055
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800055
DA 2019-10-28
ER

PT J
AU Santana, MDM
   Lira, ALD
   Minanni, CA
   Okuda, LS
   Iborra, RT
   Queiroz, MS
   Passarelli, M
AF De Fatima Mello Santana, M.
   Lopes de Araujo Lira, A.
   Minanni, C. A.
   Shimabukuro Okuda, L.
   Talada Iborra, R.
   Silva Queiroz, M.
   Passarelli, M.
TI HDL FROM DIABETIC KIDNEY DISEASE PATIENTS PRESENTS A REDUCED ABILITY IN
   REMOVING MACROPHAGE CHOLESTEROL AND INHIBITING LDL OXIDATION ACCORDING
   TO THE STAGE OF KIDNEY FAILURE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [De Fatima Mello Santana, M.; Lopes de Araujo Lira, A.; Minanni, C. A.; Shimabukuro Okuda, L.; Talada Iborra, R.; Passarelli, M.] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Lipid Lab HCFMUSP LIM10, Sao Paulo, Brazil.
   [Minanni, C. A.] Hosp Israelita Albert Einstein HIAE, Fac Israelita Ciencias Saude Albert Einstein, Sao Paulo, Brazil.
   [Talada Iborra, R.] Univ Sao Judas Tadeu, Psychol, Sao Paulo, Brazil.
   [Silva Queiroz, M.] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Unidade Diabet,Med Clin, Sao Paulo, Brazil.
   [Passarelli, M.] Univ Nove Julho, Programa Posgrad Med, Med, Sao Paulo, Brazil.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0660
BP E102
EP E103
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800297
DA 2019-10-28
ER

PT J
AU De Flaviis, C
   D'Ardes, D
   Pierdomenico, AM
   Bellisario, I
   Tiberio, F
   La Scorciosa, C
   Pierdomenico, M
   Dell'Acqua, A
   Di Monte, D
   Caradio, F
   Rossi, I
   Cipollone, F
   Bucci, M
AF De Flaviis, C.
   D'Ardes, D.
   Pierdomenico, A. M.
   Bellisario, I.
   Tiberio, F.
   La Scorciosa, C.
   Pierdomenico, M.
   Dell'Acqua, A.
   Di Monte, D.
   Caradio, F.
   Rossi, I.
   Cipollone, F.
   Bucci, M.
TI STATIN-INDUCED MYOPATHY: DIFFERENT STRATEGIES FOR MANAGEMENT AND
   DIFFICULT CHALLENGES TO REDUCE CARDIOVASCULAR RISK
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [De Flaviis, C.; D'Ardes, D.; Bellisario, I.; Di Monte, D.; Caradio, F.; Rossi, I.; Cipollone, F.; Bucci, M.] Univ G dAnnunzio, Ctr Diag & Therapy Dyslipidemia, Hosp SS Annunziata, Chieti, Italy.
   [Pierdomenico, A. M.] Univ G dAnnunzio, Clin Res Ctr CeSI MeT, Chieti, Italy.
   [Tiberio, F.; La Scorciosa, C.; Pierdomenico, M.; Dell'Acqua, A.] Univ G dAnnunzio, Sch Med, Chieti, Italy.
   [Cipollone, F.; Bucci, M.] Clin Res Ctr CeSI MeT, Chieti, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0765
BP E202
EP E202
DI 10.1016/j.atherosclerosis.2019.06.614
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800612
DA 2019-10-28
ER

PT J
AU De Gonzalo-Calvo, D
   Vilades, D
   Martinez-Camblor, P
   Vea, A
   Nasarre, L
   Toro, R
   Vega, JS
   Leta, R
   Puig-Grifol, N
   Benitez, S
   Sanchez-Quesada, JL
   Carreras, F
   Llorente-Cortes, V
AF De Gonzalo-Calvo, D.
   Vilades, D.
   Martinez-Camblor, P.
   Vea, A.
   Nasarre, L.
   Toro, R.
   Sanchez Vega, J.
   Leta, R.
   Puig-Grifol, N.
   Benitez, S.
   Sanchez-Quesada, J. L.
   Carreras, F.
   Llorente-Cortes, V.
TI MICRORNAS AS CIRCULATING BIOMARKERS OF EPICARDIAL FAT VOLUME: A
   MULTIDETECTOR COMPUTED TOMOGRAPHY STUDY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [De Gonzalo-Calvo, D.; Llorente-Cortes, V.] CSIC, Biomed Res Inst St Pau IIB St Pau, Inst Biomed Res Barcelona IIBB, CIBERCV,Lipids & Cardiovasc Pathol, Barcelona, Spain.
   [Vilades, D.; Sanchez Vega, J.; Leta, R.; Carreras, F.] Hosp Santa Creu & Sant Pau, Cardiac Imaging Unit, Barcelona, Spain.
   [Martinez-Camblor, P.] Univ Autonoma Chile, Dartmouth Coll, Geisel Sch Med, Hanover, NH USA.
   [Vea, A.; Nasarre, L.] Biomed Res Inst St Pau, Lipids & Cardiovasc Pathol, Barcelona, Spain.
   [Toro, R.] Univ Cadiz, Inst Res & Innovat Biomed Sci, Dept Med, Cadiz, Spain.
   [Puig-Grifol, N.] Univ Autonoma Barcelona, Biomed Res Inst St Pau, Cardiovasc Biochem, Barcelona, Spain.
   [Benitez, S.] Biomed Res Inst St Pau, Cardiovasc Biochem, Barcelona, Spain.
   [Sanchez-Quesada, J. L.] Biomed Res Inst St Pau, Cardiovasc Biochem, CIBERDEM, Barcelona, Spain.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0370
BP E71
EP E72
DI 10.1016/j.atherosclerosis.2019.06.204
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800203
DA 2019-10-28
ER

PT J
AU De Groot, M
   Haitjema, S
   Blasse, E
   van Solinge, W
   Hoefer, I
AF De Groot, M.
   Haitjema, S.
   Blasse, E.
   van Solinge, W.
   Hoefer, I.
TI IMPROVED TRIAGE OF NON-STEMI PATIENTS WITH INCONCLUSIVE HEARTSCORE AT
   EMERGENCY DEPARTMENTS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [De Groot, M.; Haitjema, S.; Blasse, E.; van Solinge, W.; Hoefer, I.] Univ Med Ctr Utrecht, Lab Clin Chem & Haematol, Utrecht, Netherlands.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1020
BP E116
EP E116
DI 10.1016/j.atherosclerosis.2019.06.335
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800334
DA 2019-10-28
ER

PT J
AU Della Pepa, G
   Monti, S
   Vetrani, C
   Vitale, M
   Izzo, A
   Lombardi, G
   Salamone, D
   Fusco, A
   Tommasone, M
   Clemente, G
   Bozzetto, L
   Annuzzi, G
   Mancini, M
   Mirabelli, P
   Salvatore, M
   Riccardi, G
   Rivellese, AA
AF Della Pepa, G.
   Monti, S.
   Vetrani, C.
   Vitale, M.
   Izzo, A.
   Lombardi, G.
   Salamone, D.
   Fusco, A.
   Tommasone, M.
   Clemente, G.
   Bozzetto, L.
   Annuzzi, G.
   Mancini, M.
   Mirabelli, P.
   Salvatore, M.
   Riccardi, G.
   Rivellese, A. A.
TI TREATING NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2
   DIABETES BY TARGETING MULTIPLE DIETARY COMPONENTS: THE PORTFOLIO DIET
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Della Pepa, G.; Vetrani, C.; Vitale, M.; Izzo, A.; Lombardi, G.; Salamone, D.; Fusco, A.; Tommasone, M.; Clemente, G.; Bozzetto, L.; Annuzzi, G.; Riccardi, G.; Rivellese, A. A.] Univ Naples Federico II, Clin Med & Surg, Naples, Italy.
   [Monti, S.; Mirabelli, P.; Salvatore, M.] IRCCS, SDN Fdn, Naples, Italy.
   [Mancini, M.] CNR, Inst Biostruct & Bioimaging, Naples, Italy.
NR 0
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0981
BP E117
EP E117
DI 10.1016/j.atherosclerosis.2019.06.340
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800339
DA 2019-10-28
ER

PT J
AU Demikhov, O
   Demikhova, N
   Zakharchenko, M
   Bumeister, L
AF Demikhov, O.
   Demikhova, N.
   Zakharchenko, M.
   Bumeister, L.
TI DYNAMIC OF ENDOTHELIAL DYSFUNCTION FACTORS DURING TREATMENT IN RENAL
   HYPERTENSIVE PATIENTS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Demikhov, O.; Demikhova, N.; Zakharchenko, M.; Bumeister, L.] Sumy State Univ, Family Med, Sumy, Ukraine.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0029
BP E260
EP E260
DI 10.1016/j.atherosclerosis.2019.06.802
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800800
DA 2019-10-28
ER

PT J
AU Demikhova, N
   Mazur, T
AF Demikhova, N.
   Mazur, T.
TI THE CORRELATION BETWEEN POLYMORPHISM OF CYP7A1 GENE AND INDEX OF LEFT
   VENTRICULAR MASS FOR HYPERTENSIVE PATIENTS WITH DIABETIC NEPHROPATHY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Demikhova, N.; Mazur, T.] Sumy State Univ, Family Med, Sumy, Ukraine.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0028
BP E123
EP E123
DI 10.1016/j.atherosclerosis.2019.06.358
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800356
DA 2019-10-28
ER

PT J
AU Demikhova, N
   Yarmolenko, O
   Bumeister, V
   Prykhodko, O
AF Demikhova, N.
   Yarmolenko, O.
   Bumeister, V.
   Prykhodko, O.
TI CORRECTION OF MYOCARDIAL CHANGES ON AN ANIMAL EXPERIMENTAL MODEL WITH
   MELDONIM
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Demikhova, N.] Sumy State Univ, Family Med Dept, Sumy, Ukraine.
   [Yarmolenko, O.; Bumeister, V.; Prykhodko, O.] Sumy State Univ, Morphol Dept, Sumy, Ukraine.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0879
BP E259
EP E259
DI 10.1016/j.atherosclerosis.2019.06.798
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800796
DA 2019-10-28
ER

PT J
AU Depuydt, M
   Prange, KHM
   Slenders, L
   Elbersen, D
   Boltjes, A
   de Jager, SCA
   Slutter, BA
   Bot, I
   van der Laan, SW
   Mokry, M
   Pasterkamp, G
   de Winther, MPJ
   Kuiper, J
AF Depuydt, M.
   Prange, K. H. M.
   Slenders, L.
   Elbersen, D.
   Boltjes, A.
   de Jager, S. C. A.
   Slutter, B. A.
   Bot, I.
   van der Laan, S. W.
   Mokry, M.
   Pasterkamp, G.
   de Winther, M. P. J.
   Kuiper, J.
TI MICROANATOMY OF ADVANCED HUMAN ATHEROSCLEROTIC PLAQUES THROUGH
   SINGLE-CELL TRANSCRIPTOMICS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Depuydt, M.; Slutter, B. A.; Bot, I.; Kuiper, J.] Leiden Acad Ctr Drug Res, BioTherapeut, Leiden, Netherlands.
   [Prange, K. H. M.; de Winther, M. P. J.] Amsterdam UMC, Dept Med Biochem, Amsterdam, Netherlands.
   [Slenders, L.; Boltjes, A.; Mokry, M.; Pasterkamp, G.] UMC Utrecht, Lab Clin Chem & Haematol, Utrecht, Netherlands.
   [Elbersen, D.; de Jager, S. C. A.; van der Laan, S. W.] UMC Utrecht, Lab Expt Cardiol, Utrecht, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0547
BP E5
EP E5
DI 10.1016/j.atherosclerosis.2019.06.013
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800013
DA 2019-10-28
ER

PT J
AU Derosa, G
   Guasti, L
   Maresca, AM
   Tandurella, N
   Fiorenza, A
   Girola, A
   Colombo, E
   Pagnoni, N
   Maffioli, P
AF Derosa, G.
   Guasti, L.
   Maresca, A. M.
   Tandurella, N.
   Fiorenza, A.
   Girola, A.
   Colombo, E.
   Pagnoni, N.
   Maffioli, P.
TI EFFECTS OF PCSK-9 INHIBITORS ON LIPID PROFILE: AN ITALIAN, REAL LIFE,
   MULTICENTRIC EXPERIENCE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Derosa, G.] Univ Pavia, Internal Med & Therapeut, Pavia, Italy.
   [Guasti, L.; Maresca, A. M.; Tandurella, N.] Univ Insubria, Res Ctr Dyslipidaemia, Varese, Italy.
   [Fiorenza, A.; Girola, A.; Colombo, E.] Osped G Salvini, ASST Rhodense, Internal Med, Garbagnate Milanese, Italy.
   [Pagnoni, N.] Azienda Spedali Civili Brescia, Internal Med, Gardone Val Trompia, Italy.
   [Maffioli, P.] IRCCS Policlin San Matteo, Internal Med, Pavia, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1055
BP E199
EP E199
DI 10.1016/j.atherosclerosis.2019.06.604
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800602
DA 2019-10-28
ER

PT J
AU Desamericq, G
   Fagnani, F
   Emery, C
   Gourmelen, J
   Chauny, JV
   Kutikova, L
AF Desamericq, G.
   Fagnani, F.
   Emery, C.
   Gourmelen, J.
   Chauny, J. V.
   Kutikova, L.
TI REAL-WORLD CHARACTERISTICS AND RISK OF CARDIOVASCULAR EVENTS IN HIGH
   CARDIOVASCULAR RISK PATIENTS IN FRANCE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Desamericq, G.; Chauny, J. V.] Amgen SAS, Value Access & Policy, Boulogne Billancourt, France.
   [Fagnani, F.] Cemka Eval, Direct, Bourg La Reine, France.
   [Emery, C.] Cemka Eval, Biostat, Bourg La Reine, France.
   [Gourmelen, J.] UVSQ, INSERM, Unite Cohortes Epidemiol Populat, UMS 011, Villejuif, France.
   [Kutikova, L.] Amgen Europe GmbH, Global Hlth Econ, Rotkreuz, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0113
BP E180
EP E180
DI 10.1016/j.atherosclerosis.2019.06.546
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800544
DA 2019-10-28
ER

PT J
AU Despres, AA
   Perrot, N
   Tastet, L
   Pouliot, A
   Shen, M
   Chen, HY
   Bourgeois, R
   Trottier, M
   Guimond, J
   Tessier, M
   Nadeau, M
   Sebastien, T
   Couture, P
   Dweck, M
   Tsimikas, S
   Thanassoulis, G
   Pibarot, P
   Clavel, MACMA
   Arsenault, B
AF Despres, A. A.
   Perrot, N.
   Tastet, L.
   Pouliot, A.
   Shen, M.
   Chen, H. Y.
   Bourgeois, R.
   Trottier, M.
   Guimond, J.
   Tessier, M.
   Nadeau, M.
   Sebastien, T.
   Couture, P.
   Dweck, M.
   Tsimikas, S.
   Thanassoulis, G.
   Pibarot, P.
   Clavel, M. A. C. Marie-Annick
   Arsenault, B.
TI LIPOPROTEIN(A), OXIDIZED PHOSPHOLIPIDS, AND AORTIC VALVE
   MICROCALCIFICATION ASSESSED BY 18F-NAF PET/CT
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Despres, A. A.; Perrot, N.; Tastet, L.; Shen, M.; Bourgeois, R.; Trottier, M.; Guimond, J.; Tessier, M.; Nadeau, M.; Sebastien, T.; Pibarot, P.; Clavel, M. A. C. Marie-Annick; Arsenault, B.] IUCPQ, Cardiol, Quebec City, PQ, Canada.
   [Pouliot, A.] IUCPQ, Cardioloy, Quebec City, PQ, Canada.
   [Chen, H. Y.; Thanassoulis, G.] McGill Univ, Cardiol, Hlth Res Ctr, Montreal, PQ, Canada.
   [Couture, P.] Univ Laval, Med, Quebec City, PQ, Canada.
   [Dweck, M.] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland.
   [Tsimikas, S.] Univ Calif San Diego, Div Cardiovasc Dis, San Diego, CA 92103 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0151
BP E110
EP E111
DI 10.1016/j.atherosclerosis.2019.06.322
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800321
DA 2019-10-28
ER

PT J
AU Deykin, A
   Silaeva, Y
   Leonova, E
AF Deykin, A.
   Silaeva, Y.
   Leonova, E.
TI A NOVEL HYPOTHESIS: ERYTHROCYTE SENESCENCE PLAYS A KEY ROLE IN THE
   ATHEROSCLEROSIS DEVELOPMENT
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Deykin, A.; Silaeva, Y.] Russian Acad Sci, Ctr Collect Usage, Inst Gene Biol, Moscow, Russia.
   [Leonova, E.] St Petersburg State Univ, Inst Translat Biomed, St Petersburg, Russia.
FU Russian Scientific FoundationRussian Science Foundation (RSF)
   [17-75-20249]
FX This work is supported by a grant from the Russian Scientific Foundation
   No 17-75-20249
NR 0
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0800
BP E240
EP E241
DI 10.1016/j.atherosclerosis.2019.06.738
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800736
DA 2019-10-28
ER

PT J
AU Doring, Y
   van der Vorst, E
   Mandl, M
   Muller, M
   Neideck, C
   Jansen, Y
   Hristov, M
   Meiler, S
   Noels, H
   Soehnlein, O
   Drechsler, M
   Weber, C
AF Doering, Y.
   van der Vorst, E.
   Mandl, M.
   Mueller, M.
   Neideck, C.
   Jansen, Y.
   Hristov, M.
   Meiler, S.
   Noels, H.
   Soehnlein, O.
   Drechsler, M.
   Weber, C.
TI HEMATOPOIETIC CHEMR23 FUELS ATHEROSCLEROSIS BY SUSTAINING A M1
   MACROPHAGE-PHENOTYPE AND GUIDANCE OF PLASMACYTOID DENDRITIC CELLS TO
   MURINE LESIONS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Doering, Y.; van der Vorst, E.; Mandl, M.; Mueller, M.; Neideck, C.; Jansen, Y.; Hristov, M.; Meiler, S.; Soehnlein, O.; Drechsler, M.; Weber, C.] Ludwig Maximilians Univ Munchen, IPEK, Munich, Germany.
   [Noels, H.] Rhein Westfal TH Aachen, Imcar, Aachen, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0361
BP E45
EP E45
DI 10.1016/j.atherosclerosis.2019.06.128
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800127
DA 2019-10-28
ER

PT J
AU Dolezelova, E
   Prasnicka, A
   Sa, ICI
   Hroch, M
   Hyspler, R
   Ticha, A
   Pericacho, M
   Micuda, S
   Nachtigal, P
AF Dolezelova, E.
   Prasnicka, A.
   Sa, I. C. I.
   Hroch, M.
   Hyspler, R.
   Ticha, A.
   Pericacho, M.
   Micuda, S.
   Nachtigal, P.
TI HIGH SOLUBLE ENDOGLIN LEVELS AFFECT BILE ACIDS AND CHOLESTEROL
   METABOLISM IN MICE LIVER
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Dolezelova, E.; Prasnicka, A.; Sa, I. C. I.; Nachtigal, P.] Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Biol & Med Sci, Hradec Kralove, Czech Republic.
   [Hroch, M.] Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Biochem, Hradec Kralove, Czech Republic.
   [Hyspler, R.; Ticha, A.] Univ Hosp Hradec Kralove, Dept Res & Dev, Hradec Kralove, Czech Republic.
   [Pericacho, M.] Univ Salamanca, Dept Physiol & Pharmacol, Salamanca, Spain.
   [Micuda, S.] Charles Univ Prague, Fac Med Hradec Kralove, Dept Pharmacol, Hradec Kralove, Czech Republic.
FU AZV CR [17-31754A]
FX Supported AZV CR number 17-31754A.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0175
BP E118
EP E118
DI 10.1016/j.atherosclerosis.2019.06.343
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800342
DA 2019-10-28
ER

PT J
AU Dolly, S
   Moteea, S
   Preston, C
   Watson, V
   Bulugahapitiya, S
AF Dolly, S.
   Moteea, S.
   Preston, C.
   Watson, V.
   Bulugahapitiya, S.
TI CARDIAC CHEST PAIN EVALUATION IN PATIENTS WITH DIABETES AND AN
   INTERMEDIATE PROBABILITY OF CAD (CORONARY ARTERY DISEASE)
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Dolly, S.; Moteea, S.; Preston, C.; Watson, V.; Bulugahapitiya, S.] Bradford Royal Infirm, Dept Cardiol, Leeds, W Yorkshire, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1060
BP E192
EP E193
DI 10.1016/j.atherosclerosis.2019.06.584
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800582
DA 2019-10-28
ER

PT J
AU Donners, M
   van der Vorst, E
   Theodorou, K
   Rademakers, T
   van Buul, J
   Hermans, A
   Tomlinson, M
   Lehrke, M
   Lebherz, C
   Dreymueller, D
   Ludwig, A
   Bentzon, J
   Biessen, E
AF Donners, M.
   van der Vorst, E.
   Theodorou, K.
   Rademakers, T.
   van Buul, J.
   Hermans, A.
   Tomlinson, M.
   Lehrke, M.
   Lebherz, C.
   Dreymueller, D.
   Ludwig, A.
   Bentzon, J.
   Biessen, E.
TI A DISINTEGRIN AND METALLOPROTEASE ADAM10 CONTROLS ENDOTHELIAL FUNCTIONS
   IN ATHEROSCLEROSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Donners, M.; van der Vorst, E.; Theodorou, K.; Biessen, E.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Pathol, Maastricht, Netherlands.
   [van der Vorst, E.] Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent, Munich, Germany.
   [Rademakers, T.; van Buul, J.] Sanquin Res, Amsterdam, Netherlands.
   [Rademakers, T.; van Buul, J.] Dept Mol Cell Biol, Landsteiner Lab, Amsterdam, Netherlands.
   [Hermans, A.; Tomlinson, M.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.
   [Lehrke, M.; Lebherz, C.] Univ Hosp Aachen, Dept Internal Med 1, Aachen, Germany.
   [Dreymueller, D.; Ludwig, A.] Rhein Westfal TH Aachen, Inst Pharmacol & Toxicol, Aachen, Germany.
   [Bentzon, J.] Ctr Nacl Invest Cardiovasc Carlos III, Expt Pathol, Madrid, Spain.
   [Bentzon, J.] Aarhus Univ, Dept Clin Med, Aarhus, Denmark.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0436
BP E4
EP E5
DI 10.1016/j.atherosclerosis.2019.06.012
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800012
DA 2019-10-28
ER

PT J
AU Douna, H
   Amersfoort, J
   Schaftenaar, F
   Bot, I
   Binder, C
   Yagita, H
   van Puijvelde, G
   Kuiper, J
   Foks, A
AF Douna, H.
   Amersfoort, J.
   Schaftenaar, F.
   Bot, I.
   Binder, C.
   Yagita, H.
   van Puijvelde, G.
   Kuiper, J.
   Foks, A.
TI BTLA STIMULATION PROTECTS AGAINST ATHEROSCLEROSIS BY REGULATING
   FOLLICULAR B CELLS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Douna, H.; Amersfoort, J.; Schaftenaar, F.; Bot, I.; van Puijvelde, G.; Kuiper, J.; Foks, A.] Leiden Univ, LACDR, BioTherapeut, Leiden, Netherlands.
   [Binder, C.] Med Univ Vienna, Lab Med, Vienna, Austria.
   [Yagita, H.] Juntendo Univ, Sch Med, Immunol, Tokyo, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0465
BP E100
EP E100
DI 10.1016/j.atherosclerosis.2019.06.290
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800289
DA 2019-10-28
ER

PT J
AU Douna, H
   Smit, V
   van Puijvelde, G
   Binder, C
   Bot, I
   Kuchroo, V
   Lichtman, A
   Kuiper, J
   Foks, A
AF Douna, H.
   Smit, V.
   van Puijvelde, G.
   Binder, C.
   Bot, I.
   Kuchroo, V.
   Lichtman, A.
   Kuiper, J.
   Foks, A.
TI TIM-1 MUCIN DOMAIN-MUTANT MICE DISPLAY EXACERBATED ATHEROSCLEROSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Douna, H.; Smit, V.; van Puijvelde, G.; Bot, I.; Kuiper, J.; Foks, A.] LACDR Leiden Univ, Dept BioTherapeut, Leiden, Netherlands.
   [Binder, C.] Med Univ Vienna, Dept Lab Med, Vienna, Austria.
   [Kuchroo, V.; Lichtman, A.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.
   [Kuchroo, V.] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA.
   [Lichtman, A.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0480
BP E25
EP E26
DI 10.1016/j.atherosclerosis.2019.06.074
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800073
DA 2019-10-28
ER

PT J
AU Dragoti, J
   Gjergo, H
   Doko, A
   Petrela, E
   Goda, A
AF Dragoti, J.
   Gjergo, H.
   Doko, A.
   Petrela, E.
   Goda, A.
TI IMPACT OF CULPRIT VESSEL ON LEFT VENTRICULAR FUNCTION AFTER PCI IN ST
   ELEVATION MYOCARDIAL INFARCTION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Dragoti, J.; Gjergo, H.; Doko, A.; Goda, A.] Univ Hosp Ctr Mother Theresa, Dept Cardiol, Tirana, Albania.
   [Petrela, E.] Univ Hosp Ctr Mother Theresa, Stat Serv, Tirana, Albania.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0763
BP E156
EP E156
DI 10.1016/j.atherosclerosis.2019.06.469
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800467
DA 2019-10-28
ER

PT J
AU Drogari, E
   Hamilton, J
   Mollaki, V
   Sdoggou, T
   Galina, P
   Kamenets, E
   Zakharova, E
AF Drogari, E.
   Hamilton, J.
   Mollaki, V.
   Sdoggou, T.
   Galina, P.
   Kamenets, E.
   Zakharova, E.
TI LYSOSOMAL ACID LIPASE DEFICIENCY IN GREECE: ENZYMATIC AND MOLECULAR
   ANALYSIS OF 33 PATIENTS USING DBS SCREENING
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Drogari, E.; Mollaki, V.; Sdoggou, T.] Univ Athens, Dept Pediat 1, Unit Inherited Metab Dis, Athens, Greece.
   [Hamilton, J.] CGH Lab, Dept Biochem, Glasgow, Lanark, Scotland.
   [Galina, P.] Aghia Sophia Childrens Hosp, Dept Radiol, Athens, Greece.
   [Kamenets, E.; Zakharova, E.] Res Ctr Med Genet, Moscow, Russia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0323
BP E234
EP E235
DI 10.1016/j.atherosclerosis.2019.06.721
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800719
DA 2019-10-28
ER

PT J
AU Dugani, S
   Zubaid, M
   Rashed, W
   Gullerud, R
   Balayah, Z
   Mora, S
   Alsheikh-Ali, A
AF Dugani, S.
   Zubaid, M.
   Rashed, W.
   Gullerud, R.
   Balayah, Z.
   Mora, S.
   Alsheikh-Ali, A.
TI DETERMINANTS OF IN-HOSPITAL MORTALITY FOLLOWING PREMATURE VERSUS
   CONVENTIONAL ACUTE CORONARY SYNDROME
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Dugani, S.] Mayo Clin, Div Hosp Internal Med, Rochester, MN USA.
   [Zubaid, M.] Kuwait Univ, Dept Med, Kuwait, Kuwait.
   [Rashed, W.] Minist Hlth, Mubarak Al Kabeer Hosp, Dept Med, Kuwait, Kuwait.
   [Gullerud, R.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA.
   [Balayah, Z.; Alsheikh-Ali, A.] Mohammed Bin Rashid Univ Med & Hlth Sci, Coll Med, Dubai, U Arab Emirates.
   [Mora, S.] Harvard Med Sch, Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA.
   [Mora, S.] Harvard Med Sch, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0715
BP E115
EP E115
DI 10.1016/j.atherosclerosis.2019.06.334
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800333
DA 2019-10-28
ER

PT J
AU Dumitriu, I
   Bullenkamp, J
   Mengoni, V
   Kaski, JC
AF Dumitriu, I.
   Bullenkamp, J.
   Mengoni, V.
   Kaski, J. C.
TI DEEP PHENOTYPING OF PRO-INFLAMMATORY CD4+CD28NULL T LYMPHOCYTES IN
   PATIENTS WITH ATHEROSCLEROSIS REVEALS DISTINCT GENE SIGNATURES AND
   FUNCTION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Dumitriu, I.; Bullenkamp, J.; Mengoni, V.; Kaski, J. C.] St Georges Univ London, Mol & Clin Sci Res Inst, London, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0807
BP E24
EP E24
DI 10.1016/j.atherosclerosis.2019.06.070
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800069
DA 2019-10-28
ER

PT J
AU Duparc, T
   Trenteseaux, C
   Combes, G
   Merian, J
   Ghezalli, L
   Najib, S
   Martinez, LO
AF Duparc, T.
   Trenteseaux, C.
   Combes, G.
   Merian, J.
   Ghezalli, L.
   Najib, S.
   Martinez, L. O.
TI ADDITIONAL PROTECTIVE EFFECT OF P2Y13 PURINERGIC RECEPTOR IN
   CARDIOMETABOLIC DISEASES: ROLE IN NON-ALCOHOLIC FATTY LIVER DISEASE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Duparc, T.; Trenteseaux, C.; Combes, G.; Merian, J.; Ghezalli, L.; Najib, S.; Martinez, L. O.] INSERM, Inst Cardiovasc & Metab Dis, UMR 1048, UPS, Toulouse, France.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0275
BP E1
EP E2
DI 10.1016/j.atherosclerosis.2019.06.004
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800004
DA 2019-10-28
ER

PT J
AU Dusilova, T
   Kovar, J
   Drobny, M
   Sedivy, P
   Dezortova, M
   Hajek, M
AF Dusilova, T.
   Kovar, J.
   Drobny, M.
   Sedivy, P.
   Dezortova, M.
   Hajek, M.
TI GLUCOSE AND FRUCTOSE DIFFER IN THEIR ACUTE EFFECT ON HEPATIC FAT CONTENT
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Dusilova, T.] Inst Clin & Expt Med, Expt Med Ctr, Atherosclerosis Res Lab, Prague, Czech Republic.
   [Kovar, J.] Inst Clin & Expt Med, Expt Med Ctr, Prague, Czech Republic.
   [Drobny, M.; Sedivy, P.; Dezortova, M.; Hajek, M.] Inst Clin & Expt Med, Radiodiagnost & Intervent Radiol Dept, Prague, Czech Republic.
NR 0
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0407
BP E145
EP E146
DI 10.1016/j.atherosclerosis.2019.06.434
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800432
DA 2019-10-28
ER

PT J
AU Dzobo, K
   Stiekema, L
   Cupido, A
   Pereira, JB
   Zhang, X
   Prange, K
   de Winther, M
   Stroes, E
   Bahjat, M
AF Dzobo, K.
   Stiekema, L.
   Cupido, A.
   Pereira, J. Belo
   Zhang, X.
   Prange, K.
   de Winther, M.
   Stroes, E.
   Bahjat, M.
TI IDENTIFICATION OF THE KEY MOLECULAR EVENTS TRIGGERED BY LIPOPROTEIN (A)
   IN PERIPHERAL MONOCYTES
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Dzobo, K.; Stiekema, L.; Cupido, A.; Pereira, J. Belo; Zhang, X.; Stroes, E.; Bahjat, M.] AMC, Dept Vasc Med, Amsterdam, Netherlands.
   [Prange, K.; de Winther, M.] AMC, Dept Med Biochem, Amsterdam, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0936
BP E231
EP E231
DI 10.1016/j.atherosclerosis.2019.06.708
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800706
DA 2019-10-28
ER

PT J
AU Elgohari, A
AF Elgohari, A.
TI EFFECT OF DIABETIC DURATION ON LEFT VENTRICULAR GLOBAL LONGITUDINAL
   STRAIN BY SPECKLE TRACKING IMAGING
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Elgohari, A.] Res Inst, Dept Cardiol, Cairo, Egypt.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0064
BP E125
EP E125
DI 10.1016/j.atherosclerosis.2019.06.365
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800363
DA 2019-10-28
ER

PT J
AU Eman, A
   van Roon, AM
   Stel, AJ
   Smit, AJ
   van Goor, H
   Mulder, DJ
AF Eman, A.
   van Roon, A. M.
   Stel, A. J.
   Smit, A. J.
   van Goor, H.
   Mulder, D. J.
TI LOW BODY MASS INDEX IS ASSOCIATED WITH ABNORMAL NAILFOLD CAPILLAROSCOPIC
   PATTERNS IN SUBJECTS WITH RAYNAUD'S PHENOMENON
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Eman, A.; van Roon, A. M.; Smit, A. J.; Mulder, D. J.] Univ Med Ctr Groningen, Dept Internal Med, Div Vasc Med, Groningen, Netherlands.
   [Stel, A. J.] Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands.
   [van Goor, H.] Univ Med Ctr Groningen, Dept Pathol & Med Biol, Sect Pathol, Groningen, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0395
BP E261
EP E261
DI 10.1016/j.atherosclerosis.2019.06.806
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800804
DA 2019-10-28
ER

PT J
AU Emanuelsson, F
   Marott, S
   Tybjaerg-Hansen, A
   Nordestgaard, B
   Benn, M
AF Emanuelsson, F.
   Marott, S.
   Tybjaerg-Hansen, A.
   Nordestgaard, B.
   Benn, M.
TI HIGH GLUCOSE LEVELS AND RISK OF VASCULAR DISEASES - OBSERVATIONAL AND
   MENDELIAN RANDOMIZATION STUDIES OF THE GENERAL POPULATION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Emanuelsson, F.; Marott, S.; Tybjaerg-Hansen, A.; Benn, M.] Rigshosp, Dept Clin Biochem, Copenhagen, Denmark.
   [Nordestgaard, B.] Herlev & Gentofte Hosp, Dept Clin Biochem, Copenhagen, Denmark.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0353
BP E9
EP E9
DI 10.1016/j.atherosclerosis.2019.06.023
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800023
DA 2019-10-28
ER

PT J
AU Evsevyeva, M
   Sergeeva, O
   Prokhorenko-Kolomoytseva, I
   Rusidi, A
   Pavlov, K
   Aksenenko, V
AF Evsevyeva, M.
   Sergeeva, O.
   Prokhorenko-Kolomoytseva, I.
   Rusidi, A.
   Pavlov, K.
   Aksenenko, V.
TI LIPID STATUS IN YOUNG WOMEN WITH REPRODUCTIVE DYSFUNCTION, DEPENDING ON
   THEIR BODY MASS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Evsevyeva, M.; Sergeeva, O.; Prokhorenko-Kolomoytseva, I.; Rusidi, A.; Pavlov, K.; Aksenenko, V.] Stavropol State Med Univ, Dept Internal Dis, Stavropol, Russia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0905
BP E231
EP E231
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800708
DA 2019-10-28
ER

PT J
AU Evsevyeva, M
   Eremin, M
   Rusidi, A
   Fursova, E
   Koshel, V
   Shchetinin, E
AF Evsevyeva, M.
   Eremin, M.
   Rusidi, A.
   Fursova, E.
   Koshel, V.
   Shchetinin, E.
TI DYSLIPIDEMIA AND SYNDROME OF EARLY VASCULAR AGING IN YOUNG ADULTS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Evsevyeva, M.; Eremin, M.; Rusidi, A.; Fursova, E.; Koshel, V.; Shchetinin, E.] Stavropol State Med Univ, Dept Internal Dis, Stavropol, Russia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0910
BP E194
EP E194
DI 10.1016/j.atherosclerosis.2019.06.589
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800587
DA 2019-10-28
ER

PT J
AU Evsevyeva, M
   Sergeeva, O
   Rusidi, A
AF Evsevyeva, M.
   Sergeeva, O.
   Rusidi, A.
TI HEREDITARY STATUS AND LIPID PROFILE IN PREGNANT WOMEN
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Evsevyeva, M.; Sergeeva, O.; Rusidi, A.] Stavropol State Med Univ, Dept Internal Med, Stavropol, Russia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0949
BP E231
EP E232
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800709
DA 2019-10-28
ER

PT J
AU Farnier, M
   Mouhat, B
   Pommier, T
   Yao, H
   Maza, M
   Chague, F
   Bichat, F
   Cottin, Y
   Zeller, M
AF Farnier, M.
   Mouhat, B.
   Pommier, T.
   Yao, H.
   Maza, M.
   Chague, F.
   Bichat, F.
   Cottin, Y.
   Zeller, M.
TI PREVALENCE AND SEVERITY OF CORONARY DISEASE IN PATIENTS WITH FAMILIAL
   HYPERCHOLESTEROLEMIA HOSPITALIZED FOR AN ACUTE MYOCARDIAL INFARCTION:
   DATA FROM THE RICO SURVEY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Farnier, M.] LIpid Clin, Point Med, Dijon, France.
   [Farnier, M.; Mouhat, B.; Pommier, T.; Yao, H.; Maza, M.; Chague, F.; Bichat, F.; Cottin, Y.] Univ Hosp Ctr Dijon Bourgogne, Cardiol, Dijon, France.
   [Zeller, M.] Univ Bourgogne Franche Comte, UFR Sci Sante, Pec2, EA 7460, Dijon, France.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0349
BP E114
EP E115
DI 10.1016/j.atherosclerosis.2019.06.332
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800331
DA 2019-10-28
ER

PT J
AU Fassaert, LM
   Timmerman, N
   van Koeverden, ID
   Pasterkamp, G
   de Kleijn, DP
   de Borst, GJ
AF Fassaert, L. M.
   Timmerman, N.
   van Koeverden, I. D.
   Pasterkamp, G.
   de Kleijn, D. P.
   de Borst, G. J.
TI PREOPERATIVE HYPERTENSION IS ASSOCIATED WITH ATHEROSCLEROTIC PLAQUE
   VULNERABILITY IN PATIENTS UNDERGOING CAROTID ENDARTERECTOMY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Fassaert, L. M.; Timmerman, N.; de Kleijn, D. P.; de Borst, G. J.] Univ Utrecht, Med Ctr, Dept Vasc Surg, Utrecht, Netherlands.
   [van Koeverden, I. D.] Univ Utrecht, Med Ctr, Dept Expt Cardiol, Utrecht, Netherlands.
   [Pasterkamp, G.] Univ Utrecht, Med Ctr, Lab Clin Chem & Hematol, Utrecht, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0598
BP E247
EP E247
DI 10.1016/j.atherosclerosis.2019.06.760
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800758
DA 2019-10-28
ER

PT J
AU Fauste, E
   Aguirre, R
   Rodrigo, S
   Rodriguez, L
   Alvarez-Millan, JJ
   Panadero, MI
   Otero, P
   Bocos, C
AF Fauste, E.
   Aguirre, R.
   Rodrigo, S.
   Rodriguez, L.
   Alvarez-Millan, J. J.
   Panadero, M. I.
   Otero, P.
   Bocos, C.
TI FRUCTOSE INTAKE IN PREGNANCY AFFECTS ONE-CARBON METABOLISM OF FEMALE
   PROGENY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Fauste, E.; Aguirre, R.; Rodrigo, S.; Rodriguez, L.; Panadero, M. I.; Otero, P.; Bocos, C.] CEU San Pablo Univ, Fac Pharm Chem & Biochem, Madrid, Spain.
   [Alvarez-Millan, J. J.] CQS, Madrid, Spain.
FU Programa Estatal de I+D+i RETOS [SAF2017-89537-R]; FEDER fundsEuropean
   Union (EU)
FX This work was supported by a grant from Programa Estatal de I+D+i RETOS
   (SAF2017-89537-R) and co-funded by FEDER funds. E. Fauste is a FPU
   fellowship.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0191
BP E32
EP E32
DI 10.1016/j.atherosclerosis.2019.06.094
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800093
DA 2019-10-28
ER

PT J
AU Fechner, E
   Bilet, L
   Peters, HPF
   Hiemstra, H
   Schrauwen, P
   Mensink, RP
AF Fechner, E.
   Bilet, L.
   Peters, H. P. F.
   Hiemstra, H.
   Schrauwen, P.
   Mensink, R. P.
TI INVESTIGATING THE EFFECTIVENESS OF A HEALTHY DIET ON CARDIOVASCULAR RISK
   MARKERS - A CHALLENGE-BASED HUMAN TRIAL
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Fechner, E.; Bilet, L.; Schrauwen, P.; Mensink, R. P.] Maastricht Univ, Nutr & Movement Sci, Maastricht, Netherlands.
   [Peters, H. P. F.; Hiemstra, H.] Unilever, Res & Dev, Vlaardingen, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0878
BP E148
EP E148
DI 10.1016/j.atherosclerosis.2019.06.441
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800439
DA 2019-10-28
ER

PT J
AU Fechner, E
   Bilet, L
   Peters, HPF
   Hiemstra, H
   Mensink, RP
   Schrauwen, P
AF Fechner, E.
   Bilet, L.
   Peters, H. P. F.
   Hiemstra, H.
   Mensink, R. P.
   Schrauwen, P.
TI INVESTIGATING THE EFFECTIVENESS OF A HEALTHY DIET ON METABOLIC
   FLEXIBILITY AND INSULIN SENSITIVITY - A CHALLENGE-BASED HUMAN TRIAL
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Fechner, E.; Bilet, L.; Mensink, R. P.; Schrauwen, P.] Maastricht Univ, Nutr & Movement Sci, Maastricht, Netherlands.
   [Peters, H. P. F.; Hiemstra, H.] Unilever, Res & Dev, Vlaardingen, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0877
BP E132
EP E132
DI 10.1016/j.atherosclerosis.2019.06.389
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800387
DA 2019-10-28
ER

PT J
AU Feeman, W
AF Feeman, W., Jr.
TI ENHANCED PREDICTION OF THE POPULATION AT RISK OF ATHEROTHROMBOTIC
   DISEASE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Feeman, W., Jr.] Bowling Green Study, Bowling Green, OH USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1097
BP E276
EP E277
DI 10.1016/j.atherosclerosis.2019.06.857
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800855
DA 2019-10-28
ER

PT J
AU Pardo, JF
   Fernandez, JLQ
   Ferraro, L
   Guirao, EY
   Felices, FJH
   Riquelme, NL
   Alcazar, IIP
   Hernandez, FC
   Andreu, FRL
AF Fernandez Pardo, J.
   Quilez Fernandez, J. L.
   Ferraro, L.
   Yague Guirao, E.
   Hernandez Felices, F. J.
   Lopez Riquelme, N.
   Iniesta-Pino Alcazar, I.
   Canizares Hernandez, F.
   Lopez Andreu, F. R.
TI PSEUDOHYPERTRIGLYCERIDEMIA CAN BE DETECTED BY 2D-DIFFUSION-ORDERED
   1H-NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Fernandez Pardo, J.; Ferraro, L.; Hernandez Felices, F. J.; Iniesta-Pino Alcazar, I.; Lopez Andreu, F. R.] Hosp Gen Univ Reina Sofia, Internal Med, Murcia, Spain.
   [Quilez Fernandez, J. L.; Yague Guirao, E.; Lopez Riquelme, N.; Canizares Hernandez, F.] Hosp Gen Univ Reina Sofia, Clin Chem, Murcia, Spain.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0822
BP E236
EP E236
DI 10.1016/j.atherosclerosis.2019.06.725
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800723
DA 2019-10-28
ER

PT J
AU Pardo, JF
   Ferraro, L
   Guirao, EY
   Fernandez, JLQ
   Lopez, AH
   Martinez, MM
   Riquelme, NL
   Gascon, AM
   Andreu, FRL
AF Fernandez Pardo, J.
   Ferraro, L.
   Yague Guirao, E.
   Quilez Fernandez, J. L.
   Hernandez Lopez, A.
   Martinez Martinez, M.
   Lopez Riquelme, N.
   Martin Gascon, A.
   Lopez Andreu, F. R.
TI PSEUDOHYPERTRIGLYCERIDEMIA, A POTENTIALLY DANGEROUS CONDITION DUE TO
   UNNECESSARY IATROGENIC DAMAGE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Fernandez Pardo, J.; Ferraro, L.; Martinez Martinez, M.; Martin Gascon, A.; Lopez Andreu, F. R.] Hosp Gen Univ Reina Sofia, Internal Med, Murcia, Spain.
   [Yague Guirao, E.; Quilez Fernandez, J. L.; Lopez Riquelme, N.] Hosp Gen Univ Reina Sofia, Clin Chem, Murcia, Spain.
   [Hernandez Lopez, A.] Hosp Gen Univ Reina Sofia, Endocrinol, Murcia, Spain.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0874
BP E237
EP E237
DI 10.1016/j.atherosclerosis.2019.06.728
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800726
DA 2019-10-28
ER

PT J
AU Ferrer, M
   Rojas, MM
   Villalpando, DM
   Aguilera, AA
   Garcia, HS
AF Ferrer, M.
   Rojas, M. M.
   Villalpando, D. M.
   Aguilera, A. A.
   Garcia, H. S.
TI EFFECTS OF CLA ON ORCHIDECTOMY-ASSOCIATED ALTERATIONS IN SERUM
   BIOMARKERS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Ferrer, M.; Villalpando, D. M.] Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain.
   [Rojas, M. M.; Villalpando, D. M.; Garcia, H. S.] Inst Tecnol Veracruz, Unidad Invest & Desarrollo Alimentos, Veracruz, Mexico.
   [Aguilera, A. A.] Univ Veracruzana, Fac Bioanal, Veracruz, Mexico.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0823
BP E173
EP E174
DI 10.1016/j.atherosclerosis.2019.06.526
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800524
DA 2019-10-28
ER

PT J
AU Ferri, N
   Lupo, MG
   Poggio, P
   Camera, M
   Faggin, E
   Rattazzi, M
AF Ferri, N.
   Lupo, M. G.
   Poggio, P.
   Camera, M.
   Faggin, E.
   Rattazzi, M.
TI PCSK9 9 INDUCES VASCULAR CALCIFICATION UNDER UREMIC CONDITIONS: IN VITRO
   AND IN VIVO STUDY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Ferri, N.; Lupo, M. G.] Univ Padua, Pharmaceut & Pharmacol Sci, Padua, Italy.
   [Poggio, P.] Ctr Cardiol Monzino IRCCS, Unit Study Aort Valvular & Coronary Pathol, Milan, Italy.
   [Camera, M.] Univ Milan, Pharmacol & Biomol Sci, Milan, Italy.
   [Faggin, E.; Rattazzi, M.] Univ Padua, Dept Med, Padua, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0360
BP E10
EP E11
DI 10.1016/j.atherosclerosis.2019.06.028
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800028
DA 2019-10-28
ER

PT J
AU Filatova, A
   Potekhina, A
   Radukhina, N
   Ruleva, N
   Sherstyuk, E
   Noeva, E
   Provatorov, S
   Arefieva, T
AF Filatova, A.
   Potekhina, A.
   Radukhina, N.
   Ruleva, N.
   Sherstyuk, E.
   Noeva, E.
   Provatorov, S.
   Arefieva, T.
TI IMMUNOMODULATING PROPERTIES OF ATORVASTATIN AND ROSUVASTATIN
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Filatova, A.; Radukhina, N.; Ruleva, N.; Arefieva, T.] Minist Hlth Russian Federat, Natl Med Res Ctr Cardiol, Lab Cell Immunol, Inst Expt Cardiol, Moscow, Russia.
   [Potekhina, A.; Noeva, E.; Provatorov, S.] Minist Hlth Russian Federat, Natl Med Res Ctr Cardiol, Dept Pulm Hypertens & Heart Dis, Inst Clin Cardiol, Moscow, Russia.
   [Sherstyuk, E.] Minist Hlth Russian Federat, Natl Med Res Ctr Cardiol, Lab Problems Atherosclerosis, Inst Clin Cardiol, Moscow, Russia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0243
BP E202
EP E203
DI 10.1016/j.atherosclerosis.2019.06.616
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800614
DA 2019-10-28
ER

PT J
AU Filatova, A
   Klesareva, E
   Ruleva, N
   Radukhina, N
   Potekhina, A
   Egiazaryan, M
   Noeva, E
   Arefieva, T
   Afanasieva, O
AF Filatova, A.
   Klesareva, E.
   Ruleva, N.
   Radukhina, N.
   Potekhina, A.
   Egiazaryan, M.
   Noeva, E.
   Arefieva, T.
   Afanasieva, O.
TI THE DYNAMICS OF CIRCULATING PSCK9, LP(A) AND PCSK9-APOB100 LIPOPROTEINS
   COMPLEXES DURING STATIN THERAPY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Filatova, A.; Ruleva, N.; Radukhina, N.; Arefieva, T.] Minist Hlth Russian Federat, Lab Cell Immuno, Inst Expt Cardiol, Natl Med Res Ctr Cardiol, Moscow, Russia.
   [Klesareva, E.; Egiazaryan, M.; Afanasieva, O.] Minist Hlth Russian Federat, Natl Med Res Ctr Cardiol, Lab Problems Atherosclerosis, Inst Expt Cardiol, Moscow, Russia.
   [Potekhina, A.; Noeva, E.] Minist Hlth Russian Federat, Natl Med Res Ctr Cardiol, Dept Pulm Hypertens & Heart Dis, Inst Clin Cardiol, Moscow, Russia.
RI Klesareva, Elena Aleksandrovna/M-2852-2018
OI Klesareva, Elena Aleksandrovna/0000-0002-0682-8699
FU RFBRRussian Foundation for Basic Research (RFBR) [17-04-00127]
FX The work was supported by RFBR, project 17-04-00127
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0247
BP E204
EP E204
DI 10.1016/j.atherosclerosis.2019.06.620
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800618
DA 2019-10-28
ER

PT J
AU Filippas-Ntekouan, S
   Pappa, E
   Tzavella, E
   Tellis, K
   Tselepis, A
   Elisaf, M
   Bairaktari, E
   Tsimihodimos, V
AF Filippas-Ntekouan, S.
   Pappa, E.
   Tzavella, E.
   Tellis, K.
   Tselepis, A.
   Elisaf, M.
   Bairaktari, E.
   Tsimihodimos, V.
TI EFFECT OF ANTI-HYPERGLYCEMIC AGENTS ON SERUM PCSK9 LEVELS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Filippas-Ntekouan, S.; Pappa, E.; Tzavella, E.; Elisaf, M.; Tsimihodimos, V.] Univ Ioannina, Dept Internal Med, Ioannina, Greece.
   [Tellis, K.; Tselepis, A.] Univ Ioannina, Dept Biochem, Ioannina, Greece.
   [Bairaktari, E.] Univ Ioannina, Dept Clin Chem, Ioannina, Greece.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0502
BP E128
EP E128
DI 10.1016/j.atherosclerosis.2019.06.375
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800373
DA 2019-10-28
ER

PT J
AU Filippas-Ntekouan, S
   Tellis, K
   Tselepis, A
   Bairaktari, E
   Dimitriou, T
   Christopoulou, E
   Elisaf, M
   Tsimihodimos, V
AF Filippas-Ntekouan, S.
   Tellis, K.
   Tselepis, A.
   Bairaktari, E.
   Dimitriou, T.
   Christopoulou, E.
   Elisaf, M.
   Tsimihodimos, V.
TI EFFECT OF DAPAGLIFLOZIN AND SITAGLIPTIN ON SERUM LIPIDS AND LIPOPROTEIN
   SUBFRACTIONS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Filippas-Ntekouan, S.; Dimitriou, T.; Christopoulou, E.; Elisaf, M.; Tsimihodimos, V.] Univ Ioannina, Dept Internal Med, Ioannina, Greece.
   [Tellis, K.; Tselepis, A.] Univ Ioannina, Dept Biochem, Ioannina, Greece.
   [Bairaktari, E.] Univ Ioannina, Dept Clin Chem, Ioannina, Greece.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0499
BP E131
EP E131
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800382
DA 2019-10-28
ER

PT J
AU Filippi, A
   Alexandru, N
   Voicu, G
   Constantinescu, CA
   Tucureanu, M
   Rebleanu, D
   Fenyo, M
   Simionescu, D
   Simionescu, A
   Manduteanu, I
   Georgescu, A
AF Filippi, A.
   Alexandru, N.
   Voicu, G.
   Constantinescu, C. A.
   Tucureanu, M.
   Rebleanu, D.
   Fenyo, M.
   Simionescu, D.
   Simionescu, A.
   Manduteanu, I.
   Georgescu, A.
TI EARLY DIABETES INDUCES ALTERATIONS IN ENDOTHELIAL PROGENITOR CELL
   PHENOTYPE AND HOMING IN MICE SUSCEPTIBLE TO ATHEROSCLEROSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Filippi, A.; Alexandru, N.; Georgescu, A.] Inst Cellular Biol & Pathol Nicolae Simionescu, Pathophysiol & Pharmacol, Bucharest, Romania.
   [Voicu, G.; Constantinescu, C. A.; Tucureanu, M.; Rebleanu, D.; Manduteanu, I.] Inst Cellular Biol & Pathol Nicolae Simionescu, Biopathol & Therapy Inflammat, Bucharest, Romania.
   [Fenyo, M.] Inst Cellular Biol & Pathol Nicolae Simionescu, Genom Transcript & Mol Therapies, Bucharest, Romania.
   [Simionescu, D.; Simionescu, A.] Clemson Univ, Bioengn, Clemson, SC USA.
FU Competitiveness Operational Program 2014-2020, THERAVALDIS [P_37_298,
   104362, 115/13.09.2016]
FX Competitiveness Operational Program 2014-2020, THERAVALDIS, Project ID
   P_37_298, MySMIS code: 104362, Contract no. 115/13.09.2016.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0647
BP E97
EP E97
DI 10.1016/j.atherosclerosis.2019.06.281
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800280
DA 2019-10-28
ER

PT J
AU Filou, S
   Zvintzou, E
   Kalogeropoulou, C
   Xepapadaki, E
   Kypreos, K
AF Filou, S.
   Zvintzou, E.
   Kalogeropoulou, C.
   Xepapadaki, E.
   Kypreos, K.
TI FUNCTIONAL INTERACTION BETWEEN APOLIPOPROTEINS A2 AND E IN THE
   REGULATION OF PLASMA CHOLESTEROL AND TRIGLYCERIDES LEVELS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Filou, S.; Zvintzou, E.; Kalogeropoulou, C.; Xepapadaki, E.; Kypreos, K.] Univ Patras, Sch Med, Patras, Greece.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0110
BP E106
EP E106
DI 10.1016/j.atherosclerosis.2019.06.308
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800307
DA 2019-10-28
ER

PT J
AU Fitzsimons, S
   McCarthy, C
   Bruen, R
   Belton, O
AF Fitzsimons, S.
   McCarthy, C.
   Bruen, R.
   Belton, O.
TI MICRORNA-155 AND CONJUGATED LINOLEIC ACID IN THE CONTEXT OF
   ATHEROSCLEROSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Fitzsimons, S.; Bruen, R.; Belton, O.] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin, Ireland.
   [McCarthy, C.] Univ Coll Cork, Dept Pharmacol & Therapeut, Cork, Ireland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0754
BP E24
EP E24
DI 10.1016/j.atherosclerosis.2019.06.069
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800068
DA 2019-10-28
ER

PT J
AU Fogacci, F
   Grassi, D
   Rizzo, M
   Cicero, A
AF Fogacci, F.
   Grassi, D.
   Rizzo, M.
   Cicero, A.
TI METABOLIC EFFECT OF BERBERINE-SILYMARIN ASSOCIATION: A META-ANALYSIS OF
   RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIALS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Fogacci, F.; Cicero, A.] Alma Mater Studiorum Univ Bologna, Med & Surg Sci Dept, Bologna, Italy.
   [Grassi, D.] Univ Aquila, Dept Life Hlth & Environm Sci, Laquila, Italy.
   [Rizzo, M.] Univ Palermo, Dept Internal Med & Med Specialties, Palermo, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0901
BP E148
EP E149
DI 10.1016/j.atherosclerosis.2019.06.442
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800440
DA 2019-10-28
ER

PT J
AU Fogacci, S
   Fogacci, F
   Cicero, A
AF Fogacci, S.
   Fogacci, F.
   Cicero, A.
TI DOES VITAMIN D SUPPLEMENTATION REDUCE THE RISK OF PRE-ECLAMPSIA?
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Fogacci, S.; Fogacci, F.; Cicero, A.] Alma Mater Studiorum Univ Bologna, Med & Surg Sci Dept, Bologna, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1050
BP E88
EP E88
DI 10.1016/j.atherosclerosis.2019.06.256
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800255
DA 2019-10-28
ER

PT J
AU Fontaine, M
   Aliyev, T
   Sikkens, R
   Jin, H
   van Greevenbroek, M
   Van der Kallen, C
   Schalkwijk, C
   Stehouwer, C
   Sluimer, J
   Temmerman, L
   Mengerink, Y
   Biessen, E
AF Fontaine, M.
   Aliyev, T.
   Sikkens, R.
   Jin, H.
   van Greevenbroek, M.
   Van der Kallen, C.
   Schalkwijk, C.
   Stehouwer, C.
   Sluimer, J.
   Temmerman, L.
   Mengerink, Y.
   Biessen, E.
TI BARCODING IN OBESE: WHO'S AT INCREASED RISK FOR THE DEVELOPMENT OF
   CARDIOVASCULAR DISEASE?
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Fontaine, M.; Jin, H.; Sluimer, J.; Temmerman, L.; Biessen, E.] CARIM Maastricht Univ Med Ctr, Dept Pathol, Maastricht, Netherlands.
   [Aliyev, T.] CERN, Openlab, Geneva, Switzerland.
   [Sikkens, R.; Mengerink, Y.] DSM Resolve, Chromatog & Mass Spectrometry Dept, Geleen, Netherlands.
   [van Greevenbroek, M.; Van der Kallen, C.; Schalkwijk, C.; Stehouwer, C.] CARIM Maastricht Univ Med Ctr, Dept Internal Med, Maastricht, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0472
BP E86
EP E86
DI 10.1016/j.atherosclerosis.2019.06.249
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800248
DA 2019-10-28
ER

PT J
AU Foscolou, A
   Tyrovolas, S
   Chrysohoou, C
   Critselis, E
   Rallidis, L
   Panagiotakos, D
AF Foscolou, A.
   Tyrovolas, S.
   Chrysohoou, C.
   Critselis, E.
   Rallidis, L.
   Panagiotakos, D.
TI TYPES OF FATS/OILS AND THEIR ASSOCIATION WITH HEALTHY AGEING: A COMBINED
   ANALYSIS OF THE ATTICA AND MEDIS EPIDEMIOLOGICAL STUDIES
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Foscolou, A.; Tyrovolas, S.; Critselis, E.; Panagiotakos, D.] Harokopio Univ Athens, Dept Nutr & Dietet, Athens, Greece.
   [Chrysohoou, C.] Univ Athens, Cardiol Clin 1, Athens, Greece.
   [Rallidis, L.] Univ Athens, Cardiol Clin 2, Athens, Greece.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0320
BP E32
EP E32
DI 10.1016/j.atherosclerosis.2019.06.095
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800094
DA 2019-10-28
ER

PT J
AU Foscolou, A
   Tyrovolas, S
   Chrysohoou, C
   Rallidis, L
   Panagiotakos, D
AF Foscolou, A.
   Tyrovolas, S.
   Chrysohoou, C.
   Rallidis, L.
   Panagiotakos, D.
TI PROTEIN AND CARBOHYDRATE CONSUMPTION IN RELATION TO HEALTHY AGEING: A
   COMBINED ANALYSIS OF THE ATTICA AND MEDIS EPIDEMIOLOGICAL STUDIES
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Foscolou, A.; Tyrovolas, S.; Panagiotakos, D.] Harokopio Univ Athens, Dept Nutr & Dietet, Athens, Greece.
   [Chrysohoou, C.] Univ Athens, Cardiol Clin 1, Athens, Greece.
   [Rallidis, L.] Univ Athens, Cardiol Clin 2, Athens, Greece.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0319
BP E147
EP E147
DI 10.1016/j.atherosclerosis.2019.06.438
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800436
DA 2019-10-28
ER

PT J
AU Fournier, N
   Dakroub, H
   Benoist, JF
   Allaoui, F
   Sayet, G
   Paul, JL
AF Fournier, N.
   Dakroub, H.
   Benoist, J. F.
   Allaoui, F.
   Sayet, G.
   Paul, J. L.
TI EICOSAPENTAENOIC ACID (EPA) DIFFERENTIALLY AFFECTS ABCA1-MEDIATED
   CHOLESTEROL EFFLUX FROM PRIMARY HUMAN MACROPHAGES OR THP-1 CELL LINE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Fournier, N.; Dakroub, H.; Allaoui, F.; Paul, J. L.] Univ Paris Sud Paris Saclay, Equipe Macrophages Cholesterol & Atherosclerosis, LipSys2 EA 7357, Fac Pharm, Chatenay Malabry, France.
   [Fournier, N.; Paul, J. L.] Hop Europeen Georges Pompidou, AP HP, Lab Biochim, Paris, France.
   [Benoist, J. F.] Hop Robert Debre, AP HP, Lab Biochim Hormonol, Paris, France.
   [Sayet, G.] Univ Paris Sud Paris Saclay, Fac Pharm, LipSys2 EA 7357, Equipe Chim Analyt Pharmaceut, Chatenay Malabry, France.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0369
BP E239
EP E239
DI 10.1016/j.atherosclerosis.2019.06.733
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800731
DA 2019-10-28
ER

PT J
AU Fregeau, G
   Sarduy, R
   Menard, L
   Elimam, H
   da Graca, SDL
   Garcia, J
   Lubell, WD
   Ong, H
   Marleau, S
AF Fregeau, G.
   Sarduy, R.
   Menard, L.
   Elimam, H.
   da Graca, S. D. Leitao
   Garcia, J.
   Lubell, W. D.
   Ong, H.
   Marleau, S.
TI ATHEROREGRESSIVE POTENTIAL OF AZAPEPTIDES ANALOGUES OF GHRP-6 AS
   SELECTIVE CD36 LIGANDS IN APOLIPOPROTEIN E-DEFICIENT MICE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Fregeau, G.; Sarduy, R.; Menard, L.; Elimam, H.; da Graca, S. D. Leitao; Garcia, J.; Ong, H.; Marleau, S.] Univ Montreal, Fac Pharm, Montreal, PQ, Canada.
   [Lubell, W. D.] Univ Montreal, Dept Chem, Montreal, PQ, Canada.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0960
BP E20
EP E20
DI 10.1016/j.atherosclerosis.2019.06.056
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800056
DA 2019-10-28
ER

PT J
AU Frias, M
   Pagano, S
   Fetaud-Lapierre, V
   Lecour, S
   Kamau, F
   Strijdom, H
   Vuilleumier, N
AF Frias, M.
   Pagano, S.
   Fetaud-Lapierre, V.
   Lecour, S.
   Kamau, F.
   Strijdom, H.
   Vuilleumier, N.
TI ANTI-APOLIPOPROTEIN A1 AUTOANTIBODIES PREVALENCE IS INCREASED AND
   ASSOCIATED WITH HIV INFECTION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Frias, M.; Pagano, S.; Fetaud-Lapierre, V.; Vuilleumier, N.] Univ Hosp Geneva, Dept Genet & Lab Med, Geneva, Switzerland.
   [Lecour, S.] Univ Cape Town, Hatter Inst Cardiovasc Res, Fac Hlth Sci, Dept Med, Cape Town, South Africa.
   [Kamau, F.; Strijdom, H.] Stellenbosch Univ, Fac Med & Hlth Sci, Div Med Physiol, Cape Town, South Africa.
OI Strijdom, Hans/0000-0003-3726-9153
NR 0
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0421
BP E251
EP E252
DI 10.1016/j.atherosclerosis.2019.06.774
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800772
DA 2019-10-28
ER

PT J
AU Furmanik, G
   Chatrou, M
   Willems, B
   van Gorp, R
   Schmidt, H
   van Eys, G
   Bochaton-Piallat, ML
   Proudfoot, D
   Biessen, E
   Hedin, U
   Matic, LP
   Mees, B
   Shanahan, C
   Reutelingsperger, C
   Schurgers, L
AF Furmanik, G.
   Chatrou, M.
   Willems, B.
   van Gorp, R.
   Schmidt, H.
   van Eys, G.
   Bochaton-Piallat, M. L.
   Proudfoot, D.
   Biessen, E.
   Hedin, U.
   Matic, L. Perisic
   Mees, B.
   Shanahan, C.
   Reutelingsperger, C.
   Schurgers, L.
TI NOX5 REGULATES VASCULAR SMOOTH MUSCLE CELL PHENOTYPE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Furmanik, G.; Chatrou, M.; Willems, B.; van Gorp, R.; Reutelingsperger, C.; Schurgers, L.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands.
   [Schmidt, H.] Maastricht Univ, Dept Pharmacol & Personalised Med, Maastricht, Netherlands.
   [van Eys, G.] Maastricht Univ, Dept Mol Cell Biol 3, Maastricht, Netherlands.
   [Bochaton-Piallat, M. L.] Univ Geneva, Dept Pathol, Geneva, Switzerland.
   [Bochaton-Piallat, M. L.] Univ Geneva, Dept Immunol, Geneva, Switzerland.
   [Proudfoot, D.] Babraham Inst, Signalling Programme, Cambridge, England.
   [Biessen, E.] Maastricht Univ, Dept Pathol, Maastricht, Netherlands.
   [Hedin, U.; Matic, L. Perisic] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.
   [Mees, B.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands.
   [Shanahan, C.] Kings Coll London, Sch Cardiovasc Med & Sci, London, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0668
BP E27
EP E27
DI 10.1016/j.atherosclerosis.2019.06.079
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800078
DA 2019-10-28
ER

PT J
AU Galimberti, F
   Casula, M
   Olmastroni, E
   Corrao, G
   Scotti, L
   Catapano, AL
AF Galimberti, F.
   Casula, M.
   Olmastroni, E.
   Corrao, G.
   Scotti, L.
   Catapano, A. L.
TI USE OF BISPHOSPHONATES AND RISK OF CARDIOVASCULAR EVENTS: A
   POPULATION-BASED RETROSPECTIVE COHORT STUDY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Galimberti, F.; Casula, M.; Olmastroni, E.; Catapano, A. L.] Univ Milan, Epidemiol & Prevent Pharmacol Serv SEFAP, Dept Pharmacol & Biomol Sci, Milan, Italy.
   [Corrao, G.; Scotti, L.] Univ Milano Bicocca, Div Biostat Epidemiol & Publ Hlth, Dept Stat & Quantitat Methods, Milan, Italy.
   [Catapano, A. L.] IRCCS MultiMed Hosp, Milan, Italy.
RI Scotti, Lorenza/AAB-9544-2019; Casula, Manuela/AAC-4470-2019
OI Scotti, Lorenza/0000-0002-3861-9058; Casula, Manuela/0000-0002-5124-5361
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0249
BP E85
EP E85
DI 10.1016/j.atherosclerosis.2019.06.247
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800246
DA 2019-10-28
ER

PT J
AU Galimova, L
   Sadykova, D
   Slastnikova, E
AF Galimova, L.
   Sadykova, D.
   Slastnikova, E.
TI CHANGES IN AORTIC STIFFNESS IN CHILDREN WITH HETEROZYGOUS FAMILIAL
   HYPERCHOLESTEROLEMIA
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Galimova, L.] Childrens Republican Hosp, Funct & Ultrasound Diagnost, Kazan, Russia.
   [Sadykova, D.; Slastnikova, E.] Kazan State Med Univ, Hosp Pediat, Kazan, Russia.
RI Sadykova, Dinara I/O-6946-2017
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0134
BP E104
EP E104
DI 10.1016/j.atherosclerosis.2019.06.302
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800301
DA 2019-10-28
ER

PT J
AU Galimskaya, V
   Golubeva, A
   Terina, N
   Burko, N
AF Galimskaya, V.
   Golubeva, A.
   Terina, N.
   Burko, N.
TI DEPENDENCE OF DEFORMATION CHARACTERISTICS OF THE LEFT VENTRICLE
   MYOCARDIUM FROM THE SERUM C-REACTIVE PROTEIN IMPROVEMENT IN PATIENTS
   WITH MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Galimskaya, V.; Golubeva, A.; Terina, N.; Burko, N.] Penza State Univ, Therapy, Penza, Russia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0622
BP E172
EP E172
DI 10.1016/j.atherosclerosis.2019.06.522
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800520
DA 2019-10-28
ER

PT J
AU Gallo, A
   Kachenoura, N
   Kilinc, A
   Rosenbaum, D
   Mattina, A
   Carreau, V
   Eliard, SB
   Cluzel, P
   Giral, P
   Redheuil, A
   Bruckert, E
AF Gallo, A.
   Kachenoura, N.
   Kilinc, A.
   Rosenbaum, D.
   Mattina, A.
   Carreau, V.
   Eliard, S. B.
   Cluzel, P.
   Giral, P.
   Redheuil, A.
   Bruckert, E.
TI EARLY MYOCARDIAL INTERSTITIAL FIBROSIS IN HETEROZYGOUS FAMILIAL
   HYPERCHOLESTEROLEMIA
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Gallo, A.; Rosenbaum, D.; Mattina, A.; Carreau, V.; Giral, P.; Bruckert, E.] Cardiovasc Prevent Unit, Endocrinol & Metab, Paris, France.
   [Kachenoura, N.] Sorbonne Univ, INSERM 1146, CNRS 7371, Lab Imagerie Biomed, Paris, France.
   [Kilinc, A.; Redheuil, A.] Inst Cardiometab & Nutr ICAN, Imaging Core Lab, Paris, France.
   [Eliard, S. B.] La Concept Hosp, AP HM, Nutr Metab Dis & Endocrinol Dept, Marseille, France.
   [Cluzel, P.] Grp Hosp Pitie Salpetriere, AP HP, Pole Imagerie, Dept Imagerie Cardiovasc & Radiol Intervent, Paris, France.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0980
BP E42
EP E42
DI 10.1016/j.atherosclerosis.2019.06.120
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800119
DA 2019-10-28
ER

PT J
AU Gapon, L
   Akimov, A
   Gakova, E
   Kayumova, M
   Kuznetsov, V
AF Gapon, L.
   Akimov, A.
   Gakova, E.
   Kayumova, M.
   Kuznetsov, V.
TI ASSOCIATIONS OF PARAMETERS OF STRESS AT WORK AND CLUSTERS OF METABOLIC
   SYNDROME IN MALES OF OPEN URBAN POPULATION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Gapon, L.] Russian Acad Sci, Tyumen Cardiol Res Ctr, Tomsk Natl Res Med Ctr, Sci Div Clin Cardiol, Tyumen, Russia.
   [Akimov, A.; Gakova, E.; Kayumova, M.] Russian Acad Sci, Tyumen Cardiol Res Ctr, Tomsk Natl Res Med Ctr, Lab Epidemiol & Prevent Cardiovasc Dis, Tyumen, Russia.
   [Kuznetsov, V.] Russian Acad Sci, Tyumen Cardiol Res Ctr, Tomsk Natl Res Med Ctr, Dept Instrumental Diagnost, Tyumen, Russia.
NR 0
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0366
BP E177
EP E177
DI 10.1016/j.atherosclerosis.2019.06.536
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800534
DA 2019-10-28
ER

PT J
AU Gapon, L
   Akimova, E
   Gakova, E
   Akimov, A
   Kuznetsov, V
AF Gapon, L.
   Akimova, E.
   Gakova, E.
   Akimov, A.
   Kuznetsov, V.
TI TRAIT ANXIETY AND ATHEROGENIC FRACTIONS OF LIPOPROTEINS IN MALES OF OPEN
   POPULATION OF MIDDLE-URBANIZED SIBERIAN CITY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Gapon, L.] Russian Acad Sci, Sci Div Clin Cardiol, Tomsk Natl Res Med Ctr, Tyumen Cardiol Res Ctr, Tyumen, Russia.
   [Akimova, E.; Gakova, E.; Akimov, A.] Russian Acad Sci, Lab Epidemiol & Prevent Cardiovasc Dis, Tomsk Natl Res Med Ctr, Tyumen Cardiol Res Ctr, Tyumen, Russia.
   [Kuznetsov, V.] Russian Acad Sci, Dept Instrumental Diagnost, Tomsk Natl Res Med Ctr, Tyumen Cardiol Res Ctr, Tyumen, Russia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0358
BP E193
EP E194
DI 10.1016/j.atherosclerosis.2019.06.587
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800585
DA 2019-10-28
ER

PT J
AU Gapon, L
   Shurkevich, N
   Vetoshkin, A
   Gubin, D
AF Gapon, L.
   Shurkevich, N.
   Vetoshkin, A.
   Gubin, D.
TI SUBCLINICAL CAROTID ATHEROSCLEROSIS: CORRELATION OF CARDIAC REMODELING
   AND LOAD TEST RESULTS IN THE ARCTIC WATCH WORKERS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Gapon, L.] Russian Acad Sci, Sci Div Clin Cardiol, Tomsk Natl Res Med Ctr, Tyumen Cardiol Res Ctr, Tyumen, Russia.
   [Shurkevich, N.; Vetoshkin, A.] Russian Acad Sci, Tyumen Cardiol Res Ctr, Tomsk Natl Res Med Ctr, Arterial Hypertens Dept, Tyumen, Russia.
   [Gubin, D.] Tyumen State Med Univ, Minist Healthcare Russian Federat, Dept Biol, Tyumen, Russia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0582
BP E175
EP E176
DI 10.1016/j.atherosclerosis.2019.06.532
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800530
DA 2019-10-28
ER

PT J
AU Gapon, L
   Vetoshkin, A
   Shurkevich, N
   Gubin, D
AF Gapon, L.
   Vetoshkin, A.
   Shurkevich, N.
   Gubin, D.
TI DYNAMICS OF CAROTID ARTERIES REMODELING IN PATIENTS WITH ARTERIAL
   HYPERTENSION IN THE FAR NORTH CONDITIONS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Gapon, L.] Russian Acad Sci, Tyumen Cardiol Res Ctr, Tomsk Natl Res Med Ctr, Sci Div Clin Cardiol, Tyumen, Russia.
   [Vetoshkin, A.; Shurkevich, N.] Russian Acad Sci, Tyumen Cardiol Res Ctr, Tomsk Natl Res Med Ctr, Arterial Hypertens Dept, Tyumen, Russia.
   [Gubin, D.] Tyumen State Med Univ, Minist Healthcare Russian Federat, Dept Biol, Tyumen, Russia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0604
BP E176
EP E176
DI 10.1016/j.atherosclerosis.2019.06.533
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800531
DA 2019-10-28
ER

PT J
AU Gapon, L
   Kayumova, M
   Akimov, A
   Kuznetsov, V
AF Gapon, L.
   Kayumova, M.
   Akimov, A.
   Kuznetsov, V.
TI LIPOPROTEINS AND DEPRESSION IN MALES OF OPEN POPULATION OF MIDDLE-
   URBANIZED SIBERIAN CITY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Gapon, L.] Russian Acad Sci, Tyumen Cardiol Res Ctr, Tomsk Natl Res Med Ctr, Sci Div Clin Cardiol, Tyumen, Russia.
   [Kayumova, M.; Akimov, A.] Russian Acad Sci, Tyumen Cardiol Res Ctr, Tomsk Natl Res Med Ctr, Lab Epidemiol & Prevent Cardiovasc Dis, Tyumen, Russia.
   [Kuznetsov, V.] Russian Acad Sci, Tyumen Cardiol Res Ctr, Tomsk Natl Res Med Ctr, Dept Instrumental Diagnost, Tyumen, Russia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0373
BP E194
EP E194
DI 10.1016/j.atherosclerosis.2019.06.588
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800586
DA 2019-10-28
ER

PT J
AU Garcon, D
   Ayer, A
   Moreau, F
   Arnaud, L
   Robine, S
   Seidah, N
   Prat, A
   Prieur, X
   Pichelin, M
   Cariou, B
   Le May, C
AF Garcon, D.
   Ayer, A.
   Moreau, F.
   Arnaud, L.
   Robine, S.
   Seidah, N.
   Prat, A.
   Prieur, X.
   Pichelin, M.
   Cariou, B.
   Le May, C.
TI GENERATION AND PHENOTYPICAL CHARACTERIZATION OF AN INTESTINAL PCSK9
   DEFICIENT MICE.
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Garcon, D.; Ayer, A.; Moreau, F.; Arnaud, L.; Prieur, X.; Pichelin, M.; Cariou, B.; Le May, C.] Inst Thorax, Inserm UMR 1087, CNRS UMR 6291, Nantes, France.
   [Robine, S.] Inst Curie, Unite Mixte Rech 144, Paris, France.
   [Seidah, N.; Prat, A.] Montreal Clin Res Inst, Biochem Neuroendocrinol Lab, Montreal, PQ, Canada.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0985
BP E233
EP E233
DI 10.1016/j.atherosclerosis.2019.06.715
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800713
DA 2019-10-28
ER

PT J
AU Garcon, D
   Ayer, A
   Moreau, F
   Seidah, N
   Prat, A
   Prieur, X
   Pichelin, M
   Cariou, B
   Le May, C
AF Garcon, D.
   Ayer, A.
   Moreau, F.
   Seidah, N.
   Prat, A.
   Prieur, X.
   Pichelin, M.
   Cariou, B.
   Le May, C.
TI PHARMACOLOGICAL INHIBITION AND HEPATIC-DEFICIENCY OF PCSK9 REDUCE
   POST-PRANDIAL LIPEMIA IN MICE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Garcon, D.; Ayer, A.; Moreau, F.; Prieur, X.; Pichelin, M.; Cariou, B.; Le May, C.] INSERM, UMR 1087, CNRS UMR 6291, Inst Thorax, Nantes, France.
   [Seidah, N.; Prat, A.] Montreal Clin Res Inst IRCM, Biochem Neuroendocrinol Lab, Montreal, PQ, Canada.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0982
BP E3
EP E3
DI 10.1016/j.atherosclerosis.2019.06.008
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800008
DA 2019-10-28
ER

PT J
AU Gargalskaite, U
   Rinkuniene, E
   Petrulionyte, E
   Kutkiene, S
   Dzenkeviciute, V
   Saulyte-Mikulskiene, A
   Staigyte, J
   Skiauteryte, E
   Laucevicius, A
AF Gargalskaite, U.
   Rinkuniene, E.
   Petrulionyte, E.
   Kutkiene, S.
   Dzenkeviciute, V.
   Saulyte-Mikulskiene, A.
   Staigyte, J.
   Skiauteryte, E.
   Laucevicius, A.
TI GENDER-BASED DIFFERENCES OF MIDDLE AGED LITHUANIANS IN OBESITY AND
   VISCERAL OBESITY ACCORDING TO NATIONWIDE LITHUANIAN PRIMARY PREVENTION
   PROGRAM
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Gargalskaite, U.; Rinkuniene, E.; Kutkiene, S.; Saulyte-Mikulskiene, A.; Staigyte, J.; Skiauteryte, E.; Laucevicius, A.] Vilnius Univ, Fac Med, Clin Cardiac & Vasc Dis, Vilnius, Lithuania.
   [Gargalskaite, U.; Rinkuniene, E.; Kutkiene, S.; Dzenkeviciute, V.; Saulyte-Mikulskiene, A.; Staigyte, J.; Skiauteryte, E.; Laucevicius, A.] Vilnius Univ Hosp Santaros Clin, Ctr Cardiol & Angiol, Vilnius, Lithuania.
   [Petrulionyte, E.] Vilnius Univ, Fac Med, Vilnius, Lithuania.
   [Dzenkeviciute, V.] Vilnius Univ, Fac Med, Clin Internal Dis Family Med & Oncol, Vilnius, Lithuania.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0290
BP E174
EP E174
DI 10.1016/j.atherosclerosis.2019.06.527
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800525
DA 2019-10-28
ER

PT J
AU Gargalskaite, U
   Rinkuniene, E
   Petrulionyte, E
   Kutkiene, S
   Dzenkeviciute, V
   Skiauteryte, E
   Laucevicius, A
AF Gargalskaite, U.
   Rinkuniene, E.
   Petrulionyte, E.
   Kutkiene, S.
   Dzenkeviciute, V.
   Skiauteryte, E.
   Laucevicius, A.
TI TRENDS IN PREVALENCE OF DYSLIPIDEMIA AND SEVERE DYSLIPIDEMIA IN
   MIDDLE-AGED MEN WITH NORMAL WAIST CIRCUMFERENCE AND VISCERAL OBESITY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Gargalskaite, U.; Rinkuniene, E.; Kutkiene, S.; Skiauteryte, E.; Laucevicius, A.] Vilnius Univ, Fac Med, Clin Cardiac & Vasc Dis, Vilnius, Lithuania.
   [Gargalskaite, U.; Rinkuniene, E.; Kutkiene, S.; Dzenkeviciute, V.; Skiauteryte, E.; Laucevicius, A.] Vilnius Univ Hosp Santaros Clin, Ctr Cardiol & Angiol, Vilnius, Lithuania.
   [Petrulionyte, E.] Vilnius Univ, Fac Med, Vilnius, Lithuania.
   [Dzenkeviciute, V.] Vilnius Univ, Fac Med, Clin Internal Dis Family Med & Oncol, Vilnius, Lithuania.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0309
BP E137
EP E137
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800402
DA 2019-10-28
ER

PT J
AU Gargalskaite, U
   Rinkuniene, E
   Petrulionyte, E
   Kutkiene, S
   Dzenkeviciute, V
   Skiauteryte, E
   Laucevicius, A
AF Gargalskaite, U.
   Rinkuniene, E.
   Petrulionyte, E.
   Kutkiene, S.
   Dzenkeviciute, V.
   Skiauteryte, E.
   Laucevicius, A.
TI PREVALENCE OF DYSLIPIDEMIA AND SEVERE DYSLIPIDEMIA IN MIDDLE-AGED WOMEN
   WITH NORMAL WAIST CIRCUMFERENCE AND VISCERAL OBESITY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Gargalskaite, U.; Rinkuniene, E.; Kutkiene, S.; Skiauteryte, E.; Laucevicius, A.] Vilnius Univ, Fac Med, Clin Cardiac & Vasc Dis, Vilnius, Lithuania.
   [Gargalskaite, U.; Rinkuniene, E.; Kutkiene, S.; Dzenkeviciute, V.; Skiauteryte, E.; Laucevicius, A.] Vilnius Univ Hosp Santaros Clin, Ctr Cardiol & Angiol, Vilnius, Lithuania.
   [Petrulionyte, E.] Vilnius Univ, Fac Med, Vilnius, Lithuania.
   [Dzenkeviciute, V.] Vilnius Univ, Fac Med, Clin Internal Dis Family Med & Oncol, Vilnius, Lithuania.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0292
BP E136
EP E136
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800401
DA 2019-10-28
ER

PT J
AU Gargalskaite, U
   Rinkuniene, E
   Petrulionyte, E
   Kutkiene, S
   Dzenkeviciute, V
   Skiauteryte, E
   Staigyte, J
   Siauryte-Mikulskiene, A
   Laucevicius, A
AF Gargalskaite, U.
   Rinkuniene, E.
   Petrulionyte, E.
   Kutkiene, S.
   Dzenkeviciute, V.
   Skiauteryte, E.
   Staigyte, J.
   Siauryte-Mikulskiene, A.
   Laucevicius, A.
TI TRENDS IN PREVALENCE OF OBESITY AND VISCERAL OBESITY IN 50-54-YEAR-OLD
   LITHUANIAN MEN AND WOMEN OVER 2009-2016 ACCORDING TO NATIONWIDE PRIMARY
   PREVENTION PROGRAM
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Gargalskaite, U.; Rinkuniene, E.; Kutkiene, S.; Skiauteryte, E.; Staigyte, J.; Siauryte-Mikulskiene, A.; Laucevicius, A.] Vilnius Univ, Fac Med, Clin Cardiac & Vasc Dis, Vilnius, Lithuania.
   [Gargalskaite, U.; Rinkuniene, E.; Kutkiene, S.; Dzenkeviciute, V.; Skiauteryte, E.; Staigyte, J.; Siauryte-Mikulskiene, A.; Laucevicius, A.] Vilnius Univ Hosp, Santaros Clin, Ctr Cardiol & Angiol, Vilnius, Lithuania.
   [Petrulionyte, E.] Vilnius Univ, Fac Med, Vilnius, Lithuania.
   [Dzenkeviciute, V.] Vilnius Univ, Fac Med, Clin Internal Dis Family Med & Oncol, Vilnius, Lithuania.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0269
BP E170
EP E170
DI 10.1016/j.atherosclerosis.2019.06.514
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800512
DA 2019-10-28
ER

PT J
AU Garside, B
   Liu, Y
   Neelamekam, S
   Ho, JH
   Dhage, S
   Kwok, S
   Jones, SA
   Soran, H
AF Garside, B.
   Liu, Y.
   Neelamekam, S.
   Ho, J. Hoong
   Dhage, S.
   Kwok, S.
   Jones, S. A.
   Soran, H.
TI APOLIPOPROTEIN B-100 DECREASES IN ASSOCIATION WITH REDUCTION IN PCSK9
   CONCENTRATION IN ACID SPHINGOMYELINASE DEFICIENCY FOLLOWING ENZYME
   REPLACEMENT THERAPY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Garside, B.; Neelamekam, S.; Ho, J. Hoong; Dhage, S.; Kwok, S.; Soran, H.] Manchester Univ NHS Fdn Trust, Manchester Royal Infirm, Cardiovasc Trials Unit, Manchester, Lancs, England.
   [Liu, Y.] Univ Manchester, Div Cardiovasc Sci, Core Technol Facil, Manchester, Lancs, England.
   [Jones, S. A.] Manchester Univ NHS Fdn Trust, St Marys Hosp, Manchester Ctr Genom Med, Manchester, Lancs, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0984
BP E29
EP E30
DI 10.1016/j.atherosclerosis.2019.06.087
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800086
DA 2019-10-28
ER

PT J
AU Gautier, T
   Deckert, V
   Aires, V
   Le Guern, N
   Patoli, D
   Lemaire, S
   Maquart, G
   Bataille, A
   Xolin, M
   Magnani, C
   Masson, D
   Harscoet, E
   Da Silva, B
   Houdebine, LM
   Jolivet, G
   Lagrost, L
AF Gautier, T.
   Deckert, V.
   Aires, V.
   Le Guern, N.
   Patoli, D.
   Lemaire, S.
   Maquart, G.
   Bataille, A.
   Xolin, M.
   Magnani, C.
   Masson, D.
   Harscoet, E.
   Da Silva, B.
   Houdebine, L. M.
   Jolivet, G.
   Lagrost, L.
TI HUMAN APOLIPOPROTEIN C1 TRANSGENESIS TO INHIBIT CETP AND TO ATTENUATE
   ATHEROSCLEROSIS IN HYPERCHOLESTEROLEMIC RABBITS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Gautier, T.; Deckert, V.; Aires, V.; Le Guern, N.; Patoli, D.; Lemaire, S.; Maquart, G.; Bataille, A.; Xolin, M.; Magnani, C.; Masson, D.; Lagrost, L.] INSERM, UMR123 Lipids Nutr Canc, Dijon, France.
   [Harscoet, E.; Da Silva, B.; Houdebine, L. M.; Jolivet, G.] INRA, Reprod & Dev Biol, Jouy En Josas, France.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0230
BP E81
EP E81
DI 10.1016/j.atherosclerosis.2019.06.233
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800232
DA 2019-10-28
ER

PT J
AU Gavrilova, N
   Metelskaya, V
   Zhatkina, M
   Yarovaya, E
AF Gavrilova, N.
   Metelskaya, V.
   Zhatkina, M.
   Yarovaya, E.
TI HOW TO DETECT CORONARY ATHEROSCLEROSIS: AN INTEGRATED BIOMARKER AS A
   DIAGNOSTIC TOOL.
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Gavrilova, N.; Zhatkina, M.] Natl Res Ctr Prevent Med, Cardiol, Moscow, Russia.
   [Metelskaya, V.; Yarovaya, E.] Natl Res Ctr Prevent Med, Biochem, Moscow, Russia.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0240
BP E183
EP E183
DI 10.1016/j.atherosclerosis.2019.06.554
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800552
DA 2019-10-28
ER

PT J
AU Gaye, B
   Vignac, M
   Bjorck, HM
   Olsson, C
   Franco-Cereceda, A
   Eriksson, P
AF Gaye, B.
   Vignac, M.
   Bjorck, H. M.
   Olsson, C.
   Franco-Cereceda, A.
   Eriksson, P.
TI PREDICTION OF THE DEVELOPMENT OF AORTIC DILATATION IN PATIENTS WITH
   BICUSPID (BAV) VERSUS TRICUSPID (TAV) AORTIC VALVES.
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Gaye, B.; Vignac, M.; Bjorck, H. M.; Olsson, C.; Franco-Cereceda, A.; Eriksson, P.] Karolinska Inst, Dept Med Solna, Cardiovasc Med Unit, Stockholm, Sweden.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1141
BP E277
EP E277
DI 10.1016/j.atherosclerosis.2019.06.858
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800856
DA 2019-10-28
ER

PT J
AU Gazzotti, M
   Casula, M
   Olmastroni, E
   Bonaiti, F
   Grigore, L
   Catapano, AL
AF Gazzotti, M.
   Casula, M.
   Olmastroni, E.
   Bonaiti, F.
   Grigore, L.
   Catapano, A. L.
TI PREVALENCE OF STATIN-ASSOCIATED MUSCLE SYMPTOMS IN ITALY: THE PROSISA
   STUDY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Gazzotti, M.; Casula, M.; Olmastroni, E.; Bonaiti, F.; Catapano, A. L.] Univ Milan, Dept Pharmacol & Biomol Sci, Epidemiol & Prevent Pharmacol Serv SEFAP, Milan, Italy.
   [Grigore, L.; Catapano, A. L.] IRCCS MultiMed Hosp, Sesto San Giovanni, MI, Italy.
   [Grigore, L.] Bassini Hosp, SISA Ctr Study Atherosclerosis, Cinisello Balsamo, MI, Italy.
RI Casula, Manuela/AAC-4470-2019
OI Casula, Manuela/0000-0002-5124-5361
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0410
BP E88
EP E88
DI 10.1016/j.atherosclerosis.2019.06.257
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800256
DA 2019-10-28
ER

PT J
AU Gellert-Kristensen, H
   Dalila, N
   Nielsen, SF
   Nordestgaard, B
   Tybjaerg-Hansen, A
   Stender, S
AF Gellert-Kristensen, H.
   Dalila, N.
   Nielsen, S. Fallgaard
   Nordestgaard, B.
   Tybjaerg-Hansen, A.
   Stender, S.
TI IDENTIFICATION AND REPLICATION OF SIX LOCI ASSOCIATED WITH GALLSTONE
   DISEASE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Gellert-Kristensen, H.; Dalila, N.; Tybjaerg-Hansen, A.; Stender, S.] Rigshosp, Clin Biochem, Copenhagen, Denmark.
   [Nielsen, S. Fallgaard; Nordestgaard, B.] Herlev Hosp, Clin Biochem, Herlev, Denmark.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0627
BP E119
EP E119
DI 10.1016/j.atherosclerosis.2019.06.346
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800345
DA 2019-10-28
ER

PT J
AU Gencer, S
   van der Vorst, E
   Jansen, Y
   Bianchini, M
   Peters, L
   Muller, M
   Bayasgalan, S
   Megens, R
   Sohnlein, O
   Doring, Y
   Weber, C
AF Gencer, S.
   van der Vorst, E.
   Jansen, Y.
   Bianchini, M.
   Peters, L.
   Mueller, M.
   Bayasgalan, S.
   Megens, R.
   Soehnlein, O.
   Doering, Y.
   Weber, C.
TI ENDOTHELIAL ATYPICAL CHEMOKINE RECEPTOR-3 IS A NOVEL DRIVER OF
   ATHEROSCLEROSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Gencer, S.; van der Vorst, E.; Jansen, Y.; Bianchini, M.; Peters, L.; Mueller, M.; Bayasgalan, S.; Megens, R.; Soehnlein, O.; Doering, Y.; Weber, C.] Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent, Munich, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0453
BP E18
EP E18
DI 10.1016/j.atherosclerosis.2019.06.051
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800051
DA 2019-10-28
ER

PT J
AU Genkel, V
   Shaposhnik, I
AF Genkel, V.
   Shaposhnik, I.
TI CAROTID PLAQUE BUT NOT FEMORAL PLAQUE PREDICTS CARDIOVASCULAR EVENTS IN
   PATIENTS AT HIGH AND VERY HIGH CARDIOVASCULAR RISK
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Genkel, V.; Shaposhnik, I.] South Ural State Med Univ, Internal Med, Chelyabinsk, Russia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0045
BP E178
EP E178
DI 10.1016/j.atherosclerosis.2019.06.540
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800538
DA 2019-10-28
ER

PT J
AU Genkel, V
   Salashenko, A
   Sumerkina, V
   Shaposhnik, I
AF Genkel, V.
   Salashenko, A.
   Sumerkina, V.
   Shaposhnik, I.
TI ABNORMALITIES OF THE PROTEIN C ANTICOAGULANT PATHWAY AS A POSSIBLE
   MARKER OF POLYVASCULAR PERIPHERAL ARTERIAL DISEASE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Genkel, V.; Salashenko, A.; Shaposhnik, I.] South Ural State Med Univ, Internal Med, Chelyabinsk, Russia.
   [Sumerkina, V.] South Ural State Med Univ, Cent Res Lab, Chelyabinsk, Russia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0044
BP E140
EP E140
DI 10.1016/j.atherosclerosis.2019.06.415
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800413
DA 2019-10-28
ER

PT J
AU Gerasymenko, O
   Zupanets, I
   Bezugla, N
   Grintsov, Y
   Tarasenko, O
AF Gerasymenko, O.
   Zupanets, I.
   Bezugla, N.
   Grintsov, Y.
   Tarasenko, O.
TI THE PERSPECTIVES FOR USE OF A NEW HERBAL SUPPLEMENT IN THE TREATMENT OF
   SUBCLINICAL ATHEROSCLEROSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Gerasymenko, O.; Zupanets, I.; Bezugla, N.; Grintsov, Y.; Tarasenko, O.] Natl Univ Pharm Clin Pharmacol & Clin Pharm, Kharkive, Ukraine.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0594
BP E146
EP E146
DI 10.1016/j.atherosclerosis.2019.06.435
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800433
DA 2019-10-28
ER

PT J
AU Gerasymenko, O
   Zupanets, I
AF Gerasymenko, O.
   Zupanets, I.
TI THE STUDY OF INTERRELATION BETWEEN HYPERLIPIDEMIA AND GLUCOSE METABOLISM
   IMPAIRMENT IN HYPERTENSIVE PATIENTS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Gerasymenko, O.; Zupanets, I.] Natl Univ Pharm, Clin Pharmacol & Clin Pharm, Kharkive, Ukraine.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0586
BP E131
EP E131
DI 10.1016/j.atherosclerosis.2019.06.385
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800383
DA 2019-10-28
ER

PT J
AU Ghaleb, Y
   Elbitar, S
   Loste, A
   El Khoury, P
   Abou-Khalil, Y
   Nicolas, G
   Le Borgne, M
   Moulin, P
   Di-Filippo, M
   Charriere, S
   Iliozer, H
   Rabes, JP
   Boileau, C
   Abifadel, M
   Varret, M
AF Ghaleb, Y.
   Elbitar, S.
   Loste, A.
   El Khoury, P.
   Abou-Khalil, Y.
   Nicolas, G.
   Le Borgne, M.
   Moulin, P.
   Di-Filippo, M.
   Charriere, S.
   Iliozer, H.
   Rabes, J. P.
   Boileau, C.
   Abifadel, M.
   Varret, M.
TI IMPLICATION OF LRP6 VARIANTS IN FAMILIAL HYPERCHOLESTEROLEMIA
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Ghaleb, Y.; Elbitar, S.; Loste, A.; El Khoury, P.; Abou-Khalil, Y.; Le Borgne, M.; Boileau, C.; Abifadel, M.; Varret, M.] INSERM, LVTS U1148, Paris, France.
   [Nicolas, G.] INSERM, Umr 1149, Paris, France.
   [Moulin, P.; Charriere, S.; Iliozer, H.] Hosp Civils Lyon, Louis Pradel Cardiovasc Hosp, Dept Endocrinol Nutr & Metab Dis, Bron, France.
   [Di-Filippo, M.] Hosp Civils Lyon, Dept Biochem & Mol Biol, Bron, France.
   [Rabes, J. P.] Ambroise Pare Hosp, AP HP, HUPIFO, Lab Biochem & Mol Genet, Boulogne, France.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0438
BP E80
EP E80
DI 10.1016/j.atherosclerosis.2019.06.231
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800230
DA 2019-10-28
ER

PT J
AU Giammanco, A
   Noto, D
   Trevisin, M
   Mattina, A
   Cardella, A
   Spina, R
   Scrimali, C
   Brucato, F
   Ingrassia, V
   Valenti, V
   Misiano, G
   Barbagallo, CM
   Ganci, A
   Cefalu, AB
   Averna, M
AF Giammanco, A.
   Noto, D.
   Trevisin, M.
   Mattina, A.
   Cardella, A.
   Spina, R.
   Scrimali, C.
   Brucato, F.
   Ingrassia, V.
   Valenti, V.
   Misiano, G.
   Barbagallo, C. M.
   Ganci, A.
   Cefalu, A. B.
   Averna, M.
TI PREVALENCE OF STATIN INTOLERANCE IN A COHORT OF OUTPATIENTS IN A LIPID
   CLINIC
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Giammanco, A.; Noto, D.; Trevisin, M.; Mattina, A.; Cardella, A.; Spina, R.; Scrimali, C.; Brucato, F.; Ingrassia, V.; Valenti, V.; Misiano, G.; Barbagallo, C. M.; Ganci, A.; Cefalu, A. B.; Averna, M.] Azienda Osped Univ Policlin Paolo Giaccone, Dipartimento Biomed Med Interna & Specialist, Palermo, Italy.
RI Giammanco, Antonina/AAA-8904-2019; Noto, Davide/AAA-9208-2019
OI Giammanco, Antonina/0000-0002-3088-3049; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0486
BP E201
EP E201
DI 10.1016/j.atherosclerosis.2019.06.612
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800610
DA 2019-10-28
ER

PT J
AU Serret, MG
   Barrilero, R
   Heras, M
   Yanes, O
   Correig, X
   Amigo, N
AF Gil Serret, M.
   Barrilero, R.
   Heras, M.
   Yanes, O.
   Correig, X.
   Amigo, N.
TI LIPID PROFILING OF LIPOPROTEIN FRACTIONS USING 1H-NMR SPECTROSCOPY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Gil Serret, M.; Amigo, N.] Biosfer Teslab SL, Res & Dev, Reus, Spain.
   [Barrilero, R.; Yanes, O.; Correig, X.] Univ Rovira & Virgili, Dept Elect Engn, Metabol Platform, Tarragona, Spain.
   [Heras, M.] Univ Rovira & Virgili, Unit Lipids & Atherosclerosis URLA, Tarragona, Spain.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1071
BP E220
EP E220
DI 10.1016/j.atherosclerosis.2019.06.673
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800671
DA 2019-10-28
ER

PT J
AU Giovannucci, J
   Oo, H
   O'Brien, R
   Hare, D
AF Giovannucci, J.
   Oo, H.
   O'Brien, R.
   Hare, D.
TI THE PREVALENCE OF FAMILIAL HYPERCHOLESTEROLAEMIA IN PATIENTS PRESENTING
   WITH CLINICAL CORONARY ARTERY DISEASE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Giovannucci, J.; Oo, H.; O'Brien, R.; Hare, D.] Univ Melbourne, Sch Med, Melbourne, Vic, Australia.
   [Giovannucci, J.; Oo, H.; O'Brien, R.] Austin Hlth, Dept Endocrinol, Melbourne, Vic, Australia.
   [Giovannucci, J.; Oo, H.; Hare, D.] Austin Hlth, Dept Cardiol, Melbourne, Vic, Australia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0556
BP E67
EP E67
DI 10.1016/j.atherosclerosis.2019.06.193
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800192
DA 2019-10-28
ER

PT J
AU Girona, J
   Rodriguez-Borjabad, C
   Ibarretxe, D
   Vallve, JC
   Ferre, R
   Heras, M
   Rodriguez-Calvo, R
   Guaita-Esteruelas, S
   Martinez-Micaelo, N
   Plana, N
   Masana, L
AF Girona, J.
   Rodriguez-Borjabad, C.
   Ibarretxe, D.
   Vallve, J. C.
   Ferre, R.
   Heras, M.
   Rodriguez-Calvo, R.
   Guaita-Esteruelas, S.
   Martinez-Micaelo, N.
   Plana, N.
   Masana, L.
TI CIRCULATING GRP78/BIP IS INCREASED IN PATIENTS WITH OBESITY AND RELATED
   METABOLIC DISORDERS AND IS ASSOCIATED WITH ATHEROSCLEROSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Girona, J.; Vallve, J. C.; Heras, M.; Rodriguez-Calvo, R.] Univ Rovira & Virgili, CIBERDEM, IISPV, Res Unit Lipids & Atherosclerosis, Reus, Spain.
   [Rodriguez-Borjabad, C.; Ibarretxe, D.; Ferre, R.; Plana, N.; Masana, L.] Univ Rovira & Virgili, St Joan Univ Hosp, CIBERDEM, IISPV,Vasc Med & Metab Unit, Reus, Spain.
   [Guaita-Esteruelas, S.; Martinez-Micaelo, N.] Univ Rovira & Virgili, IISPV, Res Unit Lipids & Atherosclerosis, Reus, Spain.
NR 0
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0600
BP E136
EP E136
DI 10.1016/j.atherosclerosis.2019.06.402
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800400
DA 2019-10-28
ER

PT J
AU Gkolfinopoulou, C
   Bourtsala, A
   Chroni, A
AF Gkolfinopoulou, C.
   Bourtsala, A.
   Chroni, A.
TI THE NATURAL HUMAN APOA-I MUTATION V19L, THAT HAS BEEN ASSOCIATED WITH
   INCREASED HDL-CHOLESTEROL LEVELS, ALTERS APOA-I AND HDL STRUCTURE AND
   FUNCTIONALITY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Gkolfinopoulou, C.; Bourtsala, A.; Chroni, A.] Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens, Greece.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0219
BP E106
EP E106
DI 10.1016/j.atherosclerosis.2019.06.309
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800308
DA 2019-10-28
ER

PT J
AU Goeritzer, M
   Schlager, S
   Vujic, N
   Kolb, D
   Schuligoi, R
   Heinemann, A
   Radovic, B
   Kratky, D
AF Goeritzer, M.
   Schlager, S.
   Vujic, N.
   Kolb, D.
   Schuligoi, R.
   Heinemann, A.
   Radovic, B.
   Kratky, D.
TI LOSS OF ADIPOSE TRIGLYCERIDE LIPASE AFFECTS PLATELET FUNCTION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Goeritzer, M.; Vujic, N.; Kolb, D.; Radovic, B.; Kratky, D.] Med Univ Graz, Gottfried Schatz Res Ctr, Graz, Austria.
   [Schlager, S.] RCV Wien, Boehringer Ingelheim, Vienna, Austria.
   [Schuligoi, R.; Heinemann, A.] Med Univ Graz, Otto Loewi Res Ctr, Graz, Austria.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0232
BP E60
EP E60
DI 10.1016/j.atherosclerosis.2019.06.171
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800170
DA 2019-10-28
ER

PT J
AU Gojkovic-Bukarica, L
   Rajkovic, J
   Djokic, V
   Gostimirovic, M
   Heinle, H
   Novakovic, R
AF Gojkovic-Bukarica, L.
   Rajkovic, J.
   Djokic, V.
   Gostimirovic, M.
   Heinle, H.
   Novakovic, R.
TI THE EFFECT OF RESVERATROL, WINE POLYPHENOL, ON THE VASODILATATION OF RAT
   RENAL ARTERY WITHOUT ENDOTHELIUM: ROLE OF POTASSIUM CHANNELS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Gojkovic-Bukarica, L.; Rajkovic, J.; Djokic, V.; Gostimirovic, M.; Novakovic, R.] Univ Belgrade, Fac Med, Inst Pharmacol Clin Pharmacol & Toxicol, Belgrade, Serbia.
   [Heinle, H.] Univ Tubingen, Inst Physiol, Tubingen, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0288
BP E260
EP E261
DI 10.1016/j.atherosclerosis.2019.06.804
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800802
DA 2019-10-28
ER

PT J
AU Goossens, P
   Lu, C
   van Zandvoort, M
   Donners, M
   Gijbels, M
   Biessen, E
AF Goossens, P.
   Lu, C.
   van Zandvoort, M.
   Donners, M.
   Gijbels, M.
   Biessen, E.
TI SPATIAL MAPPING OF MACROPHAGE HETEROGENEITY IN MURINE ATHEROSCLEROTIC
   PLAQUES
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Goossens, P.; Lu, C.; Donners, M.; Gijbels, M.; Biessen, E.] Maastricht Univ, Dept Pathol, Maastricht, Netherlands.
   [van Zandvoort, M.] Maastricht Univ, Mol Cell Biol, Maastricht, Netherlands.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0623
BP E52
EP E53
DI 10.1016/j.atherosclerosis.2019.06.147
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800146
DA 2019-10-28
ER

PT J
AU Gostimirovic, M
   Rajkovic, J
   Novakovic, R
   Djokic, V
   Bukarica, A
   Gojkovic-Bukarica, L
AF Gostimirovic, M.
   Rajkovic, J.
   Novakovic, R.
   Djokic, V.
   Bukarica, A.
   Gojkovic-Bukarica, L.
TI THE EFFECTS OF POTASSIUM CHANNEL OPENER P1075 ON ISOLATED SAPHENOUS VEIN
   OBTAINED FROM PATIENTS WITH AND WITHOUT TYPE 2 DIABETES MELLITUS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Gostimirovic, M.; Rajkovic, J.; Novakovic, R.; Djokic, V.; Gojkovic-Bukarica, L.] Univ Belgrade, Inst Pharmacol Clin Pharmacol & Toxicol, Fac Med, Basic Pharmacol, Belgrade, Serbia.
   [Bukarica, A.] Univ Belgrade, Basic, Fac Med, Belgrade, Serbia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0571
BP E258
EP E259
DI 10.1016/j.atherosclerosis.2019.06.797
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800795
DA 2019-10-28
ER

PT J
AU Grechanyk, M
   Kuryata, O
AF Grechanyk, M.
   Kuryata, O.
TI SUBCLINICAL ATHEROSCLEROSIS, ECHOCARDIOGRAPHIC RANGES, LEVEL OF
   TRANSAMINASE IN PATIENTS WITH CORONARY HEART DISEASE WITH PRESERVED
   EJECTION FRACTION COMBINED WITH NONALCOHOLIC FATTY LIVER DISEASE.
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Grechanyk, M.; Kuryata, O.] Dnepropetrovsk Med Acad Hlth, Minist Ukraine, State Estab, Dnepr, Ukraine.
RI Kuryata, Olexandr/J-1005-2017
OI Kuryata, Olexandr/0000-0001-7642-0077
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0840
BP E159
EP E160
DI 10.1016/j.atherosclerosis.2019.06.480
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800478
DA 2019-10-28
ER

PT J
AU Grechanyk, M
   Kuryata, A
AF Grechanyk, M.
   Kuryata, A.
TI INTERRELATION LEVEL OF INSULIN, INSULINRESISTANCE, ENDOTHELIAL FUNCTION
   AND LEVEL OF LEPTIN IN PATIENTS WITH CORONARY HEART DISEASE IN
   COMBINATION WITH NONALCOHOLIC FATTY LIVER DISEASE.
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Grechanyk, M.; Kuryata, A.] Dnepropetrovsk Med Acad, Internal Med, Dnepr, Ukraine.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0974
BP E132
EP E132
DI 10.1016/j.atherosclerosis.2019.06.390
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800388
DA 2019-10-28
ER

PT J
AU Grechanyk, M
AF Grechanyk, M.
TI EFFECT OF OMEGA-3 POLYUNSATURATED FATTY ACIDS ON ENDOTHELIAL FUNCTION,
   LEPTIN LEVEL, BLOOD LIPID PROFILE IN PATIENTS WITH CORONARY HEART
   DISEASE IN COMBINATION WITH NON-ALCOHOLIC STEATOSIS.
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Grechanyk, M.] Dnepropetrovsk Med Acad, Internal Med, Dnepr, Ukraine.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0818
BP E145
EP E145
DI 10.1016/j.atherosclerosis.2019.06.432
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800430
DA 2019-10-28
ER

PT J
AU Grefhorst, A
   Reeskamp, LF
   Huijgen, R
   Hovingh, GK
AF Grefhorst, A.
   Reeskamp, L. F.
   Huijgen, R.
   Hovingh, G. K.
TI STATINS REDUCE HEPATIC ANGPTL3 EXPRESSION AND SECRETION, LIKELY BY
   INTERFERING WITH LXR-MEDIATED TRANSCRIPTION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Grefhorst, A.] Amsterdam UMC, Dept Expt Vasc Med, Amsterdam, Netherlands.
   [Reeskamp, L. F.; Huijgen, R.; Hovingh, G. K.] Amsterdam UMC, Dept Vasc Med, Amsterdam, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0391
BP E37
EP E37
DI 10.1016/j.atherosclerosis.2019.06.108
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800107
DA 2019-10-28
ER

PT J
AU Greve, AM
   Christoffersen, M
   Frikke-Schmidt, R
   Nordestgaard, BG
   Tybjaerg-Hansen, A
AF Greve, A. M.
   Christoffersen, M.
   Frikke-Schmidt, R.
   Nordestgaard, B. G.
   Tybjaerg-Hansen, A.
TI PLASMA TRANSTHYRETIN AND RISK OF INCIDENT HEART FAILURE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Greve, A. M.; Christoffersen, M.; Frikke-Schmidt, R.; Tybjaerg-Hansen, A.] Rigshosp, Klin Biokem Afdeling, DK-3011 Copenhagen OE, Denmark.
   [Frikke-Schmidt, R.; Nordestgaard, B. G.; Tybjaerg-Hansen, A.] Univ Copenhagen, Inst Clin Med, Fac Hlth & Med Sci, Copenhagen, Denmark.
   [Frikke-Schmidt, R.; Nordestgaard, B. G.; Tybjaerg-Hansen, A.] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Copenhagen Gen Populat Study, Herlev, Denmark.
   [Nordestgaard, B. G.] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Klin Biokem Afdeling, Herlev, Denmark.
   [Nordestgaard, B. G.; Tybjaerg-Hansen, A.] Copenhagen Univ Hosp, Bispebjerg & Frederiksberg Hosp, Copenhagen City Heart Study, Copenhagen, Denmark.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0953
BP E66
EP E66
DI 10.1016/j.atherosclerosis.2019.06.188
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800187
DA 2019-10-28
ER

PT J
AU Grevengoed, T
   Trammell, S
   Svenningsen, J
   Calder, P
   Cravatt, B
   Gillum, M
AF Grevengoed, T.
   Trammell, S.
   Svenningsen, J.
   Calder, P.
   Cravatt, B.
   Gillum, M.
TI N-ACYL TAURINES ARE FISH OIL-REGULATED BILIARY LIPIDS THAT LOWER LIPID
   ABSORPTION AND PLASMA TG
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Grevengoed, T.; Trammell, S.; Svenningsen, J.; Gillum, M.] Univ Copenhagen, NNF Ctr Basic Metab, Copenhagen, Denmark.
   [Calder, P.] Univ Southampton, Fac Med, Southampton, Hants, England.
   [Cravatt, B.] Scripps Res Inst, Chem, La Jolla, CA 92037 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0524
BP E232
EP E232
DI 10.1016/j.atherosclerosis.2019.06.713
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800711
DA 2019-10-28
ER

PT J
AU Groenhof, K
   Kofink, D
   Bots, M
   Lely, T
   Asselbergs, F
   Haitjema, S
AF Groenhof, K.
   Kofink, D.
   Bots, M.
   Lely, T.
   Asselbergs, F.
   Haitjema, S.
TI LEARNING FROM OUR HEALTHCARE SYSTEM: THE ANALYSIS OF LDL-CHOLESTEROL
   TARGET ATTAINMENT IN PATIENTS WITH ESTABLISHED CARDIOVASCULAR DISEASE IN
   ROUTINE CARE DATA
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Groenhof, K.; Bots, M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
   [Kofink, D.; Asselbergs, F.] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands.
   [Lely, T.] Univ Med Ctr Utrecht, Dept Obstet, Utrecht, Netherlands.
   [Haitjema, S.] Univ Med Ctr Utrecht, Lab Clin Chem & Haematol, Utrecht, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0962
BP E84
EP E84
DI 10.1016/j.atherosclerosis.2019.06.244
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800243
DA 2019-10-28
ER

PT J
AU Groselj, U
   Bratanic, N
   Mlinaric, M
   Battelino, T
AF Groselj, U.
   Bratanic, N.
   Mlinaric, M.
   Battelino, T.
TI LIVER TRANSPLANTATION IN A PATIENT WITH HOMOZYGOUS FAMILIAL
   HYPERCHOLESTEROLEMIA - LONG-TERM FOLLOW UP AND LITERATURE REVIEW
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Groselj, U.; Bratanic, N.; Mlinaric, M.; Battelino, T.] UMC, Univ Childrens Hosp Ljubljana, Dept Pediat Endocrinol Diabet & Metab, Ljubljana, Slovenia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0848
BP E207
EP E207
DI 10.1016/j.atherosclerosis.2019.06.629
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800627
DA 2019-10-28
ER

PT J
AU Guardiola, M
   Oliva, I
   Sanchez, M
   Plana, N
   Masana, L
   Monk, D
   Ribalta, J
AF Guardiola, M.
   Oliva, I.
   Sanchez, M.
   Plana, N.
   Masana, L.
   Monk, D.
   Ribalta, J.
TI PCSK9 PROMOTER METHYLATION IS ASSOCIATED WITH SMALL LDL PARTICLES IN
   PATIENTS WITH TYPE 2 DIABETES AND METABOLIC SYNDROME
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Guardiola, M.; Oliva, I.; Plana, N.; Masana, L.; Ribalta, J.] Univ Rovira & Virgili, Unitat Recerca Lipids & Arteriosclerosi, Dept Med & Cirurgia, Reus, Spain.
   [Sanchez, M.; Monk, D.] Bellvitge Inst Biomed Res IDIBELL, Imprinting & Canc Grp, Epigenet & Canc Biol Program PEBC, Barcelona, Spain.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0606
BP E43
EP E43
DI 10.1016/j.atherosclerosis.2019.06.123
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800122
DA 2019-10-28
ER

PT J
AU Guclu-Geyik, F
   Koseoglu, P
   Ozsoy, SD
   Cetin, HK
   Balkanay, OO
   Yildiz, CE
   Goksedef, D
   Coban, N
   Komurcu-Bayrak, AE
   Erginel-Unaltuna, N
AF Guclu-Geyik, F.
   Koseoglu, P.
   Ozsoy, S. D.
   Cetin, H. K.
   Balkanay, O. O.
   Yildiz, C. E.
   Goksedef, D.
   Coban, N.
   Komurcu-Bayrak, A. E.
   Erginel-Unaltuna, N.
TI IDENTIFICATION OF MIRNA PROFILING IN EPICARDIAL ADIPOSE TISSUE OF
   PATIENTS WITH ATHEROSCLEROSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Guclu-Geyik, F.; Koseoglu, P.; Coban, N.; Komurcu-Bayrak, A. E.; Erginel-Unaltuna, N.] Istanbul Univ, Geneticts, Aziz Sancar Inst Expt Med, Istanbul, Turkey.
   [Ozsoy, S. D.; Cetin, H. K.; Yildiz, C. E.] Istanbul Univ Cerrahpasa, Cardiovasc Surg, Inst Cardiol, Istanbul, Turkey.
   [Balkanay, O. O.; Goksedef, D.] Istanbul Univ Cerrahpasa, Cardiovasc Surg, Cerrahpasa Med Fac, Istanbul, Turkey.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0682
BP E194
EP E194
DI 10.1016/j.atherosclerosis.2019.06.590
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800588
DA 2019-10-28
ER

PT J
AU Gugliucci, A
   Bains, Y
   Caccavello, R
   Wen, M
   Erkin-Cakmak, A
   Mulligan, K
   Lustig, R
   Noworolski, S
   Schwarz, JM
AF Gugliucci, A.
   Bains, Y.
   Caccavello, R.
   Wen, M.
   Erkin-Cakmak, A.
   Mulligan, K.
   Lustig, R.
   Noworolski, S.
   Schwarz, J. M.
TI SHORT-TERM ISOCALORIC FRUCTOSE RESTRICTION IMPROVES POSTPRANDIAL
   LIPOPROTEIN SUBCLASS PROFILES
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Gugliucci, A.; Bains, Y.; Caccavello, R.; Mulligan, K.; Lustig, R.; Schwarz, J. M.] Touro Univ Calif, Res, Vallejo, CA USA.
   [Wen, M.] UCSF, Endocrinol, San Francisco, CA USA.
   [Erkin-Cakmak, A.] UCSF, Pediat Endocrinol, San Francisco, CA USA.
   [Noworolski, S.] UCSF, Radiol, San Francisco, CA USA.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0031
BP E59
EP E60
DI 10.1016/j.atherosclerosis.2019.06.169
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800168
DA 2019-10-28
ER

PT J
AU Hardtner, C
   Kornemann, J
   Krebs, K
   Sharipova, D
   Dufner, B
   Hoppe, N
   Pieterman, E
   Princen, MGH
   Ho-Tin-Noe, B
   Bode, C
   Zirlik, A
   Hilgendorf, I
   Ehlert, C
AF Haerdtner, C.
   Kornemann, J.
   Krebs, K.
   Sharipova, D.
   Dufner, B.
   Hoppe, N.
   Pieterman, E.
   Princen, M. G. H.
   Ho-Tin-Noe, B.
   Bode, C.
   Zirlik, A.
   Hilgendorf, I.
   Ehlert, C.
TI ORAL ATORVASTATIN INDUCES PLAQUE REGRESSION BY INHIBITING MACROPHAGE
   PROLIFERATION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Haerdtner, C.; Kornemann, J.; Krebs, K.; Sharipova, D.; Dufner, B.; Hoppe, N.; Bode, C.; Zirlik, A.; Hilgendorf, I.; Ehlert, C.] Univ Heart Ctr Freiburg Bad Krozingen, Cardiol & Angiol 1, Freiburg, Germany.
   [Pieterman, E.; Princen, M. G. H.] Netherlands Org Appl Sci Res TNO Prevent & Hlth, Leiden, Netherlands.
   [Ho-Tin-Noe, B.] Univ Paris Diderot, INSERM, U1148, Lab Vasc Translat Sci, Paris, France.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0226
BP E78
EP E78
DI 10.1016/j.atherosclerosis.2019.06.225
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800224
DA 2019-10-28
ER

PT J
AU Haitjema, S
   Bezemer, T
   de Groot, M
   Huisman, A
   Blasse, E
   van Solinge, W
   Hoefer, I
AF Haitjema, S.
   Bezemer, T.
   de Groot, M.
   Huisman, A.
   Blasse, E.
   van Solinge, W.
   Hoefer, I.
TI RED CELL DISTRIBUTION WIDTH: HORSEMAN OF THE PATHOPHYSIOLOGICAL
   APOCALYPSE?
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Haitjema, S.; Bezemer, T.; de Groot, M.; Huisman, A.; Blasse, E.; van Solinge, W.; Hoefer, I.] Univ Med Ctr Utrecht, Lab Clin Chem & Haematol, Utrecht, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1017
BP E167
EP E167
DI 10.1016/j.atherosclerosis.2019.06.505
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800503
DA 2019-10-28
ER

PT J
AU Hamed, W
   Reda, A
   Magdy, A
   Mounir, H
AF Hamed, W.
   Reda, A.
   Magdy, A.
   Mounir, H.
TI SUBCLINICAL ATHEROSCLEROSIS IN ASYMPTOMATIC PATIENTS WITH METABOLIC
   SYNDROME: THE ROLE OF MULTI-SLICE COMPUTED TOMOGRAPHY CORONARY
   ANGIOGRAPHY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Hamed, W.] Menoufia Univ, Cardiol, Shibin Al Kawm, Egypt.
   [Reda, A.] Menoufia Univ, Cardiol, Cairo, Egypt.
   [Magdy, A.; Mounir, H.] Heart Inst, Cardiol, Cairo, Egypt.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0075
BP E138
EP E138
DI 10.1016/j.atherosclerosis.2019.06.410
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800408
DA 2019-10-28
ER

PT J
AU Hamilton, JA
   Bodde, J
   Tasik, GD
   Kolar, E
   Burritt, N
   Erion, K
   Sitaram, M
   Deeney, J
   Hajjar, DP
   Gotto, AM
   Corkey, B
   Sponseller, C
AF Hamilton, J. A.
   Bodde, J.
   Tasik, G. Datu
   Kolar, E.
   Burritt, N.
   Erion, K.
   Sitaram, M.
   Deeney, J.
   Hajjar, D. P.
   Gotto, A. M.
   Corkey, B.
   Sponseller, C.
TI EFFECTS OF DIFFERENT STATINS ON INSULIN STORAGE AND SECRETION FROM
   PANCREATIC beta-CELLS: MECHANISMS AND CLINICAL IMPLICATIONS.
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Hamilton, J. A.; Bodde, J.] Boston Univ, Sch Med, Physiol & Biophys, Boston, MA 02118 USA.
   [Tasik, G. Datu; Kolar, E.; Burritt, N.; Erion, K.; Sitaram, M.; Deeney, J.] Boston Univ, Sch Med, Endocrinol Diabet & Nutr, Boston, MA 02118 USA.
   [Corkey, B.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.
   [Sponseller, C.] Kowa Pharmaceut Amer Inc, Montgomery, AL USA.
   [Hajjar, D. P.; Gotto, A. M.] Cornell Univ, Weilll Cornell Med, Dept Pathol, New York, NY 10021 USA.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0533
BP E94
EP E94
DI 10.1016/j.atherosclerosis.2019.06.272
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800271
DA 2019-10-28
ER

PT J
AU Han, SH
   Yu, J
   Youngwoo, JA
   Chun, OP
   Kon, KK
AF Han, S. H.
   Yu, J.
   Youngwoo, J. Albert
   Chun, O. Pyung
   Kon, K. Kwang
TI METABOLIC PARAMETERS AS INDEPENDENT MARKERS FOR CORONARY ENDOTHELIAL
   DYSFUNCTION IN HUMANS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Han, S. H.; Yu, J.; Youngwoo, J. Albert; Chun, O. Pyung; Kon, K. Kwang] Gachon Univ, Cardiol, Gil Hosp, Incheon, South Korea.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0069
BP E263
EP E263
DI 10.1016/j.atherosclerosis.2019.06.814
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800812
DA 2019-10-28
ER

PT J
AU Harada-Shiba, M
   Arai, H
   Nohara, A
   Sato, K
   Hirayama, A
   Ako, J
   Naito, Y
   Ozaki, A
   Nakamura, M
AF Harada-Shiba, M.
   Arai, H.
   Nohara, A.
   Sato, K.
   Hirayama, A.
   Ako, J.
   Naito, Y.
   Ozaki, A.
   Nakamura, M.
TI NOVEL INSIGHTS FROM GENETIC AND CLINICAL DATA OF FAMILIAL
   HYPERCHOLESTEROLEMIA IN PATIENTS PRESENTING WITH ACUTE CORONARY
   SYNDROME: EXPLORE-J REGISTRY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Harada-Shiba, M.] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Mol Innovat Lipidol, Osaka, Japan.
   [Arai, H.] Natl Ctr Geriatr & Gerontol, Obu, Aichi, Japan.
   [Nohara, A.] Kanazawa Univ, Grad Sch Med Sci, Dept Lipidol, Kanazawa, Ishikawa, Japan.
   [Sato, K.] Tokyo Womens Med Univ, Dept Cardiol, Tokyo, Japan.
   [Hirayama, A.] Osaka Police Hosp, Cardiovasc Div, Osaka, Japan.
   [Ako, J.] Kitasato Univ, Dept Cardiovasc Med, Sagamihara, Kanagawa, Japan.
   [Naito, Y.; Ozaki, A.] Sanofi KK, Diabet & Cardiovasc Med Operat, Tokyo, Japan.
   [Nakamura, M.] Toho Univ, Ohashi Med Ctr, Div Cardiovasc Med, Tokyo, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0348
BP E90
EP E90
DI 10.1016/j.atherosclerosis.2019.06.262
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800261
DA 2019-10-28
ER

PT J
AU Hartgers, M
   Reeskamp, R
   Winkelmeijer, M
   Volta, A
   Hovingh, K
   Grehorst, A
AF Hartgers, M.
   Reeskamp, R.
   Winkelmeijer, M.
   Volta, A.
   Hovingh, K.
   Grehorst, A.
TI VARIANTS IN SIGNAL TRANSDUCING ADAPTOR FAMILY MEMBER 1 (STAP1) DO NOT
   AFFECT LDL-CHOLESTEROL
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Hartgers, M.; Reeskamp, R.; Hovingh, K.] Amsterdam Univ Med Ctr, Locat AMC, Vasc Med, Amsterdam, Netherlands.
   [Winkelmeijer, M.; Grehorst, A.] Amsterdam Univ Med Ctr, Locat AMC, Expt Vasc Med, Amsterdam, Netherlands.
   [Volta, A.] Univ Florence, Dept Expt & Clin Med, Florence, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0933
BP E79
EP E79
DI 10.1016/j.atherosclerosis.2019.06.229
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800228
DA 2019-10-28
ER

PT J
AU Hartman, R
   Siemelink, M
   Haitjema, S
   Luijk, R
   Dekkers, K
   Boltjes, A
   de Borst, GJ
   Heijmans, B
   Asselbergs, F
   Pasterkamp, G
   Van der Laan, SW
   den Ruijter, H
AF Hartman, R.
   Siemelink, M.
   Haitjema, S.
   Luijk, R.
   Dekkers, K.
   Boltjes, A.
   de Borst, G. J.
   Heijmans, B.
   Asselbergs, F.
   Pasterkamp, G.
   Van der Laan, S. W.
   den Ruijter, H.
TI AUTOSOMAL SEXUAL DIMORPHISM IN METHYLATION OF ADVANCED ATHEROSCLEROTIC
   CAROTID PLAQUES
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Hartman, R.; den Ruijter, H.] Univ Utrecht, Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands.
   [Siemelink, M.] Univ Utrecht, Univ Med Ctr Utrecht, Clin Genet, Utrecht, Netherlands.
   [Haitjema, S.; Boltjes, A.; Pasterkamp, G.; Van der Laan, S. W.] Univ Utrecht, Univ Med Ctr Utrecht, Lab Clin Chem & Hematol, Utrecht, Netherlands.
   [Luijk, R.; Dekkers, K.; Heijmans, B.] Leiden Univ, Med Ctr, Mol Epidemiol, Leiden, Netherlands.
   [de Borst, G. J.] Univ Utrecht, Univ Med Ctr Utrecht, Vasc Surg, Utrecht, Netherlands.
   [Asselbergs, F.] Univ Utrecht, Univ Med Ctr Utrecht, Cardiol, Utrecht, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1005
BP E66
EP E66
DI 10.1016/j.atherosclerosis.2019.06.189
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800188
DA 2019-10-28
ER

PT J
AU Hartog, M
   Hartog, L
   Hartog, J
   Groothuis, J
   Wind, A
   Aertsen, M
AF Hartog, M.
   Hartog, L.
   Hartog, J.
   Groothuis, J.
   Wind, A.
   Aertsen, M.
TI PREVENTION OF ISCHEMIC CEREBRAL EVENTS BY DETECTION OF ATRIAL
   FIBRILLATION IN HIGH RISK PATIENTS.
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Hartog, M.] Leiden Univ, Fac Med, Bilthoven, Netherlands.
   [Hartog, L.] Katholieke Univ Leuven, Biomed Lab Tech, Leuven, Belgium.
   [Hartog, J.; Groothuis, J.; Wind, A.; Aertsen, M.] Diakonessen Hosp, Cardiol, Utrecht, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1101
BP E277
EP E277
DI 10.1016/j.atherosclerosis.2019.06.859
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800857
DA 2019-10-28
ER

PT J
AU Heijmans, R
   Singh, S
   Lieverse, A
   Gornik, O
   Sijbrands, E
   Lauc, G
   van Hoek, M
AF Heijmans, R.
   Singh, S.
   Lieverse, A.
   Gornik, O.
   Sijbrands, E.
   Lauc, G.
   van Hoek, M.
TI IGG N-GLYCAN PATTERNS ARE ASSOCIATED WITH ISCHEMIC HEART DISEASE IN TYPE
   2 DIABETES
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Heijmans, R.; Singh, S.; Sijbrands, E.; van Hoek, M.] Erasmus MC, Internal Med, Rotterdam, Netherlands.
   [Singh, S.; Lieverse, A.] Maxima Med Ctr, Internal Med, Eindhoven, Netherlands.
   [Gornik, O.; Lauc, G.] Univ Zagreb, Fac Pharm & Biochem, Zagreb, Croatia.
   [Lauc, G.] Geno Glycosci, Res Lab, Zagreb, Croatia.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0927
BP E116
EP E117
DI 10.1016/j.atherosclerosis.2019.06.338
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800337
DA 2019-10-28
ER

PT J
AU Heintjes, E
   Hartgers, ML
   Bezemer, I
   Hovingh, GK
   Stroes, ES
   Penning-van Beest, F
   Kutikova, L
   Lucius, B
   Renes, J
   Villa, G
   Herings, R
AF Heintjes, E.
   Hartgers, M. L.
   Bezemer, I.
   Hovingh, G. K.
   Stroes, E. S.
   Penning-van Beest, F.
   Kutikova, L.
   Lucius, B.
   Renes, J.
   Villa, G.
   Herings, R.
TI REAL-WORLD USE OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9
   INHIBITOR (PCSK9-I) ANTIBODIES IN THE NETHERLANDS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Heintjes, E.; Bezemer, I.; Penning-van Beest, F.; Herings, R.] PHARMO Inst Drug Outcomes Res, Utrecht, Netherlands.
   [Hartgers, M. L.; Hovingh, G. K.; Stroes, E. S.] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Vasc Med, Amsterdam, Netherlands.
   [Kutikova, L.; Villa, G.] Amgen Europe GmbH, Global Hlth Econ, Zug, Switzerland.
   [Lucius, B.] Amgen BV, Value Access & Policy Dept, Breda, Switzerland.
   [Renes, J.] Amgen BV, Dept Med, Breda, Switzerland.
   [Herings, R.] Univ Amsterdam, Dept Epidemiol & Biostat, Amsterdam Univ Med Ctr, Amsterdam, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0729
BP E199
EP E200
DI 10.1016/j.atherosclerosis.2019.06.606
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800604
DA 2019-10-28
ER

PT J
AU Hennig, B
   Petriello, M
AF Hennig, B.
   Petriello, M.
TI HEALTHFUL NUTRITION AS A MODIFIER OF ENVIRONMENTAL POLLUTANT-INDUCED
   INFLAMMATORY DISEASES: IMPLICATIONS IN ATHEROSCLEROSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Hennig, B.] Univ Kentucky, Superfund Res Ctr, Lexington, KY 40506 USA.
   [Petriello, M.] Univ Kentucky, Cardiovasc Med, Lexington, KY 40506 USA.
NR 0
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0058
BP E268
EP E269
DI 10.1016/j.atherosclerosis.2019.06.830
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800828
DA 2019-10-28
ER

PT J
AU Ho, JH
   Liu, Y
   Adam, S
   Azmi, S
   Dhage, S
   Syed, A
   Ammori, BJ
   Donn, R
   Gibson, MJ
   Malik, RA
   Yang, X
   Durrington, PN
   Tsimikas, S
   Soran, H
AF Ho, J. H.
   Liu, Y.
   Adam, S.
   Azmi, S.
   Dhage, S.
   Syed, A.
   Ammori, B. J.
   Donn, R.
   Gibson, M. J.
   Malik, R. A.
   Yang, X.
   Durrington, P. N.
   Tsimikas, S.
   Soran, H.
TI DIVERGENT CHANGES IN LIPOPROTEIN(A) AND OXIDISED PHOSPHOLIPIDS FOLLOWING
   METABOLIC SURGERY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Ho, J. H.; Liu, Y.; Adam, S.; Dhage, S.; Donn, R.; Durrington, P. N.; Soran, H.] Univ Manchester, Lipid Res Grp, Manchester, Lancs, England.
   [Azmi, S.] Manchester Univ NHS Fdn Trust, Dept Med, Manchester, Lancs, England.
   [Syed, A.; Gibson, M. J.] Salford Royal NHS Fdn Trust, Dept Endocrinol & Diabet, Salford, Lancs, England.
   [Ammori, B. J.] Salford Royal NHS Fdn Trust, Dept Surg, Salford, Lancs, England.
   [Malik, R. A.] Weill Cornell Med, Dept Med, Doha, Qatar.
   [Yang, X.; Tsimikas, S.] Univ Calif San Diego, Div Cardiovasc Med, La Jolla, CA 92093 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0640
BP E230
EP E230
DI 10.1016/j.atherosclerosis.2019.06.706
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800704
DA 2019-10-28
ER

PT J
AU Ho, JH
   Adam, S
   Liu, Y
   Azmi, S
   Dhage, S
   Syed, A
   Ammori, BJ
   Donn, R
   Malik, RA
   Yang, X
   Tsimikas, S
   Soran, H
AF Ho, J. H.
   Adam, S.
   Liu, Y.
   Azmi, S.
   Dhage, S.
   Syed, A.
   Ammori, B. J.
   Donn, R.
   Malik, R. A.
   Yang, X.
   Tsimikas, S.
   Soran, H.
TI REDUCTION IN AUTOANTIBODIES TO OXIDISED LDL AND APOB-IMMUNE COMPLEXES
   FOLLOWING METABOLIC SURGERY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Ho, J. H.; Adam, S.; Liu, Y.; Dhage, S.; Donn, R.; Soran, H.] Univ Manchester, Lipid Res Grp, Manchester, Lancs, England.
   [Azmi, S.] Manchester Univ NHS Fdn Trust, Dept Med, Manchester, Lancs, England.
   [Syed, A.] Salford Royal NHS Fdn Trust, Dept Endocrinol, Salford, Lancs, England.
   [Ammori, B. J.] Salford Royal NHS Fdn Trust, Dept Surg, Salford, Lancs, England.
   [Malik, R. A.] Weill Cornell Med Qatar, Dept Med, Doha, Qatar.
   [Yang, X.; Tsimikas, S.] Univ Calif San Diego, Div Cardiovasc Med, La Jolla, CA 92093 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0655
BP E82
EP E82
DI 10.1016/j.atherosclerosis.2019.06.238
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800237
DA 2019-10-28
ER

PT J
AU Hoekstra, M
   Ouweneel, A
   Nahon, J
   Geerling, J
   Van Eck, M
AF Hoekstra, M.
   Ouweneel, A.
   Nahon, J.
   Geerling, J.
   Van Eck, M.
TI SR-BI DEFICIENCY UNCOUPLES THE DEVELOPMENT OF HYPERTRIGLYCERIDEMIA AND
   ATHEROSCLEROSIS FROM HEPATIC STEATOSIS AAND GLUCOSE INTOLERANCE IN OBESE
   MICE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Hoekstra, M.; Ouweneel, A.; Nahon, J.; Geerling, J.; Van Eck, M.] Leiden Acad Ctr Drug Res, BioTherapeut, Leiden, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0615
BP E121
EP E121
DI 10.1016/j.atherosclerosis.2019.06.352
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800351
DA 2019-10-28
ER

PT J
AU Hofbauer, TM
   Mangold, A
   Ondracek, AS
   Scherz, T
   Seidl, V
   Lang, IM
AF Hofbauer, T. M.
   Mangold, A.
   Ondracek, A. S.
   Scherz, T.
   Seidl, V.
   Lang, I. M.
TI FIBROCYTES AND NEUTROPHIL EXTRACELLULAR TRAPS AT THE CULPRIT LESION SITE
   IN MYOCARDIAL INFARCTION: A ROLE FOR MONOCYTE CHEMOATTRACTANT PROTEIN 1
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Hofbauer, T. M.; Mangold, A.; Ondracek, A. S.; Scherz, T.; Seidl, V.; Lang, I. M.] Med Univ Vienna, Dept Cardiol Internal Med 2, Vienna, Austria.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0672
BP E24
EP E24
DI 10.1016/j.atherosclerosis.2019.06.068
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800067
DA 2019-10-28
ER

PT J
AU Hong, SJ
   Choi, SY
   Han, SH
   Choi, YJ
   Ahn, T
AF Hong, S. J.
   Choi, S. Y.
   Han, S. H.
   Choi, Y. J.
   Ahn, T.
TI SAFETY AND TOLERABILITY OF ATORVASTATIN CALCIUM ANHYDROUS IN KOREAN
   PATIENTS WITH DYSLIPIDEMIA: THE FINAL ANALYSIS FROM THE LAMP STUDY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Hong, S. J.] Korea Univ, Anam Hosp, Dept Cardiol, Seoul, South Korea.
   [Choi, S. Y.] Ajou Univ Hosp, Dept Cardiol, Suwon, South Korea.
   [Han, S. H.; Ahn, T.] Gachon Univ, Gil Hosp, Dept Cardiol, Inchon, South Korea.
   [Choi, Y. J.] Sejong Gen Hoapital, Dept Cardiol, Puchon, South Korea.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0265
BP E204
EP E204
DI 10.1016/j.atherosclerosis.2019.06.621
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800619
DA 2019-10-28
ER

PT J
AU Hong, SJ
   Lim, DS
AF Hong, S. J.
   Lim, D. S.
TI PERI-PROCEDURAL MYOCARDIAL INFARCTION WAS SIGNIFICANTLY REDUCED WITH
   PITAVASTATIN 4 MG WHEN COMPARED TO PITAVASTATIN 1MG
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Hong, S. J.; Lim, D. S.] Korea Univ, Anam Hosp, Dept Cardiol, Seoul, South Korea.
NR 0
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0266
BP E36
EP E36
DI 10.1016/j.atherosclerosis.2019.06.106
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800105
DA 2019-10-28
ER

PT J
AU Hoogendoorn, A
   den Hoedt, S
   van der Zee-van Vark, L
   Dorst, K
   Jager-van Beugen, E
   van der Steen, AFW
   Roeters-van Lennep, J
   Wentzel, JJ
   Mulder, MT
AF Hoogendoorn, A.
   den Hoedt, S.
   van der Zee-van Vark, L.
   Dorst, K.
   Jager-van Beugen, E.
   van der Steen, A. F. W.
   Roeters-van Lennep, J.
   Wentzel, J. J.
   Mulder, M. T.
TI A DISTINCT LDL PROFILE TO PREDICT THE RISK OF CARDIOVASCULAR DISEASE IN
   FAMILIAL HYPERCHOLESTEROLEMIA SUBJECTS: INITIAL PRE-CLINICAL RESULTS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Hoogendoorn, A.; van der Steen, A. F. W.; Wentzel, J. J.] Erasmus MC, Cardiol, Biomed Engn, Rotterdam, Netherlands.
   [den Hoedt, S.; van der Zee-van Vark, L.; Dorst, K.; Jager-van Beugen, E.; Roeters-van Lennep, J.; Mulder, M. T.] Erasmus MC, Internal Med Lab Vasc Med, Sect Pharmacol & Vasc Med, Rotterdam, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0889
BP E220
EP E220
DI 10.1016/j.atherosclerosis.2019.06.672
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800670
DA 2019-10-28
ER

PT J
AU Hoogendoorn, A
   Krabbendam-Peters, I
   Hartman, EMJ
   Hekkert, MVT
   van Gaalen, K
   Witberg, KT
   Ligthart, JMR
   Drouet, L
   van der Heiden, K
   van der Steen, AFW
   Duncker, DJ
   Wentzel, JJ
AF Hoogendoorn, A.
   Krabbendam-Peters, I.
   Hartman, E. M. J.
   Hekkert, M. Visser-te Lintel
   van Gaalen, K.
   Witberg, K. T.
   Ligthart, J. M. R.
   Drouet, L.
   van der Heiden, K.
   van der Steen, A. F. W.
   Duncker, D. J.
   Wentzel, J. J.
TI AN ADULT PORCINE MODEL OF FAMILIAL HYPERCHOLESTEROLEMIA TO STUDY NATURAL
   CORONARY ATHEROSCLEROTIC PLAQUE DEVELOPMENT AND DESTABILIZATION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Hoogendoorn, A.; Hartman, E. M. J.; van Gaalen, K.; van der Heiden, K.; van der Steen, A. F. W.; Wentzel, J. J.] Erasmus MC, Cardiol, Biomed Engn, Rotterdam, Netherlands.
   [Krabbendam-Peters, I.; Hekkert, M. Visser-te Lintel; Duncker, D. J.] Erasmus MC, Cardiol, Expt Cardiol, Rotterdam, Netherlands.
   [Witberg, K. T.; Ligthart, J. M. R.] Erasmus MC, Cardiol, Intervent Cardiol, Rotterdam, Netherlands.
   [Drouet, L.] Hosp Lariboisiere, Dept Angiohematol, Paris, France.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0888
BP E271
EP E271
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800835
DA 2019-10-28
ER

PT J
AU Hoogendoorn, A
   Kok, AM
   Hartman, EMJ
   Chiastra, C
   Casadonte, L
   Coenen, A
   Korteland, SA
   van der Heiden, K
   Gijsen, FJH
   Duncker, DJ
   van der Steen, AFW
   Wentzel, JJ
AF Hoogendoorn, A.
   Kok, A. M.
   Hartman, E. M. J.
   Chiastra, C.
   Casadonte, L.
   Coenen, A.
   Korteland, S. A.
   van der Heiden, K.
   Gijsen, F. J. H.
   Duncker, D. J.
   van der Steen, A. F. W.
   Wentzel, J. J.
TI CORONARY VULNERABLE PLAQUE DEVELOPMENT IS PROMOTED BY MULTIDIRECTIONAL
   WALL SHEAR STRESS - A PRE-CLINICAL IMAGING STUDY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Hoogendoorn, A.; Kok, A. M.; Hartman, E. M. J.; Korteland, S. A.; van der Heiden, K.; Gijsen, F. J. H.; van der Steen, A. F. W.; Wentzel, J. J.] Erasmus MC, Cardiol Biomed Engn, Rotterdam, Netherlands.
   [Chiastra, C.] Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, Lab Biol Struct Mech, Milan, Italy.
   [Casadonte, L.] Amsterdam UMC, Biomed Engn & Phys, Amsterdam, Netherlands.
   [Coenen, A.] Erasmus MC, Cardiol Radiol, Rotterdam, Netherlands.
   [Duncker, D. J.] Erasmus MC, Cardiol Expt Cardiol, Rotterdam, Netherlands.
RI Chiastra, Claudio/AAA-3101-2019
OI Chiastra, Claudio/0000-0003-2070-6142
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0819
BP E105
EP E105
DI 10.1016/j.atherosclerosis.2019.06.307
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800306
DA 2019-10-28
ER

PT J
AU Hoogeveen, R
   Sun, W
   Ballantyne, C
AF Hoogeveen, R.
   Sun, W.
   Ballantyne, C.
TI SMALL DENSE LDL-CHOLESTEROL (SDLDL-C) AS A RISK ENHANCER OF
   ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD): THE ATHEROSCLEROSIS RISK
   IN COMMUNITIES (ARIC) STUDY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Hoogeveen, R.; Sun, W.; Ballantyne, C.] Baylor Coll Med, Med, Houston, TX 77030 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1125
BP E278
EP E278
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800858
DA 2019-10-28
ER

PT J
AU Hoogeveen, R
   Opstal, TSJ
   Kaiser, Y
   Kroon, J
   Knol, RJJ
   Bax, WA
   Verberne, HJ
   Cornel, JH
   Stroes, ES
AF Hoogeveen, R.
   Opstal, T. S. J.
   Kaiser, Y.
   Kroon, J.
   Knol, R. J. J.
   Bax, W. A.
   Verberne, H. J.
   Cornel, J. H.
   Stroes, E. S.
TI PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 ANTIBODIES ATTENUATE
   ARTERIAL WALL INFLAMMATION IN STATIN INTOLERANT PATIENTS IN ABSENCE OF
   CRP CHANGE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Hoogeveen, R.; Kaiser, Y.; Kroon, J.; Stroes, E. S.] Univ Amsterdam, Med Ctr, Vasc Med, Amsterdam, Netherlands.
   [Opstal, T. S. J.; Cornel, J. H.] Noordwest Ziekenhuisgrp, Cardiol, Alkmaar, Netherlands.
   [Knol, R. J. J.] Noordwest Ziekenhuisgrp, Nucl Med, Alkmaar, Netherlands.
   [Bax, W. A.] Noordwest Ziekenhuisgrp, Internal Med, Alkmaar, Netherlands.
   [Verberne, H. J.] Univ Amsterdam, Med Ctr, Radiol & Nucl Med, Amsterdam, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0111
BP E12
EP E12
DI 10.1016/j.atherosclerosis.2019.06.033
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800033
DA 2019-10-28
ER

PT J
AU Houde, M
   Carrier, E
   Grandbois, M
   Bkaily, G
   Warner, TD
   Korporaal, SJA
   Van Eck, M
   D'Orleans-Juste, P
AF Houde, M.
   Carrier, E.
   Grandbois, M.
   Bkaily, G.
   Warner, T. D.
   Korporaal, S. J. A.
   Van Eck, M.
   D'Orleans-Juste, P.
TI ALTERED INHIBITION OF PLATELET AGGREGATION IN HYPERCHOLEROLEMIA IN MICE
   AND HUMANS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Houde, M.; Van Eck, M.] Leiden Univ, BioTherapeut, Leiden, Netherlands.
   [Carrier, E.; Grandbois, M.; D'Orleans-Juste, P.] Univ Sherbrooke, Pharmacol & Physiol, Sherbrooke, PQ, Canada.
   [Bkaily, G.] Univ Sherbrooke, Anat & Biol Cellulaire, Sherbrooke, PQ, Canada.
   [Warner, T. D.] Queen Mary Univ London, Blizard Inst, London, England.
   [Korporaal, S. J. A.] Utrecht Med Ctr, Expt Cardiol, Utrecht, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0727
BP E109
EP E110
DI 10.1016/j.atherosclerosis.2019.06.320
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800319
DA 2019-10-28
ER

PT J
AU Hsieh, FI
   Huang, JY
   Chiou, HY
   Li-Ming, L
   Jeng, JS
   Lin, HJ
   Hu, CJ
AF Hsieh, F. I.
   Huang, J. Y.
   Chiou, H. Y.
   Li-Ming, L.
   Jeng, J. S.
   Lin, H. J.
   Hu, C. J.
TI IMPACT OF SIRT6 AND SIRT7 GENETIC POLYMORPHISMS ON RISK OF EARLY-ONSET
   ISCHEMIC STROKE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Hsieh, F. I.; Huang, J. Y.; Chiou, H. Y.] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan.
   [Li-Ming, L.] Shin Kong WHS Mem Hosp, Dept Neurol, Taipei, Taiwan.
   [Jeng, J. S.] Natl Taiwan Univ Hosp, Stroke Ctr, Taipei, Taiwan.
   [Jeng, J. S.] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan.
   [Lin, H. J.] Chi Mei Med Ctr, Dept Neurol, Tainan, Taiwan.
   [Hu, C. J.] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei, Taiwan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0299
BP E196
EP E196
DI 10.1016/j.atherosclerosis.2019.06.595
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800593
DA 2019-10-28
ER

PT J
AU Huang, JY
   Chiou, HY
   Lien, LM
   Jeng, JS
   Lin, HJ
   Hu, CJ
   Hsieh, FI
AF Huang, J. Y.
   Chiou, H. Y.
   Lien, L. M.
   Jeng, J. S.
   Lin, H. J.
   Hu, C. J.
   Hsieh, F. I.
TI SIGNIFICANT ASSOCIATIONS OF NRF1 GENETIC POLYMORPHISMS WITH THE RISK OF
   EARLY-ONSET ISCHEMIC STROKE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Huang, J. Y.; Chiou, H. Y.; Hsieh, F. I.] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan.
   [Lien, L. M.] Shin Kong WHS Mem Hosp, Dept Neurol, Taipei, Taiwan.
   [Jeng, J. S.] Natl Taiwan Univ Hosp, Stroke Ctr & Dept Neurol, Taipei, Taiwan.
   [Lin, H. J.] Chi Mei Med Ctr, Dept Neurol, Tainan, Taiwan.
   [Hu, C. J.] Taipei Med Univ, Dept Neurol, Shuang Ho Hosp, New Taipei, Taiwan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0338
BP E162
EP E163
DI 10.1016/j.atherosclerosis.2019.06.490
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800488
DA 2019-10-28
ER

PT J
AU Hug, K
   Tauchi, M
   Raaz-Schrauder, D
   Stumpfe, F
   Achenbach, S
   Dietel-Schor, B
   Urschel, K
AF Hug, K.
   Tauchi, M.
   Raaz-Schrauder, D.
   Stumpfe, F.
   Achenbach, S.
   Dietel-Schor, B.
   Urschel, K.
TI SHEAR STRESS-DEPENDENT EXPRESSION OF GLYPICAN-4 AND HEPARAN SULFATE IN
   DIFFERENT PRIMARY HUMAN ENDOTHELIAL CELLS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Hug, K.; Tauchi, M.; Raaz-Schrauder, D.; Achenbach, S.; Dietel-Schor, B.; Urschel, K.] Friedrich Alexander Univ Erlangen Nurnberg, Cardiol & Angiol, Erlangen, Germany.
   [Stumpfe, F.] Friedrich Alexander Univ Erlangen Nurnberg, Obstet & Gynecol, Erlangen, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0626
BP E266
EP E266
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800819
DA 2019-10-28
ER

PT J
AU Humphries, S
   Cooper, J
   Capps, N
   Durrington, P
   Jones, B
   McDowell, I
   Soran, H
   Neil, A
AF Humphries, S.
   Cooper, J.
   Capps, N.
   Durrington, P.
   Jones, B.
   McDowell, I.
   Soran, H.
   Neil, A.
TI CORONARY HEART DISEASE MORTALITY IN SEVERE AND NON-SEVERE FAMILIAL
   HYPER-CHOLESTEROLAEMIA : DATA FROM THE UK SIMON BROOME FH REGISTER.
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Humphries, S.] UCL, Inst Cardiovasc Sci, London, England.
   [Cooper, J.] ICS, Cardiovasc Genet, London, England.
   [Capps, N.] Princess Royal Hosp, Clin Biochem, Telford, Shrops, England.
   [Durrington, P.] Univ Manchester, Cardiovasc Res Grp, Manchester, Lancs, England.
   [Jones, B.] Imperial Coll London, Invest Med, London, England.
   [McDowell, I.] Univ Hosp Wales, Med Biochem & Immunol, Cardiff, S Glam, Wales.
   [Soran, H.] Cent Manchester Univ Hosp NHS Fdn Trust, Chem Pathol, Manchester, Lancs, England.
   [Neil, A.] Univ Oxford, Wolfson Coll, Oxford, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0118
BP E89
EP E89
DI 10.1016/j.atherosclerosis.2019.06.260
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800259
DA 2019-10-28
ER

PT J
AU Hung, KY
   Huang, JW
   Chao, CT
AF Hung, K. Y.
   Huang, J. W.
   Chao, C. T.
TI FRAILTY PREDICTS A HIGHER RISK OF CARDIOVASCULAR EVENTS AMONG PATIENTS
   WITH DIABETIC KIDNEY DISEASE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Hung, K. Y.] Natl Taiwan Univ Hosp, Hsinchu Branch, Superintendent Off, Hsinchu, Taiwan.
   [Huang, J. W.] Natl Taiwan Univ Hosp, Internal Med, Taipei, Taiwan.
   [Chao, C. T.] Natl Taiwan Univ Hosp, Beihu Branch, Internal Med, Taipei, Taiwan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0873
BP E118
EP E118
DI 10.1016/j.atherosclerosis.2019.06.342
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800341
DA 2019-10-28
ER

PT J
AU Ibi, D
   Noordam, R
   van Klinken, J
   Li-Gao, R
   de Mutsert, R
   Trompet, S
   Christen, T
   van Heemst, D
   Mook-Kanamori, D
   Rosendaal, F
   Jukema, J
   Rensen, P
   van Dijk, K
AF Ibi, D.
   Noordam, R.
   van Klinken, J.
   Li-Gao, R.
   de Mutsert, R.
   Trompet, S.
   Christen, T.
   van Heemst, D.
   Mook-Kanamori, D.
   Rosendaal, F.
   Jukema, J.
   Rensen, P.
   van Dijk, K.
TI COMMON GENETIC VARIATION IN HEPATIC LIPASE (LIPC) ASSOCIATED WITH
   POSTPRANDIAL LIPID METABOLISM IN A GENOME-WIDE ASSOCIATION AND
   METABOLOMICS STUDY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Ibi, D.; van Klinken, J.; van Dijk, K.] LUMC, Human Genet, Leiden, Netherlands.
   [Noordam, R.] Leiden Univ, Med Ctr, Dept Internal Med, Leiden, Netherlands.
   [Li-Gao, R.; de Mutsert, R.; Christen, T.; Mook-Kanamori, D.; Rosendaal, F.] LUMC, Clin Epidemiol, Leiden, Netherlands.
   [Trompet, S.; van Heemst, D.] LUMC, Internal Med, Leiden, Netherlands.
   [Jukema, J.] LUMC, Cardiol, Leiden, Netherlands.
   [Rensen, P.] LUMC, Endocrinol, Leiden, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0616
BP E70
EP E70
DI 10.1016/j.atherosclerosis.2019.06.199
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800198
DA 2019-10-28
ER

PT J
AU Ilic, GG
   Milorad, J
AF Ilic, G. Grujic
   Milorad, J.
TI MONITORING CERTAIN MARKERS IN PREVENTION OF CARDIOVASCULAR DISEASE IN
   ADULTHOOD
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Ilic, G. Grujic] Hlth Ctr, Pediat, Nish, Serbia.
   [Milorad, J.] Hlth Ctr, Med Sport, Nish, Serbia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0074
BP E169
EP E169
DI 10.1016/j.atherosclerosis.2019.06.511
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800509
DA 2019-10-28
ER

PT J
AU Ilina, L
   Vlasova, E
   Kurbanov, S
   Afanasieva, O
   Afanasieva, M
   Shiryaev, A
   Vasiliev, V
   Galyautdinov, D
   Pokrovsky, S
   Akchurin, R
AF Ilina, L.
   Vlasova, E.
   Kurbanov, S.
   Afanasieva, O.
   Afanasieva, M.
   Shiryaev, A.
   Vasiliev, V.
   Galyautdinov, D.
   Pokrovsky, S.
   Akchurin, R.
TI LIPOPROTEIN (A) IN PATIENTS WITH DIFFUSE CORONARY ARTERY ATHEROSCLEROSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Ilina, L.; Vlasova, E.; Kurbanov, S.; Shiryaev, A.; Vasiliev, V.; Galyautdinov, D.; Akchurin, R.] Natl Med Res Ctr Cardiol, Cardiosurg Dept, Moscow, Russia.
   [Afanasieva, O.; Afanasieva, M.; Pokrovsky, S.] Natl Med Res Ctr Cardiol, Lab Atherosclerosis, Moscow, Russia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0595
BP E229
EP E230
DI 10.1016/j.atherosclerosis.2019.06.704
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800702
DA 2019-10-28
ER

PT J
AU Ionin, V
   Skuridin, D
   Petrisheva, E
   Zaslavskaya, E
   Polyakova, E
   Belyaeva, O
   Baranova, E
   Shlyakhto, E
AF Ionin, V.
   Skuridin, D.
   Petrisheva, E.
   Zaslavskaya, E.
   Polyakova, E.
   Belyaeva, O.
   Baranova, E.
   Shlyakhto, E.
TI ARTERIAL STIFFNESS, GALECTIN-3, TGF-BETA1 AND DIASTOLIC DYSFUNCTION IN
   PATIENTS WITH ATRIAL FIBRILLATION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Ionin, V.; Baranova, E.; Shlyakhto, E.] Almazov Natl Med Res Ctr, Metab Syndrome Lab, St Petersburg, Russia.
   [Skuridin, D.; Petrisheva, E.; Zaslavskaya, E.; Polyakova, E.; Belyaeva, O.] Pavlov First St Petersburg State Med Univ, Fac Therapy, St Petersburg, Russia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0276
BP E62
EP E63
DI 10.1016/j.atherosclerosis.2019.06.178
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800177
DA 2019-10-28
ER

PT J
AU Isayeva, A
   Vovchenko, M
   Galchinskaya, V
AF Isayeva, A.
   Vovchenko, M.
   Galchinskaya, V.
TI PLASMA LIPIDS AND BODY COMPOSITION IN PATIENTS WITH DIFFERENT PHYSICAL
   ACTIVITY DEPENDING ON POLYMORPHISM OF BETA-2 AND 3-ADRENERGIC RECEPTOR
   GENES
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Isayeva, A.; Vovchenko, M.; Galchinskaya, V.] LT Malaya Natl Ukrainian Acad Med Sci, Natl Inst Therapy, Dept Chron Noncommunicable Dis Prevent, Kharkov, Ukraine.
   Kharkiv, Kharkov, Ukraine.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0479
BP E188
EP E188
DI 10.1016/j.atherosclerosis.2019.06.568
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800566
DA 2019-10-28
ER

PT J
AU Iskhakov, S
   Uzokov, J
   Kamilova, S
AF Iskhakov, S.
   Uzokov, J.
   Kamilova, S.
TI COMPARATIVE ANALYSIS OF THE INFLAMMATORY BIOMARKERS IN PATIENTS WITH
   STABLE CORONARY ARTERY DISEASE AND METABOLIC SYNDROME
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Iskhakov, S.; Kamilova, S.] Republican Specialized Sci Pract Med Ctr Therapy, Intervent Cardiol, Tashkent, Uzbekistan.
   [Uzokov, J.] Republican Specialized Sci Pract Med Ctr Therapy, Cardiol, Tashkent, Uzbekistan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0531
BP E171
EP E171
DI 10.1016/j.atherosclerosis.2019.06.519
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800517
DA 2019-10-28
ER

PT J
AU Ismail, Z
   Nawawi, H
AF Ismail, Z.
   Nawawi, H.
TI HIGH PREVALENCE OF OBESITY IN WEST MALAYSIA AND ITS ASSOCIATION WITH
   CORONARY RISK PROFILES AND MARITAL STATUS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Ismail, Z.; Nawawi, H.] Univ Teknol MARA, Fac Med, Inst Pathol Lab & Forens Med I PPerForM, Publ Hlth Med, Sungai Buloh Selangor, Malaysia.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0987
BP E139
EP E139
DI 10.1016/j.atherosclerosis.2019.06.412
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800410
DA 2019-10-28
ER

PT J
AU Ito, Y
   Nagaike, H
AF Ito, Y.
   Nagaike, H.
TI INCREASED ANGIOPOIETIN LIKE PROTEIN 4 (ANGPTL4) IS ASSOCIATED WITH
   HIGHER CONCENTRATION OF LDL- TRIGLYCERIDES IN TYPE 2 DIABETES
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Ito, Y.; Nagaike, H.] Denka Seiken Co Ltd, R&D Ctr, Niigata, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0254
BP E80
EP E81
DI 10.1016/j.atherosclerosis.2019.06.232
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800231
DA 2019-10-28
ER

PT J
AU Ito, Y
AF Ito, Y.
TI CLINICAL SIGNIFICANCE OF APOLIPOPROTEIN E-CONTAINING HDL
   CHOLESTEROL/TOTAL HDL CHOLESTEROL RATIO IN PATIENTS WITH FAMILIAL
   HYPERCHOLESTEROLEMIA DIABETES
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Ito, Y.] Denka Seiken Co Ltd, R&D Ctr, Niigata, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0253
BP E226
EP E226
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800689
DA 2019-10-28
ER

PT J
AU Ivanov, S
   Viaud, M
   Vujic, N
   Duta-Mare, M
   Dugail, I
   Hainault, I
   Stehlik, C
   Marchetti, S
   Boyer, L
   Guinamard, R
   Foufelle, F
   Bochem, A
   Hovingh, KG
   Thorp, EB
   Gautier, EL
   Kratky, D
   Yvan-Charvet, L
AF Ivanov, S.
   Viaud, M.
   Vujic, N.
   Duta-Mare, M.
   Dugail, I.
   Hainault, I.
   Stehlik, C.
   Marchetti, S.
   Boyer, L.
   Guinamard, R.
   Foufelle, F.
   Bochem, A.
   Hovingh, K. G.
   Thorp, E. B.
   Gautier, E. L.
   Kratky, D.
   Yvan-Charvet, L.
TI LYSOSOMAL CHOLESTEROL HYDROLYSIS COUPLES EFFEROCYTOSIS TO
   ANTI-INFLAMMATORY OXYSTEROL PRODUCTION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Ivanov, S.; Viaud, M.; Marchetti, S.; Boyer, L.; Guinamard, R.; Yvan-Charvet, L.] Univ Cote Azur, INSERM, U1065, C3M, Nice, France.
   [Vujic, N.; Duta-Mare, M.; Kratky, D.] Med Univ, Gottfried Schatz Res Ctr Cell Signaling Metab & A, Mol Biol & Biochem, Graz, Austria.
   [Dugail, I.; Gautier, E. L.] Pierre & Marie Curie Univ, Hop Pitie, ICAN Inst Cardiometab & Nutr, INSERM,UMR S 1166, Blvd Hop, Paris, France.
   [Hainault, I.; Foufelle, F.] INSERM, UMRS 1138, Ctr Rech Cordeliers, Paris, France.
   [Stehlik, C.; Thorp, E. B.] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA.
   [Bochem, A.] Acad Med Ctr Amsterdam, Cardiol, Amsterdam, Netherlands.
   [Hovingh, K. G.] Acad Med Ctr Amsterdam, Dept Vasc Med, Amsterdam, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0133
BP E77
EP E77
DI 10.1016/j.atherosclerosis.2019.06.223
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800222
DA 2019-10-28
ER

PT J
AU Ivanova, O
   Lebedeva, A
   Grivel, JC
   Shpektor, A
   Vasilieva, E
   Margolis, L
AF Ivanova, O.
   Lebedeva, A.
   Grivel, J. C.
   Shpektor, A.
   Vasilieva, E.
   Margolis, L.
TI IMPACT OF T-LYMPHOCYTE POPULATIONS ON LONG-TERM CARDIOVASCULAR PROGNOSIS
   IN PATIENTS WITH CORONARY ARTERY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Ivanova, O.; Lebedeva, A.; Shpektor, A.; Vasilieva, E.] Moscow State Univ Med & Dent, Lab Atherothrombosis, Moscow, Russia.
   [Grivel, J. C.] Sidra Med & Res Ctr, Deep Phenotyping Core, Doha, Qatar.
   [Margolis, L.] NICHHD, Srct Intracellular Interact, Washington, DC USA.
FU Russian Science FoundationRussian Science Foundation (RSF) [18-15-00420]
FX This work was supported by the Russian Science Foundation grant
   #18-15-00420
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0842
BP E34
EP E35
DI 10.1016/j.atherosclerosis.2019.06.102
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800101
DA 2019-10-28
ER

PT J
AU Ivanovna, VK
   Borisovna, EY
   Zubareva, M
   Alexeevna, TR
   Yurievna, ES
   Georgievna, GK
   Nikolaevich, VT
AF Ivanovna, V. Kaminnaya
   Borisovna, E. Yarovaya
   Zubareva, M.
   Alexeevna, T. Rozhkova
   Yurievna, E. Solovieva
   Georgievna, G. Konovalova
   Nikolaevich, V. Titov
TI VARIABILITY OF THE QUANTITATIVE CONTENT OF FATTY ACIDS OF BLOOD PLASMA
   IN PATIENTS WITH CARDIOVASCULAR DISEASE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Ivanovna, V. Kaminnaya; Zubareva, M.; Alexeevna, T. Rozhkova; Yurievna, E. Solovieva] FGBU Natl Med Res Ctr Cardiol Russia, Dept Atherosclerosis Problems, Moscow, Russia.
   [Borisovna, E. Yarovaya] Lomonosov Moscow State Univ, Dept Probabil Theory, Fac Mech & Math, Moscow, Russia.
   [Georgievna, G. Konovalova] FGBU Natl Med Res Ctr Cardiol Russia, Dept Biochem Free Rad Proc, Moscow, Russia.
   [Nikolaevich, V. Titov] FGBU Natl Med Res Ctr Cardiol Russia, Lab Clin Biochem Lipid Metab, Moscow, Russia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1138
BP E288
EP E288
DI 10.1016/j.atherosclerosis.2019.06.893
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800891
DA 2019-10-28
ER

PT J
AU Iyen, B
   Weng, S
   Kai, J
   Akyea, R
   Leonardi-Bee, J
   Roderick, P
   Humphries, S
   Qureshi, N
AF Iyen, B.
   Weng, S.
   Kai, J.
   Akyea, R.
   Leonardi-Bee, J.
   Roderick, P.
   Humphries, S.
   Qureshi, N.
TI RISK OF CARDIOVASCULAR DISEASE OUTCOMES IN PRIMARY CARE PATIENTS WITH
   FAMILIAL HYPERCHOLESTEROLAEMIA: A PROSPECTIVE COHORT STUDY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Iyen, B.; Weng, S.; Kai, J.; Akyea, R.; Qureshi, N.] Univ Nottingham, Div Primary Care, Primary Care Stratified Med Grp, Nottingham, England.
   [Leonardi-Bee, J.] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham, England.
   [Roderick, P.] Univ Southampton, Fac Med, Primary Care & Populat Sci, Southampton, Hants, England.
   [Humphries, S.] UCL, Inst Cardiovasc Sci, London, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0123
BP E89
EP E90
DI 10.1016/j.atherosclerosis.2019.06.261
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800260
DA 2019-10-28
ER

PT J
AU Iyengar, S
   Nair, T
AF Iyengar, S.
   Nair, T.
TI GENDER BIAS AND LESSONS LEARNT
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Iyengar, S.] Manipal Hosp, Cardiol, Bangalore, Karnataka, India.
   [Nair, T.] PRS Hosp, Cardiol, Trivendrum, India.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0691
BP E173
EP E173
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800522
DA 2019-10-28
ER

PT J
AU Iyengar, S
   Gupta, R
   Thangam, S
   Cn, M
   Patil, C
AF Iyengar, S.
   Gupta, R.
   Thangam, S.
   Cn, M.
   Patil, C.
TI STABLE ISCHEMIC HEART DISEASE: COULD NOT PREVENT IT ? STABILIZE IT !
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Iyengar, S.; Patil, C.] Manipal Hosp, Cardiol, Bangalore, Karnataka, India.
   [Gupta, R.] Eterna Heart Care Ctr & Res Inst, Cardiol, Jaipur, Rajasthan, India.
   [Thangam, S.] Norwich Clin Serv, Res, Bangalore, Karnataka, India.
   [Cn, M.] Sri Jaideva, Cardiol, Bangalore, Karnataka, India.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0510
BP E188
EP E188
DI 10.1016/j.atherosclerosis.2019.06.569
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800567
DA 2019-10-28
ER

PT J
AU Jacobin-Valat, MJ
   Hemadou, A
   Fontayne, A
   Lorenzato, C
   Laroche-Traineau, J
   Mondon, P
   Claverol, S
   Ducasse, E
   Sanchez, S
   Ottones, F
   Duonor-Cerutti, M
   Clofent-Sanchez, G
AF Jacobin-Valat, M. J.
   Hemadou, A.
   Fontayne, A.
   Lorenzato, C.
   Laroche-Traineau, J.
   Mondon, P.
   Claverol, S.
   Ducasse, E.
   Sanchez, S.
   Ottones, F.
   Duonor-Cerutti, M.
   Clofent-Sanchez, G.
TI IN VIVO HUMAN SCFV PHAGE DISPLAY ASSISTED IDENTIFICATION OF GALECTIN-3
   AS A NEW BIOMARKER FOR ATHEROSCLEROSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Jacobin-Valat, M. J.; Hemadou, A.; Lorenzato, C.; Laroche-Traineau, J.; Sanchez, S.; Ottones, F.; Clofent-Sanchez, G.] CNRS, UMR5536, CRMSB, INSB, Bordeaux, France.
   [Fontayne, A.; Mondon, P.] LFB Biotechnol, Unite Ingn Biotherapeut, R&D Unit, Lille, France.
   [Claverol, S.] CGFB, Prote POLE, Bordeaux, France.
   [Ducasse, E.] CHU Pellegrin, Cardiol, Bordeaux, France.
   [Duonor-Cerutti, M.] CNRS, UPS3044, BaculoMabs, Bordeaux, France.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0864
BP E166
EP E166
DI 10.1016/j.atherosclerosis.2019.06.502
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800500
DA 2019-10-28
ER

PT J
AU Jalil, A
   Thomas, C
   Bourgeois, T
   Masson, D
AF Jalil, A.
   Thomas, C.
   Bourgeois, T.
   Masson, D.
TI MODIFICATION OF ARACHIDONIC ACID METABOLISM WITHIN MACROPHAGES LEADS TO
   AN ALTERATION OF THEIR EFFEROCYTOSIS ABILITY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Jalil, A.; Thomas, C.; Bourgeois, T.; Masson, D.] INSERM, UMR1231, Lipness Team, Dijon, France.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0167
BP E77
EP E78
DI 10.1016/j.atherosclerosis.2019.06.224
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800223
DA 2019-10-28
ER

PT J
AU Janczura, M
   Iwaniec, T
   Gielicz, A
   Kotula-Horowitz, K
   Stanisz, A
   Rosa, R
   Domagala, T
AF Janczura, M.
   Iwaniec, T.
   Gielicz, A.
   Kotula-Horowitz, K.
   Stanisz, A.
   Rosa, R.
   Domagala, T.
TI INTERRELATIONSHIP OF OXIDATIVE STRESS AND INFLAMMATORY STATE WITH
   CAROTID INTIMA-MEDIA THICKNESS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Janczura, M.] John Paul 2 Hosp, Clin Dept Thorac & Oncol Surg, Krakow, Poland.
   [Iwaniec, T.; Gielicz, A.] Jagiellonian Univ, Sch Med, Dept Internal Med, Krakow, Poland.
   [Kotula-Horowitz, K.] Minist Interior & Adm, Dept Internal Med, Hlth Care Ctr, Krakow, Poland.
   [Stanisz, A.] Jagiellonian Univ, Sch Med, Dept Bioinformat & Telemed, Krakow, Poland.
   [Rosa, R.] Minist Interior & Adm, Dept Anesthesiol & Intens Care, Hlth Care Ctr, Krakow, Poland.
   [Domagala, T.] Jagiellonian Univ, Sch Med, Dept Med Biochem, Krakow, Poland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0518
BP E175
EP E175
DI 10.1016/j.atherosclerosis.2019.06.531
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800529
DA 2019-10-28
ER

PT J
AU Jandeleit-Dahm, K
   Sourris, K
   Stehli, J
   Shaw, J
AF Jandeleit-Dahm, K.
   Sourris, K.
   Stehli, J.
   Shaw, J.
TI NOX-5 EXPRESSION IN CIRCULATING PERIPHERAL BLOOD MONONUCLEAR CELLS: A
   POTENTIAL BIOMARKER FOR ACCELERATED CARDIOVASCULAR DISEASE IN DIABETES
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Jandeleit-Dahm, K.] Monash Univ, Cent Clin Sch, Diabet, Melbourne, Vic, Australia.
   [Sourris, K.] Monash Univ, Diabet, Melbourne, Vic, Australia.
   [Stehli, J.; Shaw, J.] Alfred Hlth, Cardiol, Melbourne, Vic, Australia.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0339
BP E126
EP E126
DI 10.1016/j.atherosclerosis.2019.06.368
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800366
DA 2019-10-28
ER

PT J
AU Jin, H
   Goossens, P
   Karel, J
   Daemen, M
   Sluimer, J
   Biessen, E
AF Jin, H.
   Goossens, P.
   Karel, J.
   Daemen, M.
   Sluimer, J.
   Biessen, E.
TI INTEGRATIVE MULTI-OMICS ANALYSIS OF HUMAN ATHEROSCLEROSIS REVEALS AN
   INTRAPLAQUE BLEEDING ASSOCIATED NETWORK, WHICH OFFERS BETTER PREDICTION
   OF DISEASE STAGE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Jin, H.; Goossens, P.; Sluimer, J.; Biessen, E.] Maastricht UMC, Pathol, Maastricht, Netherlands.
   [Karel, J.] Maastricht Univ, Data Sci & Knowledge Engn, Maastricht, Netherlands.
   [Daemen, M.] Amsterdam UMC, Pathol, Amsterdam, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0625
BP E63
EP E63
DI 10.1016/j.atherosclerosis.2019.06.180
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800179
DA 2019-10-28
ER

PT J
AU Joo, HJ
   Lee, D
   Jung, HW
   Lim, DS
AF Joo, H. J.
   Lee, D.
   Jung, H. W.
   Lim, D. S.
TI MEDIATION ANALYSIS ON THE ASSOCIATION BETWEEN STATIN USE AND FASTING
   GLUCOSE LEVEL
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Joo, H. J.; Lim, D. S.] Korea Univ, Anam Hosp, Cardiol, Seoul, South Korea.
   [Lee, D.; Jung, H. W.] Korea Univ, Sch Business, Seoul, South Korea.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0046
BP E129
EP E129
DI 10.1016/j.atherosclerosis.2019.06.378
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800376
DA 2019-10-28
ER

PT J
AU Joris, P
   Draijer, R
   Fuchs, D
   Mensink, R
AF Joris, P.
   Draijer, R.
   Fuchs, D.
   Mensink, R.
TI EFFECT OF A-LINOLENIC ACID ON VASCULAR FUNCTION AND METABOLIC RISK
   MARKERS DURING THE FASTING AND POSTPRANDIAL PHASE: A RANDOMIZED
   PLACEBO-CONTROLLED TRIAL IN UNTREATED (PRE) HYPERTENSIVE SUBJECTS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Joris, P.; Mensink, R.] Maastricht Univ, Dept Nutr & Movement Sci, Maastricht, Netherlands.
   [Draijer, R.; Fuchs, D.] Unilever Res Labs, Dept Future Hlth & Wellness, Vlaardingen, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0909
BP E33
EP E33
DI 10.1016/j.atherosclerosis.2019.06.097
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800096
DA 2019-10-28
ER

PT J
AU Juhasz, I
   Ujfalusi, S
   Lorincz, H
   Varga, V
   Somodi, ES
   Harangi, M
   Seres, I
   Paragh, G
AF Juhasz, I.
   Ujfalusi, S.
   Lorincz, H.
   Varga, V.
   Somodi, E. S.
   Harangi, M.
   Seres, I.
   Paragh, G.
TI CIRCULATING AFAMIN LEVEL CORRELATES WITH LIPOPROTEIN SUBPOPULATIONS IN
   NON-DIABETIC OBESE PATIENTS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Juhasz, I.; Ujfalusi, S.; Lorincz, H.; Varga, V.; Somodi, E. S.; Harangi, M.; Seres, I.; Paragh, G.] Univ Debrecen, Fac Med, Dept Internal Med, Debrecen, Hungary.
FU National Research, Development and Innovation [K115723, PD124126];
   European UnionEuropean Union (EU); European Regional Development
   FundEuropean Union (EU);  [GINOP-2.3.2-15-2016-00005]
FX This work is supported by a grant from the National Research,
   Development and Innovation K115723, the National Research, Development
   and Innovation PD124126 and the GINOP-2.3.2-15-2016-00005 projects. The
   GINOP project is co-financed by the European Union and the European
   Regional Development Fund.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0649
BP E165
EP E165
DI 10.1016/j.atherosclerosis.2019.06.498
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800496
DA 2019-10-28
ER

PT J
AU Junna, N
   Ripatti, P
   Surakka, I
   Ripatti, S
   Widen, E
AF Junna, N.
   Ripatti, P.
   Surakka, I.
   Ripatti, S.
   Widen, E.
TI CLINICAL MANAGEMENT AND GENETIC ARCHITECTURE OF SEVERE
   HYPERCHOLESTEROLEMIA IN FINLAND
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Junna, N.; Ripatti, P.; Ripatti, S.; Widen, E.] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland.
   [Surakka, I.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0634
BP E86
EP E87
DI 10.1016/j.atherosclerosis.2019.06.251
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800250
DA 2019-10-28
ER

PT J
AU Kabardieva, M
   Komlev, A
   Kuchin, I
   Kolegaev, A
   Lepilin, P
   Imaev, T
   Akchurin, R
AF Kabardieva, M.
   Komlev, A.
   Kuchin, I.
   Kolegaev, A.
   Lepilin, P.
   Imaev, T.
   Akchurin, R.
TI LIPID LEVELS IN PATIENTS WITH ABDOMINAL AORTIC DILATATION AND ABDOMINAL
   AORTIC ANEURYSM (AAA)
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kabardieva, M.] Natl Cardiol Res Ctr, Dept Atherosclerosis, Moscow, Russia.
   [Komlev, A.; Kuchin, I.; Kolegaev, A.; Lepilin, P.; Imaev, T.; Akchurin, R.] Natl Cardiol Res Ctr, Dept Cardiovasc Surg, Moscow, Russia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0400
BP E160
EP E161
DI 10.1016/j.atherosclerosis.2019.06.483
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800481
DA 2019-10-28
ER

PT J
AU Kachkovskii, M
   Egorova, A
AF Kachkovskii, M.
   Egorova, A.
TI FIRST ESTIMATES OF THE PREVALENCE OF FAMILIAL HYPERCHOLESTEROLEMIA IN
   THE SAMARA REGION OF RUSSIA
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kachkovskii, M.; Egorova, A.] Med Univ Reaviz, Res Inst Atherosclerosis & Dyslipidemia, Samara, Russia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0545
BP E208
EP E208
DI 10.1016/j.atherosclerosis.2019.06.633
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800631
DA 2019-10-28
ER

PT J
AU Kadiri, JJ
   Rinne, P
AF Kadiri, J. J.
   Rinne, P.
TI MELANOCORTIN-3 RECEPTOR SELECTIVE ACTIVATION SUPPRESSES SYSTEMIC
   INFLAMMATION IN EXPERIMENTAL ATHEROSCLEROSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kadiri, J. J.] Res Ctr Physiol & Pharmacol, Pharmacol, Inst Biomed, Turku, Finland.
   [Rinne, P.] Univ Turku Finland, Pharmacol, Inst Biomed, Turku, Finland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0409
BP E245
EP E245
DI 10.1016/j.atherosclerosis.2019.06.753
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800751
DA 2019-10-28
ER

PT J
AU Kalinskaya, A
   Uzhakhova, K
   Vasilieva, H
   Shpektor, A
AF Kalinskaya, A.
   Uzhakhova, K.
   Vasilieva, H.
   Shpektor, A.
TI ENDOGENOUS FIBRINOLYSIS AND ENDOTHELIAL FUNCTION IN PATIENTS WITH A
   HISTORY OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kalinskaya, A.; Uzhakhova, K.; Vasilieva, H.; Shpektor, A.] Moscow State Univ Med & Dent, Moscow, Russia.
FU Russian Science FoundationRussian Science Foundation (RSF) [18-75-10123]
FX This work was supported by the Russian Science Foundation grant
   #18-75-10123
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0423
BP E141
EP E141
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800416
DA 2019-10-28
ER

PT J
AU Kallend, D
   Collins, M
   Kastelein, J
   Landmesser, U
   Leiter, L
   Ray, K
   Robson, R
   Stoekenbroek, R
   Wright, RS
   Wijngaard, P
AF Kallend, D.
   Collins, M.
   Kastelein, J.
   Landmesser, U.
   Leiter, L.
   Ray, K.
   Robson, R.
   Stoekenbroek, R.
   Wright, R. S.
   Wijngaard, P.
TI EFFICACY, SAFETY AND PHARMACOKINETICS OF INCLISIRAN BY RENAL FUNCTION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kallend, D.; Stoekenbroek, R.; Wijngaard, P.] Medicines Co, ORION Project, Parsippany, NJ USA.
   [Collins, M.] Univ Auckland, Dept Renal Med, Auckland, New Zealand.
   [Kastelein, J.] Acad Med Ctr, Vasc Med, Amsterdam, Netherlands.
   [Landmesser, U.] Charite Univ Med Berlin, Dept Cardiol, Berlin, Germany.
   [Leiter, L.] Univ Toronto, Div Endocrinol & Metab, Toronto, ON, Canada.
   [Ray, K.] Imperial Coll London, Dept Primary Care & Publ Hlth, London, England.
   [Robson, R.] Christchurch Hosp, Dept Nephrol, Christchurch, New Zealand.
   [Wright, R. S.] Mayo Clin, Dept Cardiovasc Med, Rochester, MN USA.
RI Ray, Kausik/Z-2055-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0576
BP E38
EP E38
DI 10.1016/j.atherosclerosis.2019.06.112
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800111
DA 2019-10-28
ER

PT J
AU Kalmykov, V
   Vinogradov, K
   Zamkova, M
AF Kalmykov, V.
   Vinogradov, K.
   Zamkova, M.
TI DEVELOPMENT OF TRANSGENIC MOUSE MODEL SUPERPRODUCER SEALIDASE WITH
   SECRETION INTO THE BLOOD
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kalmykov, V.; Vinogradov, K.; Zamkova, M.] Russian Acad Sci, Ctr Collect Usage, Inst Biol Gene, Moscow, Russia.
FU  [RSF 17-75-20249]
FX This work was sapportid by grand RSF 17-75-20249
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0741
BP E240
EP E240
DI 10.1016/j.atherosclerosis.2019.06.737
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800735
DA 2019-10-28
ER

PT J
AU Kalogeropoulou, C
   Hatziri, A
   Constantinou, C
   Karavia, E
   Kypreos, K
AF Kalogeropoulou, C.
   Hatziri, A.
   Constantinou, C.
   Karavia, E.
   Kypreos, K.
TI ISOFORM-SPECIFIC EFFECTS OF APOE ON BODY WEIGHT GAIN AND GLUCOSE
   METABOLISM
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kalogeropoulou, C.; Hatziri, A.; Constantinou, C.; Karavia, E.; Kypreos, K.] Univ Patras, Med, Patras, Greece.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0139
BP E108
EP E108
DI 10.1016/j.atherosclerosis.2019.06.316
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800315
DA 2019-10-28
ER

PT J
AU Kalstad, AA
   Sjur, T
   Myhre, PL
   Kristian, L
   Opstad, TB
   Tveit, A
   Schmidt, EB
   Solheim, S
   Arnesen, H
   Seljeflot, I
AF Kalstad, A. A.
   Sjur, T.
   Myhre, P. L.
   Kristian, L.
   Opstad, T. B.
   Tveit, A.
   Schmidt, E. B.
   Solheim, S.
   Arnesen, H.
   Seljeflot, I.
TI ASSOCIATIONS BETWEEN LEUKOCYTE TELOMERE LENGTH AND MARKERS OF
   ENDOTHELIAL FUNCTION AND ACTIVATION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kalstad, A. A.; Kristian, L.; Opstad, T. B.; Solheim, S.; Arnesen, H.; Seljeflot, I.] Oslo Univ Hosp Ullevaal, Ctr Clin Heart Res, Dept Cardiol, Oslo, Norway.
   [Kalstad, A. A.; Sjur, T.; Opstad, T. B.; Tveit, A.; Arnesen, H.; Seljeflot, I.] Univ Oslo, Inst Clin Med, Oslo, Norway.
   [Sjur, T.] Akershus Univ Hosp HF, Div Med, Lorenskog, Norway.
   [Myhre, P. L.] Akershus Univ Hosp HF, Dept Cardiol, Lorenskog, Norway.
   [Tveit, A.] Vestre Viken Hosp Trust, Baerum Hosp, Dept Med Res, Gjettum, Norway.
   [Schmidt, E. B.] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0552
BP E265
EP E265
DI 10.1016/j.atherosclerosis.2019.06.820
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800818
DA 2019-10-28
ER

PT J
AU Kaltoft, M
   Langsted, A
   Nordestgaard, BG
AF Kaltoft, M.
   Langsted, A.
   Nordestgaard, B. G.
TI OBESITY AS A CAUSAL RISK FACTOR FOR AORTIC VALVE STENOSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kaltoft, M.; Langsted, A.; Nordestgaard, B. G.] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, Herlev, Denmark.
   [Kaltoft, M.; Langsted, A.; Nordestgaard, B. G.] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Copenhagen Gen Populat Study, Herlev, Denmark.
   [Nordestgaard, B. G.] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0402
BP E69
EP E69
DI 10.1016/j.atherosclerosis.2019.06.197
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800196
DA 2019-10-28
ER

PT J
AU Kanasaki, A
   Jiang, Z
   Mizokami, T
   Shirouchi, B
   Iida, T
   Nagata, Y
   Sato, M
AF Kanasaki, A.
   Jiang, Z.
   Mizokami, T.
   Shirouchi, B.
   Iida, T.
   Nagata, Y.
   Sato, M.
TI D-ALLULOSE ALTERS SERUM CHOLESTEROL LEVELS PARTLY VIA REDUCING SERUM
   PCSK9 LEVELS IN HAMSTERS.
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kanasaki, A.; Iida, T.] Matsutani Chem Ind Co Ltd, Res & Dev, Itami, Hyogo, Japan.
   [Jiang, Z.; Mizokami, T.; Shirouchi, B.; Sato, M.] Kyushu Univ, Dept Biosci & Biotechnol, Fac Agr, Lab Nutr Chem,Grad Sch, Fukuoka, Japan.
   [Nagata, Y.] Nagasaki Univ, Ctr Ind Univ & Govt Cooperat, Nagasaki, Japan.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0578
BP E201
EP E201
DI 10.1016/j.atherosclerosis.2019.06.611
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800609
DA 2019-10-28
ER

PT J
AU Karnebeek, K
   Plat, J
   Vreugdenhil, A
AF Karnebeek, K.
   Plat, J.
   Vreugdenhil, A.
TI EARLY DEVELOPMENT OF NAFLD IN GENETICALLY PREDISPOSED CHILDREN WITH
   OBESITY DOES NOT COINCIDE WITH METABOLIC DERANGEMENTS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Karnebeek, K.; Vreugdenhil, A.] Maastricht Univ, Med Ctr, Ctr Overweight Adolescent & Childrens Healthcare, Dept Pediat, Maastricht, Netherlands.
   [Karnebeek, K.; Plat, J.] Maastricht Univ, Dept Nutr & Movement Sci, Sch Nutr & Translat Res Metab NUTRIM, Maastricht, Netherlands.
   [Vreugdenhil, A.] Maastricht Univ, Sch Nutr & Translat Res Metab NUTRIM, Maastricht, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0810
BP E122
EP E122
DI 10.1016/j.atherosclerosis.2019.06.354
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800353
DA 2019-10-28
ER

PT J
AU Kashiba, A
   Ueda, K
   Uematsu, Y
   Utsumi, M
   Miyai, N
   Arita, M
AF Kashiba, A.
   Ueda, K.
   Uematsu, Y.
   Utsumi, M.
   Miyai, N.
   Arita, M.
TI BLOOD PRESSURE-VARIATION BY ROOM TEMPERATURE IN HOME PRESSURE AMONG
   METABOLIC SYNDROME USING HOME BLOOD PRESSURE WEB-BASED MONITORING
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kashiba, A.; Ueda, K.] Katsuragi City Off, Ctr Hlth, Katsuragi City, Japan.
   [Uematsu, Y.; Utsumi, M.; Miyai, N.; Arita, M.] Wakayama Med Univ, Dept Hlth & Nursing Sci, Wakayama, Japan.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0593
BP E155
EP E155
DI 10.1016/j.atherosclerosis.2019.06.466
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800464
DA 2019-10-28
ER

PT J
AU Kashtanova, E
   Polonskaya, Y
   Stakhneva, E
   Kurguzov, A
   Murashov, I
   Shramko, V
   Ragino, Y
AF Kashtanova, E.
   Polonskaya, Y.
   Stakhneva, E.
   Kurguzov, A.
   Murashov, I.
   Shramko, V.
   Ragino, Y.
TI THE BLOOD BIOMARKERS ASSOCIATED WITH UNSTABLE ATHEROSCLEROTIC PLAQUES IN
   PATIENTS WITH CORONARY ATHEROSCLEROSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kashtanova, E.; Polonskaya, Y.; Stakhneva, E.; Shramko, V.; Ragino, Y.] Russian Acad Sci, Res Inst Internal & Prevent Med, Branch Inst Cytol & Genet, Siberian Branch,Lab Clin Biochem & Hormonal Res T, Novosibirsk, Russia.
   [Kurguzov, A.; Murashov, I.] Minist Hlth Russian Federat, Natl Med Res Ctr, Fed State Budgetary Inst, Cardiol, Novosibirsk, Russia.
FU RFBRRussian Foundation for Basic Research (RFBR) [0324-2018-0001]; 
   [19-015-00055]
FX The study was performed in the framework of the budget theme of the
   State assignment No 0324-2018-0001, and with the financial support of
   RFBR Grant No. 19-015-00055.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1096
BP E278
EP E278
DI 10.1016/j.atherosclerosis.2019.06.861
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800859
DA 2019-10-28
ER

PT J
AU Kasim, NAM
   Chua, YA
   Razak, SA
   Yap, BW
   Nawawi, HM
AF Kasim, N. A. Mohd
   Chua, Y. A.
   Razak, S. Abdul
   Yap, B. W.
   Nawawi, H. Mohd
CA MyHEBAT-CRES Investigators
TI IMPACT OF CORONARY RISK FACTORS IN DIFFERENT INCOME GROUPS IN MALAYSIAN
   COHORT
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kasim, N. A. Mohd; Razak, S. Abdul; Nawawi, H. Mohd; MyHEBAT-CRES Investigators] Univ Teknol MARA, Fac Med, Sg Buloh, Malaysia.
   [Chua, Y. A.] Univ Teknol MARA, Inst Pathol Lab & Forens Med I PPerForM, Sg Buloh, Malaysia.
   [Yap, B. W.] Univ Teknol MARA, Fac Comp & Math Sci, Shah Alam, Malaysia.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1012
BP E192
EP E192
DI 10.1016/j.atherosclerosis.2019.06.581
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800579
DA 2019-10-28
ER

PT J
AU Kassner, U
   Soll, D
   Hollstein, T
   Spira, D
   Bobbert, T
   Steinhagen-Thiessen, E
AF Kassner, U.
   Soll, D.
   Hollstein, T.
   Spira, D.
   Bobbert, T.
   Steinhagen-Thiessen, E.
TI SHORT REPORT OF A LONGTERM OUTCOME OF A PATIENT WITH LYSOSOMAL ACID
   LIPASE DEFICIENCY AND FIRST RESULTS AFTER INITIATION OF TREATMENT WITH
   SEBELIPASE ALFA
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kassner, U.; Soll, D.; Hollstein, T.; Spira, D.; Bobbert, T.; Steinhagen-Thiessen, E.] Charite Univ Med Berlin, Stoffwechselctr, Lipidclin, Berlin, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0460
BP E202
EP E202
DI 10.1016/j.atherosclerosis.2019.06.615
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800613
DA 2019-10-28
ER

PT J
AU Kassner, U
   Hollstein, T
   Schumann, F
   Grenkowitz, T
   Scharnagl, H
   Marz, W
   Steinhagen-Thiessen, E
AF Kassner, U.
   Hollstein, T.
   Schumann, F.
   Grenkowitz, T.
   Scharnagl, H.
   Maerz, W.
   Steinhagen-Thiessen, E.
TI PROPROTEIN CONVERTASE SUBTILISIN/ KEXIN TYPE 9 ANTIBODIES (PCSK9-I)
   TREATMENT OF CARDIOVASCULAR HIGH RISK PATIENTS IN CLINICAL PRACTICE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kassner, U.; Hollstein, T.; Schumann, F.; Grenkowitz, T.; Steinhagen-Thiessen, E.] Charite Univ Med Berlin, Stoffwechselctr Lipidclin, Berlin, Germany.
   [Scharnagl, H.; Maerz, W.] LKH Univ Klinikum Graz, Klin Chem & Lab Med, Graz, Austria.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0376
BP E212
EP E212
DI 10.1016/j.atherosclerosis.2019.06.645
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800643
DA 2019-10-28
ER

PT J
AU Katamadze, N
   Golovina, A
   Berstein, L
   Sayganov, S
AF Katamadze, N.
   Golovina, A.
   Berstein, L.
   Sayganov, S.
TI ASSOCIATIONS OF CARDIOVASCULAR RISK FACTORS WITH CAROTID INTIMA-MEDIA
   THICKNESS AND PLAQUE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Katamadze, N.; Golovina, A.; Berstein, L.; Sayganov, S.] North Western State Med Univ, Dept Cardiol, St Petersburg, Russia.
RI Katamadze, Nana/R-7137-2016
OI Katamadze, Nana/0000-0002-3172-0305
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0306
BP E185
EP E185
DI 10.1016/j.atherosclerosis.2019.06.560
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800558
DA 2019-10-28
ER

PT J
AU Katzmann, J
   Schurfeld, C
   Marz, W
   Laufs, U
AF Katzmann, J.
   Schuerfeld, C.
   Maerz, W.
   Laufs, U.
TI CASE REPORT - RAPID REGRESSION OF XANTHOMAS UNDER LIPOPROTEIN APHERESIS
   IN A BOY WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Katzmann, J.; Laufs, U.] Univ Klinikum Leipzig, Klin & Poliklin Kardiol, Leipzig, Germany.
   [Schuerfeld, C.] GZ Vauban, Gemeinschaftspraxis, Saarlouis, Germany.
   [Maerz, W.] Synlab Holding Deutschland GmbH, Synlab Acad, Mannheim, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0216
BP E211
EP E212
DI 10.1016/j.atherosclerosis.2019.06.643
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800641
DA 2019-10-28
ER

PT J
AU Katzmann, J
   Laufs, U
   Ference, BA
AF Katzmann, J.
   Laufs, U.
   Ference, B. A.
TI A MENDELIAN RANDOMIZATION ANALYSIS OF LIPOPROTEIN(A) LOWERING AND
   CARDIOVASCULAR RISK STRATIFIED BY LDL CHOLESTEROL, GENDER, AND
   ANTIPLATELET THERAPY: IMPLICATIONS FOR CLINICAL OUTCOME TRIALS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Katzmann, J.; Laufs, U.] Univ Klinikum Leipzig, Klin & Poliklin Kardiol, Leipzig, Germany.
   [Ference, B. A.] Univ Cambridge, Ctr Nat Randomized Trials, Cambridge, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0777
BP E8
EP E8
DI 10.1016/j.atherosclerosis.2019.06.021
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800021
DA 2019-10-28
ER

PT J
AU Kechida, M
   Jomaa, W
   Mesfar, R
   Daada, S
   Klii, R
   Hammami, S
   Khochtali, I
AF Kechida, M.
   Jomaa, W.
   Mesfar, R.
   Daada, S.
   Klii, R.
   Hammami, S.
   Khochtali, I.
TI CARDIOVASCULAR RISK IN SYSTEMIC LUPUS ERYTHEMATOSUS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kechida, M.; Mesfar, R.; Daada, S.; Klii, R.; Hammami, S.; Khochtali, I.] Fattouma Bourguiba Univ Hosp, Internal Med & Endocrinol Dept, Monastir, Tunisia.
   [Jomaa, W.] Fattouma Bourguiba Univ Hosp, Cardiol Dept B, Monastir, Tunisia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0857
BP E190
EP E190
DI 10.1016/j.atherosclerosis.2019.06.576
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800574
DA 2019-10-28
ER

PT J
AU Kepler, T
   Kuusik, K
   Lepner, U
   Starkopf, J
   Zilmer, M
   Eha, J
   Lieberg, J
   Kals, J
AF Kepler, T.
   Kuusik, K.
   Lepner, U.
   Starkopf, J.
   Zilmer, M.
   Eha, J.
   Lieberg, J.
   Kals, J.
TI REMOTE ISCHAEMIC PRECONDITIONING ATTENUATES KIDNEY INJURY
   PERIOPERATIVELY IN PATIENTS UNDERGOING SURGICAL LOWER LIMB
   REVASCULARISATION: RESULTS FROM A RANDOMIZED DOUBLE-BLINDED CONTROLLED
   TRIAL
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kepler, T.; Lepner, U.; Lieberg, J.; Kals, J.] Univ Tartu, Inst Clin Med, Dept Surg, Tartu, Estonia.
   [Kuusik, K.; Eha, J.] Univ Tartu, Dept Cardiol, Inst Clin Med, Tartu, Estonia.
   [Starkopf, J.] Univ Tartu, Dept Anaesthesiol & Intens Care, Inst Clin Med, Tartu, Estonia.
   [Zilmer, M.] Univ Tartu, Dept Biochem, Inst Biomed & Translat Med, Ctr Excellence Genom, Tartu, Estonia.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0150
BP E104
EP E104
DI 10.1016/j.atherosclerosis.2019.06.303
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800302
DA 2019-10-28
ER

PT J
AU Kerimkulova, A
   Bektasheva, E
   Lunegova, O
   Abilova, S
   Asanbaev, A
   Esenbekova, J
   Asanaliev, N
   Turatbekova, A
   Isaeva, A
   Mirrakhimov, E
AF Kerimkulova, A.
   Bektasheva, E.
   Lunegova, O.
   Abilova, S.
   Asanbaev, A.
   Esenbekova, J.
   Asanaliev, N.
   Turatbekova, A.
   Isaeva, A.
   Mirrakhimov, E.
TI ASSOCIATION OF INTIMA-MEDIA THICKNESS OF CAROTID ARTERIES WITH INSULIN
   RESISTANCE IN ETHNIC KYRGYZES
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kerimkulova, A.; Bektasheva, E.; Lunegova, O.; Abilova, S.; Asanbaev, A.; Esenbekova, J.; Asanaliev, N.; Turatbekova, A.; Isaeva, A.; Mirrakhimov, E.] Kyrgyz State Med Acad, Fac Therapy, Bishkek, Kyrgyzstan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0432
BP E261
EP E262
DI 10.1016/j.atherosclerosis.2019.06.807
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800805
DA 2019-10-28
ER

PT J
AU Kerimkulova, A
   Lunegova, O
   Abilova, S
   Neronova, K
   Zakirov, U
   Moldobaeva, A
   Adylbekova, A
   Murzalieva, E
   Mirrakhimov, E
AF Kerimkulova, A.
   Lunegova, O.
   Abilova, S.
   Neronova, K.
   Zakirov, U.
   Moldobaeva, A.
   Adylbekova, A.
   Murzalieva, E.
   Mirrakhimov, E.
TI RELATIONSHIPS BETWEEN FINNISH DIABETES RISK SCORE (FINDRISC) AND
   CARDIOMETABOLIC RISK FACTORS IN KYRGYZ NATIVE SUBJECTS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kerimkulova, A.; Lunegova, O.; Abilova, S.; Neronova, K.; Zakirov, U.; Moldobaeva, A.; Adylbekova, A.; Murzalieva, E.; Mirrakhimov, E.] Kyrgyz State Med Acad IK Akhunbaev, Fac Therapy, Bishkek, Kyrgyzstan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0444
BP E187
EP E188
DI 10.1016/j.atherosclerosis.2019.06.567
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800565
DA 2019-10-28
ER

PT J
AU Kharlamov, A
AF Kharlamov, A.
TI PLASMONIC PHOTOTHERMAL THERAPY OF ATHEROSCLEROSIS AND PREPARATION OF
   TARGET LESION IN PATIENTS WITH ARTERIAL REMODELING: SUBANALYSIS OF
   NANOM-FIM TRIAL
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kharlamov, A.] De Haar Res Fdn, Dept Intervent Cardiovasc Biomed, Amsterdam, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0294
BP E34
EP E34
DI 10.1016/j.atherosclerosis.2019.06.100
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800099
DA 2019-10-28
ER

PT J
AU Kharlamov, A
AF Kharlamov, A.
TI CAN DROPPING LDL-C CAUSE REGRESSION OF ATHEROSCLEROSIS OR SHOULD TOXIC
   LDL-C BE ERADICATED? A POOLED STUDY OF PLAQUE BURDEN REDUCTION IN
   LIPID-LOWERING TRIALS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kharlamov, A.] De Haar Res Fdn, Dept Intervent Cardiovasc Biomed, Amsterdam, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0295
BP E104
EP E104
DI 10.1016/j.atherosclerosis.2019.06.304
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800303
DA 2019-10-28
ER

PT J
AU Kim, CD
   Jang, EJ
   Baek, SE
   Park, SY
AF Kim, C. D.
   Jang, E. J.
   Baek, S. E.
   Park, S. Y.
TI HMGB1 ENHANCES RAGE EXPRESSION VIA 5-LIPOXYGENASE SIGNALING LEADING TO
   AN INCREASE IN AGE-MEDIATED PROLIFERATION OF VASCULAR SMOOTH MUSCLE
   CELLS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kim, C. D.; Jang, E. J.; Baek, S. E.; Park, S. Y.] Pusan Natl Univ, Sch Med, Pharmacol, Yangsan, South Korea.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0886
BP E259
EP E259
DI 10.1016/j.atherosclerosis.2019.06.799
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800797
DA 2019-10-28
ER

PT J
AU Kim, CJ
   Kim, MA
AF Kim, C. J.
   Kim, M. A.
TI INFLUENCE OF CHANGES IN TRIGLYCERIDE LEVELS ON LIPOPROTEIN (A) LEVELS
   WITH LIPID LOWERING THERAPY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kim, C. J.] Chung Ang Univ Hosp, Cardiol, Seoul, South Korea.
   [Kim, M. A.] Seoul Natl Univ, Boramae Hosp, Cardiol, Seoul, South Korea.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0630
BP E230
EP E230
DI 10.1016/j.atherosclerosis.2019.06.705
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800703
DA 2019-10-28
ER

PT J
AU Kim, CY
   Lee, YS
   Ra, MN
AF Kim, C. Y.
   Lee, Y. S.
   Ra, M. N.
TI RISK FACTORS FOR DEVELOPMENT OF DIABETES AMONG PATIENTS WITH LOW- TO
   MODERATE-INTENSITY STATIN THERAPY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kim, C. Y.; Lee, Y. S.; Ra, M. N.] Daegu Catholic Med Ctr, Cardiol, Daegu, South Korea.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0572
BP E89
EP E89
DI 10.1016/j.atherosclerosis.2019.06.259
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800258
DA 2019-10-28
ER

PT J
AU Kim, S
   Chae, J
   Jung, L
   Lee, S
   Lee, S
   Rhee, S
   Kim, W
   Ko, J
   Lee, J
   Kim, Y
AF Kim, S.
   Chae, J.
   Jung, L.
   Lee, S.
   Lee, S.
   Rhee, S.
   Kim, W.
   Ko, J.
   Lee, J.
   Kim, Y.
TI CYTOCHROME EPOXYGENASE P450 2J PROMOTE PPAR A -MEDIATED AUTOPHAGY IN
   OB-/OB- RATS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kim, S.; Chae, J.; Jung, L.; Lee, S.; Lee, S.; Rhee, S.; Kim, W.; Ko, J.; Lee, J.; Kim, Y.] Chonbuk Natl Univ, Sch Med, Cardiol, Jeonju, South Korea.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0635
BP E121
EP E122
DI 10.1016/j.atherosclerosis.2019.06.353
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800352
DA 2019-10-28
ER

PT J
AU Kim, SH
   Kim, HL
   Moon, I
   Kim, MA
AF Kim, S. H.
   Kim, H. L.
   Moon, I.
   Kim, M. A.
TI INTER-ARM AND INTER-LEG BLOOD PRESSURE DIFFERENCES AND CARDIOVASCULAR
   OUTCOMES IN PATIENTS AFTER PERCUTANEOUS CORONARY INTERVENTION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kim, S. H.; Kim, H. L.; Moon, I.; Kim, M. A.] Seoul Natl Univ, Seoul Boramae Hosp, Coll Med, Cardiol, Seoul, South Korea.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0749
BP E156
EP E156
DI 10.1016/j.atherosclerosis.2019.06.468
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800466
DA 2019-10-28
ER

PT J
AU Kim, TK
   Jeon, S
   Oh, GT
AF Kim, T. K.
   Jeon, S.
   Oh, G. T.
TI ENDOTHELIAL TKK1 DEFICIENCY ACCELERATES THE PATHOGENESIS OF
   ATHEROSCLEROSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kim, T. K.; Jeon, S.; Oh, G. T.] Ewha Womans Univ, Life Sci, Seoul, South Korea.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0712
BP E98
EP E99
DI 10.1016/j.atherosclerosis.2019.06.286
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800285
DA 2019-10-28
ER

PT J
AU Kim, TN
   Nguyen, NMT
   Do, LD
   Le, AH
   Truong, HT
AF Kim, T. N.
   Nguyen, N. M. T.
   Do, L. D.
   Le, A. H.
   Truong, H. T.
TI PARENTAL AWARENESS ABOUT SCREENING, DIAGNOSIS AND TREATMENT FOR CHILDREN
   WITH FAMILIAL HYPERCHOLESTEROLAEMIA IN A DEVELOPING COUNTRY: A PILOT
   SURVEY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kim, T. N.; Nguyen, N. M. T.; Do, L. D.; Truong, H. T.] Hanoi Med Univ, Vietnam Natl Heart Inst, Hanoi, Vietnam.
   [Le, A. H.] Vietnam Natl Univ, Sch Med & Pharm, Hanoi, Vietnam.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0179
BP E211
EP E211
DI 10.1016/j.atherosclerosis.2019.06.642
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800640
DA 2019-10-28
ER

PT J
AU Kim, W
   Cho, JH
   Young, JYRJ
AF Kim, W.
   Cho, J. H.
   Young, J. Y. Rhew Jay
TI PLATELET ACTIVITY DOSE NOT ASSOCIATED WITH HEMOGLOBIN LEVEL IN PATIENTS
   WITH HEMODIALYSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kim, W.] Kyung Hee Univ Hosp, Cardiovasc, Seoul, South Korea.
   [Cho, J. H.] Suncheon St Garolo Hosp, Cardiovasc, Sunchon, South Korea.
   [Young, J. Y. Rhew Jay] Jeonju Presbyterian Hosp, Cardiovasc, Jeonju, South Korea.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0284
BP E140
EP E140
DI 10.1016/j.atherosclerosis.2019.06.417
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800415
DA 2019-10-28
ER

PT J
AU Kim, W
   Young, RJ
   Hyun, CJ
AF Kim, W.
   Young, R. Jay
   Hyun, C. Jang
TI BAY 60-2770 ATTENUATES DOXORUBICIN-INDUCED CARDIOTOXICITY BY PREVENTING
   MITOCHONDRIAL MEMBRANE POTENTIAL LOSS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kim, W.] Kyung Hee Univ Hosp, Cardiovasc, Seoul, South Korea.
   [Young, R. Jay] Jeongju Presbyterian Hosp, Cardiovasc Dept, Jeonju, South Korea.
   [Hyun, C. Jang] Suncheon St Garolo Hosp, Cardiovasc, Sunchon, South Korea.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0282
BP E152
EP E152
DI 10.1016/j.atherosclerosis.2019.06.454
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800452
DA 2019-10-28
ER

PT J
AU Kimura, A
AF Kimura, A.
TI DOES THE POLYMORPHISM OF PGC-1A INFLUENCE THE PWV OF THE LONG-LIVED
   PERSON BORN IN THE 1940S WHO EXPERIENCED A ROUGH MEAL IN EARLY
   CHILDHOOD?
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kimura, A.] Gunma PAZ Univ, Grad Sch Hlth Sci, Takasaki, Gumma, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0464
BP E197
EP E197
DI 10.1016/j.atherosclerosis.2019.06.599
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800597
DA 2019-10-28
ER

PT J
AU Kirichenko, T
   Orekhova, V
   Myasoedova, V
   Melnichenko, A
   Sobenin, I
   Orekhov, A
AF Kirichenko, T.
   Orekhova, V.
   Myasoedova, V.
   Melnichenko, A.
   Sobenin, I.
   Orekhov, A.
TI NATURAL PRODUCTS FOR ANTI-ATHEROSCLEROTIC THERAPY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kirichenko, T.; Orekhova, V.; Myasoedova, V.; Melnichenko, A.; Sobenin, I.; Orekhov, A.] Inst Gen Pathol & Pathophysiol, Lab Angiopathol, Moscow, Russia.
FU Russian Science FoundationRussian Science Foundation (RSF) [19-15-00268]
FX This work was supported by the Russian Science Foundation (Grant
   #19-15-00268).
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0307
BP E152
EP E152
DI 10.1016/j.atherosclerosis.2019.06.455
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800453
DA 2019-10-28
ER

PT J
AU Kirichenko, T
   Myasoedova, V
   Sobenin, I
   Wetzker, R
   Orekhov, A
AF Kirichenko, T.
   Myasoedova, V.
   Sobenin, I.
   Wetzker, R.
   Orekhov, A.
TI CAROTID IMT PROGRESSION IN HIV-INFECTED SUBJECTS WITH AND WITHOUT
   ANTIRETROVIRAL THERAPY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kirichenko, T.; Myasoedova, V.; Sobenin, I.; Orekhov, A.] Inst Gen Pathol & Pathophysiol, Lab Angiopathol, Moscow, Russia.
   [Wetzker, R.] Clin Anesteziol, Jena, Germany.
   [Wetzker, R.] Univ Klinikum, Jena, Germany.
FU Russian Science FoundationRussian Science Foundation (RSF) [19-15-00268]
FX This work was supported by the Russian Science Foundation (Grant #
   19-15-00268).
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0704
BP E155
EP E156
DI 10.1016/j.atherosclerosis.2019.06.467
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800465
DA 2019-10-28
ER

PT J
AU Kiss, M
   Porsch, F
   Goderle, L
   Hladik, A
   Knapp, S
   Binder, CJ
AF Kiss, M.
   Porsch, F.
   Goederle, L.
   Hladik, A.
   Knapp, S.
   Binder, C. J.
TI HEMATOPOIETIC TREM2 DEFICIENCY INCREASES PLASMA CHOLESTEROL AND
   TRIGLYCERIDE LEVELS AND AGGRAVATES ATHEROSCLEROSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kiss, M.; Porsch, F.; Goederle, L.; Hladik, A.; Knapp, S.; Binder, C. J.] Med Univ Vienna, Vienna, Austria.
   [Kiss, M.; Porsch, F.; Goederle, L.; Binder, C. J.] Austrian Acad Sci, CeMM Res Ctr Mol Med, Dept Med & Chem Lab Diagnost, Vienna, Austria.
   [Hladik, A.; Knapp, S.] Austrian Acad Sci, CeMM Res Ctr Mol Med, Dept Med 1, Lab Infect Biol, Vienna, Austria.
OI Porsch, Florentina/0000-0002-2633-6632
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0999
BP E11
EP E11
DI 10.1016/j.atherosclerosis.2019.06.029
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800029
DA 2019-10-28
ER

PT J
AU Klimushina, M
   Smetnev, S
   Kiseleva, A
   Meshkov, A
   Gumanova, N
   Metelskaya, V
AF Klimushina, M.
   Smetnev, S.
   Kiseleva, A.
   Meshkov, A.
   Gumanova, N.
   Metelskaya, V.
TI COMMON VARIANTS IN ADIPOQ GENE ARE ASSOCIATED WITH INSULIN LEVELS AND
   INSULIN RESISTANCE IN WOMEN
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Klimushina, M.; Gumanova, N.; Metelskaya, V.] Natl Res Ctr Prevent Med, Dept Biochem Markers Chron Noncommunicable Dis Re, Moscow, Russia.
   [Smetnev, S.; Kiseleva, A.; Meshkov, A.] Natl Res Ctr Prevent Med, Dept Clin Cardiol & Mol Genet, Moscow, Russia.
FU RFBRRussian Foundation for Basic Research (RFBR) [18-315-00272]
FX The study was funded by RFBR, research project No 18-315-00272.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0893
BP E133
EP E133
DI 10.1016/j.atherosclerosis.2019.06.392
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800390
DA 2019-10-28
ER

PT J
AU Klimushina, M
   Smetnev, S
   Kutsenko, V
   Gumanova, N
   Metelskaya, V
AF Klimushina, M.
   Smetnev, S.
   Kutsenko, V.
   Gumanova, N.
   Metelskaya, V.
TI IL-6 GENE SNP RS1800795 IS SEX-DEPENDENTLY ASSOCIATED WITH SERUM
   C-REACTIVE PROTEIN LEVELS AND CORONARY ATHEROSCLEROSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Klimushina, M.; Gumanova, N.; Metelskaya, V.] Natl Res Ctr Prevent Med, Dept Biochem Markers Chron Noncommunicable Dis Re, Moscow, Russia.
   [Smetnev, S.] Natl Res Ctr Prevent Med, Dept Clin Cardiol & Mol Genet, Moscow, Russia.
   [Kutsenko, V.] Natl Res Ctr Prevent Med, Dept Epidemiol Chron Noncommunicable Dis, Moscow, Russia.
   [Kutsenko, V.] Moscow MV Lomonosov State Univ, Dept Mech & Math, Moscow, Russia.
FU Russian Science FoundationRussian Science Foundation (RSF) [18-75-00087]
FX The work was supported by Russian Science Foundation No 18-75-00087.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0227
BP E243
EP E243
DI 10.1016/j.atherosclerosis.2019.06.747
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800745
DA 2019-10-28
ER

PT J
AU Klingenschmid, G
   Tschiderer, L
   Nagrani, R
   Willeit, J
   Laukkanen, J
   Schett, G
   Kiechl, S
   Willeit, P
AF Klingenschmid, G.
   Tschiderer, L.
   Nagrani, R.
   Willeit, J.
   Laukkanen, J.
   Schett, G.
   Kiechl, S.
   Willeit, P.
TI ASSOCIATION OF OSTEOPROTEGERIN WITH CARDIOVASCULAR RISK IN GENERAL AND
   HIGH-RISK POPULATIONS: META-ANALYSIS OF 28 PROSPECTIVE STUDIES INVOLVING
   53,892 PARTICIPANTS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Klingenschmid, G.; Tschiderer, L.; Willeit, J.; Kiechl, S.; Willeit, P.] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria.
   [Nagrani, R.] Leibniz Inst Prevent Res & Epidemiol, Dept Epidemiol Methods & Etiol Res, Bremen, Germany.
   [Laukkanen, J.] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland.
   [Schett, G.] Univ Erlangen Nurnberg, Dept Internal Med 3, Erlangen, Germany.
   [Willeit, P.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1053
BP E63
EP E64
DI 10.1016/j.atherosclerosis.2019.06.181
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800180
DA 2019-10-28
ER

PT J
AU Knoka, E
   Trusinskis, K
   Mazule, M
   Briede, I
   Kumsars, I
   Jegere, S
   Narbute, I
   Sondore, D
   Erglis, A
AF Knoka, E.
   Trusinskis, K.
   Mazule, M.
   Briede, I.
   Kumsars, I.
   Jegere, S.
   Narbute, I.
   Sondore, D.
   Erglis, A.
TI ASSOCIATION BETWEEN CIRCULATING MICRORNAS AND METABOLIC BIOMARKERS IN
   PATIENTS WITH PREDIABETES WITH OR WITHOUT EARLY ATHEROSCLEROSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Knoka, E.; Trusinskis, K.; Mazule, M.; Briede, I.; Kumsars, I.; Jegere, S.; Narbute, I.; Sondore, D.; Erglis, A.] Pauls Stradins Clin Univ Hosp, Cardiol, Riga, Latvia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0130
BP E64
EP E64
DI 10.1016/j.atherosclerosis.2019.06.183
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800182
DA 2019-10-28
ER

PT J
AU Kocyigit, D
   Gurses, K
   Taydas, O
   Poker, A
   Hazirolan, T
   Ozer, N
   Tokgozoglu, L
AF Kocyigit, D.
   Gurses, K.
   Taydas, O.
   Poker, A.
   Hazirolan, T.
   Ozer, N.
   Tokgozoglu, L.
TI FEMORAL INTIMA-MEDIA THICKNESS IS A PREDICTOR OF CARDIOVASCULAR EVENTS
   IN A LOW-MODERATE CARDIOVASCULAR RISK POPULATION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kocyigit, D.] Afyonkarahisar Dinar State Hosp, Cardiol Clin, Afyon, Turkey.
   [Gurses, K.] Adnan Menderes Univ, Fac Med, Basic Med Sci, Aydin, Turkey.
   [Taydas, O.; Poker, A.; Hazirolan, T.] Hacettepe Univ, Radiol, Fac Med, Ankara, Turkey.
   [Ozer, N.; Tokgozoglu, L.] Hacettepe Univ, Fac Med, Cardiol, Ankara, Turkey.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0194
BP E50
EP E50
DI 10.1016/j.atherosclerosis.2019.06.143
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800142
DA 2019-10-28
ER

PT J
AU Kojic, Z
AF Kojic, Z.
TI MYOCARDIAL OXYGEN CONSUMPTION IN RABBITS TREATED WITH RAMIPRIL DURING
   THE COURSE OF EXPERIMENTAL HYPERCHOLESTEROLEMIA
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kojic, Z.] Univ Belgrade, Dept Med Physiol, Fac Med, Belgrade, Serbia.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0885
BP E157
EP E157
DI 10.1016/j.atherosclerosis.2019.06.473
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800471
DA 2019-10-28
ER

PT J
AU Komir, I
   Seric, S
   Ovrakh, T
   Riabukha, V
   Strona, V
AF Komir, I.
   Seric, S.
   Ovrakh, T.
   Riabukha, V.
   Strona, V.
TI SPECIFICS OF EXPRESSION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS
   (PPAR gamma) GENE IN PATIENTS WITH IHD COMBINED WITH TYPE 2 DIABETES
   MELLITUS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Komir, I.; Seric, S.; Ovrakh, T.; Riabukha, V.; Strona, V.] NAMS Ukraine, Govt Inst LT Malaya Therapy Natl Inst, Dept Atherosclerosis & Coronary Artery Dis, Kharkov, Ukraine.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1007
BP E272
EP E272
DI 10.1016/j.atherosclerosis.2019.06.841
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800839
DA 2019-10-28
ER

PT J
AU Konstantinov, V
   Kuznetsova, T
   Korneva, V
   Serebrenitskaya, M
   Mandelshtam, M
   Sonicheva, N
AF Konstantinov, V.
   Kuznetsova, T.
   Korneva, V.
   Serebrenitskaya, M.
   Mandelshtam, M.
   Sonicheva, N.
TI FAMILIAL HYPERCHOLESTEROLAEMIA IN THE NORTH-WEST REGION OF RUSSIA
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Konstantinov, V.; Serebrenitskaya, M.] Mechnikov North West State Med Univ, Hosp Therapy & Cardiol, St Petersburg, Russia.
   [Kuznetsova, T.; Korneva, V.] Petrozavodsk State Univ, Fac Therapy Phthisiatry Infect Dis & Epidemiol, Petrozavodsk, Russia.
   [Mandelshtam, M.] Res Inst Expt Med, Mol Genet, St Petersburg, Russia.
   [Sonicheva, N.] Hlth In Code Lab, Sci Comm, La Coruna, Spain.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0471
BP E213
EP E214
DI 10.1016/j.atherosclerosis.2019.06.650
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800648
DA 2019-10-28
ER

PT J
AU Korneva, V
   Kuznetsova, T
AF Korneva, V.
   Kuznetsova, T.
TI INFLUENCE OF LEVEL TOTAL CHOLESTEROL AND LOW DENSITY LIPOPROTEIN'S TO
   EPICARDIAL FAT THICKNESS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Korneva, V.; Kuznetsova, T.] Petrozavodsk State Univ, Faculthy Therapy Dept, Petrozavodsk, Russia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0135
BP E161
EP E161
DI 10.1016/j.atherosclerosis.2019.06.485
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800483
DA 2019-10-28
ER

PT J
AU Korzh, O
   Lavrova, E
   Krasnokutskiy, S
AF Korzh, O.
   Lavrova, E.
   Krasnokutskiy, S.
TI OMENTIN-1 AND VISFATIN AS BIOMARKERS FOR ATHEROTHROMBOTIC COMPLICATIONS
   IN TYPE 2 DIABETIC PATIENTS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Korzh, O.; Lavrova, E.; Krasnokutskiy, S.] Kharkiv Med Acad Postgrad Educ, Gen Practice Family Med, Kharkov, Ukraine.
NR 0
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0273
BP E162
EP E162
DI 10.1016/j.atherosclerosis.2019.06.488
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800486
DA 2019-10-28
ER

PT J
AU Koskimies, J
   Heinonen, S
   Jukarainen, S
   Ek, V
   Hakkarainen, A
   Lundbom, N
   Boren, J
   Pietilainen, K
   Taskinen, MR
   Matikainen, N
   Soderlund, S
AF Koskimies, J.
   Heinonen, S.
   Jukarainen, S.
   Ek, V.
   Hakkarainen, A.
   Lundbom, N.
   Boren, J.
   Pietilainen, K.
   Taskinen, M. R.
   Matikainen, N.
   Soderlund, S.
TI ADIPOCYTE SIZE IN OBESITY WITH AND WITHOUT METABOLIC SYNDROME
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Koskimies, J.; Heinonen, S.; Jukarainen, S.; Ek, V.; Pietilainen, K.; Taskinen, M. R.; Matikainen, N.; Soderlund, S.] Helsinki Univ Hosp, Res Programs Unit, Diabet & Obes, Dept Internal Med, Helsinki, Finland.
   [Hakkarainen, A.; Lundbom, N.] Helsinki Univ Hosp, HUS Med Imaging Ctr, Radiol, Helsinki, Finland.
   [Boren, J.] Sahlgrens Univ Hosp, Wallenberg Lab, Gothenburg, Sweden.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0892
BP E72
EP E72
DI 10.1016/j.atherosclerosis.2019.06.205
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800204
DA 2019-10-28
ER

PT J
AU Kosmacheva, H
   Babich, A
AF Kosmacheva, H.
   Babich, A.
TI LIPID SPECTRUM AND GLOMERULAR FILTRATION RATE IN LIVER TRANSPLANT
   RECIPIENTS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kosmacheva, H.] Reg Clin Hosp 1, State Budgetary Healthcare Inst Res Inst, Minist Hlth Krasnodar Reg, Dept Cardiol, Krasnodar, Russia.
   [Babich, A.] Reg Clin Hosp 1, State Budgetary Healthcare Inst Res Inst, Minist Hlth Krasnodar Reg, Dept Gastroenterol, Krasnodar, Russia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1045
BP E124
EP E124
DI 10.1016/j.atherosclerosis.2019.06.363
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800361
DA 2019-10-28
ER

PT J
AU Kostic, S
   Djuric, M
   Colovic, M
   Krstic, D
   Djuric, D
AF Kostic, S.
   Djuric, M.
   Colovic, M.
   Krstic, D.
   Djuric, D.
TI THE EFFECTS OF HYDROGEN SULFIDE SYNTHASE INHIBITION FOLLOWING ACUTE
   ADMINISTRATION OF HOMOCYSTEINE ON OXIDATIVE STRESS MARKERS IN RAT PLASMA
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kostic, S.; Djuric, D.] Univ Belgrade, Fac Med, Inst Med Physiol Richard Burian, Belgrade, Serbia.
   [Djuric, M.] Univ Clin Hosp Ctr Dr Dragisa Misovic Dedinje, Dept Anesthesiol Reanimatol & Intens Care Med, Belgrade, Serbia.
   [Colovic, M.] Univ Belgrade, Vinca Inst Nucl Sci, Dept Phys Chem, Belgrade, Serbia.
   [Krstic, D.] Univ Belgrade, Fac Med, Inst Med Chem, Belgrade, Serbia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0853
BP E274
EP E274
DI 10.1016/j.atherosclerosis.2019.06.849
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800847
DA 2019-10-28
ER

PT J
AU Kostner, G
   Vujic, N
   Kratky, D
AF Kostner, G.
   Vujic, N.
   Kratky, D.
TI MIR-206 DEFICIENCY RESULTS IN A FAVORABLE PHENOTYPE: RELEVANCE FOR
   TYPE-2 DIABETES MELLITUS AND METABOLIC SYNDROME
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kostner, G.; Vujic, N.] Gottfried Schatz Res Ctr, Mol Biol & Biochem, Graz, Austria.
   [Kratky, D.] Gottfried Schatz Resarch Ctr, Graz, Austria.
   [Kratky, D.] Bio TechMed, Mol Biol abd Biochem, Graz, Austria.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0192
BP E129
EP E130
DI 10.1016/j.atherosclerosis.2019.06.381
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800379
DA 2019-10-28
ER

PT J
AU Kotova, J
   Zuikova, A
   Pashkov, A
   Strahova, N
AF Kotova, J.
   Zuikova, A.
   Pashkov, A.
   Strahova, N.
TI ROLE OF THE OXIDATIVE MODIFICATION OF PROTEINS IN THE PROGRESSION OF
   CORONARY ATHEROSCLEROSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kotova, J.; Zuikova, A.; Strahova, N.] Voronezh State Med Univ, Policlin Therapy, Voronezh, Russia.
   [Pashkov, A.] Voronezh State Med Univ, Biol, Voronezh, Russia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0913
BP E249
EP E249
DI 10.1016/j.atherosclerosis.2019.06.765
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800763
DA 2019-10-28
ER

PT J
AU Kovalkova, N
   Ragino, Y
   Denisova, D
   Scherbakova, L
   Voevoda, M
AF Kovalkova, N.
   Ragino, Y.
   Denisova, D.
   Scherbakova, L.
   Voevoda, M.
TI STUDY OF ASSOCIATIONS OF CARDIOMETABOLIC RISK FACTORS AND RENAL FUNCTION
   IN THE RUSSIAN POPULATION OF 25-45 YEARS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kovalkova, N.; Ragino, Y.; Denisova, D.; Scherbakova, L.; Voevoda, M.] Russian Acad Sci, Lab Clin Biochem & Hormonal Studies Therapeut Dis, Res Inst Internal & Prevent Med,Siberian Branch, IIPM,Branch IC&G SB RAS,Branch Inst Cytol & Genet, Novosibirsk, Russia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1091
BP E284
EP E284
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800877
DA 2019-10-28
ER

PT J
AU Krammer, C
   Besson-Girard, S
   Gokce, O
   Schulte, C
   El Bounkari, O
   Bernhagen, J
AF Krammer, C.
   Besson-Girard, S.
   Gokce, O.
   Schulte, C.
   El Bounkari, O.
   Bernhagen, J.
TI EFFECTS OF MIF-DEFICIENCY ON AGE-RELATED B CELL PHENOTYPES AND
   POPULATION DIVERSITY IN ATHEROSCLEROSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Krammer, C.; El Bounkari, O.; Bernhagen, J.] Ludwig Maximilians Univ LMU Munich, Inst Stroke & Dementia Res ISD, Vasc Biol, Munich, Germany.
   [Besson-Girard, S.; Gokce, O.] Ludwig Maximilians Univ LMU Munich, Inst Stroke & Dementia Res ISD, Syst Neurosci, Munich, Germany.
   [Schulte, C.] Rhein Westfal TH Aachen, Inst Mol Cardiovasc Res IMCAR, Pathol Mech Underlying Atherosclerosis, Univ Hosp Aachen, Aachen, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0770
BP E248
EP E248
DI 10.1016/j.atherosclerosis.2019.06.762
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800760
DA 2019-10-28
ER

PT J
AU Kravchenko, G
   Krasilnikova, O
AF Kravchenko, G.
   Krasilnikova, O.
TI JNK ACTIVATION IS ACCOMPANIED BY CERAMIDES AND DIACYLGLYCEROL
   ACCUMULATION IN ISOLATED HEPATOCYTES
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kravchenko, G.; Krasilnikova, O.] Natl Univ Pharm, Biochem, Kharkov, Ukraine.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0993
BP E234
EP E234
DI 10.1016/j.atherosclerosis.2019.06.719
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800717
DA 2019-10-28
ER

PT J
AU Krishnappa, M
   Shah, M
   Parmar, K
   Joshi, S
   Maroo, S
   Parmar, D
AF Krishnappa, M.
   Shah, M.
   Parmar, K.
   Joshi, S.
   Maroo, S.
   Parmar, D.
TI SAROGLITAZAR REDUCES PREDICTOR LIPID BIOMARKERS OF CARDIOVASCULAR
   DISEASES
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Krishnappa, M.; Shah, M.; Parmar, K.; Joshi, S.; Maroo, S.] Cadila Healthcare Ltd, Zydus Res Ctr, Clin Res & Dev, Ahmadabad, Gujarat, India.
   [Parmar, D.] Zydus Discovery DMCC, Clin R&D, Dubai, U Arab Emirates.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0155
BP E35
EP E35
DI 10.1016/j.atherosclerosis.2019.06.104
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800103
DA 2019-10-28
ER

PT J
AU Krougly, L
   Fomicheva, O
   Karpov, Y
   Pogorelova, O
   Tripoten, M
   Balakhonova, T
   Popkova, T
   Gerasimova, E
AF Krougly, L.
   Fomicheva, O.
   Karpov, Y.
   Pogorelova, O.
   Tripoten, M.
   Balakhonova, T.
   Popkova, T.
   Gerasimova, E.
TI DIFFERENT NEOVASCULARIZATION GRADE OF CAROTID ARTERY ATHEROSCLEROTIC
   PLAQUE IN RHEUMATOID ARTHRITIS PATIENTS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Krougly, L.] Natl Med Res Ctr Cardiol, Sci & Org Dept, Moscow, Russia.
   [Fomicheva, O.; Karpov, Y.] Natl Med Res Ctr Cardiol, Angiol Dept, Moscow, Russia.
   [Pogorelova, O.; Tripoten, M.; Balakhonova, T.] Natl Med Res Ctr Cardiol, Ultrasound Lab, Moscow, Russia.
   [Popkova, T.; Gerasimova, E.] VA Nasonova Res Inst Rheumatol, Syst Rheumat Dis Lab, Moscow, Russia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0590
BP E155
EP E155
DI 10.1016/j.atherosclerosis.2019.06.465
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800463
DA 2019-10-28
ER

PT J
AU Kubatova, H
   Cermakova, H
   Lesna, IK
   Cejkova, S
   Fronek, J
   Janousek, L
   Poledne, R
   Pit'ha, J
AF Kubatova, H.
   Cermakova, H.
   Lesna, I. Kralova
   Cejkova, S.
   Fronek, J.
   Janousek, L.
   Poledne, R.
   Pit'ha, J.
TI ULTRASOUND AND IMMUNOLOGICAL PROPERTIES OF CAROTID ARTERY PLAQUES: A
   COMBINED APPROACH
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kubatova, H.; Lesna, I. Kralova; Cejkova, S.; Poledne, R.; Pit'ha, J.] Inst Clin & Expt Med, Expt Med Ctr, Atherosclerosis Res Lab, Prague, Czech Republic.
   [Cermakova, H.; Fronek, J.; Janousek, L.] Inst Clin & Expt Med, Transplantat Ctr, Dept Transplantat Surg, Prague, Czech Republic.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0346
BP E238
EP E239
DI 10.1016/j.atherosclerosis.2019.06.732
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800730
DA 2019-10-28
ER

PT J
AU Kubekina, M
   Silaeva, Y
AF Kubekina, M.
   Silaeva, Y.
TI CREATING MUTATIONS ASSOCIATED WITH ATHEROSCLEROSIS BY CRISPR/CAS9 GENE
   EDITING SYSTEM OF THE MITOCHONDRIAL GENOME IN MICE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kubekina, M.; Silaeva, Y.] Russian Acad Sci, Ctr Collect Usage, Inst Gene Biol, Moscow, Russia.
FU RSFRussian Science Foundation (RSF) [17-75-20249]
FX This studywas supported by RSF (Grant # 17-75-20249)
NR 0
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0733
BP E266
EP E267
DI 10.1016/j.atherosclerosis.2019.06.824
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800822
DA 2019-10-28
ER

PT J
AU Kulik, A
   Rosloniec, E
   Madejski, P
   Mika, P
AF Kulik, A.
   Rosloniec, E.
   Madejski, P.
   Mika, P.
TI DOES WALKING PERFORMANCE REFLECT A DAILY PHYSICAL ACTIVITY OF
   CLAUDICANTS?
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kulik, A.; Rosloniec, E.] Poznan Univ Phys Educ, Fac Phys Culture Gorzow Wielkopolski, Gorzow Wielkopolski, Poland.
   [Madejski, P.; Mika, P.] Univ Phys Educ, Fac Rehabil, Krakow, Poland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0329
BP E154
EP E154
DI 10.1016/j.atherosclerosis.2019.06.461
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800459
DA 2019-10-28
ER

PT J
AU Kumar, A
AF Kumar, A.
TI DEMONSTRATING THE DECLINE IN CORONARY HEART DISEASE MORTALITY IN THE
   WEST DELHI, INDIA BETWEEN 2014 TO 2017
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kumar, A.] JMI, Biosci, Delhi, India.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0740
BP E87
EP E87
DI 10.1016/j.atherosclerosis.2019.06.254
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800253
DA 2019-10-28
ER

PT J
AU Kumar, N
   Khanna, R
AF Kumar, N.
   Khanna, R.
TI PHARMACEUTICAL AND BIOPHARMACEUTICAL EVALUATION OF EXTRACTS FROM
   DIFFERENT PLANT PARTS OF INDIGENOUS ORIGIN FOR THEIR HYPOGLYCEMIC
   RESPONSES IN RATS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kumar, N.; Khanna, R.] Vivekananda Global Univ, Dept Basic & Appl Biol, Jaipur, Rajasthan, India.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0662
BP E147
EP E147
DI 10.1016/j.atherosclerosis.2019.06.436
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800434
DA 2019-10-28
ER

PT J
AU Kume, N
   Yasuda, D
   Torii, H
   Hiraoka, Y
AF Kume, N.
   Yasuda, D.
   Torii, H.
   Hiraoka, Y.
TI REDUCED HEPATIC MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN (MTP)
   EXPRESSION IN A MOUSE MODEL OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)
   INDUCED BY CHOLINE-DEFICIENT HIGH FAT DIET (CDAHFD)
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kume, N.; Yasuda, D.; Torii, H.; Hiraoka, Y.] Kobe Gakuin Univ, Clin Pharm, Kobe, Hyogo, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0902
BP E122
EP E122
DI 10.1016/j.atherosclerosis.2019.06.355
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800354
DA 2019-10-28
ER

PT J
AU Kurbanov, S
   Akchurin, R
   Shiryaev, A
   Vasiliev, V
   Galyautdinov, D
   Vlasova, E
   Ilina, L
   Latypov, R
   Mayorov, G
   Zaykovskiy, V
   Mukimov, S
AF Kurbanov, S.
   Akchurin, R.
   Shiryaev, A.
   Vasiliev, V.
   Galyautdinov, D.
   Vlasova, E.
   Ilina, L.
   Latypov, R.
   Mayorov, G.
   Zaykovskiy, V.
   Mukimov, S.
TI MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH DIFFUSE CORONARY ARTERY
   DISEASE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kurbanov, S.; Akchurin, R.; Shiryaev, A.; Vasiliev, V.; Galyautdinov, D.; Vlasova, E.; Ilina, L.; Latypov, R.; Mayorov, G.; Zaykovskiy, V.; Mukimov, S.] Natl Med Res Ctr Cardiol, Cardiosurg Dept, Moscow, Russia.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0443
BP E155
EP E155
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800462
DA 2019-10-28
ER

PT J
AU Kuret, T
   Sodin-Semrl, S
   Lakota, K
   Mrak-Poljsak, K
   Cucnik, S
   Erman, A
AF Kuret, T.
   Sodin-Semrl, S.
   Lakota, K.
   Mrak-Poljsak, K.
   Cucnik, S.
   Erman, A.
TI INTERLEUKIN-1B INDUCES INTRACELLULAR SERUM AMYLOID A1 EXPRESSION IN
   HUMAN CORONARY ENDOTHELIAL CELLS AND PROMOTES ITS INTERCELLULAR EXCHANGE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kuret, T.; Sodin-Semrl, S.; Lakota, K.; Mrak-Poljsak, K.; Cucnik, S.] Univ Med Ctr Ljubljana, Dept Rheumatol, Ljubljana, Slovenia.
   [Kuret, T.; Cucnik, S.] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia.
   [Sodin-Semrl, S.; Lakota, K.] Univ Primorska, Fac Math Nat Sci & Informat Technol, Koper, Slovenia.
   [Erman, A.] Univ Ljubljana, Inst Cell Biol, Ljubljana, Slovenia.
   [Erman, A.] Univ Ljubljana, Fac Med, Ljubljana, Slovenia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0099
BP E264
EP E264
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800813
DA 2019-10-28
ER

PT J
AU Kurmus, O
   Aslan, T
   Eren, M
   Ekici, B
   Fahri, AE
AF Kurmus, O.
   Aslan, T.
   Eren, M.
   Ekici, B.
   Fahri, A. Erkan
TI DISCORDANCE OF LOW DENSITY LIPOPROTEIN CHOLESTEROL AND NON-HIGH DENSITY
   LIPOPROTEIN CHOLESTEROL AND CORONARY ARTERY DISEASE SEVERITY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kurmus, O.; Aslan, T.; Eren, M.; Ekici, B.; Fahri, A. Erkan] Ufuk Univ, Cardiol, Ankara, Turkey.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0087
BP E179
EP E180
DI 10.1016/j.atherosclerosis.2019.06.544
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800542
DA 2019-10-28
ER

PT J
AU Kurmus, O
   Eren, M
   Aslan, T
AF Kurmus, O.
   Eren, M.
   Aslan, T.
TI RELATIONSHIP BETWEEN DISCORDANCE OF LIPID PARAMETERS AND MORTALITY AFTER
   ACUTE CORONARY SYNDROME
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kurmus, O.; Eren, M.; Aslan, T.] Ufuk Univ, Cardiol, Ankara, Turkey.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0723
BP E190
EP E190
DI 10.1016/j.atherosclerosis.2019.06.574
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800572
DA 2019-10-28
ER

PT J
AU Kusov, P
   Deikin, A
AF Kusov, P.
   Deikin, A.
TI DEVELOPING NOVEL TRANSGENIC MICE MODEL OF ATHEROGENESIS WITH CONDITIONAL
   OXIDATIVE STRESS BY INTRODUCTION OF EPITHELIUM-SPECIFIC INDUCIBLE
   MITOCHONDRIAL POLG WITH MUTAGENIC ACTIVITY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kusov, P.] Skolkovo Inst Scence & Technol, Life Sci, Moscow, Russia.
   [Deikin, A.] Inst Gene Biol, Ctr Collect Usage, Moscow, Russia.
FU RSF foundationRussian Science Foundation (RSF) [17-75-20249]
FX Described work was supported by RSF foundation, grant 17-75-20249.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0737
BP E99
EP E99
DI 10.1016/j.atherosclerosis.2019.06.287
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800286
DA 2019-10-28
ER

PT J
AU Kutkiene, S
   Gargalskaite, U
   Petrulionyte, E
   Rinkuniene, E
   Skiauteryte, E
   Laucevicius, A
AF Kutkiene, S.
   Gargalskaite, U.
   Petrulionyte, E.
   Rinkuniene, E.
   Skiauteryte, E.
   Laucevicius, A.
TI PREVALENCE AND AGING TENDENCIES OF CARDIOMETABOLIC RISK FACTORS IN
   MIDDLE-AGED LITHUANIAN MEN-WITHDR BY AUTHOR-
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kutkiene, S.; Gargalskaite, U.; Rinkuniene, E.; Skiauteryte, E.; Laucevicius, A.] Vilnius Univ, Fac Med, Clin Cardiac & Vasc Dis, Vilnius, Lithuania.
   [Kutkiene, S.; Gargalskaite, U.; Rinkuniene, E.; Skiauteryte, E.; Laucevicius, A.] Vilnius Univ Hosp Santaros Clin, Ctr Cardiol & Angiol, Vilnius, Lithuania.
   [Petrulionyte, E.] Vilnius Univ, Fac Med, Vilnius, Lithuania.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0441
BP E273
EP E273
DI 10.1016/j.atherosclerosis.2019.06.846
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800844
DA 2019-10-28
ER

PT J
AU Kutkiene, S
   Gargalskaite, U
   Petrulionyte, E
   Rinkuniene, E
   Laucevicius, A
AF Kutkiene, S.
   Gargalskaite, U.
   Petrulionyte, E.
   Rinkuniene, E.
   Laucevicius, A.
TI BODY MASS INDEX AND WAIST CIRCUMFERENCE ANALYSIS IN MIDDLE-AGED
   LITHUANIAN MEN WITHOUT OVERT CVD
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kutkiene, S.; Gargalskaite, U.; Rinkuniene, E.; Laucevicius, A.] Vilnius Univ, Fac Med, Clin Cardiac & Vasc Dis, Vilnius, Lithuania.
   [Kutkiene, S.; Gargalskaite, U.; Rinkuniene, E.; Laucevicius, A.] Vilnius Univ Hosp Santaros Clin, Ctr Cardiol & Angiol, Vilnius, Lithuania.
   [Petrulionyte, E.] Vilnius Univ, Fac Med, Vilnius, Lithuania.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0482
BP E174
EP E174
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800527
DA 2019-10-28
ER

PT J
AU Kutkiene, S
   Gargalskaite, U
   Petrulionyte, E
   Rinkuniene, E
   Skiauteryte, E
   Laucevicius, A
AF Kutkiene, S.
   Gargalskaite, U.
   Petrulionyte, E.
   Rinkuniene, E.
   Skiauteryte, E.
   Laucevicius, A.
TI PREVALENCE AND AGING TENDENCIES OF CARDIOMETABOLIC RISK FACTORS IN
   MIDDLE-AGED LITHUANIAN WOMEN
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kutkiene, S.; Gargalskaite, U.; Rinkuniene, E.; Skiauteryte, E.; Laucevicius, A.] Vilnius Univ, Fac Med, Clin Cardiac & Vasc Dis, Vilnius, Lithuania.
   [Kutkiene, S.; Gargalskaite, U.; Rinkuniene, E.; Skiauteryte, E.; Laucevicius, A.] Vilnius Univ Hosp Santaros Clin, Ctr Cardiol & Angiol, Vilnius, Lithuania.
   [Petrulionyte, E.] Vilnius Univ, Fac Med, Vilnius, Lithuania.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0437
BP E187
EP E187
DI 10.1016/j.atherosclerosis.2019.06.565
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800563
DA 2019-10-28
ER

PT J
AU Kutkiene, S
   Petrulioniene, Z
   Gargalskaite, U
   Saulyte-Mikulskiene, A
   Staigyte, J
   Rinkuniene, E
   Dzenkeviciute, V
   Laucevicius, A
AF Kutkiene, S.
   Petrulioniene, Z.
   Gargalskaite, U.
   Saulyte-Mikulskiene, A.
   Staigyte, J.
   Rinkuniene, E.
   Dzenkeviciute, V.
   Laucevicius, A.
TI COMPARISON OF BLOOD LIPID PARAMETERS BETWEEN GROUPS WITH AND WITHOUT
   ABDOMINAL OBESITY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kutkiene, S.; Petrulioniene, Z.; Gargalskaite, U.; Saulyte-Mikulskiene, A.; Staigyte, J.; Rinkuniene, E.; Laucevicius, A.] Vilnius Univ, Fac Med, Clin Cardiac & Vasc Dis, Vilnius, Lithuania.
   [Kutkiene, S.; Petrulioniene, Z.; Gargalskaite, U.; Saulyte-Mikulskiene, A.; Staigyte, J.; Rinkuniene, E.; Dzenkeviciute, V.; Laucevicius, A.] Vilnius Univ Hosp Santaros Clin, Ctr Cardiol & Angiol, Vilnius, Lithuania.
   [Dzenkeviciute, V.] Vilnius Univ, Fac Med, Clin Internal Dis Family Med & Oncol, Vilnius, Lithuania.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0948
BP E137
EP E138
DI 10.1016/j.atherosclerosis.2019.06.407
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800405
DA 2019-10-28
ER

PT J
AU Kutkiene, S
   Gargalskaite, U
   Petrulionyte, E
   Rinkuniene, E
   Laucevicius, A
AF Kutkiene, S.
   Gargalskaite, U.
   Petrulionyte, E.
   Rinkuniene, E.
   Laucevicius, A.
TI BODY MASS INDEX AND WAIST CIRCUMFERENCE ANALYSIS IN MIDDLE-AGED
   LITHUANIAN WOMEN WITHOUT OVERT CVD
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kutkiene, S.; Gargalskaite, U.; Rinkuniene, E.; Laucevicius, A.] Vilnius Univ, Fac Med, Clin Cardiac & Vasc Dis, Vilnius, Lithuania.
   [Kutkiene, S.; Gargalskaite, U.; Rinkuniene, E.; Laucevicius, A.] Vilnius Univ Hosp Santaros Clin, Ctr Cardiol & Angiol, Vilnius, Lithuania.
   [Petrulionyte, E.] Vilnius Univ, Fac Med, Vilnius, Lithuania.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0478
BP E174
EP E174
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800526
DA 2019-10-28
ER

PT J
AU Kyselak, O
   Soska, V
AF Kyselak, O.
   Soska, V.
TI CHILD WITH FAMILIAL HYPERCHOLESTEROLEMIA PHENOTYPE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Kyselak, O.; Soska, V.] St Annes Univ Hosp, Dept Biochem, Brno, Czech Republic.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0781
BP E219
EP E220
DI 10.1016/j.atherosclerosis.2019.06.670
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800668
DA 2019-10-28
ER

PT J
AU Lacy, M
   Gerdes, N
   Ahmadsei, M
   Karshovska, E
   Kuipers, M
   Heemskerk, J
   Burger, C
   Reim, S
   Weber, C
   Atzler, D
   Lutgens, E
AF Lacy, M.
   Gerdes, N.
   Ahmadsei, M.
   Karshovska, E.
   Kuipers, M.
   Heemskerk, J.
   Buerger, C.
   Reim, S.
   Weber, C.
   Atzler, D.
   Lutgens, E.
TI PLATELET CD40L DOES NOT AFFECT ATHEROGENESIS, BUT IS A KEY PLAYER IN
   ATHEROTHROMBOSIS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Lacy, M.; Gerdes, N.; Ahmadsei, M.; Karshovska, E.; Buerger, C.; Reim, S.; Weber, C.; Atzler, D.; Lutgens, E.] Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent, Munich, Germany.
   [Lacy, M.; Ahmadsei, M.; Weber, C.; Atzler, D.] Partner Site Munich Heart Alliance, German Ctr Cardiovasc Res DZHK, Munich, Germany.
   [Gerdes, N.] Univ Dusseldorf, Div Cardiol Pulmonol & Vasc Med, Dusseldorf, Germany.
   [Kuipers, M.; Heemskerk, J.; Weber, C.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands.
   [Atzler, D.; Lutgens, E.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Amsterdam, Netherlands.
   [Atzler, D.] Ludwig Maximilians Univ Munchen, Walther Straub Inst Pharmacol & Toxicol, Munich, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0591
BP E48
EP E48
DI 10.1016/j.atherosclerosis.2019.06.138
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800137
DA 2019-10-28
ER

PT J
AU Lacy, M
   Gerdes, N
   Burger, C
   Winkels, H
   Nitz, K
   Reim, S
   Weber, C
   Atzler, D
   Lutgens, E
AF Lacy, M.
   Gerdes, N.
   Buerger, C.
   Winkels, H.
   Nitz, K.
   Reim, S.
   Weber, C.
   Atzler, D.
   Lutgens, E.
TI DEFICIENCY OF CD40-CD40L SIGNALING IN DCS AND T CELLS ATTENUATES
   ATHEROSCLEROSIS THROUGH REDUCTIONS IN TH1 POPULATIONS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Lacy, M.; Gerdes, N.; Buerger, C.; Winkels, H.; Nitz, K.; Reim, S.; Weber, C.; Atzler, D.; Lutgens, E.] Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent, Munich, Germany.
   [Lacy, M.; Nitz, K.; Weber, C.; Atzler, D.] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany.
   [Gerdes, N.] Univ Dusseldorf, Div Cardiol Pulmonol & Vasc Med, Dusseldorf, Germany.
   [Winkels, H.; Atzler, D.; Lutgens, E.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Amsterdam, Netherlands.
   [Atzler, D.] Ludwig Maximilians Univ Munchen, Walther Straub Inst Pharmacol & Toxicol, Munich, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0884
BP E5
EP E6
DI 10.1016/j.atherosclerosis.2019.06.015
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800015
DA 2019-10-28
ER

PT J
AU Lagache, S
   Sohrabi, Y
   Schnack, L
   Waltenberger, J
   Reinecke, H
   Findeisen, H
AF Lagache, S.
   Sohrabi, Y.
   Schnack, L.
   Waltenberger, J.
   Reinecke, H.
   Findeisen, H.
TI TREATMENT OF HUVEC CELLS WITH OXLDL OR BCG INDUCES A SUSTAINED BUT
   DISTINCT PROINFLAMMATORY PRIMING
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Lagache, S.; Sohrabi, Y.; Schnack, L.; Waltenberger, J.; Reinecke, H.; Findeisen, H.] Univ Hosp Munster, Dept Cardiol Coronary & Peripheral Vasc Dis Heart, Munster, Germany.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1018
BP E250
EP E250
DI 10.1016/j.atherosclerosis.2019.06.769
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800767
DA 2019-10-28
ER

PT J
AU Lambrecht, L
   Wobst, J
   Wolf, B
   Schunkert, H
   Kessler, T
AF Lambrecht, L.
   Wobst, J.
   Wolf, B.
   Schunkert, H.
   Kessler, T.
TI PLATELET INHIBITION IN CARRIERS OF THE GUCY1A3 CORONARY ARTERY DISEASE
   RISK ALLELE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Lambrecht, L.; Wobst, J.; Wolf, B.; Schunkert, H.; Kessler, T.] Tech Univ Munich, German Heart Ctr, Expt Cardiol, Munich, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0114
BP E140
EP E140
DI 10.1016/j.atherosclerosis.2019.06.416
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800414
DA 2019-10-28
ER

PT J
AU Lamiquiz, I
   Hindy, G
   Mateo-Gallego, R
   Bea, AM
   Perez-Calahorra, S
   Baila-Rueda, L
   Marco-Benedi, V
   Martin, C
   Cenarro, A
   Kathiresan, S
   Civeira, F
AF Lamiquiz, I.
   Hindy, G.
   Mateo-Gallego, R.
   Bea, A. M.
   Perez-Calahorra, S.
   Baila-Rueda, L.
   Marco-Benedi, V.
   Martin, C.
   Cenarro, A.
   Kathiresan, S.
   Civeira, F.
TI WHOLE-EXOME SEQUENCING IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
   WITHOUT FUNCTIONAL MUTATION IN CANDIDATE GENES.
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Lamiquiz, I.; Mateo-Gallego, R.; Bea, A. M.; Perez-Calahorra, S.; Baila-Rueda, L.; Marco-Benedi, V.; Cenarro, A.; Civeira, F.] Univ Zaragoza, Hosp Univ Miguel Servet, CIBERCV, IIS Aragon,Unidad Clin & Invest Lipidos & Arterio, Zaragoza, Spain.
   [Lamiquiz, I.; Hindy, G.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA.
   [Hindy, G.] Lund Univ, Skane Univ Hosp, Dept Clin Sci Malmo, Jan Waldenstroms Gata 35, SE-20502 Malmo, Sweden.
   [Martin, C.] Univ Basque Country, UPV EHU, Dept Bioquim & Biol Mol, Unidad Biofis,CSIC, Bilbao, Spain.
   [Kathiresan, S.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.
   [Kathiresan, S.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.
   [Kathiresan, S.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.
NR 0
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0747
BP E92
EP E93
DI 10.1016/j.atherosclerosis.2019.06.268
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800267
DA 2019-10-28
ER

PT J
AU Langslet, G
   Hovingh, GK
   Guyton, JR
   Baccara-Dinet, MT
   Letierce, A
   Manvelian, G
   Farnier, M
AF Langslet, G.
   Hovingh, G. K.
   Guyton, J. R.
   Baccara-Dinet, M. T.
   Letierce, A.
   Manvelian, G.
   Farnier, M.
TI REGIONAL VARIATIONS IN ALIROCUMAB DOSING PATTERNS DURING AN OPEN-LABEL
   EXTENSION STUDY IN PATIENTS WITH HETEROZYGOUS FAMILIAL
   HYPERCHOLESTEROLAEMIA
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Langslet, G.] Oslo Univ Hosp, Lipid Clin, Oslo, Norway.
   [Hovingh, G. K.] Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands.
   [Guyton, J. R.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27706 USA.
   [Baccara-Dinet, M. T.] Sanofi, Clin Dev R&D, Montpellier, France.
   [Letierce, A.] Sanofi, Res & Dev, Chilly Mazarin, France.
   [Manvelian, G.] Regeneron Pharmaceut Inc, Cardiovasc & Metab Therapeut, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.
   [Farnier, M.] CHU Dijon Bourgogne, Lipid Clin, Point Med, Dijon, France.
   [Farnier, M.] CHU Dijon Bourgogne, Dept Cardiol, Dijon, France.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1006
BP E37
EP E38
DI 10.1016/j.atherosclerosis.2019.06.110
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800109
DA 2019-10-28
ER

PT J
AU Langsted, A
   Nordestgaard, BG
   Kamstrup, PR
AF Langsted, A.
   Nordestgaard, B. G.
   Kamstrup, P. R.
TI LIPOPROTEIN(A) AND RISK OF ISCHEMIC STROKE IN THE GENERAL POPULATION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Langsted, A.; Nordestgaard, B. G.; Kamstrup, P. R.] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0589
BP E112
EP E112
DI 10.1016/j.atherosclerosis.2019.06.325
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800324
DA 2019-10-28
ER

PT J
AU Larsen, LE
AF Larsen, L. Elmann
TI A MURINE MODEL OF TMEM199-CDG, A GOLGI TRAFFICKING DEFECT, HAS ABERRANT
   PROTEIN GALACTOSYLATION AND FATTY LIVER
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Larsen, L. Elmann] AMC Med Res, Expt Vasc Med, Groningen, Netherlands.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-1132
BP E276
EP E276
DI 10.1016/j.atherosclerosis.2019.06.856
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800854
DA 2019-10-28
ER

PT J
AU Lasserre, S
   Charrieres, S
   Vimont, A
   Valero, R
   Gallo, A
   Bruckert, E
AF Lasserre, S.
   Charrieres, S.
   Vimont, A.
   Valero, R.
   Gallo, A.
   Bruckert, E.
TI PREDICTION OF CARDIOVASCULAR EVENTS IN FAMILIAL HYPERCHOLESTEROLEMIA
   (FH): DATA FROM THE FRENCH FH REGISTRY AND EXTERNAL VALIDATION OF
   SAFEHEART EQUATION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Lasserre, S.; Valero, R.] APHM, Dept Nutr Metab Dis Endocrinol, Marseille, France.
   [Charrieres, S.] Univ Lyon 1, Hosp Civils Lyon, Dept Endocrinol, Bron, France.
   [Vimont, A.] PH Expertise, Paris, France.
   [Gallo, A.; Bruckert, E.] AP HP, Dept Endocrinol & Prevent Cardiovasc Dis, Inst Cardio Metab & Nutr ICAN, Paris, France.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0832
BP E91
EP E91
DI 10.1016/j.atherosclerosis.2019.06.264
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800263
DA 2019-10-28
ER

PT J
AU Lasticova, M
   Visek, J
   Blaha, V
   Blaha, M
   Lanska, M
   Dolezelova, E
   Nachtigal, P
AF Lasticova, M.
   Visek, J.
   Blaha, V.
   Blaha, M.
   Lanska, M.
   Dolezelova, E.
   Nachtigal, P.
TI EFFECT OF TREATMENT WITH STATINS ON PARAMETERS OF DYSLIPIDEMIA AND
   ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Lasticova, M.; Visek, J.; Blaha, V.] Charles Univ Prague, Fac Med Hradec Kralove, Internal Dept Gerontol & Metab 3, Hradec Kralove, Czech Republic.
   [Blaha, M.; Lanska, M.] Charles Univ Prague, Fac Med Hradec Kralove, Internal Dept Hematol 4, Hradec Kralove, Czech Republic.
   [Dolezelova, E.; Nachtigal, P.] Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Biol & Med Sci, Hradec Kralove, Czech Republic.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0324
BP E264
EP E265
DI 10.1016/j.atherosclerosis.2019.06.818
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800816
DA 2019-10-28
ER

PT J
AU Laursen, R
   Dahl, M
   Lindholt, J
   Hogh, A
AF Laursen, R.
   Dahl, M.
   Lindholt, J.
   Hogh, A.
TI PREVALENCE OF PERIPHERAL ARTERIAL DISEASE, HYPERTENSION AND DIABETES IN
   A POPULATION OF 66-82 YEARS OLD ASYMPTOMATIC WOMEN 6 YEARS AFTER
   SCREENING-DETECTED CAROTID PLAQUE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Laursen, R.; Dahl, M.; Hogh, A.] Viborg Hosp, Reg Hosp Cent Jutland, Vasc Surg Res Unit, Dept Vasc Surg, Viborg, Denmark.
   [Lindholt, J.] Odense Univ Hosp, Dept Cardiothorac & Vasc Surg, Elitary Res Ctr Individualized Med Arterial Dis C, Odense, Denmark.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0614
BP E31
EP E32
DI 10.1016/j.atherosclerosis.2019.06.093
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800092
DA 2019-10-28
ER

PT J
AU Lavin-Plaza, B
   Andia, M
   Eykyn, T
   Phinikaridou, A
   Xavier, A
   Botnar, R
AF Lavin-Plaza, B.
   Andia, M.
   Eykyn, T.
   Phinikaridou, A.
   Xavier, A.
   Botnar, R.
TI ANTIHYPERTENSIVE AND HYPOGLYCEMIC THERAPY REDUCES BODY AND LIVER FAT
   DEPOSITION IN A MURINE MODEL OF NON-ALCOHOLIC FATTY LIVER DISEASE
   (NAFLD)
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Lavin-Plaza, B.; Eykyn, T.; Phinikaridou, A.; Botnar, R.] Kings Coll London, Sch Biomed Engn & Imaging Sci, London, England.
   [Andia, M.; Xavier, A.; Botnar, R.] Pontificia Univ Catolica, Dept Radiol, Santiago, Chile.
   [Andia, M.; Xavier, A.; Botnar, R.] Pontificia Univ Catolica, Biomed Imaging Ctr, Santiago, Chile.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0166
BP E120
EP E121
DI 10.1016/j.atherosclerosis.2019.06.350
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800349
DA 2019-10-28
ER

PT J
AU Lavin-Plaza, B
   Phinikaridou, A
   Andia, M
   Rashid, I
   Potter, M
   Botnar, R
AF Lavin-Plaza, B.
   Phinikaridou, A.
   Andia, M.
   Rashid, I.
   Potter, M.
   Botnar, R.
TI FOCAL AORTIC VASCULAR INJURY ALTERS REMOTE ATHEROSCLEROTIC PLAQUE
   PROGRESSION: AN IN VIVO MURINE MRI STUDY
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Lavin-Plaza, B.; Phinikaridou, A.; Rashid, I.; Potter, M.; Botnar, R.] Kings Coll London, Sch Biomed Engn & Imaging Sci, London, England.
   [Andia, M.; Botnar, R.] Pontificia Univ Catolica, Dept Radiol, Santiago, Chile.
   [Andia, M.; Botnar, R.] Pontificia Univ Catolica, Biomed Imaging Ctr, Santiago, Chile.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0165
BP E47
EP E47
DI 10.1016/j.atherosclerosis.2019.06.136
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800135
DA 2019-10-28
ER

PT J
AU Lazaro, I
   Cofan, M
   Surra, J
   Gomez-Guerrero, C
   Ortega, E
   Osada, J
   Dantas, AP
   Sala-Vila, A
AF Lazaro, I.
   Cofan, M.
   Surra, J.
   Gomez-Guerrero, C.
   Ortega, E.
   Osada, J.
   Dantas, A. P.
   Sala-Vila, A.
TI WALNUT INCLUSION IN A PALM-BASED HIGH-FAT AND HIGH-CHOLESTEROL DIET
   WITHOUT CHANGING TOTAL ENERGY SUPPLY STABILISES ADVANCED ATHEROMA PLAQUE
   THROUGH AN ANTI-INFLAMMATORY MECHANISM IN APOE-DEFICIENT MICE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Lazaro, I.] ISCIII, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Inst Clin Cardiovasc,Expt Cardiol, Barcelona, Spain.
   [Cofan, M.; Ortega, E.; Sala-Vila, A.] Hosp Clin Barcelona, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Endocrinol & Nutr Serv, ISCIII,IDIBAPS,Lipid Clin, Barcelona, Spain.
   [Surra, J.] Escuela Politecn Super Huesca, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Dept Prod Anim, ISCIII, Huesca, Spain.
   [Gomez-Guerrero, C.] Univ Autonoma Madrid, CIBER Diabet & Enfermedades Metab CIBERDEM, IIS Fdn Jimenez Diaz, ISCIII,Renal Vasc & Diabet Res Lab, Madrid, Spain.
   [Osada, J.] Univ Zaragoza, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Inst Invest Sanitaria Aragon, ISCIII,Dept Bioquim & Biol Mol & Celular, Zaragoza, Spain.
   [Dantas, A. P.] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Inst Clin Cardiovasc, Barcelona, Spain.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0828
BP E49
EP E49
DI 10.1016/j.atherosclerosis.2019.06.140
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800139
DA 2019-10-28
ER

PT J
AU Lebedeva, A
   Fitzgerald, W
   Molodtsov, I
   Shpektor, A
   Margolis, L
   Vasilieva, E
AF Lebedeva, A.
   Fitzgerald, W.
   Molodtsov, I.
   Shpektor, A.
   Margolis, L.
   Vasilieva, E.
TI CYTOKINES EXPRESSION AND PACKAGING INTO EXTRACELLULAR VESICLES IS
   CHANGED IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Lebedeva, A.; Shpektor, A.; Vasilieva, E.] Moscow State Univ Med & Dent, Lab Atherothrombosis, Moscow, Russia.
   [Fitzgerald, W.; Margolis, L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Sect Intercellular Interact, Bethesda, MD USA.
   [Molodtsov, I.] NF Gamaleya Fed Natl Res Ctr Epidemiol & Microbio, Lab Cell Microbiol, Moscow, Russia.
FU Russian Science FoundationRussian Science Foundation (RSF) [18-15-00420]
FX This work was supported by the Russian Science Foundation grant
   #18-15-00420
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0872
BP E248
EP E249
DI 10.1016/j.atherosclerosis.2019.06.764
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800762
DA 2019-10-28
ER

PT J
AU Lee, GL
   Yeh, CC
   Wu, JY
   Lin, HC
   Wang, YF
   Kuo, YY
   Hsieh, YTH
   Hsu, YJ
   Kuo, CC
AF Lee, G. L.
   Yeh, C. C.
   Wu, J. Y.
   Lin, H. C.
   Wang, Y. F.
   Kuo, Y. Y.
   Hsieh, Y. T. H.
   Hsu, Y. J.
   Kuo, C. C.
TI TLR2 PROMOTES VSMC CALCIFICATION VIA THE CONCERTED ACTIONS OF OPG
   SUPPRESSION AND IL-6-MEDIATED RANKL INDUCTION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Lee, G. L.; Yeh, C. C.; Wu, J. Y.; Lin, H. C.; Wang, Y. F.; Kuo, Y. Y.; Hsieh, Y. T. H.; Kuo, C. C.] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan.
   [Hsu, Y. J.] Triserv Gen Hosp, Div Nephrol, Taipei, Taiwan.
   [Hsu, Y. J.] Triserv Gen Hosp, Dept Med, Taipei, Taiwan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0596
BP E27
EP E27
DI 10.1016/j.atherosclerosis.2019.06.078
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800077
DA 2019-10-28
ER

PT J
AU Lee, M
   Al-sharea, A
   Henstridge, D
   Hamilton, J
   Sviridov, D
   Murphy, A
AF Lee, M.
   Al-sharea, A.
   Henstridge, D.
   Hamilton, J.
   Sviridov, D.
   Murphy, A.
TI MITOCHONDRIAL DYSFUNCTION IN M2 MACROPHAGES DIFFERENTIATED FROM HUMAN
   NON-CLASSICAL MONOCYTES IS LINKED TO FOAM CELL FORMATION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Lee, M.; Al-sharea, A.; Henstridge, D.; Murphy, A.] Baker Heart & Diabet Inst, Immunometab, Melbourne, Vic, Australia.
   [Hamilton, J.] Univ Melbourne, Med, Melbourne, Vic, Australia.
   [Sviridov, D.] Baker Heart & Diabet Inst, Lipoprot & Atherosclerosis, Melbourne, Vic, Australia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0667
BP E13
EP E13
DI 10.1016/j.atherosclerosis.2019.06.035
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800035
DA 2019-10-28
ER

PT J
AU Lee, SJL
   Dong-Soon, I
AF Lee, S. J. L.
   Dong-Soon, I.
TI OMEGA-3 POLYUNSATURATED FATTY ACIDS PROTECT ENDOTHELIAL ADHESION OF
   MONOCYTES THROUGH FFA4 IN MONOCYTES
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Lee, S. J. L.; Dong-Soon, I.] Pusan Natl Univ, Coll Pharm, Pusan, South Korea.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0060
BP E237
EP E238
DI 10.1016/j.atherosclerosis.2019.06.729
PG 2
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800727
DA 2019-10-28
ER

PT J
AU Leiherer, A
   Muendlein, A
   Saely, CH
   Larcher, B
   Mader, A
   Fraunberger, P
   Ulmer, H
   Nagel, G
   Drexel, H
   Concin, H
AF Leiherer, A.
   Muendlein, A.
   Saely, C. H.
   Larcher, B.
   Mader, A.
   Fraunberger, P.
   Ulmer, H.
   Nagel, G.
   Drexel, H.
   Concin, H.
TI EARLY ASSESSED TOTAL CHOLESTEROL SIGNIFICANTLY IMPROVES THE PREDICTION
   OF CARDIOVASCULAR RISK IN LATER LIFE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Leiherer, A.; Muendlein, A.] Acad Teaching Hosp Feldkirch, Vorarlberg Inst Vasc Invest & Treatment, Feldkirch, Austria.
   [Saely, C. H.] Private Univ Principal Liechtenstein, Med Sci, Triesen, Liechtenstein.
   [Larcher, B.; Mader, A.] Acad Teaching Hosp Feldkirch, Med 1, Feldkirch, Austria.
   [Fraunberger, P.] Acad Teaching Hosp Feldkirch, Med Cent Labs, Feldkirch, Austria.
   [Ulmer, H.] Innsbruck Med Univ, Med Stat Informat & Hlth Econ, Innsbruck, Austria.
   [Nagel, G.] Aks Gesundheit GmbH, Vorarlberg Hlth Promot Programme, Bregenz, Austria.
   [Drexel, H.] Univ Hosp Bern, Swiss Cardiovasc Ctr, Bern, Switzerland.
   [Concin, H.] Aks Gesundheit GmbH, Head Off Bregenz, Bregenz, Austria.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0665
BP E115
EP E115
DI 10.1016/j.atherosclerosis.2019.06.333
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800332
DA 2019-10-28
ER

PT J
AU Leiherer, A
   Luetjohann, D
   Muendlein, A
   Kathrin, G
   Saely, CH
   Brandtner, EM
   Larcher, B
   Mader, A
   Fraunberger, P
   Drexel, H
AF Leiherer, A.
   Luetjohann, D.
   Muendlein, A.
   Kathrin, G.
   Saely, C. H.
   Brandtner, E. M.
   Larcher, B.
   Mader, A.
   Fraunberger, P.
   Drexel, H.
TI BETATROPHIN PREDICTS CARDIOVASCULAR EVENTS INDEPENDENTLY FROM THE
   PRESENCE OF TYPE 2 DIABETES AND CORONARY ARTERY DISEASE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Leiherer, A.; Muendlein, A.; Kathrin, G.; Brandtner, E. M.] Acad Teaching Hosp Feldkirch, Vorarlberg Inst Vasc Invest & Treatment, Feldkirch, Austria.
   [Luetjohann, D.] Univ Clin Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany.
   [Saely, C. H.] Private Univ Principal Liechtenstein, Med Sci, Triesen, Liechtenstein.
   [Larcher, B.; Mader, A.] Acad Teaching Hosp Feldkirch, Med 1, Feldkirch, Austria.
   [Fraunberger, P.] Acad Teaching Hosp Feldkirch, Med Cent Labs, Feldkirch, Austria.
   [Drexel, H.] Univ Hosp Bern, Swiss Cardiovasc Ctr, Bern, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0234
BP E62
EP E62
DI 10.1016/j.atherosclerosis.2019.06.177
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800176
DA 2019-10-28
ER

PT J
AU Leiherer, A
   Muendlein, A
   Geiger, K
   Saely, CH
   Brandtner, EM
   Larcher, B
   Mader, A
   Fraunberger, P
   Drexel, H
AF Leiherer, A.
   Muendlein, A.
   Geiger, K.
   Saely, C. H.
   Brandtner, E. M.
   Larcher, B.
   Mader, A.
   Fraunberger, P.
   Drexel, H.
TI TARGETED METABOLOMICS IDENTIFIES ELEVATED SEROTONIN LEVELS IN CARRIERS
   OF A TCF7L2 DIABETES-RISK ALLELE
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Leiherer, A.; Muendlein, A.; Geiger, K.; Brandtner, E. M.] Acad Teaching Hosp Feldkirch, Vorarlberg Inst Vasc Invest & Treatment, Feldkirch, Austria.
   [Saely, C. H.] Private Univ Principal Liechtenstein, Med Sci, Triesen, Liechtenstein.
   [Larcher, B.; Mader, A.] Acad Teaching Hosp Feldkirch, Med 1, Feldkirch, Austria.
   [Fraunberger, P.] Acad Teaching Hosp Feldkirch, Med Cent Labs, Feldkirch, Austria.
   [Drexel, H.] Univ Hosp Bern, Swiss Cardiovasc Ctr, Bern, Switzerland.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0231
BP E196
EP E196
DI 10.1016/j.atherosclerosis.2019.06.597
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800595
DA 2019-10-28
ER

PT J
AU Li, C
   Zhang, S
   Zhang, L
   Gai, Z
   Li, Y
AF Li, C.
   Zhang, S.
   Zhang, L.
   Gai, Z.
   Li, Y.
TI FXR ACTIVATION REDUCES TGF-B-MEDIATED VASCULAR INFLAMMATION AND
   CALCIFICATION
SO ATHEROSCLEROSIS
LA English
DT Meeting Abstract
CT 87th Congress of the European-Atherosclerosis-Society (EAS)
CY MAY 26-29, 2019
CL Maastricht, NETHERLANDS
SP European Atherosclerosis Soc
C1 [Li, C.; Zhang, S.; Zhang, L.; Gai, Z.; Li, Y.] Shandong Univ Tradit Chinese Med, Sch Clin Med 1, Jinan, Shandong, Peoples R China.
   [Li, C.; Gai, Z.] Univ Hosp Zurich, Dept Clin Pharmacol & Toxicol, Zurich, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD AUG
PY 2019
VL 287
MA EAS19-0083
BP E75
EP E75
DI 10.1016/j.atherosclerosis.2019.06.216
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA IS4GE
UT WOS:000482110800215
DA 2019-10-28
ER

EF